Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,Melanoma in situ,A1BG,Alpha-1B-glycoprotein,19694,77,1.37 [0.39-4.83],0.6262608591996393
Chapter II Neoplasms,Melanoma in situ,AAMDC,Mth938 domain-containing protein,19167,75,1.21 [0.81-1.82],0.3564189819324547
Chapter II Neoplasms,Melanoma in situ,AARSD1,Alanyl-tRNA editing protein Aarsd1,22484,88,0.89 [0.63-1.24],0.4858534224793451
Chapter II Neoplasms,Melanoma in situ,ABCA2,ATP-binding cassette sub-family A member 2,19066,75,0.70 [0.36-1.35],0.2864596366635997
Chapter II Neoplasms,Melanoma in situ,ABHD14B,Protein ABHD14B,22361,89,1.02 [0.74-1.41],0.8853704661969788
Chapter II Neoplasms,Melanoma in situ,ABL1,Tyrosine-protein kinase ABL1,22484,88,1.07 [0.81-1.42],0.6142472825083809
Chapter II Neoplasms,Melanoma in situ,ABO,Histo-blood group ABO system transferase,19669,77,0.97 [0.83-1.12],0.6549340557776204
Chapter II Neoplasms,Melanoma in situ,ABRAXAS2,BRISC complex subunit Abraxas 2,19066,75,0.88 [0.62-1.24],0.4494320625617539
Chapter II Neoplasms,Melanoma in situ,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",22078,88,1.00 [0.79-1.26],0.9929417582827672
Chapter II Neoplasms,Melanoma in situ,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",19287,76,1.12 [0.87-1.45],0.3681578520497571
Chapter II Neoplasms,Melanoma in situ,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",19665,77,1.06 [0.83-1.35],0.6474030083155335
Chapter II Neoplasms,Melanoma in situ,ACAN,Aggrecan core protein,22385,87,1.25 [0.63-2.48],0.5147921059972267
Chapter II Neoplasms,Melanoma in situ,ACE,Angiotensin-converting enzyme,19669,77,1.13 [0.49-2.60],0.7792172643983513
Chapter II Neoplasms,Melanoma in situ,ACE2,Angiotensin-converting enzyme 2,22187,88,1.04 [0.71-1.52],0.8596607386687818
Chapter II Neoplasms,Melanoma in situ,ACHE,Acetylcholinesterase,19255,75,1.13 [0.57-2.21],0.7315438232498479
Chapter II Neoplasms,Melanoma in situ,ACOT13,Acyl-coenzyme A thioesterase 13,19566,77,1.11 [0.92-1.36],0.2753406511890283
Chapter II Neoplasms,Melanoma in situ,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,22589,89,1.47 [1.09-1.99],0.0119677256893965
Chapter II Neoplasms,Melanoma in situ,ACP1,Low molecular weight phosphotyrosine protein phosphatase,19117,75,1.01 [0.62-1.65],0.9600781342592564
Chapter II Neoplasms,Melanoma in situ,ACP5,Tartrate-resistant acid phosphatase type 5,22697,89,0.54 [0.30-0.99],0.0469526834521726
Chapter II Neoplasms,Melanoma in situ,ACP6,Lysophosphatidic acid phosphatase type 6,22750,90,1.44 [1.04-1.98],0.0271630433613162
Chapter II Neoplasms,Melanoma in situ,ACRBP,Acrosin-binding protein,19560,77,1.25 [0.72-2.17],0.4274234299925097
Chapter II Neoplasms,Melanoma in situ,ACRV1,Acrosomal protein SP-10,19117,75,1.18 [0.65-2.15],0.5922076862547024
Chapter II Neoplasms,Melanoma in situ,ACSL1,Long-chain-fatty-acid--CoA ligase 1,19066,75,1.30 [0.81-2.07],0.2716820000044402
Chapter II Neoplasms,Melanoma in situ,ACTA2,"Actin, aortic smooth muscle",22187,88,0.83 [0.51-1.34],0.4414550307130518
Chapter II Neoplasms,Melanoma in situ,ACTN2,Alpha-actinin-2,19066,75,1.22 [0.84-1.77],0.3059122607475236
Chapter II Neoplasms,Melanoma in situ,ACTN4,Alpha-actinin-4,22161,88,0.75 [0.38-1.48],0.4030259470655484
Chapter II Neoplasms,Melanoma in situ,ACVRL1,Serine/threonine-protein kinase receptor R3,22405,88,0.92 [0.41-2.09],0.8420641414587482
Chapter II Neoplasms,Melanoma in situ,ACY1,Aminoacylase-1,22589,89,1.12 [0.82-1.53],0.4719149710501547
Chapter II Neoplasms,Melanoma in situ,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,19066,75,1.05 [0.70-1.58],0.8140872989327093
Chapter II Neoplasms,Melanoma in situ,ACYP1,Acylphosphatase-1,19172,75,1.00 [0.71-1.39],0.9789316201774098
Chapter II Neoplasms,Melanoma in situ,ADA,Adenosine deaminase,22837,90,0.94 [0.54-1.62],0.8130363530723446
Chapter II Neoplasms,Melanoma in situ,ADA2,Adenosine deaminase 2,22431,89,1.25 [0.80-1.95],0.3347346632169268
Chapter II Neoplasms,Melanoma in situ,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,19117,75,1.18 [0.63-2.21],0.5947939589630782
Chapter II Neoplasms,Melanoma in situ,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,22187,88,1.22 [0.66-2.28],0.529543747341369
Chapter II Neoplasms,Melanoma in situ,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,22440,89,1.03 [0.59-1.78],0.92852249067961
Chapter II Neoplasms,Melanoma in situ,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,22837,90,0.76 [0.46-1.24],0.2737079292032612
Chapter II Neoplasms,Melanoma in situ,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,22748,90,0.73 [0.38-1.38],0.3280734093554885
Chapter II Neoplasms,Melanoma in situ,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,19566,77,0.84 [0.40-1.79],0.6567955485173318
Chapter II Neoplasms,Melanoma in situ,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,19117,75,0.97 [0.48-1.97],0.930353229724102
Chapter II Neoplasms,Melanoma in situ,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,22859,89,0.66 [0.29-1.46],0.3036283771173687
Chapter II Neoplasms,Melanoma in situ,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,22484,88,1.00 [0.65-1.54],0.9899871243485684
Chapter II Neoplasms,Melanoma in situ,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,22187,88,0.82 [0.41-1.63],0.5717952113440872
Chapter II Neoplasms,Melanoma in situ,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,19117,75,0.67 [0.34-1.29],0.2291190855114518
Chapter II Neoplasms,Melanoma in situ,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,22658,90,1.09 [0.72-1.65],0.6954919826301462
Chapter II Neoplasms,Melanoma in situ,ADAMTSL2,ADAMTS-like protein 2,19661,77,1.01 [0.50-2.07],0.9684445899351684
Chapter II Neoplasms,Melanoma in situ,ADAMTSL4,ADAMTS-like protein 4,19167,75,1.94 [0.75-5.00],0.1720887738898628
Chapter II Neoplasms,Melanoma in situ,ADAMTSL5,ADAMTS-like protein 5,19665,77,0.63 [0.36-1.09],0.0976808124977038
Chapter II Neoplasms,Melanoma in situ,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,22078,88,0.81 [0.43-1.54],0.5149275676872307
Chapter II Neoplasms,Melanoma in situ,ADD1,Alpha-adducin,19255,75,0.97 [0.71-1.32],0.82415879618635
Chapter II Neoplasms,Melanoma in situ,ADGRB3,Adhesion G protein-coupled receptor B3,22405,88,0.65 [0.37-1.17],0.1527117766672194
Chapter II Neoplasms,Melanoma in situ,ADGRD1,Adhesion G-protein coupled receptor D1,19255,75,1.07 [0.58-1.99],0.8188525504564299
Chapter II Neoplasms,Melanoma in situ,ADGRE1,Adhesion G protein-coupled receptor E1,19566,77,1.18 [0.80-1.75],0.4101609548348881
Chapter II Neoplasms,Melanoma in situ,ADGRE2,Adhesion G protein-coupled receptor E2,22692,90,1.09 [0.55-2.14],0.8102452228048858
Chapter II Neoplasms,Melanoma in situ,ADGRE5,Adhesion G protein-coupled receptor E5,22752,88,1.08 [0.57-2.05],0.8089750071249335
Chapter II Neoplasms,Melanoma in situ,ADGRF5,Adhesion G protein-coupled receptor F5,19665,77,0.85 [0.41-1.77],0.6698708368832043
Chapter II Neoplasms,Melanoma in situ,ADGRG1,Adhesion G-protein coupled receptor G1,22484,88,1.29 [0.98-1.70],0.0733003932821457
Chapter II Neoplasms,Melanoma in situ,ADGRG2,Adhesion G-protein coupled receptor G2,22589,89,1.11 [0.55-2.24],0.7736637057368545
Chapter II Neoplasms,Melanoma in situ,ADGRV1,Adhesion G-protein coupled receptor V1,19060,77,1.10 [0.83-1.44],0.506894566124549
Chapter II Neoplasms,Melanoma in situ,ADH1B,All-trans-retinol dehydrogenase,19255,75,1.03 [0.76-1.38],0.8701745605139382
Chapter II Neoplasms,Melanoma in situ,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,22187,88,0.94 [0.75-1.19],0.6190700605252994
Chapter II Neoplasms,Melanoma in situ,ADIPOQ,Adiponectin,19694,77,1.09 [0.78-1.52],0.6094132342502405
Chapter II Neoplasms,Melanoma in situ,ADM,Pro-adrenomedullin,22789,90,1.08 [0.52-2.21],0.8442200669754576
Chapter II Neoplasms,Melanoma in situ,ADRA2A,Alpha-2A adrenergic receptor,19066,75,0.86 [0.60-1.22],0.3885206929748047
Chapter II Neoplasms,Melanoma in situ,AFAP1,Actin filament-associated protein 1,19255,75,0.96 [0.73-1.25],0.7537110704743308
Chapter II Neoplasms,Melanoma in situ,AFM,Afamin,19694,77,1.01 [0.32-3.21],0.9893930955032416
Chapter II Neoplasms,Melanoma in situ,AFP,Alpha-fetoprotein,22378,88,0.82 [0.62-1.08],0.1525412472905185
Chapter II Neoplasms,Melanoma in situ,AGBL2,Cytosolic carboxypeptidase 2,19060,77,0.96 [0.75-1.21],0.7087586767141294
Chapter II Neoplasms,Melanoma in situ,AGER,Advanced glycosylation end product-specific receptor,22540,89,0.98 [0.61-1.56],0.928288501672165
Chapter II Neoplasms,Melanoma in situ,AGR2,Anterior gradient protein 2 homolog,21832,90,0.95 [0.79-1.14],0.5588456870987393
Chapter II Neoplasms,Melanoma in situ,AGR3,Anterior gradient protein 3,22038,88,0.92 [0.66-1.27],0.6120211440904496
Chapter II Neoplasms,Melanoma in situ,AGRN,Agrin,22692,90,1.23 [0.70-2.16],0.4793756143410022
Chapter II Neoplasms,Melanoma in situ,AGRP,Agouti-related protein,22837,90,0.88 [0.62-1.26],0.4876087211624449
Chapter II Neoplasms,Melanoma in situ,AGT,Angiotensinogen,19669,77,0.77 [0.39-1.52],0.4465241021371032
Chapter II Neoplasms,Melanoma in situ,AGXT,Serine--pyruvate aminotransferase,22589,89,0.90 [0.70-1.17],0.4334899784634046
Chapter II Neoplasms,Melanoma in situ,AHCY,Adenosylhomocysteinase,22589,89,1.07 [0.81-1.40],0.6354540779775338
Chapter II Neoplasms,Melanoma in situ,AHNAK,Neuroblast differentiation-associated protein AHNAK,19167,75,0.89 [0.43-1.86],0.7651629224365766
Chapter II Neoplasms,Melanoma in situ,AHNAK2,Protein AHNAK2,19167,75,1.00 [0.46-2.19],0.9940164005082602
Chapter II Neoplasms,Melanoma in situ,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,19560,77,1.07 [0.79-1.44],0.6681446728422211
Chapter II Neoplasms,Melanoma in situ,AHSG,Alpha-2-HS-glycoprotein,19669,77,1.25 [0.56-2.82],0.5829337873161669
Chapter II Neoplasms,Melanoma in situ,AHSP,Alpha-hemoglobin-stabilizing protein,22562,90,0.90 [0.73-1.12],0.3531342677578973
Chapter II Neoplasms,Melanoma in situ,AIDA,"Axin interactor, dorsalization-associated protein",19119,72,0.99 [0.76-1.29],0.9375376234580672
Chapter II Neoplasms,Melanoma in situ,AIF1,Allograft inflammatory factor 1,22078,88,0.86 [0.60-1.24],0.4233142413240467
Chapter II Neoplasms,Melanoma in situ,AIF1L,Allograft inflammatory factor 1-like,19167,75,1.07 [0.74-1.53],0.724523981772218
Chapter II Neoplasms,Melanoma in situ,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",22439,88,1.01 [0.84-1.21],0.907269872420245
Chapter II Neoplasms,Melanoma in situ,AK1,Adenylate kinase isoenzyme 1,22589,89,0.97 [0.73-1.29],0.8403425818276496
Chapter II Neoplasms,Melanoma in situ,AK2,"Adenylate kinase 2, mitochondrial",19626,77,1.11 [0.91-1.36],0.3075449366115864
Chapter II Neoplasms,Melanoma in situ,AKAP12,A-kinase anchor protein 12,19255,75,0.70 [0.23-2.10],0.526301631484563
Chapter II Neoplasms,Melanoma in situ,AKR1B1,Aldo-keto reductase family 1 member B1,22078,88,1.14 [0.89-1.45],0.2927931286920965
Chapter II Neoplasms,Melanoma in situ,AKR1B10,Aldo-keto reductase family 1 member B10,19119,72,1.25 [0.91-1.73],0.1700626328225671
Chapter II Neoplasms,Melanoma in situ,AKR1C4,Aldo-keto reductase family 1 member C4,22187,88,1.09 [0.80-1.49],0.5899042079096595
Chapter II Neoplasms,Melanoma in situ,AKR7L,Aflatoxin B1 aldehyde reductase member 4,19117,75,1.19 [0.90-1.58],0.2191907431108668
Chapter II Neoplasms,Melanoma in situ,AKT1S1,Proline-rich AKT1 substrate 1,22029,90,0.99 [0.75-1.31],0.9551329422598162
Chapter II Neoplasms,Melanoma in situ,AKT2,RAC-beta serine/threonine-protein kinase,19635,77,1.11 [0.93-1.33],0.2380870961010856
Chapter II Neoplasms,Melanoma in situ,AKT3,RAC-gamma serine/threonine-protein kinase,21970,88,1.06 [0.76-1.48],0.7350261303023502
Chapter II Neoplasms,Melanoma in situ,ALCAM,CD166 antigen,22859,89,1.10 [0.41-2.94],0.8459845655939502
Chapter II Neoplasms,Melanoma in situ,ALDH1A1,Retinal dehydrogenase 1,22597,90,0.92 [0.65-1.31],0.6558527886857574
Chapter II Neoplasms,Melanoma in situ,ALDH2,"Aldehyde dehydrogenase, mitochondrial",19560,77,1.10 [0.76-1.60],0.6039365821350935
Chapter II Neoplasms,Melanoma in situ,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",22517,90,1.22 [0.97-1.53],0.0958052193741768
Chapter II Neoplasms,Melanoma in situ,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",19635,77,1.02 [0.64-1.61],0.9347151529719224
Chapter II Neoplasms,Melanoma in situ,ALMS1,Alstrom syndrome protein 1,19287,76,0.80 [0.47-1.38],0.4259183010712454
Chapter II Neoplasms,Melanoma in situ,ALPI,Intestinal-type alkaline phosphatase,19117,75,1.07 [0.89-1.28],0.4726533213590548
Chapter II Neoplasms,Melanoma in situ,ALPP,"Alkaline phosphatase, placental type",22484,88,1.16 [0.96-1.40],0.1335675746688338
Chapter II Neoplasms,Melanoma in situ,AMBN,Ameloblastin,22161,88,0.98 [0.49-1.96],0.963202627470216
Chapter II Neoplasms,Melanoma in situ,AMBP,Protein AMBP,22756,90,1.84 [0.72-4.65],0.1999268102132645
Chapter II Neoplasms,Melanoma in situ,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,19661,77,0.49 [0.22-1.09],0.0817002949728009
Chapter II Neoplasms,Melanoma in situ,AMFR,E3 ubiquitin-protein ligase AMFR,22029,90,0.78 [0.56-1.09],0.1421593511027574
Chapter II Neoplasms,Melanoma in situ,AMIGO1,Amphoterin-induced protein 1,19119,72,0.93 [0.58-1.49],0.7675597380129408
Chapter II Neoplasms,Melanoma in situ,AMIGO2,Amphoterin-induced protein 2,22484,88,1.33 [0.57-3.09],0.5082978588412285
Chapter II Neoplasms,Melanoma in situ,AMN,Protein amnionless,22161,88,1.10 [0.74-1.64],0.6405436045153503
Chapter II Neoplasms,Melanoma in situ,AMOT,Angiomotin,19255,75,0.84 [0.48-1.49],0.5589744950706503
Chapter II Neoplasms,Melanoma in situ,AMOTL2,Angiomotin-like protein 2,19502,77,1.13 [0.75-1.70],0.5675195769009145
Chapter II Neoplasms,Melanoma in situ,AMPD3,AMP deaminase 3,19626,77,0.88 [0.65-1.18],0.397486210396012
Chapter II Neoplasms,Melanoma in situ,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,18398,70,1.11 [0.70-1.76],0.6502082410242518
Chapter II Neoplasms,Melanoma in situ,AMY2A,Pancreatic alpha-amylase,21692,85,1.26 [0.84-1.91],0.2663995150689124
Chapter II Neoplasms,Melanoma in situ,AMY2B,Alpha-amylase 2B,21036,81,1.32 [0.87-2.01],0.1876166729572217
Chapter II Neoplasms,Melanoma in situ,ANG,Angiogenin,22505,89,1.11 [0.64-1.90],0.7113903732775306
Chapter II Neoplasms,Melanoma in situ,ANGPT1,Angiopoietin-1,22509,88,0.82 [0.66-1.01],0.0658871627114362
Chapter II Neoplasms,Melanoma in situ,ANGPT2,Angiopoietin-2,22789,90,1.19 [0.73-1.94],0.4755266315034665
Chapter II Neoplasms,Melanoma in situ,ANGPTL1,Angiopoietin-related protein 1,22285,88,1.82 [0.96-3.44],0.0663634837520242
Chapter II Neoplasms,Melanoma in situ,ANGPTL2,Angiopoietin-related protein 2,22625,90,0.95 [0.60-1.52],0.8409411625280196
Chapter II Neoplasms,Melanoma in situ,ANGPTL3,Angiopoietin-related protein 3,22573,89,1.09 [0.64-1.84],0.7501997569206249
Chapter II Neoplasms,Melanoma in situ,ANGPTL4,Angiopoietin-related protein 4,22653,90,1.23 [0.81-1.87],0.32444756655175
Chapter II Neoplasms,Melanoma in situ,ANGPTL7,Angiopoietin-related protein 7,22789,90,1.12 [0.67-1.87],0.6664660300349103
Chapter II Neoplasms,Melanoma in situ,ANK2,Ankyrin-2,19066,75,0.89 [0.64-1.25],0.5092160567650839
Chapter II Neoplasms,Melanoma in situ,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,19117,75,1.16 [0.88-1.53],0.2950292470617258
Chapter II Neoplasms,Melanoma in situ,ANKRA2,Ankyrin repeat family A protein 2,18973,75,1.38 [1.04-1.83],0.0258086046709319
Chapter II Neoplasms,Melanoma in situ,ANKRD54,Ankyrin repeat domain-containing protein 54,22078,88,1.05 [0.77-1.43],0.7644762118739881
Chapter II Neoplasms,Melanoma in situ,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,19167,75,0.95 [0.55-1.64],0.850094234717583
Chapter II Neoplasms,Melanoma in situ,ANPEP,Aminopeptidase N,22609,89,1.22 [0.63-2.35],0.5490169963608286
Chapter II Neoplasms,Melanoma in situ,ANXA1,Annexin A1,19130,74,0.68 [0.39-1.21],0.188680216081031
Chapter II Neoplasms,Melanoma in situ,ANXA10,Annexin A10,22029,90,1.07 [0.86-1.33],0.5553154769108708
Chapter II Neoplasms,Melanoma in situ,ANXA11,Annexin A11,22520,90,1.00 [0.76-1.32],0.9852811027136952
Chapter II Neoplasms,Melanoma in situ,ANXA2,Annexin A2,18876,75,1.02 [0.74-1.39],0.9099467252138588
Chapter II Neoplasms,Melanoma in situ,ANXA3,Annexin A3,22748,90,1.11 [0.85-1.44],0.4389033938482133
Chapter II Neoplasms,Melanoma in situ,ANXA4,Annexin A4,22473,88,1.08 [0.83-1.39],0.5797569149374517
Chapter II Neoplasms,Melanoma in situ,ANXA5,Annexin A5,21969,90,1.31 [0.72-2.36],0.3770541749780669
Chapter II Neoplasms,Melanoma in situ,AOC1,Amiloride-sensitive amine oxidase [copper-containing],22161,88,0.93 [0.65-1.32],0.6800841473602328
Chapter II Neoplasms,Melanoma in situ,AOC3,Membrane primary amine oxidase,22650,89,0.98 [0.52-1.83],0.947278786039057
Chapter II Neoplasms,Melanoma in situ,AP1G2,AP-1 complex subunit gamma-like 2,19560,77,1.06 [0.81-1.40],0.6510609417762445
Chapter II Neoplasms,Melanoma in situ,AP2B1,AP-2 complex subunit beta,19119,72,0.80 [0.48-1.32],0.3749409422649239
Chapter II Neoplasms,Melanoma in situ,AP3B1,AP-3 complex subunit beta-1,19566,77,1.05 [0.79-1.39],0.7471730851100864
Chapter II Neoplasms,Melanoma in situ,AP3S2,AP-3 complex subunit sigma-2,19626,77,0.92 [0.57-1.49],0.7445878834427861
Chapter II Neoplasms,Melanoma in situ,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,22484,88,1.12 [0.75-1.66],0.5830741762872766
Chapter II Neoplasms,Melanoma in situ,APCS,Serum amyloid P-component,19513,77,0.75 [0.41-1.37],0.3460026323811668
Chapter II Neoplasms,Melanoma in situ,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,22716,90,1.09 [0.81-1.47],0.5763035797724516
Chapter II Neoplasms,Melanoma in situ,APLP1,Amyloid-like protein 1,22589,89,1.18 [0.83-1.68],0.3603781816429974
Chapter II Neoplasms,Melanoma in situ,APOA1,Apolipoprotein A-I,19694,77,0.51 [0.20-1.27],0.1455896014691068
Chapter II Neoplasms,Melanoma in situ,APOA2,Apolipoprotein A-II,19669,77,0.89 [0.56-1.40],0.6027275143933566
Chapter II Neoplasms,Melanoma in situ,APOA4,Apolipoprotein A-IV,19694,77,0.44 [0.22-0.88],0.0199823492335703
Chapter II Neoplasms,Melanoma in situ,APOB,Apolipoprotein B-100,19669,77,0.96 [0.37-2.49],0.9356401531541232
Chapter II Neoplasms,Melanoma in situ,APOBR,Apolipoprotein B receptor,19167,75,1.10 [0.65-1.87],0.7193862884598617
Chapter II Neoplasms,Melanoma in situ,APOC1,Apolipoprotein C-I,19650,77,0.71 [0.37-1.37],0.31111691945668
Chapter II Neoplasms,Melanoma in situ,APOD,Apolipoprotein D,18780,72,0.79 [0.42-1.47],0.4531068853011101
Chapter II Neoplasms,Melanoma in situ,APOE,Apolipoprotein E,19694,77,0.94 [0.69-1.29],0.7078274877030787
Chapter II Neoplasms,Melanoma in situ,APOF,Apolipoprotein F,19669,77,0.67 [0.36-1.24],0.2020272697494718
Chapter II Neoplasms,Melanoma in situ,APOH,Beta-2-glycoprotein 1,22597,90,0.95 [0.56-1.61],0.8526320676046355
Chapter II Neoplasms,Melanoma in situ,APOL1,Apolipoprotein L1,19669,77,0.91 [0.63-1.30],0.6030904433456991
Chapter II Neoplasms,Melanoma in situ,APOM,Apolipoprotein M,22613,89,0.69 [0.34-1.40],0.3082686711392086
Chapter II Neoplasms,Melanoma in situ,APP,Amyloid-beta precursor protein,22563,90,0.82 [0.61-1.08],0.1573048339640342
Chapter II Neoplasms,Melanoma in situ,APPL2,DCC-interacting protein 13-beta,19255,75,1.14 [0.93-1.40],0.214685616264943
Chapter II Neoplasms,Melanoma in situ,APRT,Adenine phosphoribosyltransferase,22410,89,1.16 [0.78-1.73],0.4621727096669632
Chapter II Neoplasms,Melanoma in situ,ARAF,Serine/threonine-protein kinase A-Raf,19287,76,1.29 [0.98-1.69],0.066028086594411
Chapter II Neoplasms,Melanoma in situ,AREG,Amphiregulin,22484,88,1.18 [0.80-1.75],0.4102893355476218
Chapter II Neoplasms,Melanoma in situ,ARF6,ADP-ribosylation factor 6,19566,77,1.17 [0.95-1.45],0.1394143091412596
Chapter II Neoplasms,Melanoma in situ,ARFIP1,Arfaptin-1,19635,77,1.05 [0.76-1.44],0.7756787725967142
Chapter II Neoplasms,Melanoma in situ,ARG1,Arginase-1,22493,89,0.86 [0.61-1.23],0.4138252163538399
Chapter II Neoplasms,Melanoma in situ,ARG2,"Arginase-2, mitochondrial",19560,77,1.20 [0.78-1.86],0.3998553918271536
Chapter II Neoplasms,Melanoma in situ,ARHGAP1,Rho GTPase-activating protein 1,22078,88,1.16 [0.77-1.75],0.4828609212514345
Chapter II Neoplasms,Melanoma in situ,ARHGAP25,Rho GTPase-activating protein 25,22078,88,0.97 [0.70-1.34],0.8489160806317921
Chapter II Neoplasms,Melanoma in situ,ARHGAP30,Rho GTPase-activating protein 30,19287,76,1.00 [0.56-1.76],0.9892834755489052
Chapter II Neoplasms,Melanoma in situ,ARHGAP45,Rho GTPase-activating protein 45,19255,75,1.18 [0.90-1.55],0.2341586173365652
Chapter II Neoplasms,Melanoma in situ,ARHGAP5,Rho GTPase-activating protein 5,18973,75,1.05 [0.80-1.38],0.7340289847216556
Chapter II Neoplasms,Melanoma in situ,ARHGEF1,Rho guanine nucleotide exchange factor 1,19626,77,1.11 [0.87-1.41],0.4163842730803527
Chapter II Neoplasms,Melanoma in situ,ARHGEF10,Rho guanine nucleotide exchange factor 10,19635,77,1.08 [0.86-1.36],0.5207166152346894
Chapter II Neoplasms,Melanoma in situ,ARHGEF12,Rho guanine nucleotide exchange factor 12,22550,90,1.02 [0.85-1.22],0.8441071418761947
Chapter II Neoplasms,Melanoma in situ,ARHGEF5,Rho guanine nucleotide exchange factor 5,19060,77,1.21 [0.93-1.56],0.1542738765214209
Chapter II Neoplasms,Melanoma in situ,ARID3A,AT-rich interactive domain-containing protein 3A,19060,77,1.10 [0.64-1.87],0.739987298575242
Chapter II Neoplasms,Melanoma in situ,ARID4B,AT-rich interactive domain-containing protein 4B,22029,90,0.80 [0.48-1.33],0.3837197235454213
Chapter II Neoplasms,Melanoma in situ,ARL13B,ADP-ribosylation factor-like protein 13B,19066,75,1.08 [0.79-1.47],0.6191250783955304
Chapter II Neoplasms,Melanoma in situ,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,19066,75,0.99 [0.57-1.72],0.9796533779330724
Chapter II Neoplasms,Melanoma in situ,ARMCX2,Armadillo repeat-containing X-linked protein 2,19060,77,0.88 [0.60-1.28],0.503689331043233
Chapter II Neoplasms,Melanoma in situ,ARNT,Aryl hydrocarbon receptor nuclear translocator,22161,88,0.88 [0.51-1.52],0.6469518397643241
Chapter II Neoplasms,Melanoma in situ,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,19066,75,1.05 [0.70-1.56],0.8280629396476025
Chapter II Neoplasms,Melanoma in situ,ARSA,Arylsulfatase A,22597,90,0.87 [0.56-1.35],0.5317133817770652
Chapter II Neoplasms,Melanoma in situ,ARSB,Arylsulfatase B,22484,88,1.01 [0.72-1.43],0.9480569178755752
Chapter II Neoplasms,Melanoma in situ,ART3,Ecto-ADP-ribosyltransferase 3,22650,89,1.36 [0.77-2.41],0.2945387322529431
Chapter II Neoplasms,Melanoma in situ,ART5,Ecto-ADP-ribosyltransferase 5,19060,77,1.26 [1.00-1.59],0.0494163900637288
Chapter II Neoplasms,Melanoma in situ,ARTN,Artemin,22161,88,0.51 [0.29-0.90],0.0198884359102452
Chapter II Neoplasms,Melanoma in situ,ASAH1,Acid ceramidase,19478,77,1.24 [0.83-1.87],0.2942688122587106
Chapter II Neoplasms,Melanoma in situ,ASAH2,Neutral ceramidase,22440,89,1.27 [0.86-1.87],0.2365198828715071
Chapter II Neoplasms,Melanoma in situ,ASGR1,Asialoglycoprotein receptor 1,22440,89,1.98 [1.06-3.68],0.0316185278832269
Chapter II Neoplasms,Melanoma in situ,ASGR2,Asialoglycoprotein receptor 2,19669,77,0.92 [0.40-2.16],0.856258741094204
Chapter II Neoplasms,Melanoma in situ,ASPN,Asporin,19665,77,0.68 [0.29-1.58],0.3706127195648272
Chapter II Neoplasms,Melanoma in situ,ASPSCR1,Tether containing UBX domain for GLUT4,19635,77,1.05 [0.76-1.44],0.7659263986088815
Chapter II Neoplasms,Melanoma in situ,ASRGL1,Isoaspartyl peptidase/L-asparaginase,19167,75,1.08 [0.87-1.34],0.4953673074805239
Chapter II Neoplasms,Melanoma in situ,ASS1,Argininosuccinate synthase,19066,75,0.96 [0.72-1.28],0.773684921212165
Chapter II Neoplasms,Melanoma in situ,ATF2,Cyclic AMP-dependent transcription factor ATF-2,22029,90,0.93 [0.69-1.25],0.6353195661249931
Chapter II Neoplasms,Melanoma in situ,ATF4,Cyclic AMP-dependent transcription factor ATF-4,18973,75,0.65 [0.32-1.34],0.2442762885084639
Chapter II Neoplasms,Melanoma in situ,ATG16L1,Autophagy-related protein 16-1,19566,77,1.13 [0.87-1.46],0.3658242759429895
Chapter II Neoplasms,Melanoma in situ,ATG4A,Cysteine protease ATG4A,22078,88,0.88 [0.64-1.21],0.4303752194487459
Chapter II Neoplasms,Melanoma in situ,ATOX1,Copper transport protein ATOX1,22658,90,1.09 [0.84-1.43],0.5021934674444619
Chapter II Neoplasms,Melanoma in situ,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,19066,75,0.56 [0.30-1.04],0.0682903503269893
Chapter II Neoplasms,Melanoma in situ,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,19066,75,0.70 [0.33-1.49],0.3586824093719583
Chapter II Neoplasms,Melanoma in situ,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,19066,75,0.81 [0.44-1.51],0.513139181094229
Chapter II Neoplasms,Melanoma in situ,ATP1B4,Protein ATP1B4,18973,75,1.10 [0.66-1.83],0.7053555361554118
Chapter II Neoplasms,Melanoma in situ,ATP2B4,Plasma membrane calcium-transporting ATPase 4,19066,75,1.03 [0.74-1.44],0.851837350632084
Chapter II Neoplasms,Melanoma in situ,ATP5F1D,"ATP synthase subunit delta, mitochondrial",19066,75,0.65 [0.37-1.12],0.1216423202158784
Chapter II Neoplasms,Melanoma in situ,ATP5IF1,"ATPase inhibitor, mitochondrial",22692,90,1.05 [0.89-1.25],0.5466257066322127
Chapter II Neoplasms,Melanoma in situ,ATP5PO,"ATP synthase subunit O, mitochondrial",22029,90,0.97 [0.62-1.53],0.9084146630987188
Chapter II Neoplasms,Melanoma in situ,ATP6AP2,Renin receptor,22078,88,1.27 [0.89-1.83],0.1925028752458659
Chapter II Neoplasms,Melanoma in situ,ATP6V1D,V-type proton ATPase subunit D,22484,88,0.79 [0.37-1.68],0.5369213260386374
Chapter II Neoplasms,Melanoma in situ,ATP6V1F,V-type proton ATPase subunit F,21981,90,0.88 [0.66-1.18],0.3881163053673681
Chapter II Neoplasms,Melanoma in situ,ATP6V1G1,V-type proton ATPase subunit G 1,19167,75,1.22 [0.91-1.65],0.1858911104722113
Chapter II Neoplasms,Melanoma in situ,ATP6V1G2,V-type proton ATPase subunit G 2,19066,75,0.93 [0.74-1.17],0.5439991474506464
Chapter II Neoplasms,Melanoma in situ,ATRAID,All-trans retinoic acid-induced differentiation factor,19566,77,0.43 [0.18-1.07],0.0712329722566049
Chapter II Neoplasms,Melanoma in situ,ATRN,"Attractin, Isoform 2",19694,77,0.34 [0.09-1.22],0.0977491983445719
Chapter II Neoplasms,Melanoma in situ,ATXN10,Ataxin-10,22029,90,1.07 [0.82-1.38],0.635705623242024
Chapter II Neoplasms,Melanoma in situ,ATXN2,Ataxin-2,19060,77,0.98 [0.81-1.20],0.853108446567107
Chapter II Neoplasms,Melanoma in situ,ATXN2L,Ataxin-2-like protein,19635,77,1.20 [0.78-1.83],0.4119612714212063
Chapter II Neoplasms,Melanoma in situ,ATXN3,Ataxin-3,19626,77,1.01 [0.72-1.43],0.9419361457993086
Chapter II Neoplasms,Melanoma in situ,AXIN1,Axin-1,22550,90,1.09 [0.90-1.33],0.3889972039978545
Chapter II Neoplasms,Melanoma in situ,AXL,Tyrosine-protein kinase receptor UFO,22650,89,1.45 [0.73-2.88],0.287308078501348
Chapter II Neoplasms,Melanoma in situ,AZI2,5-azacytidine-induced protein 2,19635,77,1.26 [0.86-1.83],0.2317793399825841
Chapter II Neoplasms,Melanoma in situ,AZU1,Azurocidin,21870,85,0.96 [0.75-1.24],0.7807296413825415
Chapter II Neoplasms,Melanoma in situ,B2M,Beta-2-microglobulin,19694,77,0.95 [0.47-1.92],0.8869569384320217
Chapter II Neoplasms,Melanoma in situ,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,19066,75,0.65 [0.21-2.05],0.4674512568479265
Chapter II Neoplasms,Melanoma in situ,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",19167,75,0.58 [0.31-1.06],0.0751068530660619
Chapter II Neoplasms,Melanoma in situ,B4GALT1,"Beta-1,4-galactosyltransferase 1",22692,90,0.61 [0.30-1.23],0.1650779183296111
Chapter II Neoplasms,Melanoma in situ,B4GAT1,"Beta-1,4-glucuronyltransferase 1",22597,90,0.84 [0.39-1.84],0.6699203542108533
Chapter II Neoplasms,Melanoma in situ,BABAM1,BRISC and BRCA1-A complex member 1,19117,75,1.13 [0.56-2.31],0.7278558038953993
Chapter II Neoplasms,Melanoma in situ,BACH1,Transcription regulator protein BACH1,22550,90,1.15 [0.89-1.47],0.2843710173023773
Chapter II Neoplasms,Melanoma in situ,BAG3,BAG family molecular chaperone regulator 3,22405,88,0.93 [0.59-1.48],0.7708243793146154
Chapter II Neoplasms,Melanoma in situ,BAG4,BAG family molecular chaperone regulator 4,19117,75,1.02 [0.65-1.61],0.9314295732593174
Chapter II Neoplasms,Melanoma in situ,BAG6,Large proline-rich protein BAG6,22187,88,0.97 [0.57-1.66],0.9225459578278008
Chapter II Neoplasms,Melanoma in situ,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,22078,88,1.03 [0.76-1.40],0.8368427926723488
Chapter II Neoplasms,Melanoma in situ,BAMBI,BMP and activin membrane-bound inhibitor homolog,22078,88,0.60 [0.30-1.19],0.1437315098756239
Chapter II Neoplasms,Melanoma in situ,BANK1,B-cell scaffold protein with ankyrin repeats,22550,90,1.05 [0.88-1.25],0.5965575040262183
Chapter II Neoplasms,Melanoma in situ,BAP18,Chromatin complexes subunit BAP18,19626,77,1.06 [0.78-1.43],0.7229087798606152
Chapter II Neoplasms,Melanoma in situ,BATF,Basic leucine zipper transcriptional factor ATF-like,19119,72,1.13 [0.91-1.40],0.268641388625068
Chapter II Neoplasms,Melanoma in situ,BAX,Apoptosis regulator BAX,21999,90,1.04 [0.84-1.29],0.6872591098647816
Chapter II Neoplasms,Melanoma in situ,BCAM,Basal cell adhesion molecule,22597,90,0.63 [0.28-1.42],0.2608272870992197
Chapter II Neoplasms,Melanoma in situ,BCAN,Brevican core protein,22440,89,0.86 [0.49-1.50],0.5911494018910282
Chapter II Neoplasms,Melanoma in situ,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",19665,77,1.42 [0.76-2.67],0.2757991650835371
Chapter II Neoplasms,Melanoma in situ,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",19060,77,1.02 [0.69-1.50],0.9274807983257796
Chapter II Neoplasms,Melanoma in situ,BCHE,Cholinesterase,19297,77,1.05 [0.48-2.30],0.8953207463406552
Chapter II Neoplasms,Melanoma in situ,BCL2,Apoptosis regulator Bcl-2,19566,77,1.00 [0.67-1.50],0.9875165649946046
Chapter II Neoplasms,Melanoma in situ,BCL2L1,Bcl-2-like protein 1,19626,77,1.21 [0.97-1.51],0.0910646491892102
Chapter II Neoplasms,Melanoma in situ,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",22550,90,0.92 [0.61-1.37],0.666622975478709
Chapter II Neoplasms,Melanoma in situ,BCL2L15,Bcl-2-like protein 15,19117,75,0.95 [0.64-1.40],0.8011304885859324
Chapter II Neoplasms,Melanoma in situ,BCL7A,B-cell CLL/lymphoma 7 protein family member A,18973,75,0.96 [0.67-1.37],0.8072831756195349
Chapter II Neoplasms,Melanoma in situ,BCL7B,B-cell CLL/lymphoma 7 protein family member B,19560,77,1.00 [0.62-1.60],0.9985795192375794
Chapter II Neoplasms,Melanoma in situ,BCR,Breakpoint cluster region protein,22550,90,1.04 [0.85-1.27],0.70890888283256
Chapter II Neoplasms,Melanoma in situ,BDNF,Brain-derived neurotrophic factor,19661,77,0.97 [0.75-1.26],0.8468823366607039
Chapter II Neoplasms,Melanoma in situ,BECN1,Beclin-1,19167,75,1.11 [0.78-1.58],0.577177697308042
Chapter II Neoplasms,Melanoma in situ,BEX3,Protein BEX3,18973,75,0.69 [0.39-1.22],0.2026269570279313
Chapter II Neoplasms,Melanoma in situ,BGLAP,Osteocalcin,19661,77,1.10 [0.86-1.41],0.4487007820878924
Chapter II Neoplasms,Melanoma in situ,BGN,Biglycan,22039,88,1.07 [0.92-1.25],0.3978420744815896
Chapter II Neoplasms,Melanoma in situ,BHLHE40,Class E basic helix-loop-helix protein 40,19060,77,0.90 [0.65-1.25],0.535839645560805
Chapter II Neoplasms,Melanoma in situ,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,19066,75,0.79 [0.33-1.87],0.5880898752680566
Chapter II Neoplasms,Melanoma in situ,BID,BH3-interacting domain death agonist,22550,90,1.09 [0.84-1.43],0.5164996221151452
Chapter II Neoplasms,Melanoma in situ,BIN2,Bridging integrator 2,22597,90,1.10 [0.90-1.35],0.3607535199122713
Chapter II Neoplasms,Melanoma in situ,BIRC2,Baculoviral IAP repeat-containing protein 2,22078,88,1.18 [0.88-1.58],0.2701343300526186
Chapter II Neoplasms,Melanoma in situ,BLMH,Bleomycin hydrolase,22859,89,0.82 [0.46-1.46],0.5075948351240173
Chapter II Neoplasms,Melanoma in situ,BLNK,B-cell linker protein,19117,75,1.16 [0.66-2.04],0.6072005880903778
Chapter II Neoplasms,Melanoma in situ,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,19060,77,1.05 [0.79-1.38],0.7438256574738853
Chapter II Neoplasms,Melanoma in situ,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,19626,77,1.20 [0.71-2.05],0.4936063664301976
Chapter II Neoplasms,Melanoma in situ,BLVRB,Flavin reductase,22597,90,0.86 [0.65-1.15],0.319061408776276
Chapter II Neoplasms,Melanoma in situ,BMP10,Bone morphogenetic protein 10,19255,75,0.77 [0.36-1.67],0.5098673497648027
Chapter II Neoplasms,Melanoma in situ,BMP4,Bone morphogenetic protein 4,22405,88,0.82 [0.53-1.28],0.3836095823071187
Chapter II Neoplasms,Melanoma in situ,BMP6,Bone morphogenetic protein 6,22151,88,0.81 [0.52-1.25],0.3442136985294626
Chapter II Neoplasms,Melanoma in situ,BMPER,BMP-binding endothelial regulator protein,19255,75,1.13 [0.42-3.06],0.8135882221336727
Chapter II Neoplasms,Melanoma in situ,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,19665,77,1.10 [0.58-2.07],0.7754054351160246
Chapter II Neoplasms,Melanoma in situ,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,19117,75,1.18 [0.73-1.92],0.5050433984915802
Chapter II Neoplasms,Melanoma in situ,BOC,Brother of CDO,22187,88,0.58 [0.26-1.31],0.1914395581681134
Chapter II Neoplasms,Melanoma in situ,BOLA1,BolA-like protein 1,19060,77,0.93 [0.62-1.40],0.7230035258150449
Chapter II Neoplasms,Melanoma in situ,BOLA2_BOLA2B,BolA-like protein 2,19167,75,0.88 [0.59-1.30],0.5183894236809918
Chapter II Neoplasms,Melanoma in situ,BPIFA2,BPI fold-containing family A member 2,18484,69,1.05 [0.85-1.30],0.6609736202200132
Chapter II Neoplasms,Melanoma in situ,BPIFB1,BPI fold-containing family B member 1,22531,88,1.01 [0.74-1.37],0.9530486329269484
Chapter II Neoplasms,Melanoma in situ,BPIFB2,BPI fold-containing family B member 2,19631,77,1.17 [0.87-1.59],0.3041374050001461
Chapter II Neoplasms,Melanoma in situ,BRAP,BRCA1-associated protein,19396,77,1.21 [0.99-1.49],0.0687126802213947
Chapter II Neoplasms,Melanoma in situ,BRD1,Bromodomain-containing protein 1,19287,76,1.32 [0.71-2.43],0.3758182187235385
Chapter II Neoplasms,Melanoma in situ,BRD2,Bromodomain-containing protein 2,19060,77,1.67 [1.16-2.42],0.0063249662566085
Chapter II Neoplasms,Melanoma in situ,BRD3,Bromodomain-containing protein 3,19066,75,1.27 [0.91-1.76],0.1610449872736459
Chapter II Neoplasms,Melanoma in situ,BRDT,Bromodomain testis-specific protein,19066,75,0.91 [0.49-1.68],0.7546675370251322
Chapter II Neoplasms,Melanoma in situ,BRK1,Protein BRICK1,22029,90,1.15 [0.76-1.76],0.5069618570666634
Chapter II Neoplasms,Melanoma in situ,BRME1,Break repair meiotic recombinase recruitment factor 1,19060,77,1.13 [0.73-1.77],0.5799597797980038
Chapter II Neoplasms,Melanoma in situ,BRSK2,Serine/threonine-protein kinase BRSK2,19635,77,1.06 [0.62-1.81],0.842652005000122
Chapter II Neoplasms,Melanoma in situ,BSG,Basigin,22797,90,1.07 [0.41-2.80],0.8886775375213677
Chapter II Neoplasms,Melanoma in situ,BSND,Barttin,18973,75,1.17 [0.65-2.10],0.5973127325614669
Chapter II Neoplasms,Melanoma in situ,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,22788,90,1.00 [0.68-1.47],0.9997010131387892
Chapter II Neoplasms,Melanoma in situ,BST2,Bone marrow stromal antigen 2,22788,90,1.08 [0.77-1.53],0.6494377300505145
Chapter II Neoplasms,Melanoma in situ,BTC,Probetacellulin,22078,88,1.11 [0.88-1.40],0.3879773028510508
Chapter II Neoplasms,Melanoma in situ,BTD,Biotinidase,19694,77,0.93 [0.33-2.61],0.8979756468216227
Chapter II Neoplasms,Melanoma in situ,BTLA,B- and T-lymphocyte attenuator,18973,75,1.22 [1.03-1.46],0.0237451140225179
Chapter II Neoplasms,Melanoma in situ,BTN1A1,Butyrophilin subfamily 1 member A1,19525,76,0.52 [0.26-1.06],0.0704046197978722
Chapter II Neoplasms,Melanoma in situ,BTN2A1,Butyrophilin subfamily 2 member A1,22692,90,0.79 [0.37-1.68],0.5388352335778315
Chapter II Neoplasms,Melanoma in situ,BTN3A2,Butyrophilin subfamily 3 member A2,22550,90,1.02 [0.62-1.69],0.9236403190832436
Chapter II Neoplasms,Melanoma in situ,BTNL10,Butyrophilin-like protein 10,18973,75,0.60 [0.30-1.22],0.1600397839310925
Chapter II Neoplasms,Melanoma in situ,C19orf12,Protein C19orf12,22029,90,0.74 [0.52-1.07],0.1122651340293018
Chapter II Neoplasms,Melanoma in situ,C1GALT1C1,C1GALT1-specific chaperone 1,19066,75,0.81 [0.39-1.70],0.5831588727237909
Chapter II Neoplasms,Melanoma in situ,C1QA,Complement C1q subcomponent subunit A,22720,90,0.73 [0.32-1.67],0.4549580842014523
Chapter II Neoplasms,Melanoma in situ,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",19635,77,1.12 [0.88-1.42],0.3688513923435041
Chapter II Neoplasms,Melanoma in situ,C1QL2,Complement C1q-like protein 2,19117,75,1.06 [0.65-1.73],0.8196110192607501
Chapter II Neoplasms,Melanoma in situ,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,22650,89,1.21 [0.79-1.86],0.3868756797240005
Chapter II Neoplasms,Melanoma in situ,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,19255,75,0.62 [0.37-1.04],0.0677929588286856
Chapter II Neoplasms,Melanoma in situ,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,19635,77,0.39 [0.18-0.88],0.0229680743341283
Chapter II Neoplasms,Melanoma in situ,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,19213,75,1.37 [0.84-2.25],0.2118826498951248
Chapter II Neoplasms,Melanoma in situ,C1R,Complement C1r subcomponent,19694,77,0.72 [0.20-2.54],0.6046122541389551
Chapter II Neoplasms,Melanoma in situ,C1RL,Complement C1r subcomponent-like protein,19662,77,1.03 [0.33-3.17],0.9591503021013896
Chapter II Neoplasms,Melanoma in situ,C1S,Complement C1s subcomponent,19694,77,0.79 [0.28-2.28],0.6672029304224572
Chapter II Neoplasms,Melanoma in situ,C2,Complement C2,22613,89,1.13 [0.49-2.58],0.7793468701082163
Chapter II Neoplasms,Melanoma in situ,C2CD2L,Phospholipid transfer protein C2CD2L,21981,90,1.12 [0.75-1.69],0.5745730947816936
Chapter II Neoplasms,Melanoma in situ,C2orf69,UPF0565 protein C2orf69,19119,72,1.00 [0.68-1.47],0.9954353826905558
Chapter II Neoplasms,Melanoma in situ,C3,Complement C3,18692,74,1.09 [0.68-1.75],0.7220328246553782
Chapter II Neoplasms,Melanoma in situ,C4BPB,C4b-binding protein beta chain,22658,90,1.03 [0.66-1.63],0.8830972528072011
Chapter II Neoplasms,Melanoma in situ,C5,Complement C5,19694,77,0.59 [0.13-2.61],0.4826495180942753
Chapter II Neoplasms,Melanoma in situ,C7,Complement component C7,19218,76,1.07 [0.52-2.18],0.8621013047476495
Chapter II Neoplasms,Melanoma in situ,C7orf50,Uncharacterized protein C7orf50,19626,77,1.02 [0.41-2.56],0.9587410643868336
Chapter II Neoplasms,Melanoma in situ,C8B,Complement component C8 beta chain,19694,77,0.73 [0.36-1.47],0.3788129151576516
Chapter II Neoplasms,Melanoma in situ,C9,Complement component C9,19669,77,1.32 [0.83-2.10],0.2347705832426935
Chapter II Neoplasms,Melanoma in situ,C9orf40,Uncharacterized protein C9orf40,19566,77,0.82 [0.63-1.08],0.1590105239947173
Chapter II Neoplasms,Melanoma in situ,CA1,Carbonic anhydrase 1,22055,87,0.80 [0.59-1.09],0.1627975734326234
Chapter II Neoplasms,Melanoma in situ,CA11,Carbonic anhydrase-related protein 11,22078,88,0.88 [0.47-1.64],0.6796767738070956
Chapter II Neoplasms,Melanoma in situ,CA12,Carbonic anhydrase 12,22484,88,1.05 [0.58-1.91],0.8713180390296023
Chapter II Neoplasms,Melanoma in situ,CA13,Carbonic anhydrase 13,22350,87,1.09 [0.90-1.32],0.3620074428805477
Chapter II Neoplasms,Melanoma in situ,CA14,Carbonic anhydrase 14,22789,90,0.95 [0.55-1.66],0.8640881496633703
Chapter II Neoplasms,Melanoma in situ,CA2,Carbonic anhydrase 2,22521,90,0.89 [0.69-1.16],0.3967747835289928
Chapter II Neoplasms,Melanoma in situ,CA3,Carbonic anhydrase 3,22820,89,0.81 [0.59-1.11],0.1967091121838131
Chapter II Neoplasms,Melanoma in situ,CA4,Carbonic anhydrase 4,22859,89,0.88 [0.39-1.99],0.7639126297753038
Chapter II Neoplasms,Melanoma in situ,CA5A,"Carbonic anhydrase 5A, mitochondrial",22187,88,0.90 [0.73-1.12],0.351001416372493
Chapter II Neoplasms,Melanoma in situ,CA6,Carbonic anhydrase 6,22525,90,0.92 [0.69-1.24],0.5977146017743267
Chapter II Neoplasms,Melanoma in situ,CA7,Carbonic anhydrase 7,19287,76,1.15 [0.65-2.04],0.622992730701367
Chapter II Neoplasms,Melanoma in situ,CA8,Carbonic anhydrase-related protein,19117,75,0.84 [0.33-2.10],0.7055475201215013
Chapter II Neoplasms,Melanoma in situ,CA9,Carbonic anhydrase 9,22789,90,0.98 [0.65-1.49],0.9356824346084596
Chapter II Neoplasms,Melanoma in situ,CABP2,Calcium-binding protein 2,19119,72,1.08 [0.78-1.49],0.638022946363347
Chapter II Neoplasms,Melanoma in situ,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,19060,77,0.91 [0.46-1.80],0.7805360419390347
Chapter II Neoplasms,Melanoma in situ,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,19066,75,0.95 [0.64-1.40],0.780637834152449
Chapter II Neoplasms,Melanoma in situ,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,19060,77,1.34 [0.99-1.81],0.0556896792524481
Chapter II Neoplasms,Melanoma in situ,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,19635,77,1.10 [0.85-1.42],0.4785202586815354
Chapter II Neoplasms,Melanoma in situ,CACYBP,Calcyclin-binding protein,19212,75,1.18 [0.95-1.48],0.1346835591294931
Chapter II Neoplasms,Melanoma in situ,CADPS,Calcium-dependent secretion activator 1,19119,72,0.93 [0.54-1.60],0.8016872165368347
Chapter II Neoplasms,Melanoma in situ,CALB1,Calbindin,22484,88,1.34 [0.84-2.13],0.2256221485607557
Chapter II Neoplasms,Melanoma in situ,CALB2,Calretinin,22029,90,1.00 [0.55-1.81],0.9898771121269389
Chapter II Neoplasms,Melanoma in situ,CALCA,Calcitonin,22392,89,1.15 [0.83-1.60],0.3994428081214199
Chapter II Neoplasms,Melanoma in situ,CALCB,Calcitonin gene-related peptide 2,19626,77,0.88 [0.48-1.59],0.6610959893619435
Chapter II Neoplasms,Melanoma in situ,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,22716,90,1.06 [0.88-1.27],0.5373216607827156
Chapter II Neoplasms,Melanoma in situ,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,19167,75,1.05 [0.79-1.40],0.7235640174163473
Chapter II Neoplasms,Melanoma in situ,CALY,Neuron-specific vesicular protein calcyon,19066,75,0.87 [0.46-1.64],0.6576754964729864
Chapter II Neoplasms,Melanoma in situ,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,22078,88,1.02 [0.66-1.57],0.9395238543964348
Chapter II Neoplasms,Melanoma in situ,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,19119,72,1.26 [0.88-1.79],0.2002685179584838
Chapter II Neoplasms,Melanoma in situ,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,19635,77,1.13 [0.93-1.38],0.216826498356314
Chapter II Neoplasms,Melanoma in situ,CANT1,Soluble calcium-activated nucleotidase 1,22523,88,1.26 [0.49-3.22],0.6316457239863824
Chapter II Neoplasms,Melanoma in situ,CAPG,Macrophage-capping protein,22435,89,1.02 [0.74-1.41],0.8896985020260444
Chapter II Neoplasms,Melanoma in situ,CAPN3,Calpain-3,19560,77,0.90 [0.49-1.66],0.7387673028516313
Chapter II Neoplasms,Melanoma in situ,CAPS,Calcyphosin,19626,77,1.16 [0.99-1.37],0.0740435188207926
Chapter II Neoplasms,Melanoma in situ,CARHSP1,Calcium-regulated heat-stable protein 1,22029,90,0.85 [0.59-1.23],0.3872209379802449
Chapter II Neoplasms,Melanoma in situ,CASC3,Protein CASC3,19119,72,0.89 [0.51-1.57],0.6839358135553084
Chapter II Neoplasms,Melanoma in situ,CASP1,Caspase-1,22029,90,1.06 [0.81-1.38],0.6759207310751412
Chapter II Neoplasms,Melanoma in situ,CASP10,Caspase-10,22029,90,0.94 [0.73-1.23],0.6671395926539545
Chapter II Neoplasms,Melanoma in situ,CASP2,Caspase-2,22550,90,1.02 [0.78-1.34],0.8908344222340477
Chapter II Neoplasms,Melanoma in situ,CASP3,Caspase-3,22859,89,1.07 [0.87-1.33],0.5160467135612041
Chapter II Neoplasms,Melanoma in situ,CASP4,Caspase-4,19287,76,1.10 [0.98-1.23],0.1043316240192371
Chapter II Neoplasms,Melanoma in situ,CASP7,Caspase-7,19626,77,1.24 [0.95-1.60],0.1086644589567889
Chapter II Neoplasms,Melanoma in situ,CASP8,Caspase-8,22717,90,1.18 [0.89-1.57],0.2475747513883676
Chapter II Neoplasms,Melanoma in situ,CASP9,Caspase-9,19117,75,1.11 [0.79-1.56],0.5385417405407924
Chapter II Neoplasms,Melanoma in situ,CASQ2,Calsequestrin-2,19066,75,0.52 [0.27-0.99],0.0481656899002686
Chapter II Neoplasms,Melanoma in situ,CAT,Catalase,19367,77,0.82 [0.55-1.24],0.35416640879127
Chapter II Neoplasms,Melanoma in situ,CBLIF,Cobalamin binding intrinsic factor,22555,89,0.96 [0.75-1.24],0.7543581232515089
Chapter II Neoplasms,Melanoma in situ,CBLN1,Cerebellin-1,19060,77,0.94 [0.74-1.20],0.617547648980975
Chapter II Neoplasms,Melanoma in situ,CBLN4,Cerebellin-4,22789,90,0.74 [0.41-1.34],0.3223253969284199
Chapter II Neoplasms,Melanoma in situ,CBS,Cystathionine beta-synthase,19167,75,0.86 [0.53-1.37],0.5174556116445425
Chapter II Neoplasms,Melanoma in situ,CBX2,Chromobox protein homolog 2,19066,75,0.75 [0.39-1.44],0.3880265632836884
Chapter II Neoplasms,Melanoma in situ,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,22440,89,1.01 [0.78-1.30],0.958482070556669
Chapter II Neoplasms,Melanoma in situ,CCAR2,Cell cycle and apoptosis regulator protein 2,19626,77,0.85 [0.54-1.34],0.4820843317738241
Chapter II Neoplasms,Melanoma in situ,CCDC134,Coiled-coil domain-containing protein 134,19560,77,1.19 [0.78-1.80],0.4276524342702308
Chapter II Neoplasms,Melanoma in situ,CCDC28A,Coiled-coil domain-containing protein 28A,19119,72,1.28 [0.59-2.77],0.5334939544823694
Chapter II Neoplasms,Melanoma in situ,CCDC50,Coiled-coil domain-containing protein 50,19635,77,1.10 [0.85-1.41],0.4665870489122522
Chapter II Neoplasms,Melanoma in situ,CCDC80,Coiled-coil domain-containing protein 80,22589,89,0.79 [0.46-1.36],0.3955532715628123
Chapter II Neoplasms,Melanoma in situ,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,19167,75,0.98 [0.68-1.41],0.9273300921334408
Chapter II Neoplasms,Melanoma in situ,CCL11,Eotaxin,22837,90,0.73 [0.45-1.21],0.2221276767872451
Chapter II Neoplasms,Melanoma in situ,CCL13,C-C motif chemokine 13,22797,90,0.81 [0.62-1.07],0.1397322668852203
Chapter II Neoplasms,Melanoma in situ,CCL14,C-C motif chemokine 14,22505,89,1.02 [0.63-1.66],0.9233459254340364
Chapter II Neoplasms,Melanoma in situ,CCL15,C-C motif chemokine 15,22859,89,0.98 [0.63-1.53],0.93820479337516
Chapter II Neoplasms,Melanoma in situ,CCL16,C-C motif chemokine 16,22859,89,0.94 [0.65-1.34],0.7258058489338481
Chapter II Neoplasms,Melanoma in situ,CCL17,C-C motif chemokine 17,22557,90,0.90 [0.73-1.11],0.3301657096712302
Chapter II Neoplasms,Melanoma in situ,CCL18,C-C motif chemokine 18,22240,88,1.09 [0.84-1.40],0.5315684979222923
Chapter II Neoplasms,Melanoma in situ,CCL19,C-C motif chemokine 19,22788,90,1.04 [0.91-1.19],0.5465962851279831
Chapter II Neoplasms,Melanoma in situ,CCL2,C-C motif chemokine 2,22405,88,0.99 [0.70-1.40],0.9461475044826936
Chapter II Neoplasms,Melanoma in situ,CCL20,C-C motif chemokine 20,22837,90,0.87 [0.69-1.09],0.2272169579411031
Chapter II Neoplasms,Melanoma in situ,CCL21,C-C motif chemokine 21,22692,90,0.64 [0.38-1.05],0.0780959172594323
Chapter II Neoplasms,Melanoma in situ,CCL22,C-C motif chemokine 22,22366,90,0.75 [0.51-1.09],0.1283130104607206
Chapter II Neoplasms,Melanoma in situ,CCL23,C-C motif chemokine 23,22692,90,0.85 [0.54-1.36],0.5061184518620709
Chapter II Neoplasms,Melanoma in situ,CCL24,C-C motif chemokine 24,22653,90,0.90 [0.72-1.12],0.3413310964211577
Chapter II Neoplasms,Melanoma in situ,CCL25,C-C motif chemokine 25,22837,90,1.37 [0.94-2.01],0.1013119730081274
Chapter II Neoplasms,Melanoma in situ,CCL26,C-C motif chemokine 26,22550,90,0.79 [0.63-1.00],0.0525626180886423
Chapter II Neoplasms,Melanoma in situ,CCL27,C-C motif chemokine 27,22589,89,0.93 [0.67-1.28],0.6403611264882726
Chapter II Neoplasms,Melanoma in situ,CCL28,C-C motif chemokine 28,22475,90,0.97 [0.70-1.35],0.8533570699782883
Chapter II Neoplasms,Melanoma in situ,CCL3,C-C motif chemokine 3,22550,90,1.18 [0.89-1.57],0.2430935159193787
Chapter II Neoplasms,Melanoma in situ,CCL4,C-C motif chemokine 4,22624,90,1.00 [0.77-1.30],0.997552278149674
Chapter II Neoplasms,Melanoma in situ,CCL5,C-C motif chemokine 5,22650,89,0.95 [0.79-1.14],0.5930981822389128
Chapter II Neoplasms,Melanoma in situ,CCL7,C-C motif chemokine 7,22550,90,0.82 [0.58-1.16],0.2642783010659126
Chapter II Neoplasms,Melanoma in situ,CCL8,C-C motif chemokine 8,22756,90,0.98 [0.72-1.33],0.9115640312825504
Chapter II Neoplasms,Melanoma in situ,CCN1,CCN family member 1,22444,88,0.82 [0.65-1.04],0.1044018312056911
Chapter II Neoplasms,Melanoma in situ,CCN2,CCN family member 2,22580,90,0.86 [0.62-1.19],0.3500159067611857
Chapter II Neoplasms,Melanoma in situ,CCN3,CCN family member 3,22826,89,1.12 [0.64-1.97],0.6918077976812188
Chapter II Neoplasms,Melanoma in situ,CCN4,CCN family member 4,22789,90,0.95 [0.60-1.50],0.8094784825021053
Chapter II Neoplasms,Melanoma in situ,CCN5,CCN family member 5,22597,90,0.84 [0.52-1.37],0.4878284675408989
Chapter II Neoplasms,Melanoma in situ,CCND2,G1/S-specific cyclin-D2,19287,76,1.00 [0.56-1.79],0.9912470290321728
Chapter II Neoplasms,Melanoma in situ,CCNE1,G1/S-specific cyclin-E1,19117,75,1.08 [0.88-1.32],0.4891626689890173
Chapter II Neoplasms,Melanoma in situ,CCS,Copper chaperone for superoxide dismutase,22440,89,0.80 [0.54-1.19],0.2703874353651517
Chapter II Neoplasms,Melanoma in situ,CCT5,T-complex protein 1 subunit epsilon,22078,88,0.85 [0.54-1.34],0.4915029899067701
Chapter II Neoplasms,Melanoma in situ,CD101,Immunoglobulin superfamily member 2,19566,77,1.12 [0.67-1.85],0.6649170345186985
Chapter II Neoplasms,Melanoma in situ,CD109,CD109 antigen,22597,90,0.94 [0.54-1.66],0.8392861369820426
Chapter II Neoplasms,Melanoma in situ,CD14,Monocyte differentiation antigen CD14,22087,87,1.53 [0.98-2.39],0.0609257701514648
Chapter II Neoplasms,Melanoma in situ,CD160,CD160 antigen,22837,90,1.05 [0.69-1.57],0.8317765057967348
Chapter II Neoplasms,Melanoma in situ,CD163,Scavenger receptor cysteine-rich type 1 protein M130,22650,89,1.29 [0.84-1.99],0.2420539891418534
Chapter II Neoplasms,Melanoma in situ,CD164,Sialomucin core protein 24,22597,90,0.80 [0.36-1.74],0.5705280696291102
Chapter II Neoplasms,Melanoma in situ,CD164L2,CD164 sialomucin-like 2 protein,19119,72,1.37 [0.80-2.35],0.2462880066802748
Chapter II Neoplasms,Melanoma in situ,CD177,CD177 antigen,22568,90,0.96 [0.84-1.10],0.5626483850052275
Chapter II Neoplasms,Melanoma in situ,CD1C,T-cell surface glycoprotein CD1c,22658,90,0.87 [0.40-1.92],0.7353889020709978
Chapter II Neoplasms,Melanoma in situ,CD2,T-cell surface antigen CD2,19066,75,1.31 [0.86-1.98],0.2035786845223515
Chapter II Neoplasms,Melanoma in situ,CD200,OX-2 membrane glycoprotein,22550,90,1.50 [0.72-3.12],0.2811851170148686
Chapter II Neoplasms,Melanoma in situ,CD200R1,Cell surface glycoprotein CD200 receptor 1,22482,90,1.08 [0.63-1.87],0.7754860952136624
Chapter II Neoplasms,Melanoma in situ,CD207,C-type lectin domain family 4 member K,22092,88,0.73 [0.44-1.21],0.2249343310377204
Chapter II Neoplasms,Melanoma in situ,CD209,CD209 antigen,22636,88,0.69 [0.42-1.14],0.1489227176037713
Chapter II Neoplasms,Melanoma in situ,CD22,B-cell receptor CD22,22837,90,0.95 [0.59-1.51],0.8152737882748482
Chapter II Neoplasms,Melanoma in situ,CD226,CD226 antigen,19117,75,1.27 [0.75-2.16],0.3692223651014203
Chapter II Neoplasms,Melanoma in situ,CD244,Natural killer cell receptor 2B4,22837,90,0.86 [0.43-1.74],0.6850978356823076
Chapter II Neoplasms,Melanoma in situ,CD248,Endosialin,19661,77,0.67 [0.39-1.17],0.1609052920722814
Chapter II Neoplasms,Melanoma in situ,CD27,CD27 antigen,22658,90,0.98 [0.61-1.58],0.9354810359077784
Chapter II Neoplasms,Melanoma in situ,CD274,Programmed cell death 1 ligand 1,22440,89,0.93 [0.53-1.65],0.8118188682966586
Chapter II Neoplasms,Melanoma in situ,CD276,CD276 antigen,22583,90,1.16 [0.68-1.97],0.5885695118946219
Chapter II Neoplasms,Melanoma in situ,CD28,T-cell-specific surface glycoprotein CD28,22078,88,0.88 [0.52-1.50],0.6412997050311675
Chapter II Neoplasms,Melanoma in situ,CD2AP,CD2-associated protein,22589,89,1.13 [0.85-1.50],0.4170032922584257
Chapter II Neoplasms,Melanoma in situ,CD300A,CMRF35-like molecule 8,19255,75,0.88 [0.41-1.87],0.729748784751259
Chapter II Neoplasms,Melanoma in situ,CD300C,CMRF35-like molecule 6,22788,90,0.89 [0.51-1.56],0.6838541090063013
Chapter II Neoplasms,Melanoma in situ,CD300E,CMRF35-like molecule 2,22710,90,1.24 [0.78-1.97],0.3610392848458487
Chapter II Neoplasms,Melanoma in situ,CD300LF,CMRF35-like molecule 1,22789,90,0.90 [0.67-1.22],0.4951039007745521
Chapter II Neoplasms,Melanoma in situ,CD300LG,CMRF35-like molecule 9,22597,90,0.93 [0.56-1.54],0.7735544729794347
Chapter II Neoplasms,Melanoma in situ,CD302,CD302 antigen,22484,88,1.41 [0.75-2.64],0.2898520542574722
Chapter II Neoplasms,Melanoma in situ,CD33,Myeloid cell surface antigen CD33,22658,90,0.88 [0.70-1.09],0.2358401962159874
Chapter II Neoplasms,Melanoma in situ,CD34,Hematopoietic progenitor cell antigen CD34,22706,90,1.08 [0.50-2.36],0.8379435342898808
Chapter II Neoplasms,Melanoma in situ,CD36,Platelet glycoprotein 4,19117,75,1.00 [0.60-1.68],0.999262798682972
Chapter II Neoplasms,Melanoma in situ,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,22484,88,1.25 [0.67-2.31],0.4867724720548438
Chapter II Neoplasms,Melanoma in situ,CD3D,T-cell surface glycoprotein CD3 delta chain,19060,77,0.67 [0.31-1.44],0.3047189552866955
Chapter II Neoplasms,Melanoma in situ,CD3E,T-cell surface glycoprotein CD3 epsilon chain,19287,76,0.90 [0.47-1.71],0.7417174677521614
Chapter II Neoplasms,Melanoma in situ,CD3G,T-cell surface glycoprotein CD3 gamma chain,19117,75,1.02 [0.81-1.29],0.8770058512445189
Chapter II Neoplasms,Melanoma in situ,CD4,T-cell surface glycoprotein CD4,22508,90,0.95 [0.50-1.81],0.8766949602255587
Chapter II Neoplasms,Melanoma in situ,CD40,Tumor necrosis factor receptor superfamily member 5,22585,90,1.04 [0.71-1.52],0.8354337120812038
Chapter II Neoplasms,Melanoma in situ,CD40LG,CD40 ligand,22837,90,0.90 [0.71-1.15],0.4091044159186625
Chapter II Neoplasms,Melanoma in situ,CD46,Membrane cofactor protein,22424,89,1.30 [0.68-2.51],0.4264036547450605
Chapter II Neoplasms,Melanoma in situ,CD48,CD48 antigen,22653,90,0.84 [0.44-1.60],0.5970690835618307
Chapter II Neoplasms,Melanoma in situ,CD5,T-cell surface glycoprotein CD5,22756,90,1.12 [0.63-1.98],0.7055374206659737
Chapter II Neoplasms,Melanoma in situ,CD55,Complement decay-accelerating factor,21777,86,1.16 [0.55-2.45],0.6979392959893127
Chapter II Neoplasms,Melanoma in situ,CD58,Lymphocyte function-associated antigen 3,22549,89,0.92 [0.32-2.67],0.8795283934868218
Chapter II Neoplasms,Melanoma in situ,CD59,CD59 glycoprotein,21753,84,0.90 [0.36-2.26],0.8168426316070019
Chapter II Neoplasms,Melanoma in situ,CD5L,CD5 antigen-like,19577,77,0.98 [0.61-1.57],0.9169556801532744
Chapter II Neoplasms,Melanoma in situ,CD6,T-cell differentiation antigen CD6,22797,90,1.44 [1.02-2.04],0.0375792895639293
Chapter II Neoplasms,Melanoma in situ,CD63,CD63 antigen,22405,88,0.98 [0.68-1.40],0.900371316256324
Chapter II Neoplasms,Melanoma in situ,CD69,Early activation antigen CD69,22492,89,1.08 [0.87-1.35],0.4595564639635536
Chapter II Neoplasms,Melanoma in situ,CD7,T-cell antigen CD7,19078,75,1.67 [1.12-2.49],0.0113224610408257
Chapter II Neoplasms,Melanoma in situ,CD70,CD70 antigen,22550,90,1.07 [0.68-1.67],0.7816933260513824
Chapter II Neoplasms,Melanoma in situ,CD72,B-cell differentiation antigen CD72,19255,75,1.22 [0.71-2.08],0.4739180580310981
Chapter II Neoplasms,Melanoma in situ,CD74,HLA class II histocompatibility antigen gamma chain,22788,90,1.12 [0.65-1.92],0.6878435502607219
Chapter II Neoplasms,Melanoma in situ,CD79B,B-cell antigen receptor complex-associated protein beta chain,22837,90,0.96 [0.62-1.50],0.8704529236877528
Chapter II Neoplasms,Melanoma in situ,CD80,T-lymphocyte activation antigen CD80,19665,77,1.26 [0.65-2.42],0.4897946865113712
Chapter II Neoplasms,Melanoma in situ,CD82,CD82 antigen,19287,76,1.13 [0.71-1.81],0.5967532921073707
Chapter II Neoplasms,Melanoma in situ,CD83,CD83 antigen,22550,90,1.02 [0.58-1.81],0.9479588927366784
Chapter II Neoplasms,Melanoma in situ,CD84,SLAM family member 5,22550,90,0.95 [0.52-1.75],0.8807134623325704
Chapter II Neoplasms,Melanoma in situ,CD86,T-lymphocyte activation antigen CD86,19566,77,1.38 [0.64-2.97],0.4151434234011272
Chapter II Neoplasms,Melanoma in situ,CD8A,T-cell surface glycoprotein CD8 alpha chain,22788,90,1.19 [0.82-1.73],0.3690252983388279
Chapter II Neoplasms,Melanoma in situ,CD93,Complement component C1q receptor,21704,87,0.94 [0.50-1.76],0.8371104751846241
Chapter II Neoplasms,Melanoma in situ,CD99,CD99 antigen,22597,90,1.13 [0.43-2.99],0.805533606873442
Chapter II Neoplasms,Melanoma in situ,CD99L2,CD99 antigen-like protein 2,22597,90,1.72 [0.79-3.75],0.1749245392740684
Chapter II Neoplasms,Melanoma in situ,CDA,Cytidine deaminase,19624,77,1.23 [0.81-1.88],0.3341437742926268
Chapter II Neoplasms,Melanoma in situ,CDAN1,Codanin-1,19626,77,1.06 [0.43-2.62],0.8967487540583887
Chapter II Neoplasms,Melanoma in situ,CDC123,Cell division cycle protein 123 homolog,18973,75,1.03 [0.74-1.44],0.8479260474654577
Chapter II Neoplasms,Melanoma in situ,CDC25A,M-phase inducer phosphatase 1,18973,75,1.05 [0.62-1.76],0.8659508213372862
Chapter II Neoplasms,Melanoma in situ,CDC26,Anaphase-promoting complex subunit CDC26,19538,77,1.34 [0.99-1.80],0.056502549536651
Chapter II Neoplasms,Melanoma in situ,CDC27,Cell division cycle protein 27 homolog,22078,88,1.07 [0.79-1.46],0.670142463386772
Chapter II Neoplasms,Melanoma in situ,CDC37,Hsp90 co-chaperone Cdc37,22658,90,1.07 [0.86-1.34],0.5238356477845119
Chapter II Neoplasms,Melanoma in situ,CDC42BPB,Serine/threonine-protein kinase MRCK beta,19566,77,1.09 [0.89-1.35],0.4025086608785462
Chapter II Neoplasms,Melanoma in situ,CDCP1,CUB domain-containing protein 1,22440,89,1.01 [0.68-1.49],0.9577398783324854
Chapter II Neoplasms,Melanoma in situ,CDH1,Cadherin-1,21801,84,1.23 [0.79-1.92],0.3585824628824735
Chapter II Neoplasms,Melanoma in situ,CDH15,Cadherin-15,22740,90,1.14 [0.77-1.71],0.5099406904923218
Chapter II Neoplasms,Melanoma in situ,CDH17,Cadherin-17,22589,89,1.23 [0.94-1.60],0.1263322265904538
Chapter II Neoplasms,Melanoma in situ,CDH2,Cadherin-2,22589,89,1.02 [0.59-1.76],0.9384141894862844
Chapter II Neoplasms,Melanoma in situ,CDH22,Cadherin-22,19287,76,0.79 [0.36-1.77],0.5707983615155325
Chapter II Neoplasms,Melanoma in situ,CDH23,Cadherin-23,19626,77,0.75 [0.32-1.76],0.5134735514852713
Chapter II Neoplasms,Melanoma in situ,CDH3,Cadherin-3,22788,90,0.72 [0.42-1.25],0.244649943711341
Chapter II Neoplasms,Melanoma in situ,CDH4,Cadherin-4,19060,77,0.94 [0.59-1.50],0.7896733842941136
Chapter II Neoplasms,Melanoma in situ,CDH5,Cadherin-5,22859,89,0.91 [0.48-1.71],0.760429709554955
Chapter II Neoplasms,Melanoma in situ,CDH6,Cadherin-6,22589,89,1.00 [0.60-1.65],0.9958548953071842
Chapter II Neoplasms,Melanoma in situ,CDHR1,Cadherin-related family member 1,22029,90,0.75 [0.46-1.22],0.2518718152083241
Chapter II Neoplasms,Melanoma in situ,CDHR2,Cadherin-related family member 2,22484,88,0.85 [0.66-1.09],0.1936968389862592
Chapter II Neoplasms,Melanoma in situ,CDHR5,Cadherin-related family member 5,22589,89,0.95 [0.59-1.54],0.8462109945922232
Chapter II Neoplasms,Melanoma in situ,CDK1,Cyclin-dependent kinase 1,18973,75,0.93 [0.51-1.69],0.805381745019844
Chapter II Neoplasms,Melanoma in situ,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,19635,77,0.89 [0.60-1.32],0.5711829021219784
Chapter II Neoplasms,Melanoma in situ,CDKL5,Cyclin-dependent kinase-like 5,19060,77,1.01 [0.68-1.50],0.9543748778421428
Chapter II Neoplasms,Melanoma in situ,CDKN1A,Cyclin-dependent kinase inhibitor 1,22484,88,1.08 [0.90-1.29],0.4161665869779448
Chapter II Neoplasms,Melanoma in situ,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,22484,88,1.06 [0.86-1.30],0.5792756909206151
Chapter II Neoplasms,Melanoma in situ,CDNF,Cerebral dopamine neurotrophic factor,22484,88,1.31 [0.74-2.32],0.3553417015505334
Chapter II Neoplasms,Melanoma in situ,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,22625,90,0.51 [0.26-1.02],0.056828792413725
Chapter II Neoplasms,Melanoma in situ,CDSN,Corneodesmosin,22757,90,0.91 [0.59-1.41],0.6834681758764647
Chapter II Neoplasms,Melanoma in situ,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,22620,90,0.98 [0.38-2.54],0.9697306355633716
Chapter II Neoplasms,Melanoma in situ,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,19566,77,1.06 [0.80-1.41],0.6748600870570791
Chapter II Neoplasms,Melanoma in situ,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,19287,76,0.93 [0.66-1.32],0.7009489088280201
Chapter II Neoplasms,Melanoma in situ,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,19566,77,0.97 [0.56-1.69],0.9259690945576275
Chapter II Neoplasms,Melanoma in situ,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,19287,76,1.07 [0.67-1.72],0.7677860424032404
Chapter II Neoplasms,Melanoma in situ,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,22550,90,0.91 [0.73-1.14],0.4278090296388421
Chapter II Neoplasms,Melanoma in situ,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,22078,88,0.83 [0.54-1.25],0.3693607756572353
Chapter II Neoplasms,Melanoma in situ,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,21776,88,1.39 [1.06-1.82],0.0170147499083158
Chapter II Neoplasms,Melanoma in situ,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,19661,77,1.40 [0.80-2.45],0.2347653142687096
Chapter II Neoplasms,Melanoma in situ,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,22187,88,0.94 [0.63-1.39],0.7427275014024937
Chapter II Neoplasms,Melanoma in situ,CEBPA,CCAAT/enhancer-binding protein alpha,19117,75,1.14 [0.69-1.88],0.6028610525761082
Chapter II Neoplasms,Melanoma in situ,CEBPB,CCAAT/enhancer-binding protein beta,22187,88,0.90 [0.54-1.51],0.6893627390954306
Chapter II Neoplasms,Melanoma in situ,CELA2A,Chymotrypsin-like elastase family member 2A,19661,77,0.98 [0.67-1.42],0.9045241206964658
Chapter II Neoplasms,Melanoma in situ,CELA3A,Chymotrypsin-like elastase family member 3A,22821,89,1.10 [0.79-1.54],0.566441817884141
Chapter II Neoplasms,Melanoma in situ,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,19255,75,0.84 [0.38-1.88],0.6771726772511062
Chapter II Neoplasms,Melanoma in situ,CEMIP2,Cell surface hyaluronidase,19117,75,1.20 [0.70-2.04],0.5058506453568317
Chapter II Neoplasms,Melanoma in situ,CEND1,Cell cycle exit and neuronal differentiation protein 1,19060,77,0.92 [0.61-1.38],0.6885875768161551
Chapter II Neoplasms,Melanoma in situ,CENPF,Centromere protein F,19287,76,0.82 [0.54-1.25],0.3559880401360697
Chapter II Neoplasms,Melanoma in situ,CENPJ,Centromere protein J,19287,76,1.00 [0.73-1.35],0.9855082177866132
Chapter II Neoplasms,Melanoma in situ,CEP112,Centrosomal protein of 112 kDa,19066,75,1.16 [0.75-1.81],0.4996972455013417
Chapter II Neoplasms,Melanoma in situ,CEP152,Centrosomal protein of 152 kDa,18973,75,1.01 [0.60-1.70],0.9655349881118338
Chapter II Neoplasms,Melanoma in situ,CEP164,Centrosomal protein of 164 kDa,22161,88,1.17 [0.93-1.48],0.1880182555111658
Chapter II Neoplasms,Melanoma in situ,CEP170,Centrosomal protein of 170 kDa,19167,75,1.13 [0.85-1.50],0.3935792531156238
Chapter II Neoplasms,Melanoma in situ,CEP20,Centrosomal protein 20,22078,88,1.00 [0.77-1.29],0.9975229844938004
Chapter II Neoplasms,Melanoma in situ,CEP290,Centrosomal protein of 290 kDa,19287,76,0.89 [0.57-1.39],0.6157797942050588
Chapter II Neoplasms,Melanoma in situ,CEP350,Centrosome-associated protein 350,18973,75,1.07 [0.60-1.88],0.8264731204166457
Chapter II Neoplasms,Melanoma in situ,CEP43,Centrosomal protein 43,22010,86,0.87 [0.65-1.16],0.341100291857029
Chapter II Neoplasms,Melanoma in situ,CEP85,Centrosomal protein of 85 kDa,22078,88,1.08 [0.80-1.45],0.6204565947076142
Chapter II Neoplasms,Melanoma in situ,CERT,Ceramide transfer protein,22029,90,1.01 [0.74-1.37],0.946591547170796
Chapter II Neoplasms,Melanoma in situ,CES1,Liver carboxylesterase 1,22634,88,0.97 [0.76-1.24],0.793480838866759
Chapter II Neoplasms,Melanoma in situ,CES2,Cocaine esterase,22484,88,0.95 [0.67-1.36],0.7901018446082388
Chapter II Neoplasms,Melanoma in situ,CES3,Carboxylesterase 3,22484,88,0.93 [0.70-1.23],0.5998742717606287
Chapter II Neoplasms,Melanoma in situ,CETN2,Centrin-2,22029,90,1.00 [0.76-1.33],0.9768714380911232
Chapter II Neoplasms,Melanoma in situ,CETN3,Centrin-3,19566,77,1.17 [0.88-1.55],0.2686457659815561
Chapter II Neoplasms,Melanoma in situ,CFB,Complement factor B,19318,74,0.82 [0.41-1.64],0.5805358002299318
Chapter II Neoplasms,Melanoma in situ,CFC1,Cryptic protein,22078,88,1.15 [0.78-1.70],0.469210214700449
Chapter II Neoplasms,Melanoma in situ,CFD,Complement factor D,19694,77,0.42 [0.13-1.34],0.1441871169767201
Chapter II Neoplasms,Melanoma in situ,CFH,Complement factor H,18529,71,1.06 [0.39-2.90],0.9079248773509896
Chapter II Neoplasms,Melanoma in situ,CFHR2,Complement factor H-related protein 2,19552,77,1.41 [0.93-2.16],0.1092162882816509
Chapter II Neoplasms,Melanoma in situ,CFHR4,Complement factor H-related protein 4,19663,77,1.01 [0.75-1.36],0.9381966263696706
Chapter II Neoplasms,Melanoma in situ,CFHR5,Complement factor H-related protein 5,19403,76,1.49 [0.86-2.59],0.1574582015025905
Chapter II Neoplasms,Melanoma in situ,CFI,Complement factor I,19694,77,0.83 [0.28-2.47],0.7368488664399742
Chapter II Neoplasms,Melanoma in situ,CFP,Properdin,19694,77,0.94 [0.34-2.57],0.9011831346742591
Chapter II Neoplasms,Melanoma in situ,CGA,Glycoprotein hormones alpha chain,22597,90,0.99 [0.78-1.24],0.9029178954554796
Chapter II Neoplasms,Melanoma in situ,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,19669,77,1.23 [0.83-1.84],0.3034980435393679
Chapter II Neoplasms,Melanoma in situ,CGN,Cingulin,19119,72,0.96 [0.55-1.67],0.8831973697569317
Chapter II Neoplasms,Melanoma in situ,CGREF1,Cell growth regulator with EF hand domain protein 1,22589,89,1.01 [0.64-1.59],0.9673855276905804
Chapter II Neoplasms,Melanoma in situ,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,22078,88,0.83 [0.60-1.15],0.2573584398159927
Chapter II Neoplasms,Melanoma in situ,CHAD,Chondroadherin,19255,75,0.93 [0.61-1.40],0.7183885835521039
Chapter II Neoplasms,Melanoma in situ,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",19626,77,1.29 [0.75-2.22],0.3536855953144103
Chapter II Neoplasms,Melanoma in situ,CHCHD6,MICOS complex subunit MIC25,19560,77,1.03 [0.48-2.20],0.9320199293677612
Chapter II Neoplasms,Melanoma in situ,CHEK2,Serine/threonine-protein kinase Chk2,22187,88,0.81 [0.45-1.43],0.4587385427808141
Chapter II Neoplasms,Melanoma in situ,CHGA,Chromogranin-A,19661,77,1.05 [0.83-1.32],0.6936780865206025
Chapter II Neoplasms,Melanoma in situ,CHGB,Secretogranin-1,22697,90,0.86 [0.53-1.39],0.5360178465434233
Chapter II Neoplasms,Melanoma in situ,CHI3L1,Chitinase-3-like protein 1,22061,87,1.12 [0.88-1.43],0.3635627965185701
Chapter II Neoplasms,Melanoma in situ,CHIT1,Chitotriosidase-1,22680,88,1.01 [0.89-1.15],0.8769975176305285
Chapter II Neoplasms,Melanoma in situ,CHL1,Neural cell adhesion molecule L1-like protein,22613,89,0.68 [0.36-1.27],0.2263583745420329
Chapter II Neoplasms,Melanoma in situ,CHM,Rab proteins geranylgeranyltransferase component A 1,19119,72,1.08 [0.75-1.56],0.6649714158873472
Chapter II Neoplasms,Melanoma in situ,CHMP1A,Charged multivesicular body protein 1a,22440,89,1.05 [0.83-1.33],0.7016300274545282
Chapter II Neoplasms,Melanoma in situ,CHMP6,Charged multivesicular body protein 6,19665,77,1.26 [0.85-1.86],0.2476874024059445
Chapter II Neoplasms,Melanoma in situ,CHP1,Calcineurin B homologous protein 1,19060,77,1.11 [0.85-1.44],0.4603669881057276
Chapter II Neoplasms,Melanoma in situ,CHRDL1,Chordin-like protein 1,22653,90,0.87 [0.47-1.63],0.665249066830164
Chapter II Neoplasms,Melanoma in situ,CHRDL2,Chordin-like protein 2,22589,89,0.93 [0.65-1.32],0.6848045442847023
Chapter II Neoplasms,Melanoma in situ,CHRM1,Muscarinic acetylcholine receptor M1,19119,72,0.90 [0.47-1.70],0.7431068936277121
Chapter II Neoplasms,Melanoma in situ,CIAPIN1,Anamorsin,22658,90,1.07 [0.80-1.43],0.6591948962035654
Chapter II Neoplasms,Melanoma in situ,CILP,Cartilage intermediate layer protein 1,19661,77,0.98 [0.66-1.47],0.9379146952652262
Chapter II Neoplasms,Melanoma in situ,CINP,Cyclin-dependent kinase 2-interacting protein,19287,76,0.97 [0.59-1.61],0.9107579910907818
Chapter II Neoplasms,Melanoma in situ,CIRBP,Cold-inducible RNA-binding protein,19566,77,1.19 [0.94-1.51],0.1384300470991425
Chapter II Neoplasms,Melanoma in situ,CIT,Citron Rho-interacting kinase,19119,72,0.69 [0.40-1.18],0.1759041249921161
Chapter II Neoplasms,Melanoma in situ,CKAP4,Cytoskeleton-associated protein 4,22729,90,0.64 [0.30-1.38],0.2585605755528726
Chapter II Neoplasms,Melanoma in situ,CKB,Creatine kinase B-type,19661,77,0.79 [0.55-1.15],0.2176261634551368
Chapter II Neoplasms,Melanoma in situ,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",22509,89,0.96 [0.75-1.23],0.7441970620297809
Chapter II Neoplasms,Melanoma in situ,CLASP1,CLIP-associating protein 1,18973,75,0.91 [0.65-1.26],0.5527470532641983
Chapter II Neoplasms,Melanoma in situ,CLC,Galectin-10,22554,89,1.01 [0.76-1.34],0.957479059633187
Chapter II Neoplasms,Melanoma in situ,CLEC10A,C-type lectin domain family 10 member A,22440,89,0.81 [0.47-1.38],0.4331313788544153
Chapter II Neoplasms,Melanoma in situ,CLEC11A,C-type lectin domain family 11 member A,22549,90,1.12 [0.76-1.66],0.5579759673942937
Chapter II Neoplasms,Melanoma in situ,CLEC12A,C-type lectin domain family 12 member A,19117,75,1.75 [0.69-4.44],0.2414761511229323
Chapter II Neoplasms,Melanoma in situ,CLEC14A,C-type lectin domain family 14 member A,22597,90,0.96 [0.53-1.75],0.9002599666418217
Chapter II Neoplasms,Melanoma in situ,CLEC1A,C-type lectin domain family 1 member A,22187,88,0.92 [0.51-1.66],0.787198601771254
Chapter II Neoplasms,Melanoma in situ,CLEC1B,C-type lectin domain family 1 member B,22788,90,1.02 [0.84-1.23],0.8525471279049417
Chapter II Neoplasms,Melanoma in situ,CLEC2L,C-type lectin domain family 2 member L,19119,72,1.07 [0.71-1.62],0.7348785912501095
Chapter II Neoplasms,Melanoma in situ,CLEC3B,Tetranectin,19220,74,0.67 [0.23-1.97],0.4634960891733929
Chapter II Neoplasms,Melanoma in situ,CLEC4A,C-type lectin domain family 4 member A,22550,90,0.94 [0.54-1.63],0.8235997161067526
Chapter II Neoplasms,Melanoma in situ,CLEC4C,C-type lectin domain family 4 member C,22550,90,1.09 [0.73-1.63],0.6666032620222068
Chapter II Neoplasms,Melanoma in situ,CLEC4D,C-type lectin domain family 4 member D,22550,90,0.91 [0.66-1.24],0.5351046828109156
Chapter II Neoplasms,Melanoma in situ,CLEC4G,C-type lectin domain family 4 member G,22550,90,1.38 [0.79-2.41],0.2646751929530393
Chapter II Neoplasms,Melanoma in situ,CLEC4M,C-type lectin domain family 4 member M,19622,77,0.72 [0.46-1.14],0.1582337825091581
Chapter II Neoplasms,Melanoma in situ,CLEC5A,C-type lectin domain family 5 member A,22522,89,0.92 [0.47-1.80],0.816489865926209
Chapter II Neoplasms,Melanoma in situ,CLEC6A,C-type lectin domain family 6 member A,22078,88,0.92 [0.60-1.40],0.696751155005759
Chapter II Neoplasms,Melanoma in situ,CLEC7A,C-type lectin domain family 7 member A,22837,90,0.73 [0.60-0.90],0.0027890791316966
Chapter II Neoplasms,Melanoma in situ,CLGN,Calmegin,19119,72,1.16 [0.71-1.90],0.5462836070613297
Chapter II Neoplasms,Melanoma in situ,CLIC5,Chloride intracellular channel protein 5,19119,72,0.97 [0.47-2.00],0.9335488510564034
Chapter II Neoplasms,Melanoma in situ,CLINT1,Clathrin interactor 1,18973,75,0.62 [0.35-1.11],0.1074157765490664
Chapter II Neoplasms,Melanoma in situ,CLIP2,CAP-Gly domain-containing linker protein 2,22550,90,1.07 [0.90-1.26],0.4489028277013556
Chapter II Neoplasms,Melanoma in situ,CLMP,CXADR-like membrane protein,22789,90,0.58 [0.23-1.50],0.2616647840924606
Chapter II Neoplasms,Melanoma in situ,CLNS1A,Methylosome subunit pICln,19119,72,0.79 [0.39-1.60],0.5212085140825369
Chapter II Neoplasms,Melanoma in situ,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",22392,89,1.10 [0.90-1.34],0.3576989720019597
Chapter II Neoplasms,Melanoma in situ,CLPS,Colipase,22562,90,1.08 [0.82-1.42],0.5768906461652599
Chapter II Neoplasms,Melanoma in situ,CLSPN,Claspin,21981,90,0.76 [0.40-1.44],0.404201393867256
Chapter II Neoplasms,Melanoma in situ,CLSTN1,Calsyntenin-1,22029,90,0.86 [0.59-1.26],0.4412934476337995
Chapter II Neoplasms,Melanoma in situ,CLSTN2,Calsyntenin-2,22837,90,0.92 [0.56-1.50],0.7329103761519757
Chapter II Neoplasms,Melanoma in situ,CLSTN3,Calsyntenin-3,19626,77,0.93 [0.45-1.92],0.8434846506297121
Chapter II Neoplasms,Melanoma in situ,CLTA,Clathrin light chain A,22187,88,0.94 [0.63-1.41],0.7782938319003743
Chapter II Neoplasms,Melanoma in situ,CLU,Clusterin,19694,77,0.63 [0.22-1.76],0.3787347197835553
Chapter II Neoplasms,Melanoma in situ,CLUL1,Clusterin-like protein 1,22558,88,0.92 [0.61-1.40],0.7129974594855457
Chapter II Neoplasms,Melanoma in situ,CMC1,COX assembly mitochondrial protein homolog,19665,77,1.12 [0.88-1.42],0.3497403998898405
Chapter II Neoplasms,Melanoma in situ,CMIP,C-Maf-inducing protein,19560,77,1.10 [0.84-1.43],0.4870043242505188
Chapter II Neoplasms,Melanoma in situ,CNDP1,Beta-Ala-His dipeptidase,22650,89,1.03 [0.67-1.57],0.8962204312118904
Chapter II Neoplasms,Melanoma in situ,CNGB3,Cyclic nucleotide-gated cation channel beta-3,19060,77,0.94 [0.61-1.43],0.7645413829494336
Chapter II Neoplasms,Melanoma in situ,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",19130,75,1.07 [0.81-1.42],0.6150296412905596
Chapter II Neoplasms,Melanoma in situ,CNPY2,Protein canopy homolog 2,22187,88,1.06 [0.79-1.41],0.6976436629416136
Chapter II Neoplasms,Melanoma in situ,CNPY4,Protein canopy homolog 4,22484,88,1.03 [0.80-1.32],0.8187474777147219
Chapter II Neoplasms,Melanoma in situ,CNST,Consortin,22589,89,1.11 [0.94-1.32],0.2265214332620074
Chapter II Neoplasms,Melanoma in situ,CNTF,Ciliary neurotrophic factor,19060,77,0.77 [0.40-1.47],0.4259180990891797
Chapter II Neoplasms,Melanoma in situ,CNTN1,Contactin-1,22859,89,1.00 [0.51-1.97],0.9956532518556808
Chapter II Neoplasms,Melanoma in situ,CNTN2,Contactin-2,22789,90,0.97 [0.64-1.46],0.8722285850264931
Chapter II Neoplasms,Melanoma in situ,CNTN3,Contactin-3,22597,90,1.06 [0.61-1.84],0.8332318368857404
Chapter II Neoplasms,Melanoma in situ,CNTN4,Contactin-4,22597,90,0.65 [0.30-1.42],0.2833477431579073
Chapter II Neoplasms,Melanoma in situ,CNTN5,Contactin-5,22640,90,0.97 [0.59-1.61],0.9123375061539604
Chapter II Neoplasms,Melanoma in situ,CNTNAP2,Contactin-associated protein-like 2,22550,90,1.33 [0.84-2.10],0.2276319194774661
Chapter II Neoplasms,Melanoma in situ,CNTNAP4,Contactin-associated protein-like 4,19119,72,1.05 [0.85-1.29],0.6543023170204956
Chapter II Neoplasms,Melanoma in situ,COCH,Cochlin,19665,77,0.84 [0.52-1.36],0.4838164657283168
Chapter II Neoplasms,Melanoma in situ,COL15A1,Collagen alpha-1(XV) chain,19661,77,1.32 [0.57-3.04],0.5146311781492883
Chapter II Neoplasms,Melanoma in situ,COL18A1,Collagen alpha-1(XVIII) chain,22682,87,0.88 [0.38-2.02],0.7647810015003366
Chapter II Neoplasms,Melanoma in situ,COL1A1,Collagen alpha-1(I) chain,22859,89,0.88 [0.43-1.79],0.7234544393693714
Chapter II Neoplasms,Melanoma in situ,COL24A1,Collagen alpha-1(XXIV) chain,19566,77,0.90 [0.60-1.33],0.584767980054701
Chapter II Neoplasms,Melanoma in situ,COL28A1,Collagen alpha-1(XXVIII) chain,19119,72,0.88 [0.64-1.22],0.4532256347081849
Chapter II Neoplasms,Melanoma in situ,COL2A1,Collagen alpha-1(II) chain,19167,75,0.94 [0.72-1.24],0.6582867425268042
Chapter II Neoplasms,Melanoma in situ,COL3A1,Collagen alpha-1(III) chain,19661,77,1.04 [0.40-2.69],0.9347094619987004
Chapter II Neoplasms,Melanoma in situ,COL4A1,Collagen alpha-1(IV) chain,22589,89,1.36 [0.85-2.17],0.2029115266263831
Chapter II Neoplasms,Melanoma in situ,COL4A4,Collagen alpha-4(IV) chain,19256,76,1.14 [0.74-1.77],0.5437529905939715
Chapter II Neoplasms,Melanoma in situ,COL5A1,Collagen alpha-1(V) chain,19255,75,0.77 [0.43-1.38],0.3855178242694075
Chapter II Neoplasms,Melanoma in situ,COL6A3,Collagen alpha-3(VI) chain,22859,89,0.98 [0.56-1.74],0.9530296917751788
Chapter II Neoplasms,Melanoma in situ,COL9A1,Collagen alpha-1(IX) chain,22550,90,1.41 [1.00-2.01],0.0522691411822293
Chapter II Neoplasms,Melanoma in situ,COL9A2,Collagen alpha-2(IX) chain,19287,76,1.19 [0.81-1.76],0.3751618654094375
Chapter II Neoplasms,Melanoma in situ,COLEC12,Collectin-12,22583,90,0.79 [0.37-1.69],0.5464688012410466
Chapter II Neoplasms,Melanoma in situ,COMMD1,COMM domain-containing protein 1,19167,75,1.18 [0.83-1.69],0.3463902338936345
Chapter II Neoplasms,Melanoma in situ,COMMD9,COMM domain-containing protein 9,19560,77,1.37 [0.86-2.17],0.1809316476425929
Chapter II Neoplasms,Melanoma in situ,COMP,Cartilage oligomeric matrix protein,22321,87,1.46 [0.82-2.60],0.1962166246582959
Chapter II Neoplasms,Melanoma in situ,COMT,Catechol O-methyltransferase,21952,88,1.01 [0.81-1.27],0.9054813805790308
Chapter II Neoplasms,Melanoma in situ,COPB2,Coatomer subunit beta',19066,75,1.02 [0.60-1.72],0.943468252011606
Chapter II Neoplasms,Melanoma in situ,COPE,Coatomer subunit epsilon,22029,90,0.77 [0.48-1.23],0.2780868127504706
Chapter II Neoplasms,Melanoma in situ,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",19167,75,0.72 [0.41-1.27],0.2570125826946509
Chapter II Neoplasms,Melanoma in situ,CORO1A,Coronin-1A,22104,86,1.04 [0.84-1.28],0.7424618327936848
Chapter II Neoplasms,Melanoma in situ,CORO6,Coronin-6,19060,77,0.93 [0.50-1.73],0.8124825215750103
Chapter II Neoplasms,Melanoma in situ,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",22484,88,0.89 [0.68-1.18],0.4350766927333278
Chapter II Neoplasms,Melanoma in situ,COX6B1,Cytochrome c oxidase subunit 6B1,19665,77,1.20 [0.62-2.33],0.585018190256112
Chapter II Neoplasms,Melanoma in situ,CPA1,Carboxypeptidase A1,22859,89,1.15 [0.83-1.58],0.4076111523934107
Chapter II Neoplasms,Melanoma in situ,CPA2,Carboxypeptidase A2,22702,90,0.91 [0.68-1.22],0.5394385546401756
Chapter II Neoplasms,Melanoma in situ,CPA4,Carboxypeptidase A4,18865,75,0.88 [0.53-1.48],0.6298420961706681
Chapter II Neoplasms,Melanoma in situ,CPB1,Carboxypeptidase B,22859,89,1.16 [0.84-1.61],0.3615992699788837
Chapter II Neoplasms,Melanoma in situ,CPB2,Carboxypeptidase B2,19650,77,0.65 [0.24-1.75],0.3990599723042352
Chapter II Neoplasms,Melanoma in situ,CPE,Carboxypeptidase E,22627,90,0.80 [0.51-1.26],0.3434290761476072
Chapter II Neoplasms,Melanoma in situ,CPLX2,Complexin-2,18973,75,1.19 [0.61-2.31],0.6129110564322706
Chapter II Neoplasms,Melanoma in situ,CPM,Carboxypeptidase M,22681,90,0.89 [0.51-1.55],0.6725788738416127
Chapter II Neoplasms,Melanoma in situ,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",19117,75,0.81 [0.35-1.85],0.6120660260193147
Chapter II Neoplasms,Melanoma in situ,CPPED1,Serine/threonine-protein phosphatase CPPED1,22788,90,1.00 [0.76-1.32],0.9803165992480136
Chapter II Neoplasms,Melanoma in situ,CPQ,Carboxypeptidase Q,19619,77,0.70 [0.38-1.30],0.2602027457897523
Chapter II Neoplasms,Melanoma in situ,CPTP,Ceramide-1-phosphate transfer protein,19066,75,0.73 [0.39-1.37],0.3343987218280572
Chapter II Neoplasms,Melanoma in situ,CPVL,Probable serine carboxypeptidase CPVL,22761,90,0.60 [0.40-0.90],0.0138872832761928
Chapter II Neoplasms,Melanoma in situ,CPXM1,Probable carboxypeptidase X1,22658,90,0.93 [0.71-1.21],0.5814792091335164
Chapter II Neoplasms,Melanoma in situ,CPXM2,Inactive carboxypeptidase-like protein X2,19665,77,0.71 [0.29-1.74],0.4515347674254079
Chapter II Neoplasms,Melanoma in situ,CR1,Complement receptor type 1,19588,77,1.21 [0.65-2.24],0.5512363634853179
Chapter II Neoplasms,Melanoma in situ,CR2,Complement receptor type 2,22650,89,1.17 [0.78-1.76],0.4419142503891626
Chapter II Neoplasms,Melanoma in situ,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,22078,88,1.06 [0.85-1.31],0.6127013137117754
Chapter II Neoplasms,Melanoma in situ,CRADD,Death domain-containing protein CRADD,22392,89,1.00 [0.78-1.28],0.9890827236107624
Chapter II Neoplasms,Melanoma in situ,CREB3,Cyclic AMP-responsive element-binding protein 3,18973,75,1.40 [1.05-1.85],0.0205825877507677
Chapter II Neoplasms,Melanoma in situ,CREBZF,CREB/ATF bZIP transcription factor,18973,75,0.93 [0.39-2.20],0.8618944627432802
Chapter II Neoplasms,Melanoma in situ,CREG1,Protein CREG1,22290,87,0.94 [0.55-1.61],0.8220044524805716
Chapter II Neoplasms,Melanoma in situ,CRELD1,Protein disulfide isomerase CRELD1,19255,75,1.62 [0.91-2.91],0.1034843635368389
Chapter II Neoplasms,Melanoma in situ,CRELD2,Protein disulfide isomerase CRELD2,22653,90,0.99 [0.69-1.43],0.973555379043217
Chapter II Neoplasms,Melanoma in situ,CRH,Corticoliberin,22037,88,0.94 [0.75-1.17],0.5799345506354029
Chapter II Neoplasms,Melanoma in situ,CRHBP,Corticotropin-releasing factor-binding protein,22583,90,0.97 [0.49-1.90],0.9262875753238072
Chapter II Neoplasms,Melanoma in situ,CRHR1,Corticotropin-releasing factor receptor 1,22187,88,0.97 [0.72-1.32],0.8633412658000523
Chapter II Neoplasms,Melanoma in situ,CRIM1,Cysteine-rich motor neuron 1 protein,22692,90,0.49 [0.19-1.28],0.1477662247419721
Chapter II Neoplasms,Melanoma in situ,CRIP2,Cysteine-rich protein 2,22440,89,0.80 [0.47-1.37],0.4124793944506586
Chapter II Neoplasms,Melanoma in situ,CRISP2,Cysteine-rich secretory protein 2,22789,90,1.03 [0.76-1.39],0.8513803727047169
Chapter II Neoplasms,Melanoma in situ,CRISP3,Cysteine-rich secretory protein 3,19488,76,1.02 [0.45-2.32],0.9580561388995326
Chapter II Neoplasms,Melanoma in situ,CRKL,Crk-like protein,22619,89,1.05 [0.88-1.26],0.5656861986704789
Chapter II Neoplasms,Melanoma in situ,CRLF1,Cytokine receptor-like factor 1,22692,90,1.75 [0.83-3.71],0.1410731563663407
Chapter II Neoplasms,Melanoma in situ,CRNN,Cornulin,21946,88,0.98 [0.74-1.30],0.8920696754485125
Chapter II Neoplasms,Melanoma in situ,CRTAC1,Cartilage acidic protein 1,22859,89,0.69 [0.37-1.28],0.2436729140952701
Chapter II Neoplasms,Melanoma in situ,CRTAM,Cytotoxic and regulatory T-cell molecule,22440,89,0.98 [0.68-1.43],0.93326550737932
Chapter II Neoplasms,Melanoma in situ,CRTAP,Cartilage-associated protein,19119,72,0.91 [0.56-1.48],0.6965914634926444
Chapter II Neoplasms,Melanoma in situ,CRX,Cone-rod homeobox protein,22187,88,0.93 [0.77-1.13],0.4656441448059893
Chapter II Neoplasms,Melanoma in situ,CRYBB1,Beta-crystallin B1,19665,77,1.29 [0.92-1.79],0.1362784556210313
Chapter II Neoplasms,Melanoma in situ,CRYBB2,Beta-crystallin B2,19626,77,1.08 [0.83-1.41],0.5623149290570816
Chapter II Neoplasms,Melanoma in situ,CRYGD,Gamma-crystallin D,19626,77,1.03 [0.82-1.29],0.8054711321314713
Chapter II Neoplasms,Melanoma in situ,CRYM,Ketimine reductase mu-crystallin,19060,77,0.94 [0.70-1.27],0.6889930268687423
Chapter II Neoplasms,Melanoma in situ,CRYZL1,Quinone oxidoreductase-like protein 1,19167,75,1.07 [0.84-1.37],0.5654166386780088
Chapter II Neoplasms,Melanoma in situ,CSDE1,Cold shock domain-containing protein E1,19066,75,1.02 [0.85-1.22],0.8153693666849473
Chapter II Neoplasms,Melanoma in situ,CSF1,Macrophage colony-stimulating factor 1,22692,90,1.19 [0.59-2.38],0.6326947690814018
Chapter II Neoplasms,Melanoma in situ,CSF1R,Macrophage colony-stimulating factor 1 receptor,19669,77,1.17 [0.67-2.05],0.5778685817033087
Chapter II Neoplasms,Melanoma in situ,CSF2,Granulocyte-macrophage colony-stimulating factor,19066,75,0.50 [0.26-0.97],0.0402502528651226
Chapter II Neoplasms,Melanoma in situ,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,22440,89,1.04 [0.77-1.39],0.8179987130408364
Chapter II Neoplasms,Melanoma in situ,CSF2RB,Cytokine receptor common subunit beta,19117,75,0.51 [0.31-0.83],0.0068268642362278
Chapter II Neoplasms,Melanoma in situ,CSF3,Granulocyte colony-stimulating factor,22161,88,0.75 [0.50-1.13],0.1716029339675563
Chapter II Neoplasms,Melanoma in situ,CSF3R,Granulocyte colony-stimulating factor receptor,19117,75,1.46 [0.76-2.82],0.2536452567716007
Chapter II Neoplasms,Melanoma in situ,CSH1,Chorionic somatomammotropin hormone 1,19669,77,1.15 [0.60-2.20],0.6838437190112456
Chapter II Neoplasms,Melanoma in situ,CSNK1D,Casein kinase I isoform delta,19117,75,0.96 [0.68-1.37],0.8364129006704291
Chapter II Neoplasms,Melanoma in situ,CSNK2A1,Casein kinase II subunit alpha,19635,77,1.29 [0.80-2.06],0.2939752989666806
Chapter II Neoplasms,Melanoma in situ,CSPG4,Chondroitin sulfate proteoglycan 4,19661,77,1.00 [0.51-1.96],0.9992299049503088
Chapter II Neoplasms,Melanoma in situ,CSPG5,Chondroitin sulfate proteoglycan 5,19060,77,0.89 [0.56-1.42],0.6236157966500153
Chapter II Neoplasms,Melanoma in situ,CSRP3,Cysteine and glycine-rich protein 3,19066,75,0.95 [0.74-1.21],0.6525423314734122
Chapter II Neoplasms,Melanoma in situ,CST1,Cystatin-SN,17061,67,1.07 [0.85-1.36],0.5494467174249604
Chapter II Neoplasms,Melanoma in situ,CST3,Cystatin-C,22617,89,0.96 [0.48-1.91],0.8991777408948302
Chapter II Neoplasms,Melanoma in situ,CST5,Cystatin-D,22209,87,0.88 [0.62-1.25],0.4830400381537353
Chapter II Neoplasms,Melanoma in situ,CST6,Cystatin-M,22012,83,0.77 [0.51-1.17],0.2160203017124436
Chapter II Neoplasms,Melanoma in situ,CST7,Cystatin-F,22624,90,0.94 [0.76-1.16],0.5466793086987496
Chapter II Neoplasms,Melanoma in situ,CSTB,Cystatin-B,22276,87,1.18 [0.76-1.85],0.462264387216996
Chapter II Neoplasms,Melanoma in situ,CTAG1A_CTAG1B,Cancer/testis antigen 1,19244,76,0.97 [0.62-1.51],0.8778033129073078
Chapter II Neoplasms,Melanoma in situ,CTBS,Di-N-acetylchitobiase,19375,77,1.49 [0.64-3.49],0.3527749921274952
Chapter II Neoplasms,Melanoma in situ,CTF1,Cardiotrophin-1,22187,88,0.91 [0.73-1.15],0.4455369500435289
Chapter II Neoplasms,Melanoma in situ,CTHRC1,Collagen triple helix repeat-containing protein 1,19661,77,1.29 [0.60-2.80],0.5116843703202305
Chapter II Neoplasms,Melanoma in situ,CTLA4,Cytotoxic T-lymphocyte protein 4,19661,77,0.74 [0.35-1.56],0.4226421782735333
Chapter II Neoplasms,Melanoma in situ,CTNNA1,Catenin alpha-1,19060,77,0.89 [0.46-1.71],0.7156546593290782
Chapter II Neoplasms,Melanoma in situ,CTRB1,Chymotrypsinogen B,22597,90,1.06 [0.75-1.50],0.7469156762318658
Chapter II Neoplasms,Melanoma in situ,CTRC,Chymotrypsin-C,22592,90,1.00 [0.74-1.35],0.992652170741216
Chapter II Neoplasms,Melanoma in situ,CTRL,Chymotrypsin-like protease CTRL-1,19626,77,1.26 [0.91-1.76],0.1622686858036722
Chapter II Neoplasms,Melanoma in situ,CTSB,Cathepsin B,22607,88,0.93 [0.66-1.33],0.7016947905438273
Chapter II Neoplasms,Melanoma in situ,CTSC,Dipeptidyl peptidase 1,22548,89,1.12 [0.73-1.72],0.6097883640423685
Chapter II Neoplasms,Melanoma in situ,CTSD,Cathepsin D,21064,81,0.71 [0.41-1.25],0.2347491733274434
Chapter II Neoplasms,Melanoma in situ,CTSE,Cathepsin E,19255,75,0.71 [0.46-1.10],0.1229095752357095
Chapter II Neoplasms,Melanoma in situ,CTSF,Cathepsin F,22658,90,0.67 [0.42-1.06],0.0882720605926088
Chapter II Neoplasms,Melanoma in situ,CTSH,Pro-cathepsin H,22125,88,0.86 [0.66-1.11],0.2441617106987994
Chapter II Neoplasms,Melanoma in situ,CTSL,Cathepsin L1,22589,89,1.17 [0.54-2.55],0.6894944469162025
Chapter II Neoplasms,Melanoma in situ,CTSO,Cathepsin O,22837,90,1.17 [0.63-2.18],0.6147780266486709
Chapter II Neoplasms,Melanoma in situ,CTSS,Cathepsin S,17734,71,0.82 [0.31-2.17],0.6899883648605438
Chapter II Neoplasms,Melanoma in situ,CTSV,Cathepsin L2,22730,90,1.03 [0.66-1.62],0.8841179177881392
Chapter II Neoplasms,Melanoma in situ,CTSZ,Cathepsin Z,22571,89,0.98 [0.53-1.80],0.9390512482272804
Chapter II Neoplasms,Melanoma in situ,CUZD1,CUB and zona pellucida-like domain-containing protein 1,19119,72,1.26 [0.74-2.15],0.3970927750589964
Chapter II Neoplasms,Melanoma in situ,CWC15,Spliceosome-associated protein CWC15 homolog,19448,77,1.08 [0.78-1.49],0.6533782032185351
Chapter II Neoplasms,Melanoma in situ,CX3CL1,Fractalkine,22440,89,1.05 [0.60-1.84],0.8678753292294115
Chapter II Neoplasms,Melanoma in situ,CXADR,Coxsackievirus and adenovirus receptor,22550,90,1.22 [0.87-1.70],0.2476996278943796
Chapter II Neoplasms,Melanoma in situ,CXCL1,Growth-regulated alpha protein,22549,90,0.98 [0.81-1.19],0.8547354838604648
Chapter II Neoplasms,Melanoma in situ,CXCL10,C-X-C motif chemokine 10,22692,90,1.04 [0.80-1.37],0.7642431782144299
Chapter II Neoplasms,Melanoma in situ,CXCL11,C-X-C motif chemokine 11,22788,90,1.12 [0.90-1.40],0.3024462919396926
Chapter II Neoplasms,Melanoma in situ,CXCL12,Stromal cell-derived factor 1,22161,88,0.72 [0.45-1.17],0.1855938340139463
Chapter II Neoplasms,Melanoma in situ,CXCL13,C-X-C motif chemokine 13,22788,90,0.94 [0.68-1.29],0.6851266218724812
Chapter II Neoplasms,Melanoma in situ,CXCL14,C-X-C motif chemokine 14,22161,88,1.10 [0.83-1.45],0.52765607859655
Chapter II Neoplasms,Melanoma in situ,CXCL16,C-X-C motif chemokine 16,22820,89,1.19 [0.53-2.67],0.6647759709214073
Chapter II Neoplasms,Melanoma in situ,CXCL17,C-X-C motif chemokine 17,22837,90,0.96 [0.59-1.54],0.852669352211641
Chapter II Neoplasms,Melanoma in situ,CXCL3,C-X-C motif chemokine 3,22585,90,1.04 [0.85-1.27],0.7005688623588834
Chapter II Neoplasms,Melanoma in situ,CXCL5,C-X-C motif chemokine 5,22516,89,0.96 [0.82-1.13],0.601724463486963
Chapter II Neoplasms,Melanoma in situ,CXCL6,C-X-C motif chemokine 6,22837,90,0.89 [0.70-1.13],0.334233067498591
Chapter II Neoplasms,Melanoma in situ,CXCL8,Interleukin-8,22413,88,1.03 [0.79-1.34],0.852043983213561
Chapter II Neoplasms,Melanoma in situ,CXCL9,C-X-C motif chemokine 9,22692,90,1.06 [0.81-1.39],0.6841566636822489
Chapter II Neoplasms,Melanoma in situ,CYB5A,Cytochrome b5,18973,75,1.07 [0.81-1.41],0.6554966040988996
Chapter II Neoplasms,Melanoma in situ,CYB5R2,NADH-cytochrome b5 reductase 2,19323,75,1.32 [0.91-1.91],0.1444651341465267
Chapter II Neoplasms,Melanoma in situ,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",19066,75,1.10 [0.88-1.38],0.3956639872811084
Chapter II Neoplasms,Melanoma in situ,CYTH3,Cytohesin-3,18973,75,1.02 [0.76-1.37],0.9021165755684076
Chapter II Neoplasms,Melanoma in situ,CYTL1,Cytokine-like protein 1,19661,77,0.73 [0.29-1.85],0.5005668036838675
Chapter II Neoplasms,Melanoma in situ,DAAM1,Disheveled-associated activator of morphogenesis 1,19255,75,1.14 [0.87-1.49],0.336239174072029
Chapter II Neoplasms,Melanoma in situ,DAB2,Disabled homolog 2,22789,90,1.08 [0.91-1.28],0.3719988486247034
Chapter II Neoplasms,Melanoma in situ,DAG1,Dystroglycan,22692,90,1.04 [0.70-1.54],0.8472836378496799
Chapter II Neoplasms,Melanoma in situ,DAND5,DAN domain family member 5,19117,75,0.88 [0.58-1.34],0.5528210006547587
Chapter II Neoplasms,Melanoma in situ,DAPK2,Death-associated protein kinase 2,19117,75,1.07 [0.73-1.57],0.7330680840480848
Chapter II Neoplasms,Melanoma in situ,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,22550,90,1.02 [0.87-1.19],0.8454794254932254
Chapter II Neoplasms,Melanoma in situ,DARS1,"Aspartate--tRNA ligase, cytoplasmic",22392,89,1.04 [0.80-1.34],0.7903893613669657
Chapter II Neoplasms,Melanoma in situ,DBH,Dopamine beta-hydroxylase,19628,77,1.12 [0.89-1.41],0.3363634879512749
Chapter II Neoplasms,Melanoma in situ,DBI,Acyl-CoA-binding protein,22498,90,1.09 [0.86-1.38],0.4715579979830459
Chapter II Neoplasms,Melanoma in situ,DBN1,Drebrin,19117,75,1.48 [1.02-2.16],0.0402988234616933
Chapter II Neoplasms,Melanoma in situ,DBNL,Drebrin-like protein,22692,90,1.09 [0.89-1.33],0.4128173369980473
Chapter II Neoplasms,Melanoma in situ,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",22658,90,0.75 [0.44-1.30],0.3077170726513138
Chapter II Neoplasms,Melanoma in situ,DCC,Netrin receptor DCC,19119,72,1.04 [0.41-2.65],0.9331803425862834
Chapter II Neoplasms,Melanoma in situ,DCDC2C,Doublecortin domain-containing protein 2C,18973,75,1.14 [0.83-1.55],0.4144828221678133
Chapter II Neoplasms,Melanoma in situ,DCLRE1C,Protein artemis,18973,75,1.25 [0.65-2.43],0.5033408868550497
Chapter II Neoplasms,Melanoma in situ,DCN,Decorin,22187,88,0.99 [0.43-2.30],0.98715095187519
Chapter II Neoplasms,Melanoma in situ,DCTD,Deoxycytidylate deaminase,19255,75,1.17 [0.92-1.49],0.1928715564706589
Chapter II Neoplasms,Melanoma in situ,DCTN1,Dynactin subunit 1,22789,90,1.10 [0.83-1.45],0.5236678052367607
Chapter II Neoplasms,Melanoma in situ,DCTN2,Dynactin subunit 2,22484,88,1.05 [0.86-1.29],0.6022300478276759
Chapter II Neoplasms,Melanoma in situ,DCTN6,Dynactin subunit 6,22029,90,0.94 [0.71-1.24],0.6471982827642202
Chapter II Neoplasms,Melanoma in situ,DCTPP1,dCTP pyrophosphatase 1,22589,89,1.31 [0.71-2.42],0.3802556730974553
Chapter II Neoplasms,Melanoma in situ,DCUN1D1,DCN1-like protein 1,19060,77,1.07 [0.82-1.39],0.6234474635602363
Chapter II Neoplasms,Melanoma in situ,DCUN1D2,DCN1-like protein 2,18973,75,1.01 [0.77-1.31],0.9477325643943144
Chapter II Neoplasms,Melanoma in situ,DCXR,L-xylulose reductase,22658,90,1.01 [0.71-1.44],0.9575888263031116
Chapter II Neoplasms,Melanoma in situ,DDA1,DET1- and DDB1-associated protein 1,19066,75,0.71 [0.38-1.33],0.2850715396074114
Chapter II Neoplasms,Melanoma in situ,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",22484,88,1.25 [0.83-1.87],0.2879481437263903
Chapter II Neoplasms,Melanoma in situ,DDC,Aromatic-L-amino-acid decarboxylase,22555,89,1.29 [0.88-1.89],0.1882359399368827
Chapter II Neoplasms,Melanoma in situ,DDHD2,Phospholipase DDHD2,19635,77,1.06 [0.76-1.47],0.7308764490391289
Chapter II Neoplasms,Melanoma in situ,DDI2,Protein DDI1 homolog 2,19255,75,0.86 [0.65-1.14],0.2959621555016399
Chapter II Neoplasms,Melanoma in situ,DDR1,Epithelial discoidin domain-containing receptor 1,22788,90,0.80 [0.34-1.89],0.6141548952684236
Chapter II Neoplasms,Melanoma in situ,DDT,D-dopachrome decarboxylase,19661,77,0.82 [0.47-1.41],0.4715977096525303
Chapter II Neoplasms,Melanoma in situ,DDX1,ATP-dependent RNA helicase DDX1,19566,77,0.70 [0.42-1.17],0.1789863906742855
Chapter II Neoplasms,Melanoma in situ,DDX25,ATP-dependent RNA helicase DDX25,19119,72,1.00 [0.56-1.80],0.997560202270378
Chapter II Neoplasms,Melanoma in situ,DDX39A,ATP-dependent RNA helicase DDX39A,19117,75,1.19 [0.46-3.08],0.7268133811068115
Chapter II Neoplasms,Melanoma in situ,DDX4,Probable ATP-dependent RNA helicase DDX4,19117,75,0.68 [0.41-1.13],0.1381099342754634
Chapter II Neoplasms,Melanoma in situ,DDX53,Probable ATP-dependent RNA helicase DDX53,19119,72,1.26 [0.68-2.33],0.4588527901167284
Chapter II Neoplasms,Melanoma in situ,DDX58,Antiviral innate immune response receptor RIG-I,22078,88,1.10 [0.81-1.50],0.525646408084677
Chapter II Neoplasms,Melanoma in situ,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",22550,90,0.98 [0.81-1.19],0.8772997532874152
Chapter II Neoplasms,Melanoma in situ,DEFA1_DEFA1B,Neutrophil defensin 1,22107,86,1.16 [0.83-1.64],0.3824667081276933
Chapter II Neoplasms,Melanoma in situ,DEFB103A_DEFB103B,Beta-defensin 103,18965,75,1.17 [0.75-1.83],0.491762938482687
Chapter II Neoplasms,Melanoma in situ,DEFB104A_DEFB104B,Beta-defensin 104,19060,77,1.21 [0.86-1.70],0.2823792298197594
Chapter II Neoplasms,Melanoma in situ,DEFB116,Beta-defensin 116,19060,77,1.13 [0.89-1.44],0.3126772234224154
Chapter II Neoplasms,Melanoma in situ,DEFB118,Beta-defensin 118,19060,77,0.99 [0.68-1.45],0.9748108474581568
Chapter II Neoplasms,Melanoma in situ,DEFB4A_DEFB4B,Beta-defensin 4A,22278,87,0.93 [0.81-1.06],0.2644893550155603
Chapter II Neoplasms,Melanoma in situ,DENND2B,DENN domain-containing protein 2B,19066,75,0.95 [0.61-1.48],0.8341310833511824
Chapter II Neoplasms,Melanoma in situ,DENR,Density-regulated protein,19117,75,0.97 [0.66-1.44],0.8928456960240054
Chapter II Neoplasms,Melanoma in situ,DFFA,DNA fragmentation factor subunit alpha,22837,90,1.05 [0.80-1.38],0.7227080174701934
Chapter II Neoplasms,Melanoma in situ,DGCR6,Protein DGCR6,19060,77,1.01 [0.62-1.62],0.9819087434077064
Chapter II Neoplasms,Melanoma in situ,DGKA,Diacylglycerol kinase alpha,19117,75,1.04 [0.69-1.57],0.83434698193921
Chapter II Neoplasms,Melanoma in situ,DGKZ,Diacylglycerol kinase zeta,22161,88,1.02 [0.59-1.74],0.9499604261787328
Chapter II Neoplasms,Melanoma in situ,DHODH,Dihydroorotate dehydrogenase,19066,75,1.49 [1.12-2.00],0.0068324030486617
Chapter II Neoplasms,Melanoma in situ,DHPS,Deoxyhypusine synthase,19560,77,0.95 [0.55-1.64],0.8665450263804237
Chapter II Neoplasms,Melanoma in situ,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,19626,77,1.04 [0.66-1.64],0.8707050894631837
Chapter II Neoplasms,Melanoma in situ,DIABLO,"Diablo homolog, mitochondrial",22522,89,1.10 [0.93-1.31],0.2756616042162585
Chapter II Neoplasms,Melanoma in situ,DIPK1C,Divergent protein kinase domain 1C,19119,72,1.23 [0.77-1.97],0.3830751605641265
Chapter II Neoplasms,Melanoma in situ,DIPK2B,Divergent protein kinase domain 2B,19255,75,0.63 [0.26-1.49],0.2918961182139395
Chapter II Neoplasms,Melanoma in situ,DKK1,Dickkopf-related protein 1,22788,90,0.84 [0.61-1.14],0.2655783591011267
Chapter II Neoplasms,Melanoma in situ,DKK3,Dickkopf-related protein 3,22859,89,0.96 [0.51-1.83],0.9127474240094192
Chapter II Neoplasms,Melanoma in situ,DKK4,Dickkopf-related protein 4,22409,88,1.02 [0.67-1.54],0.943720190501653
Chapter II Neoplasms,Melanoma in situ,DKKL1,Dickkopf-like protein 1,22484,88,1.10 [0.88-1.38],0.4162451475775159
Chapter II Neoplasms,Melanoma in situ,DLG4,Disks large homolog 4,19626,77,1.14 [0.85-1.53],0.3795725668647682
Chapter II Neoplasms,Melanoma in situ,DLGAP5,Disks large-associated protein 5,19635,77,0.65 [0.36-1.17],0.15141722962897
Chapter II Neoplasms,Melanoma in situ,DLK1,Protein delta homolog 1,22859,89,0.95 [0.67-1.35],0.7734107580242282
Chapter II Neoplasms,Melanoma in situ,DLL1,Delta-like protein 1,22658,90,0.94 [0.49-1.82],0.8646330719347315
Chapter II Neoplasms,Melanoma in situ,DLL4,Delta-like protein 4,19167,75,0.85 [0.59-1.23],0.3957375028163491
Chapter II Neoplasms,Melanoma in situ,DMD,Dystrophin,19167,75,1.10 [0.72-1.68],0.654992538499438
Chapter II Neoplasms,Melanoma in situ,DMP1,Dentin matrix acidic phosphoprotein 1,19167,75,0.92 [0.66-1.29],0.6384967026839152
Chapter II Neoplasms,Melanoma in situ,DNAJA1,DnaJ homolog subfamily A member 1,18973,75,0.87 [0.51-1.46],0.5892367714424597
Chapter II Neoplasms,Melanoma in situ,DNAJA2,DnaJ homolog subfamily A member 2,22769,90,1.06 [0.85-1.33],0.6095986828985723
Chapter II Neoplasms,Melanoma in situ,DNAJA4,DnaJ homolog subfamily A member 4,19626,77,0.74 [0.54-1.01],0.0573492230102492
Chapter II Neoplasms,Melanoma in situ,DNAJB1,DnaJ homolog subfamily B member 1,22484,88,0.97 [0.78-1.19],0.7432673517909549
Chapter II Neoplasms,Melanoma in situ,DNAJB14,DnaJ homolog subfamily B member 14,19566,77,1.28 [0.93-1.75],0.1300431504984689
Chapter II Neoplasms,Melanoma in situ,DNAJB2,DnaJ homolog subfamily B member 2,19255,75,0.85 [0.56-1.28],0.4337802996462846
Chapter II Neoplasms,Melanoma in situ,DNAJB6,DnaJ homolog subfamily B member 6,19064,75,1.17 [0.90-1.53],0.2311884426369303
Chapter II Neoplasms,Melanoma in situ,DNAJB8,DnaJ homolog subfamily B member 8,22187,88,0.96 [0.69-1.34],0.818308493506628
Chapter II Neoplasms,Melanoma in situ,DNAJC21,DnaJ homolog subfamily C member 21,19626,77,1.30 [0.77-2.21],0.3249427666251537
Chapter II Neoplasms,Melanoma in situ,DNAJC6,Putative tyrosine-protein phosphatase auxilin,19167,75,1.05 [0.81-1.37],0.6965033297868721
Chapter II Neoplasms,Melanoma in situ,DNAJC9,DnaJ homolog subfamily C member 9,19566,77,0.98 [0.74-1.30],0.8945304366567333
Chapter II Neoplasms,Melanoma in situ,DNER,Delta and Notch-like epidermal growth factor-related receptor,22551,90,1.18 [0.55-2.54],0.6755863142767575
Chapter II Neoplasms,Melanoma in situ,DNLZ,DNL-type zinc finger protein,19060,77,1.00 [0.80-1.26],0.9940915783465226
Chapter II Neoplasms,Melanoma in situ,DNM1,Dynamin-1,19566,77,1.10 [0.90-1.33],0.3612738023073378
Chapter II Neoplasms,Melanoma in situ,DNM3,Dynamin-3,19635,77,1.23 [0.85-1.79],0.2719888213798525
Chapter II Neoplasms,Melanoma in situ,DNMBP,Dynamin-binding protein,22440,89,1.12 [0.83-1.51],0.4586018138610879
Chapter II Neoplasms,Melanoma in situ,DNPEP,Aspartyl aminopeptidase,19626,77,0.92 [0.64-1.32],0.6417987341488115
Chapter II Neoplasms,Melanoma in situ,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,22658,89,0.75 [0.52-1.08],0.1184359655021168
Chapter II Neoplasms,Melanoma in situ,DOC2B,Double C2-like domain-containing protein beta,19119,72,0.87 [0.43-1.73],0.6867137542731054
Chapter II Neoplasms,Melanoma in situ,DOCK9,Dedicator of cytokinesis protein 9,19060,77,1.01 [0.85-1.21],0.8986550759574037
Chapter II Neoplasms,Melanoma in situ,DOK1,Docking protein 1,19626,77,1.14 [0.96-1.34],0.1306298084023499
Chapter II Neoplasms,Melanoma in situ,DOK2,Docking protein 2,22589,89,1.09 [0.94-1.28],0.2527841271705894
Chapter II Neoplasms,Melanoma in situ,DPEP1,Dipeptidase 1,22392,89,0.87 [0.60-1.24],0.4328994202630953
Chapter II Neoplasms,Melanoma in situ,DPEP2,Dipeptidase 2,22484,88,0.81 [0.41-1.59],0.5340610185424708
Chapter II Neoplasms,Melanoma in situ,DPP10,Inactive dipeptidyl peptidase 10,22550,90,0.76 [0.43-1.34],0.3412999834971246
Chapter II Neoplasms,Melanoma in situ,DPP4,Dipeptidyl peptidase 4,22141,87,1.11 [0.57-2.15],0.7533017518466562
Chapter II Neoplasms,Melanoma in situ,DPP6,Dipeptidyl aminopeptidase-like protein 6,22484,88,1.16 [0.65-2.06],0.6144089673526325
Chapter II Neoplasms,Melanoma in situ,DPP7,Dipeptidyl peptidase 2,22401,88,1.13 [0.81-1.56],0.4702644362680535
Chapter II Neoplasms,Melanoma in situ,DPT,Dermatopontin,22859,89,1.23 [0.59-2.55],0.5862801308941121
Chapter II Neoplasms,Melanoma in situ,DPY30,Protein dpy-30 homolog,22716,90,1.14 [0.85-1.53],0.3913254124353625
Chapter II Neoplasms,Melanoma in situ,DRAXIN,Draxin,22440,89,1.00 [0.64-1.55],0.9947492567224014
Chapter II Neoplasms,Melanoma in situ,DRG2,Developmentally-regulated GTP-binding protein 2,22484,88,1.07 [0.77-1.50],0.6818843210226861
Chapter II Neoplasms,Melanoma in situ,DSC2,Desmocollin-2,22351,89,0.65 [0.35-1.17],0.1507394453344741
Chapter II Neoplasms,Melanoma in situ,DSCAM,Down syndrome cell adhesion molecule,19635,77,1.36 [0.74-2.51],0.3215239037961991
Chapter II Neoplasms,Melanoma in situ,DSG2,Desmoglein-2,22597,90,0.76 [0.38-1.54],0.4477896943973041
Chapter II Neoplasms,Melanoma in situ,DSG3,Desmoglein-3,22721,90,1.00 [0.57-1.75],0.9881858447409324
Chapter II Neoplasms,Melanoma in situ,DSG4,Desmoglein-4,22404,88,0.77 [0.53-1.12],0.1694468146494097
Chapter II Neoplasms,Melanoma in situ,DTD1,D-aminoacyl-tRNA deacylase 1,19255,75,1.14 [0.88-1.47],0.314145278668289
Chapter II Neoplasms,Melanoma in situ,DTNB,Dystrobrevin beta,19532,77,1.68 [1.05-2.68],0.0297031166191551
Chapter II Neoplasms,Melanoma in situ,DTX2,Probable E3 ubiquitin-protein ligase DTX2,19119,72,1.06 [0.76-1.48],0.7263508877580613
Chapter II Neoplasms,Melanoma in situ,DTX3,Probable E3 ubiquitin-protein ligase DTX3,22484,88,0.91 [0.40-2.05],0.8171676175376281
Chapter II Neoplasms,Melanoma in situ,DTYMK,Thymidylate kinase,19665,77,1.07 [0.79-1.47],0.6531119735461346
Chapter II Neoplasms,Melanoma in situ,DUOX2,Dual oxidase 2,22187,88,0.79 [0.57-1.08],0.1406402538456141
Chapter II Neoplasms,Melanoma in situ,DUSP13,Dual specificity protein phosphatase 13 isoform A,19560,77,1.11 [0.66-1.85],0.7026471360794877
Chapter II Neoplasms,Melanoma in situ,DUSP29,Dual specificity phosphatase 29,19119,72,1.02 [0.73-1.42],0.9058506121380058
Chapter II Neoplasms,Melanoma in situ,DUSP3,Dual specificity protein phosphatase 3,22029,90,1.23 [1.04-1.45],0.0143046171230135
Chapter II Neoplasms,Melanoma in situ,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",19566,77,1.03 [0.84-1.28],0.7591048678711112
Chapter II Neoplasms,Melanoma in situ,DXO,Decapping and exoribonuclease protein,19626,77,1.59 [1.02-2.49],0.0412624143253098
Chapter II Neoplasms,Melanoma in situ,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,19560,77,1.08 [0.71-1.65],0.708135662636536
Chapter II Neoplasms,Melanoma in situ,DYNLT1,Dynein light chain Tctex-type 1,19119,72,1.10 [0.85-1.43],0.4648948003228085
Chapter II Neoplasms,Melanoma in situ,DYNLT3,Dynein light chain Tctex-type 3,19560,77,1.38 [0.86-2.20],0.182339589414931
Chapter II Neoplasms,Melanoma in situ,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,22440,89,1.06 [0.87-1.30],0.5508613847813406
Chapter II Neoplasms,Melanoma in situ,EBI3_IL27,Interleukin-27,22750,90,1.10 [0.60-2.04],0.7515335065263088
Chapter II Neoplasms,Melanoma in situ,ECE1,Endothelin-converting enzyme 1,22029,90,1.20 [0.71-2.03],0.5052284272155558
Chapter II Neoplasms,Melanoma in situ,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",19665,77,1.02 [0.76-1.37],0.9059290007580304
Chapter II Neoplasms,Melanoma in situ,ECHS1,"Enoyl-CoA hydratase, mitochondrial",19167,75,1.06 [0.85-1.33],0.610168741274388
Chapter II Neoplasms,Melanoma in situ,ECI2,Enoyl-CoA delta isomerase 2,19066,75,1.17 [0.84-1.62],0.347433760278289
Chapter II Neoplasms,Melanoma in situ,ECM1,Extracellular matrix protein 1,19129,75,0.80 [0.45-1.41],0.4396967463535673
Chapter II Neoplasms,Melanoma in situ,ECSCR,Endothelial cell-specific chemotaxis regulator,19060,77,0.84 [0.52-1.35],0.4689620567690575
Chapter II Neoplasms,Melanoma in situ,EDA2R,Tumor necrosis factor receptor superfamily member 27,22789,90,1.03 [0.60-1.78],0.9187283419646628
Chapter II Neoplasms,Melanoma in situ,EDAR,Tumor necrosis factor receptor superfamily member EDAR,22550,90,1.05 [0.86-1.28],0.6651150689091644
Chapter II Neoplasms,Melanoma in situ,EDDM3B,Epididymal secretory protein E3-beta,19560,77,1.33 [0.84-2.08],0.2210365153085369
Chapter II Neoplasms,Melanoma in situ,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,19066,75,0.69 [0.34-1.40],0.300292683845195
Chapter II Neoplasms,Melanoma in situ,EDF1,Endothelial differentiation-related factor 1,19635,77,0.98 [0.71-1.34],0.8761587032098704
Chapter II Neoplasms,Melanoma in situ,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,22187,88,0.63 [0.35-1.12],0.1159817466225271
Chapter II Neoplasms,Melanoma in situ,EDN1,Endothelin-1,19167,75,1.44 [0.67-3.11],0.3497901594086262
Chapter II Neoplasms,Melanoma in situ,EDNRB,Endothelin receptor type B,19117,75,0.59 [0.31-1.13],0.1131772552888044
Chapter II Neoplasms,Melanoma in situ,EEF1D,Elongation factor 1-delta,19665,77,1.17 [0.93-1.46],0.1871235639135831
Chapter II Neoplasms,Melanoma in situ,EFCAB14,EF-hand calcium-binding domain-containing protein 14,19566,77,0.85 [0.36-2.00],0.7125547970173343
Chapter II Neoplasms,Melanoma in situ,EFCAB2,Dynein regulatory complex protein 8,19287,76,0.99 [0.53-1.87],0.9770682912595102
Chapter II Neoplasms,Melanoma in situ,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,22611,89,1.23 [0.66-2.28],0.5195697567723627
Chapter II Neoplasms,Melanoma in situ,EFHD1,EF-hand domain-containing protein D1,19635,77,0.99 [0.52-1.88],0.9676943471239604
Chapter II Neoplasms,Melanoma in situ,EFNA1,Ephrin-A1,22563,90,1.21 [0.60-2.44],0.5907182956650021
Chapter II Neoplasms,Melanoma in situ,EFNA4,Ephrin-A4,22405,88,1.04 [0.53-2.06],0.9013787871587255
Chapter II Neoplasms,Melanoma in situ,EFNB2,Ephrin-B2,19119,72,1.10 [0.76-1.58],0.6080959475038746
Chapter II Neoplasms,Melanoma in situ,EGF,Pro-epidermal growth factor,22553,90,0.98 [0.82-1.18],0.8491850841477993
Chapter II Neoplasms,Melanoma in situ,EGFL7,Epidermal growth factor-like protein 7,22078,88,1.09 [0.69-1.73],0.7085464883005785
Chapter II Neoplasms,Melanoma in situ,EGFLAM,Pikachurin,19566,77,1.07 [0.53-2.15],0.8597022052005949
Chapter II Neoplasms,Melanoma in situ,EGFR,Epidermal growth factor receptor,22859,89,1.09 [0.34-3.44],0.888651468882817
Chapter II Neoplasms,Melanoma in situ,EGLN1,Egl nine homolog 1,22550,90,0.95 [0.67-1.35],0.7717033128091053
Chapter II Neoplasms,Melanoma in situ,EHBP1,EH domain-binding protein 1,19665,77,1.16 [0.87-1.55],0.2995365948193613
Chapter II Neoplasms,Melanoma in situ,EHD3,EH domain-containing protein 3,19167,75,1.10 [0.91-1.34],0.3223366138125169
Chapter II Neoplasms,Melanoma in situ,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",19626,77,1.03 [0.70-1.51],0.880412440801752
Chapter II Neoplasms,Melanoma in situ,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",19498,77,1.13 [0.92-1.37],0.2415065898065625
Chapter II Neoplasms,Melanoma in situ,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,19066,75,1.02 [0.73-1.44],0.9009333002672514
Chapter II Neoplasms,Melanoma in situ,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,19167,75,0.94 [0.54-1.62],0.8187038672144277
Chapter II Neoplasms,Melanoma in situ,EIF4B,Eukaryotic translation initiation factor 4B,22440,89,1.00 [0.73-1.37],0.9914016726992444
Chapter II Neoplasms,Melanoma in situ,EIF4E,Eukaryotic translation initiation factor 4E,19117,75,1.07 [0.84-1.37],0.571310340012214
Chapter II Neoplasms,Melanoma in situ,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,22589,89,0.91 [0.68-1.22],0.5320295922099275
Chapter II Neoplasms,Melanoma in situ,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,22837,90,1.05 [0.87-1.26],0.6127303683358862
Chapter II Neoplasms,Melanoma in situ,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,19635,77,1.10 [0.80-1.52],0.5622571670138892
Chapter II Neoplasms,Melanoma in situ,EIF5,Eukaryotic translation initiation factor 5,19066,75,1.15 [0.73-1.82],0.5406822764012758
Chapter II Neoplasms,Melanoma in situ,EIF5A,Eukaryotic translation initiation factor 5A-1,22161,88,0.88 [0.45-1.74],0.7173654028712764
Chapter II Neoplasms,Melanoma in situ,ELAC1,Zinc phosphodiesterase ELAC protein 1,19635,77,1.19 [0.92-1.54],0.1893340723060873
Chapter II Neoplasms,Melanoma in situ,ELAVL4,ELAV-like protein 4,19060,77,0.98 [0.75-1.27],0.8505006425106709
Chapter II Neoplasms,Melanoma in situ,ELN,Elastin,19665,77,1.39 [0.75-2.57],0.2948129690365956
Chapter II Neoplasms,Melanoma in situ,ELOA,Elongin-A,22484,88,1.02 [0.72-1.44],0.9183558016802154
Chapter II Neoplasms,Melanoma in situ,ELOB,Elongin-B,19066,75,0.95 [0.53-1.71],0.8701298389518266
Chapter II Neoplasms,Melanoma in situ,ENAH,Protein enabled homolog,22161,88,1.14 [0.77-1.68],0.503045243526786
Chapter II Neoplasms,Melanoma in situ,ENDOU,Poly(U)-specific endoribonuclease,18162,71,1.22 [0.78-1.90],0.3852358169689238
Chapter II Neoplasms,Melanoma in situ,ENG,Endoglin,22859,89,0.97 [0.32-2.94],0.9611133434403564
Chapter II Neoplasms,Melanoma in situ,ENO1,Alpha-enolase,22555,90,1.07 [0.84-1.35],0.5915580863178957
Chapter II Neoplasms,Melanoma in situ,ENO2,Gamma-enolase,22788,90,1.01 [0.76-1.35],0.9194061663111271
Chapter II Neoplasms,Melanoma in situ,ENO3,Beta-enolase,19167,75,1.24 [0.87-1.78],0.2310109671712923
Chapter II Neoplasms,Melanoma in situ,ENOPH1,Enolase-phosphatase E1,19560,77,0.74 [0.47-1.17],0.1977193769367696
Chapter II Neoplasms,Melanoma in situ,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,19066,75,0.77 [0.33-1.80],0.5512905936748738
Chapter II Neoplasms,Melanoma in situ,ENPEP,Glutamyl aminopeptidase,19066,75,0.80 [0.45-1.45],0.466607949953319
Chapter II Neoplasms,Melanoma in situ,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,22859,89,0.96 [0.50-1.83],0.8905700403734513
Chapter II Neoplasms,Melanoma in situ,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,22692,90,0.76 [0.53-1.09],0.1346189496995589
Chapter II Neoplasms,Melanoma in situ,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,19167,75,0.92 [0.50-1.68],0.7837429425221942
Chapter II Neoplasms,Melanoma in situ,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,21891,86,0.86 [0.69-1.07],0.1682206993871471
Chapter II Neoplasms,Melanoma in situ,ENSA,Alpha-endosulfine,19560,77,1.20 [0.83-1.75],0.330161412761273
Chapter II Neoplasms,Melanoma in situ,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,22078,88,1.14 [0.75-1.75],0.5377924117373512
Chapter II Neoplasms,Melanoma in situ,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,22187,88,0.87 [0.35-2.16],0.7691524176899921
Chapter II Neoplasms,Melanoma in situ,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,22187,88,0.68 [0.37-1.27],0.2298593765567452
Chapter II Neoplasms,Melanoma in situ,ENTR1,Endosome-associated-trafficking regulator 1,19167,75,0.88 [0.58-1.34],0.5555818135176178
Chapter II Neoplasms,Melanoma in situ,EP300,Histone acetyltransferase p300,19117,75,1.39 [0.79-2.45],0.2539079093245865
Chapter II Neoplasms,Melanoma in situ,EPB41L5,Band 4.1-like protein 5,19119,72,0.91 [0.62-1.35],0.6492903913131796
Chapter II Neoplasms,Melanoma in situ,EPCAM,Epithelial cell adhesion molecule,22587,90,1.13 [0.94-1.36],0.1809342837558568
Chapter II Neoplasms,Melanoma in situ,EPGN,Epigen,19560,77,1.26 [0.89-1.78],0.2000368552487216
Chapter II Neoplasms,Melanoma in situ,EPHA1,Ephrin type-A receptor 1,22658,89,0.54 [0.32-0.92],0.0227366708778781
Chapter II Neoplasms,Melanoma in situ,EPHA10,Ephrin type-A receptor 10,22029,90,1.07 [0.82-1.39],0.6183383724758558
Chapter II Neoplasms,Melanoma in situ,EPHA2,Ephrin type-A receptor 2,21781,85,0.82 [0.42-1.61],0.5731833777138817
Chapter II Neoplasms,Melanoma in situ,EPHA4,Ephrin type-A receptor 4,19255,75,1.08 [0.49-2.38],0.8485996784995116
Chapter II Neoplasms,Melanoma in situ,EPHB4,Ephrin type-B receptor 4,22859,89,0.53 [0.24-1.19],0.1242761490014749
Chapter II Neoplasms,Melanoma in situ,EPHB6,Ephrin type-B receptor 6,22392,89,0.84 [0.45-1.55],0.5687590105887996
Chapter II Neoplasms,Melanoma in situ,EPHX2,Bifunctional epoxide hydrolase 2,22187,88,0.90 [0.65-1.24],0.5126930755181627
Chapter II Neoplasms,Melanoma in situ,EPN1,Epsin-1,19287,76,1.09 [0.69-1.74],0.7120121562838372
Chapter II Neoplasms,Melanoma in situ,EPO,Erythropoietin,22550,90,1.04 [0.82-1.34],0.7305450906464628
Chapter II Neoplasms,Melanoma in situ,EPPK1,Epiplakin,19167,75,1.24 [0.93-1.67],0.1459488740927204
Chapter II Neoplasms,Melanoma in situ,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,22755,90,1.20 [0.64-2.24],0.5623691443108069
Chapter II Neoplasms,Melanoma in situ,ERBB2,Receptor tyrosine-protein kinase erbB-2,22658,90,0.55 [0.25-1.20],0.1313930343485562
Chapter II Neoplasms,Melanoma in situ,ERBB3,Receptor tyrosine-protein kinase erbB-3,22523,89,0.73 [0.26-2.00],0.5370689958194276
Chapter II Neoplasms,Melanoma in situ,ERBB4,Receptor tyrosine-protein kinase erbB-4,22658,90,1.08 [0.49-2.39],0.8406853634195346
Chapter II Neoplasms,Melanoma in situ,ERBIN,Erbin,22484,88,1.03 [0.85-1.23],0.7761125206538035
Chapter II Neoplasms,Melanoma in situ,ERC2,ERC protein 2,19119,72,0.94 [0.68-1.28],0.6856355381659587
Chapter II Neoplasms,Melanoma in situ,ERCC1,DNA excision repair protein ERCC-1,18973,75,0.89 [0.44-1.79],0.7381517888239857
Chapter II Neoplasms,Melanoma in situ,EREG,Proepiregulin,22392,89,0.92 [0.72-1.17],0.507013584197769
Chapter II Neoplasms,Melanoma in situ,ERI1,3'-5' exoribonuclease 1,19287,76,1.13 [0.60-2.10],0.7052333332287011
Chapter II Neoplasms,Melanoma in situ,ERMAP,Erythroid membrane-associated protein,19117,75,1.36 [0.84-2.21],0.2146743005186959
Chapter II Neoplasms,Melanoma in situ,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,19560,77,0.73 [0.40-1.32],0.2957316918259628
Chapter II Neoplasms,Melanoma in situ,ERP29,Endoplasmic reticulum resident protein 29,19255,75,1.12 [0.93-1.36],0.2287301805676507
Chapter II Neoplasms,Melanoma in situ,ERP44,Endoplasmic reticulum resident protein 44,22444,88,1.38 [0.66-2.87],0.3904558598100016
Chapter II Neoplasms,Melanoma in situ,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,19066,75,0.87 [0.52-1.47],0.6077558222658761
Chapter II Neoplasms,Melanoma in situ,ESAM,Endothelial cell-selective adhesion molecule,22859,89,0.88 [0.48-1.63],0.6916118637814999
Chapter II Neoplasms,Melanoma in situ,ESM1,Endothelial cell-specific molecule 1,22583,90,1.10 [0.63-1.92],0.731595483997067
Chapter II Neoplasms,Melanoma in situ,ESPL1,Separin,18973,75,1.17 [0.85-1.62],0.3419302829643149
Chapter II Neoplasms,Melanoma in situ,ESR1,Estrogen receptor,19117,75,0.86 [0.56-1.33],0.5033472842358051
Chapter II Neoplasms,Melanoma in situ,ESYT2,Extended synaptotagmin-2,19626,77,1.12 [0.86-1.46],0.4055921494863324
Chapter II Neoplasms,Melanoma in situ,EVI2B,Protein EVI2B,18973,75,1.11 [0.68-1.80],0.6793128766950962
Chapter II Neoplasms,Melanoma in situ,EVI5,Ecotropic viral integration site 5 protein homolog,19117,75,1.06 [0.83-1.35],0.6517333591473669
Chapter II Neoplasms,Melanoma in situ,EVPL,Envoplakin,19287,76,0.84 [0.42-1.68],0.6192470842753497
Chapter II Neoplasms,Melanoma in situ,EXOSC10,Exosome component 10,19066,75,0.96 [0.66-1.41],0.8515326742421252
Chapter II Neoplasms,Melanoma in situ,EXTL1,Exostosin-like 1,19066,75,0.65 [0.37-1.16],0.1420670026436541
Chapter II Neoplasms,Melanoma in situ,EZR,Ezrin,22788,90,1.28 [0.59-2.79],0.5309259731468867
Chapter II Neoplasms,Melanoma in situ,F10,Coagulation factor X,19669,77,1.35 [0.65-2.81],0.4285826764715041
Chapter II Neoplasms,Melanoma in situ,F11,Coagulation factor XI,19406,76,0.90 [0.43-1.90],0.7882154152300838
Chapter II Neoplasms,Melanoma in situ,F11R,Junctional adhesion molecule A,22597,90,1.04 [0.75-1.45],0.8024524352566466
Chapter II Neoplasms,Melanoma in situ,F12,Coagulation factor XII,19694,77,0.80 [0.48-1.33],0.3891837719238213
Chapter II Neoplasms,Melanoma in situ,F13B,Coagulation factor XIII B chain,19577,77,0.67 [0.29-1.55],0.351454689412394
Chapter II Neoplasms,Melanoma in situ,F2,Prothrombin,19694,77,0.68 [0.16-2.91],0.6080345632590116
Chapter II Neoplasms,Melanoma in situ,F2R,Proteinase-activated receptor 1,22653,90,1.07 [0.77-1.48],0.6987453501650398
Chapter II Neoplasms,Melanoma in situ,F3,Tissue factor,22654,90,1.45 [0.75-2.81],0.2675542916376563
Chapter II Neoplasms,Melanoma in situ,F7,Coagulation factor VII,22621,89,1.42 [0.74-2.72],0.2875741104089827
Chapter II Neoplasms,Melanoma in situ,F9,Coagulation factor IX,22613,89,2.25 [0.79-6.38],0.127555722889983
Chapter II Neoplasms,Melanoma in situ,FABP1,"Fatty acid-binding protein, liver",22583,90,1.07 [0.87-1.31],0.5301889440792784
Chapter II Neoplasms,Melanoma in situ,FABP2,"Fatty acid-binding protein, intestinal",22589,89,1.07 [0.84-1.37],0.5693681510647202
Chapter II Neoplasms,Melanoma in situ,FABP3,"Fatty acid-binding protein, heart",19665,77,0.99 [0.62-1.57],0.9496865880897408
Chapter II Neoplasms,Melanoma in situ,FABP4,"Fatty acid-binding protein, adipocyte",22859,89,1.23 [0.84-1.79],0.2833455151586999
Chapter II Neoplasms,Melanoma in situ,FABP5,Fatty acid-binding protein 5,22721,90,1.13 [0.87-1.46],0.3778542020726834
Chapter II Neoplasms,Melanoma in situ,FABP6,Gastrotropin,22153,87,0.93 [0.65-1.33],0.6993435224855231
Chapter II Neoplasms,Melanoma in situ,FABP9,Fatty acid-binding protein 9,22550,90,1.04 [0.74-1.45],0.8308265196557312
Chapter II Neoplasms,Melanoma in situ,FADD,FAS-associated death domain protein,22589,89,1.03 [0.81-1.32],0.79129640039196
Chapter II Neoplasms,Melanoma in situ,FAM13A,Protein FAM13A,19566,77,1.07 [0.78-1.48],0.6663930832313436
Chapter II Neoplasms,Melanoma in situ,FAM171A2,Protein FAM171A2,19635,77,1.02 [0.89-1.16],0.8109838216413816
Chapter II Neoplasms,Melanoma in situ,FAM171B,Protein FAM171B,19560,77,1.17 [0.58-2.39],0.6574762056204508
Chapter II Neoplasms,Melanoma in situ,FAM172A,Cotranscriptional regulator FAM172A,19167,75,1.12 [0.78-1.60],0.541103884926226
Chapter II Neoplasms,Melanoma in situ,FAM20A,Pseudokinase FAM20A,19665,77,0.56 [0.25-1.24],0.1505832588382031
Chapter II Neoplasms,Melanoma in situ,FAM3B,Protein FAM3B,22484,88,1.00 [0.57-1.73],0.9888502109364952
Chapter II Neoplasms,Melanoma in situ,FAM3C,Protein FAM3C,22555,89,1.53 [0.81-2.89],0.1890013334872027
Chapter II Neoplasms,Melanoma in situ,FAM3D,Protein FAM3D,19566,77,0.76 [0.57-0.99],0.0446528792153039
Chapter II Neoplasms,Melanoma in situ,FAP,Prolyl endopeptidase FAP,22859,89,0.66 [0.33-1.33],0.2451307595989789
Chapter II Neoplasms,Melanoma in situ,FARSA,Phenylalanine--tRNA ligase alpha subunit,19119,72,1.15 [0.85-1.55],0.3590261400369642
Chapter II Neoplasms,Melanoma in situ,FAS,Tumor necrosis factor receptor superfamily member 6,22791,89,0.56 [0.27-1.15],0.1154457604905266
Chapter II Neoplasms,Melanoma in situ,FASLG,Tumor necrosis factor ligand superfamily member 6,22837,90,0.76 [0.46-1.24],0.2647507743885977
Chapter II Neoplasms,Melanoma in situ,FBLN2,Fibulin-2,19661,77,0.82 [0.39-1.70],0.5865421223175156
Chapter II Neoplasms,Melanoma in situ,FBN2,Fibrillin-2,19119,72,0.83 [0.58-1.20],0.3332111453472178
Chapter II Neoplasms,Melanoma in situ,FBP1,"Fructose-1,6-bisphosphatase 1",22589,89,1.02 [0.79-1.31],0.9012751077486776
Chapter II Neoplasms,Melanoma in situ,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,19665,77,1.04 [0.77-1.41],0.7982000670335144
Chapter II Neoplasms,Melanoma in situ,FCAR,Immunoglobulin alpha Fc receptor,22550,90,1.17 [0.79-1.73],0.4276528693822667
Chapter II Neoplasms,Melanoma in situ,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,19635,77,0.51 [0.28-0.92],0.0250850402104435
Chapter II Neoplasms,Melanoma in situ,FCER2,Low affinity immunoglobulin epsilon Fc receptor,22597,90,0.72 [0.48-1.08],0.1112961809521234
Chapter II Neoplasms,Melanoma in situ,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,22474,89,1.21 [0.85-1.72],0.2891023486466804
Chapter II Neoplasms,Melanoma in situ,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,22078,88,1.23 [0.91-1.67],0.1788145488593243
Chapter II Neoplasms,Melanoma in situ,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,22582,89,1.11 [0.76-1.62],0.5878502730482869
Chapter II Neoplasms,Melanoma in situ,FCN1,Ficolin-1,19628,77,1.00 [0.68-1.47],0.9920887108446445
Chapter II Neoplasms,Melanoma in situ,FCN2,Ficolin-2,22461,89,1.47 [0.89-2.43],0.1330786894895012
Chapter II Neoplasms,Melanoma in situ,FCRL1,Fc receptor-like protein 1,22589,89,0.82 [0.54-1.27],0.374960153560144
Chapter II Neoplasms,Melanoma in situ,FCRL2,Fc receptor-like protein 2,22729,89,0.89 [0.59-1.34],0.5717778943761921
Chapter II Neoplasms,Melanoma in situ,FCRL3,Fc receptor-like protein 3,22161,88,1.28 [0.91-1.81],0.1490542545593804
Chapter II Neoplasms,Melanoma in situ,FCRL5,Fc receptor-like protein 5,22597,90,0.86 [0.61-1.21],0.3911359558192949
Chapter II Neoplasms,Melanoma in situ,FCRL6,Fc receptor-like protein 6,22550,90,1.08 [0.82-1.43],0.5729220126557706
Chapter II Neoplasms,Melanoma in situ,FCRLB,Fc receptor-like B,22078,88,1.00 [0.72-1.38],0.9993103665549518
Chapter II Neoplasms,Melanoma in situ,FDX1,"Adrenodoxin, mitochondrial",19066,75,1.15 [0.85-1.57],0.355974877589996
Chapter II Neoplasms,Melanoma in situ,FDX2,"Ferredoxin-2, mitochondrial",19066,75,1.01 [0.68-1.49],0.9737454372762796
Chapter II Neoplasms,Melanoma in situ,FEN1,Flap endonuclease 1,22078,88,1.00 [0.76-1.33],0.9777601920477308
Chapter II Neoplasms,Melanoma in situ,FES,Tyrosine-protein kinase Fes/Fps,22078,88,1.04 [0.70-1.54],0.8578273128889513
Chapter II Neoplasms,Melanoma in situ,FETUB,Fetuin-B,22613,89,1.18 [0.67-2.08],0.5746838287283598
Chapter II Neoplasms,Melanoma in situ,FGA,Fibrinogen alpha chain,19226,74,0.84 [0.40-1.75],0.6344253332213892
Chapter II Neoplasms,Melanoma in situ,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",19635,77,1.11 [0.84-1.45],0.4610715560842372
Chapter II Neoplasms,Melanoma in situ,FGF12,Fibroblast growth factor 12,19117,75,0.92 [0.55-1.56],0.7692684717624277
Chapter II Neoplasms,Melanoma in situ,FGF16,Fibroblast growth factor 16,19117,75,1.34 [0.96-1.86],0.0814988347053249
Chapter II Neoplasms,Melanoma in situ,FGF19,Fibroblast growth factor 19,22692,90,0.98 [0.77-1.24],0.8445059281141405
Chapter II Neoplasms,Melanoma in situ,FGF2,Fibroblast growth factor 2,22550,90,1.10 [0.83-1.45],0.5000906816770896
Chapter II Neoplasms,Melanoma in situ,FGF20,Fibroblast growth factor 20,19117,75,1.13 [0.73-1.73],0.5914122601418219
Chapter II Neoplasms,Melanoma in situ,FGF21,Fibroblast growth factor 21,22750,90,1.04 [0.89-1.22],0.6282827851463807
Chapter II Neoplasms,Melanoma in situ,FGF23,Fibroblast growth factor 23,22757,90,1.22 [0.92-1.61],0.1779876379546219
Chapter II Neoplasms,Melanoma in situ,FGF3,Fibroblast growth factor 3,19117,75,1.16 [0.61-2.20],0.6490772562961404
Chapter II Neoplasms,Melanoma in situ,FGF5,Fibroblast growth factor 5,22161,88,0.75 [0.41-1.37],0.3531757986614633
Chapter II Neoplasms,Melanoma in situ,FGF6,Fibroblast growth factor 6,19117,75,0.84 [0.46-1.53],0.571224330820896
Chapter II Neoplasms,Melanoma in situ,FGF7,Fibroblast growth factor 7,18973,75,1.28 [1.05-1.57],0.0166319908394052
Chapter II Neoplasms,Melanoma in situ,FGF9,Fibroblast growth factor 9,18935,75,1.22 [0.71-2.11],0.4716823360669884
Chapter II Neoplasms,Melanoma in situ,FGFBP1,Fibroblast growth factor-binding protein 1,22658,90,1.07 [0.59-1.94],0.8229415458091521
Chapter II Neoplasms,Melanoma in situ,FGFBP2,Fibroblast growth factor-binding protein 2,19661,77,0.99 [0.64-1.53],0.9536706698901306
Chapter II Neoplasms,Melanoma in situ,FGFBP3,Fibroblast growth factor-binding protein 3,19626,77,1.13 [0.62-2.04],0.6913768531935282
Chapter II Neoplasms,Melanoma in situ,FGFR2,Fibroblast growth factor receptor 2,22658,90,0.89 [0.36-2.16],0.788824160021103
Chapter II Neoplasms,Melanoma in situ,FGFR4,Fibroblast growth factor receptor 4,19255,75,0.95 [0.63-1.44],0.7995387349837915
Chapter II Neoplasms,Melanoma in situ,FGL1,Fibrinogen-like protein 1,19669,77,1.27 [0.90-1.79],0.165425644309342
Chapter II Neoplasms,Melanoma in situ,FGR,Tyrosine-protein kinase Fgr,22029,90,1.12 [0.85-1.49],0.4231583135719915
Chapter II Neoplasms,Melanoma in situ,FH,"Fumarate hydratase, mitochondrial",19060,77,0.89 [0.67-1.19],0.4315337611929801
Chapter II Neoplasms,Melanoma in situ,FHIP2A,FHF complex subunit HOOK interacting protein 2A,19066,75,0.53 [0.31-0.91],0.0212358345736456
Chapter II Neoplasms,Melanoma in situ,FHIT,Bis(5'-adenosyl)-triphosphatase,22029,90,1.02 [0.79-1.31],0.8689457350031277
Chapter II Neoplasms,Melanoma in situ,FIS1,Mitochondrial fission 1 protein,22590,89,1.02 [0.80-1.30],0.8726251263308329
Chapter II Neoplasms,Melanoma in situ,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,19635,77,1.22 [0.98-1.52],0.0766105769385555
Chapter II Neoplasms,Melanoma in situ,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,22655,89,1.07 [0.91-1.27],0.4068327407995382
Chapter II Neoplasms,Melanoma in situ,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,22440,89,1.02 [0.67-1.54],0.940185493000552
Chapter II Neoplasms,Melanoma in situ,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,22440,89,1.03 [0.84-1.25],0.795774797716808
Chapter II Neoplasms,Melanoma in situ,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,21981,90,1.28 [0.92-1.78],0.1367606874972415
Chapter II Neoplasms,Melanoma in situ,FKBPL,FK506-binding protein-like,19566,77,1.12 [0.78-1.62],0.5358395301475489
Chapter II Neoplasms,Melanoma in situ,FLI1,Friend leukemia integration 1 transcription factor,22078,88,1.05 [0.88-1.25],0.5945667236000662
Chapter II Neoplasms,Melanoma in situ,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,22440,89,0.72 [0.37-1.43],0.3520775146976964
Chapter II Neoplasms,Melanoma in situ,FLT1,Vascular endothelial growth factor receptor 1,22444,88,0.69 [0.27-1.76],0.4381574862429381
Chapter II Neoplasms,Melanoma in situ,FLT3,Receptor-type tyrosine-protein kinase FLT3,22078,88,1.02 [0.56-1.86],0.9379078989043166
Chapter II Neoplasms,Melanoma in situ,FLT3LG,Fms-related tyrosine kinase 3 ligand,22837,90,0.70 [0.39-1.24],0.2206409556080646
Chapter II Neoplasms,Melanoma in situ,FLT4,Vascular endothelial growth factor receptor 3,22658,90,1.33 [0.75-2.35],0.3312183217225626
Chapter II Neoplasms,Melanoma in situ,FMNL1,Formin-like protein 1,22029,90,1.01 [0.77-1.34],0.9231189938457032
Chapter II Neoplasms,Melanoma in situ,FMR1,Synaptic functional regulator FMR1,22078,88,1.06 [0.62-1.83],0.8215580873678137
Chapter II Neoplasms,Melanoma in situ,FN1,Fibronectin,19694,77,0.66 [0.39-1.12],0.1206385825028651
Chapter II Neoplasms,Melanoma in situ,FNDC1,Fibronectin type III domain-containing protein 1,19626,77,1.03 [0.64-1.67],0.8889060889905899
Chapter II Neoplasms,Melanoma in situ,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,19560,77,1.19 [0.66-2.14],0.5651647217734491
Chapter II Neoplasms,Melanoma in situ,FOLH1,Glutamate carboxypeptidase 2,19117,75,1.02 [0.84-1.24],0.8578568175098312
Chapter II Neoplasms,Melanoma in situ,FOLR1,Folate receptor alpha,22551,89,0.97 [0.49-1.93],0.9401870537880948
Chapter II Neoplasms,Melanoma in situ,FOLR2,Folate receptor beta,22788,90,0.58 [0.31-1.11],0.1006443451766367
Chapter II Neoplasms,Melanoma in situ,FOLR3,Folate receptor gamma,22585,90,0.96 [0.86-1.07],0.4759076135860752
Chapter II Neoplasms,Melanoma in situ,FOS,Proto-oncogene c-Fos,18935,75,0.58 [0.31-1.09],0.089546177659317
Chapter II Neoplasms,Melanoma in situ,FOSB,Protein fosB,22029,90,0.55 [0.30-0.99],0.0461073164519042
Chapter II Neoplasms,Melanoma in situ,FOXJ3,Forkhead box protein J3,19117,75,1.13 [0.70-1.82],0.6118902952209957
Chapter II Neoplasms,Melanoma in situ,FOXO1,Forkhead box protein O1,22550,90,1.10 [0.88-1.37],0.4057261649150975
Chapter II Neoplasms,Melanoma in situ,FOXO3,Forkhead box protein O3,22078,88,1.02 [0.84-1.24],0.8578135293035833
Chapter II Neoplasms,Melanoma in situ,FRMD4B,FERM domain-containing protein 4B,19066,75,1.19 [0.88-1.62],0.2608437744057656
Chapter II Neoplasms,Melanoma in situ,FRMD7,FERM domain-containing protein 7,19119,72,1.24 [0.66-2.33],0.5049360502845843
Chapter II Neoplasms,Melanoma in situ,FRZB,Secreted frizzled-related protein 3,22365,88,0.54 [0.27-1.05],0.0711021301697138
Chapter II Neoplasms,Melanoma in situ,FSHB,Follitropin subunit beta,19167,75,1.08 [0.78-1.50],0.6467099069962591
Chapter II Neoplasms,Melanoma in situ,FST,Follistatin,22653,90,1.09 [0.76-1.56],0.6441252285461645
Chapter II Neoplasms,Melanoma in situ,FSTL1,Follistatin-related protein 1,19167,75,0.44 [0.16-1.20],0.1083445154015478
Chapter II Neoplasms,Melanoma in situ,FSTL3,Follistatin-related protein 3,22549,88,1.30 [0.71-2.40],0.3997421206795182
Chapter II Neoplasms,Melanoma in situ,FTCD,Formimidoyltransferase-cyclodeaminase,19598,77,0.97 [0.75-1.27],0.8436294475199244
Chapter II Neoplasms,Melanoma in situ,FUCA1,Tissue alpha-L-fucosidase,22732,89,1.11 [0.87-1.41],0.3865826911403985
Chapter II Neoplasms,Melanoma in situ,FUOM,Fucose mutarotase,19255,75,1.11 [0.78-1.58],0.5668743490358802
Chapter II Neoplasms,Melanoma in situ,FURIN,Furin,22658,90,1.00 [0.57-1.75],0.9989223884047668
Chapter II Neoplasms,Melanoma in situ,FUS,RNA-binding protein FUS,22047,88,0.93 [0.57-1.51],0.7718668056088365
Chapter II Neoplasms,Melanoma in situ,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",19244,76,0.59 [0.38-0.92],0.0199597155781646
Chapter II Neoplasms,Melanoma in situ,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,22788,90,0.66 [0.44-1.01],0.0532022959842334
Chapter II Neoplasms,Melanoma in situ,FUT8,"Alpha-(1,6)-fucosyltransferase",22440,89,0.77 [0.55-1.07],0.124482923332697
Chapter II Neoplasms,Melanoma in situ,FXN,"Frataxin, mitochondrial",22789,90,1.05 [0.82-1.35],0.6789012222578334
Chapter II Neoplasms,Melanoma in situ,FXYD5,FXYD domain-containing ion transport regulator 5,22161,88,1.20 [0.91-1.57],0.1960662977336399
Chapter II Neoplasms,Melanoma in situ,FYB1,FYN-binding protein 1,22562,90,1.04 [0.85-1.27],0.7141446787473607
Chapter II Neoplasms,Melanoma in situ,FZD10,Frizzled-10,19119,72,1.12 [0.81-1.56],0.4886259707517036
Chapter II Neoplasms,Melanoma in situ,FZD8,Frizzled-8,19060,77,1.13 [0.72-1.78],0.5834895149506552
Chapter II Neoplasms,Melanoma in situ,GABARAP,Gamma-aminobutyric acid receptor-associated protein,19560,77,1.03 [0.67-1.59],0.8869500815174396
Chapter II Neoplasms,Melanoma in situ,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,19287,76,0.98 [0.70-1.37],0.9170876539501408
Chapter II Neoplasms,Melanoma in situ,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,19060,77,0.94 [0.66-1.34],0.7352390984994936
Chapter II Neoplasms,Melanoma in situ,GAD1,Glutamate decarboxylase 1,18973,75,0.86 [0.37-2.04],0.7394865192946791
Chapter II Neoplasms,Melanoma in situ,GAD2,Glutamate decarboxylase 2,19117,75,1.22 [0.82-1.79],0.3239598298015947
Chapter II Neoplasms,Melanoma in situ,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,19287,76,1.06 [0.70-1.60],0.7935048987762745
Chapter II Neoplasms,Melanoma in situ,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,19167,75,1.10 [0.73-1.67],0.6499061962947584
Chapter II Neoplasms,Melanoma in situ,GAGE2A,G antigen 2A,18973,75,0.76 [0.50-1.17],0.2080290055216059
Chapter II Neoplasms,Melanoma in situ,GAL,Galanin peptides,22692,90,0.74 [0.55-1.01],0.0553780543892218
Chapter II Neoplasms,Melanoma in situ,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,22484,88,1.08 [0.55-2.16],0.8164017677440539
Chapter II Neoplasms,Melanoma in situ,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,22789,90,0.89 [0.43-1.84],0.7533187702290886
Chapter II Neoplasms,Melanoma in situ,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,22161,88,0.60 [0.38-0.96],0.0323562834369888
Chapter II Neoplasms,Melanoma in situ,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,19665,77,0.80 [0.35-1.82],0.5964961977498404
Chapter II Neoplasms,Melanoma in situ,GALNT7,N-acetylgalactosaminyltransferase 7,22484,88,0.72 [0.30-1.75],0.4689520181867025
Chapter II Neoplasms,Melanoma in situ,GAMT,Guanidinoacetate N-methyltransferase,19066,75,1.10 [0.66-1.85],0.7113512496018086
Chapter II Neoplasms,Melanoma in situ,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,18834,74,1.46 [0.73-2.92],0.2892434843996563
Chapter II Neoplasms,Melanoma in situ,GART,Trifunctional purine biosynthetic protein adenosine-3,19635,77,0.86 [0.37-2.03],0.7331339397129621
Chapter II Neoplasms,Melanoma in situ,GAS2,Growth arrest-specific protein 2,19287,76,1.08 [0.73-1.60],0.6976484999848298
Chapter II Neoplasms,Melanoma in situ,GAS6,Growth arrest-specific protein 6,22712,88,0.76 [0.36-1.62],0.4823211380736416
Chapter II Neoplasms,Melanoma in situ,GASK1A,Golgi-associated kinase 1A,19066,75,0.80 [0.48-1.35],0.4137651317684903
Chapter II Neoplasms,Melanoma in situ,GAST,Gastrin,19626,77,0.95 [0.80-1.13],0.5781945545519838
Chapter II Neoplasms,Melanoma in situ,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,18973,75,1.33 [0.59-3.03],0.4926338202511322
Chapter II Neoplasms,Melanoma in situ,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",19167,75,1.29 [0.98-1.68],0.0668389209566583
Chapter II Neoplasms,Melanoma in situ,GBA,Lysosomal acid glucosylceramidase,19119,72,1.12 [0.75-1.68],0.5714050628659215
Chapter II Neoplasms,Melanoma in situ,GBP1,Guanylate-binding protein 1,19589,77,1.09 [0.78-1.51],0.6202788698142343
Chapter II Neoplasms,Melanoma in situ,GBP2,Guanylate-binding protein 2,22161,88,1.04 [0.76-1.43],0.7856642841488977
Chapter II Neoplasms,Melanoma in situ,GBP4,Guanylate-binding protein 4,22029,90,1.06 [0.73-1.54],0.7722067317208164
Chapter II Neoplasms,Melanoma in situ,GBP6,Guanylate-binding protein 6,19066,75,0.64 [0.34-1.19],0.1543967970456194
Chapter II Neoplasms,Melanoma in situ,GC,Vitamin D-binding protein,19694,77,0.60 [0.26-1.40],0.2362074147615484
Chapter II Neoplasms,Melanoma in situ,GCC1,GRIP and coiled-coil domain-containing protein 1,19626,77,1.14 [0.93-1.40],0.2128681044517514
Chapter II Neoplasms,Melanoma in situ,GCG,Pro-glucagon,22078,88,0.88 [0.76-1.03],0.1191641507022812
Chapter II Neoplasms,Melanoma in situ,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,18788,75,0.85 [0.52-1.38],0.5057591929514869
Chapter II Neoplasms,Melanoma in situ,GCLM,Glutamate--cysteine ligase regulatory subunit,19066,75,0.74 [0.43-1.29],0.2898875849085623
Chapter II Neoplasms,Melanoma in situ,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",22484,88,0.94 [0.54-1.64],0.8314305971704216
Chapter II Neoplasms,Melanoma in situ,GDF15,Growth/differentiation factor 15,22859,89,1.32 [0.87-1.99],0.1910182867770812
Chapter II Neoplasms,Melanoma in situ,GDF2,Growth/differentiation factor 2,22589,89,0.85 [0.50-1.45],0.5446796351388491
Chapter II Neoplasms,Melanoma in situ,GDNF,Glial cell line-derived neurotrophic factor,22029,90,1.34 [0.84-2.14],0.2132543506852475
Chapter II Neoplasms,Melanoma in situ,GET3,ATPase GET3,19665,77,0.76 [0.49-1.19],0.2292195034799351
Chapter II Neoplasms,Melanoma in situ,GFAP,Glial fibrillary acidic protein,22042,88,1.11 [0.75-1.66],0.5926597439352491
Chapter II Neoplasms,Melanoma in situ,GFER,FAD-linked sulfhydryl oxidase ALR,22078,88,1.11 [0.83-1.49],0.4909789999902115
Chapter II Neoplasms,Melanoma in situ,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,22078,88,0.87 [0.72-1.05],0.149621179161663
Chapter II Neoplasms,Melanoma in situ,GFRA1,GDNF family receptor alpha-1,22750,90,0.86 [0.43-1.71],0.665068023258523
Chapter II Neoplasms,Melanoma in situ,GFRA2,GDNF family receptor alpha-2,22484,88,0.75 [0.31-1.79],0.5188627895449351
Chapter II Neoplasms,Melanoma in situ,GFRA3,GDNF family receptor alpha-3,22373,88,0.47 [0.24-0.94],0.032632700738243
Chapter II Neoplasms,Melanoma in situ,GFRAL,GDNF family receptor alpha-like,19037,77,0.94 [0.65-1.35],0.7403398552496826
Chapter II Neoplasms,Melanoma in situ,GGA1,ADP-ribosylation factor-binding protein GGA1,22029,90,0.78 [0.56-1.09],0.1420541626814695
Chapter II Neoplasms,Melanoma in situ,GGACT,Gamma-glutamylaminecyclotransferase,19665,77,1.27 [0.94-1.71],0.1140771479037073
Chapter II Neoplasms,Melanoma in situ,GGCT,Gamma-glutamylcyclotransferase,19622,77,1.30 [0.85-2.01],0.2281963203164146
Chapter II Neoplasms,Melanoma in situ,GGH,Gamma-glutamyl hydrolase,22186,85,1.17 [0.67-2.04],0.5736904115711547
Chapter II Neoplasms,Melanoma in situ,GGT1,Glutathione hydrolase 1 proenzyme,22563,90,1.10 [0.75-1.60],0.630683963024012
Chapter II Neoplasms,Melanoma in situ,GGT5,Glutathione hydrolase 5 proenzyme,22440,89,1.29 [0.56-2.95],0.5491598355742358
Chapter II Neoplasms,Melanoma in situ,GH1,Somatotropin,22555,89,0.93 [0.83-1.03],0.1723498266018728
Chapter II Neoplasms,Melanoma in situ,GH2,Growth hormone variant,22078,88,0.97 [0.86-1.08],0.5566785921237232
Chapter II Neoplasms,Melanoma in situ,GHR,Growth hormone receptor,19255,75,1.36 [0.62-2.99],0.4479483602680231
Chapter II Neoplasms,Melanoma in situ,GHRHR,Growth hormone-releasing hormone receptor,22029,90,1.03 [0.74-1.42],0.8753638706086876
Chapter II Neoplasms,Melanoma in situ,GHRL,Appetite-regulating hormone,22589,89,0.98 [0.78-1.24],0.8871625607544321
Chapter II Neoplasms,Melanoma in situ,GID8,Glucose-induced degradation protein 8 homolog,19635,77,1.17 [0.65-2.09],0.6064628792418132
Chapter II Neoplasms,Melanoma in situ,GIGYF2,GRB10-interacting GYF protein 2,19635,77,1.05 [0.79-1.40],0.741161210907598
Chapter II Neoplasms,Melanoma in situ,GIMAP7,GTPase IMAP family member 7,19255,75,1.21 [0.64-2.28],0.5653539490234207
Chapter II Neoplasms,Melanoma in situ,GIMAP8,GTPase IMAP family member 8,18973,75,0.96 [0.62-1.48],0.8626998095523365
Chapter II Neoplasms,Melanoma in situ,GIP,Gastric inhibitory polypeptide,19167,75,0.97 [0.65-1.45],0.8719923010899795
Chapter II Neoplasms,Melanoma in situ,GIPC2,PDZ domain-containing protein GIPC2,19626,77,0.97 [0.46-2.06],0.9402325083738624
Chapter II Neoplasms,Melanoma in situ,GIPC3,PDZ domain-containing protein GIPC3,19566,77,1.11 [0.89-1.40],0.3536291221786588
Chapter II Neoplasms,Melanoma in situ,GIPR,Gastric inhibitory polypeptide receptor,19117,75,0.59 [0.33-1.07],0.0804315991277474
Chapter II Neoplasms,Melanoma in situ,GIT1,ARF GTPase-activating protein GIT1,19117,75,1.10 [0.87-1.38],0.4198271520609345
Chapter II Neoplasms,Melanoma in situ,GJA8,Gap junction alpha-8 protein,18973,75,0.94 [0.65-1.36],0.7477313382263748
Chapter II Neoplasms,Melanoma in situ,GKN1,Gastrokine-1,21602,87,0.66 [0.33-1.31],0.2317966041164537
Chapter II Neoplasms,Melanoma in situ,GLA,Alpha-galactosidase A,19212,75,1.59 [0.91-2.80],0.106318418171656
Chapter II Neoplasms,Melanoma in situ,GLB1,Beta-galactosidase,22440,89,0.86 [0.54-1.39],0.5449086102460865
Chapter II Neoplasms,Melanoma in situ,GLI2,Zinc finger protein GLI2,19117,75,0.92 [0.46-1.82],0.8014375766040601
Chapter II Neoplasms,Melanoma in situ,GLO1,Lactoylglutathione lyase,22187,88,0.82 [0.60-1.14],0.2383480727080275
Chapter II Neoplasms,Melanoma in situ,GLOD4,Glyoxalase domain-containing protein 4,22551,89,0.94 [0.56-1.57],0.8187326829499519
Chapter II Neoplasms,Melanoma in situ,GLP1R,Glucagon-like peptide 1 receptor,19060,77,0.93 [0.51-1.70],0.8233024608436772
Chapter II Neoplasms,Melanoma in situ,GLRX,Glutaredoxin-1,22439,88,0.88 [0.63-1.22],0.4314343436907051
Chapter II Neoplasms,Melanoma in situ,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",19255,75,1.13 [0.88-1.44],0.346189570081838
Chapter II Neoplasms,Melanoma in situ,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,22029,90,0.89 [0.58-1.36],0.5804200224473985
Chapter II Neoplasms,Melanoma in situ,GLYR1,Putative oxidoreductase GLYR1,19560,77,0.84 [0.55-1.27],0.409820280672745
Chapter II Neoplasms,Melanoma in situ,GM2A,Ganglioside GM2 activator,19187,76,0.70 [0.36-1.34],0.2790009560952393
Chapter II Neoplasms,Melanoma in situ,GMFG,Glia maturation factor gamma,19665,77,1.25 [0.92-1.69],0.1553032338667601
Chapter II Neoplasms,Melanoma in situ,GMPR,GMP reductase 1,22837,90,0.88 [0.62-1.25],0.4843484815914051
Chapter II Neoplasms,Melanoma in situ,GMPR2,GMP reductase 2,19255,75,1.17 [0.85-1.62],0.3315689104782374
Chapter II Neoplasms,Melanoma in situ,GNAS,Neuroendocrine secretory protein 55,19635,77,0.88 [0.67-1.16],0.3761793857946697
Chapter II Neoplasms,Melanoma in situ,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,22078,88,1.11 [0.84-1.47],0.4757992726535227
Chapter II Neoplasms,Melanoma in situ,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,19119,72,0.95 [0.60-1.51],0.8349039234239134
Chapter II Neoplasms,Melanoma in situ,GNLY,Granulysin,22597,90,0.77 [0.53-1.12],0.1672892742791654
Chapter II Neoplasms,Melanoma in situ,GNPDA1,Glucosamine-6-phosphate isomerase 1,19167,75,1.41 [0.84-2.37],0.1999691697131286
Chapter II Neoplasms,Melanoma in situ,GNPDA2,Glucosamine-6-phosphate isomerase 2,19255,75,0.95 [0.51-1.77],0.8757016003022822
Chapter II Neoplasms,Melanoma in situ,GOLGA3,Golgin subfamily A member 3,19635,77,1.00 [0.75-1.32],0.9936689182372636
Chapter II Neoplasms,Melanoma in situ,GOLM2,Protein GOLM2,22788,90,1.05 [0.46-2.43],0.9063721044158082
Chapter II Neoplasms,Melanoma in situ,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,22550,90,1.06 [0.88-1.28],0.5089336628255189
Chapter II Neoplasms,Melanoma in situ,GORASP2,Golgi reassembly-stacking protein 2,19566,77,1.26 [0.81-1.97],0.3023147151034723
Chapter II Neoplasms,Melanoma in situ,GOT1,"Aspartate aminotransferase, cytoplasmic",19661,77,0.88 [0.51-1.54],0.6628073485755611
Chapter II Neoplasms,Melanoma in situ,GP1BA,Platelet glycoprotein Ib alpha chain,22461,89,1.29 [0.72-2.33],0.3920920918530887
Chapter II Neoplasms,Melanoma in situ,GP1BB,Platelet glycoprotein Ib beta chain,19066,75,1.20 [0.86-1.67],0.2841535220773168
Chapter II Neoplasms,Melanoma in situ,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,21914,87,0.92 [0.73-1.16],0.4924329337758385
Chapter II Neoplasms,Melanoma in situ,GP5,Platelet glycoprotein V,19255,75,1.29 [0.67-2.46],0.4435880486133444
Chapter II Neoplasms,Melanoma in situ,GP6,Platelet glycoprotein VI,22562,90,1.04 [0.84-1.28],0.7422598460696221
Chapter II Neoplasms,Melanoma in situ,GPA33,Cell surface A33 antigen,22484,88,1.08 [0.94-1.23],0.2944534010015279
Chapter II Neoplasms,Melanoma in situ,GPC1,Glypican-1,22789,90,1.40 [0.74-2.64],0.3055451896495745
Chapter II Neoplasms,Melanoma in situ,GPC5,Glypican-5,22440,89,0.78 [0.56-1.09],0.1399858452360401
Chapter II Neoplasms,Melanoma in situ,GPD1,Glycerol-3-phosphate dehydrogenase,19560,77,0.98 [0.63-1.52],0.9384396317395868
Chapter II Neoplasms,Melanoma in situ,GPHA2,Glycoprotein hormone alpha-2,19566,77,1.08 [0.71-1.65],0.7213487880027699
Chapter II Neoplasms,Melanoma in situ,GPI,Glucose-6-phosphate isomerase,19669,77,1.45 [0.94-2.23],0.0901404883448247
Chapter II Neoplasms,Melanoma in situ,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,19566,77,1.03 [0.75-1.42],0.8590596348659042
Chapter II Neoplasms,Melanoma in situ,GPKOW,G-patch domain and KOW motifs-containing protein,22029,90,1.27 [0.73-2.22],0.4021378928351522
Chapter II Neoplasms,Melanoma in situ,GPNMB,Transmembrane glycoprotein NMB,21974,85,1.04 [0.52-2.07],0.9212783678552406
Chapter II Neoplasms,Melanoma in situ,GPR101,Probable G-protein coupled receptor 101,19060,77,0.95 [0.66-1.38],0.7974886913460467
Chapter II Neoplasms,Melanoma in situ,GPR158,Probable G-protein coupled receptor 158,19635,77,1.05 [0.58-1.89],0.8672714097904727
Chapter II Neoplasms,Melanoma in situ,GPR15L,Protein GPR15L,19566,77,0.79 [0.55-1.14],0.2129072912149911
Chapter II Neoplasms,Melanoma in situ,GPR37,Prosaposin receptor GPR37,22187,88,1.14 [0.85-1.52],0.3743529530330699
Chapter II Neoplasms,Melanoma in situ,GPRC5C,G-protein coupled receptor family C group 5 member C,19560,77,0.68 [0.43-1.09],0.1096843307686332
Chapter II Neoplasms,Melanoma in situ,GRAP2,GRB2-related adapter protein 2,22589,89,1.08 [0.93-1.25],0.3387914881175502
Chapter II Neoplasms,Melanoma in situ,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,19665,77,1.16 [0.83-1.62],0.3942155567428488
Chapter II Neoplasms,Melanoma in situ,GRIK2,"Glutamate receptor ionotropic, kainate 2",19635,77,1.20 [0.77-1.87],0.4214402852822037
Chapter II Neoplasms,Melanoma in situ,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",19060,77,1.15 [0.83-1.58],0.3949113643674049
Chapter II Neoplasms,Melanoma in situ,GRK5,G protein-coupled receptor kinase 5,22187,88,0.82 [0.54-1.25],0.3525448750133315
Chapter II Neoplasms,Melanoma in situ,GRN,Progranulin,22500,90,0.58 [0.26-1.31],0.1906673224933534
Chapter II Neoplasms,Melanoma in situ,GRP,Gastrin-releasing peptide,19167,75,0.96 [0.64-1.46],0.8597729625290113
Chapter II Neoplasms,Melanoma in situ,GRPEL1,"GrpE protein homolog 1, mitochondrial",22484,88,1.01 [0.73-1.39],0.9629532126715564
Chapter II Neoplasms,Melanoma in situ,GRSF1,G-rich sequence factor 1,18867,75,1.14 [0.88-1.48],0.3249607336034507
Chapter II Neoplasms,Melanoma in situ,GSAP,Gamma-secretase-activating protein,22078,88,1.00 [0.81-1.24],0.9874657429667936
Chapter II Neoplasms,Melanoma in situ,GSN,Gelsolin,19600,77,0.88 [0.30-2.64],0.8239199922071536
Chapter II Neoplasms,Melanoma in situ,GSR,"Glutathione reductase, mitochondrial",19550,77,1.42 [0.51-3.95],0.5025940929142466
Chapter II Neoplasms,Melanoma in situ,GSTA1,Glutathione S-transferase A1,22554,89,1.03 [0.82-1.29],0.8077230579567432
Chapter II Neoplasms,Melanoma in situ,GSTA3,Glutathione S-transferase A3,22078,88,0.94 [0.73-1.22],0.6573064581412763
Chapter II Neoplasms,Melanoma in situ,GSTM4,Glutathione S-transferase Mu 4,19066,75,1.09 [0.82-1.44],0.5511450358378767
Chapter II Neoplasms,Melanoma in situ,GSTP1,Glutathione S-transferase P,21893,90,1.18 [0.92-1.51],0.2044417084363481
Chapter II Neoplasms,Melanoma in situ,GSTT2B,Glutathione S-transferase theta-2B,19626,77,0.99 [0.91-1.09],0.8710260776555958
Chapter II Neoplasms,Melanoma in situ,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,19287,76,1.00 [0.74-1.35],0.9949858897344755
Chapter II Neoplasms,Melanoma in situ,GTPBP2,GTP-binding protein 2,19119,72,1.17 [0.88-1.54],0.2838417562532541
Chapter II Neoplasms,Melanoma in situ,GUCA2A,Guanylin,22488,89,1.11 [0.62-1.97],0.7261932106475341
Chapter II Neoplasms,Melanoma in situ,GUCY2C,Heat-stable enterotoxin receptor,19287,76,1.00 [0.77-1.30],0.9832932477781292
Chapter II Neoplasms,Melanoma in situ,GUK1,Guanylate kinase,19066,75,0.58 [0.29-1.19],0.1368661602006511
Chapter II Neoplasms,Melanoma in situ,GUSB,Beta-glucuronidase,22697,89,1.16 [0.85-1.58],0.3428489586765884
Chapter II Neoplasms,Melanoma in situ,GYS1,"Glycogen [starch] synthase, muscle",22187,88,1.01 [0.83-1.24],0.9028173294505656
Chapter II Neoplasms,Melanoma in situ,GZMA,Granzyme A,22837,90,1.16 [0.69-1.95],0.5683777517994191
Chapter II Neoplasms,Melanoma in situ,GZMB,Granzyme B,22550,90,0.85 [0.62-1.16],0.2976633851399883
Chapter II Neoplasms,Melanoma in situ,GZMH,Granzyme H,22187,88,1.05 [0.82-1.35],0.6909710440686436
Chapter II Neoplasms,Melanoma in situ,H2AP,Huntingtin-interacting protein M,18973,75,1.09 [0.74-1.61],0.6471588981469217
Chapter II Neoplasms,Melanoma in situ,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",19066,75,0.96 [0.68-1.36],0.8205491392985299
Chapter II Neoplasms,Melanoma in situ,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",22717,90,0.84 [0.65-1.08],0.1674958967652267
Chapter II Neoplasms,Melanoma in situ,HAO1,Hydroxyacid oxidase 1,22789,90,0.88 [0.76-1.03],0.102274116898567
Chapter II Neoplasms,Melanoma in situ,HARS1,"Histidine--tRNA ligase, cytoplasmic",22597,90,1.10 [0.86-1.40],0.4417690932940847
Chapter II Neoplasms,Melanoma in situ,HAVCR1,Hepatitis A virus cellular receptor 1,22756,90,1.45 [1.08-1.95],0.0144360798565991
Chapter II Neoplasms,Melanoma in situ,HAVCR2,Hepatitis A virus cellular receptor 2,22597,90,0.85 [0.49-1.47],0.5561502162221377
Chapter II Neoplasms,Melanoma in situ,HBEGF,Proheparin-binding EGF-like growth factor,22717,90,0.92 [0.71-1.18],0.5044623000412152
Chapter II Neoplasms,Melanoma in situ,HBQ1,Hemoglobin subunit theta-1,22789,90,0.74 [0.54-1.02],0.0666397033859584
Chapter II Neoplasms,Melanoma in situ,HBZ,Hemoglobin subunit zeta,19665,77,0.93 [0.75-1.14],0.4717576554242946
Chapter II Neoplasms,Melanoma in situ,HCG22,Protein PBMUCL2,19066,75,0.62 [0.33-1.15],0.1312359324614715
Chapter II Neoplasms,Melanoma in situ,HCLS1,Hematopoietic lineage cell-specific protein,22837,90,1.12 [0.80-1.56],0.5203620362795482
Chapter II Neoplasms,Melanoma in situ,HDAC8,Histone deacetylase 8,19117,75,0.96 [0.66-1.40],0.824059074090085
Chapter II Neoplasms,Melanoma in situ,HDAC9,Histone deacetylase 9,19060,77,1.03 [0.75-1.43],0.8418851883102263
Chapter II Neoplasms,Melanoma in situ,HDDC2,5'-deoxynucleotidase HDDC2,19566,77,0.81 [0.49-1.34],0.4124474271439865
Chapter II Neoplasms,Melanoma in situ,HDGF,Hepatoma-derived growth factor,22760,90,1.11 [0.92-1.35],0.2649392482211546
Chapter II Neoplasms,Melanoma in situ,HDGFL2,Hepatoma-derived growth factor-related protein 2,19626,77,1.14 [0.82-1.58],0.4370264897418812
Chapter II Neoplasms,Melanoma in situ,HEBP1,Heme-binding protein 1,22187,88,1.08 [0.79-1.46],0.6415361003685557
Chapter II Neoplasms,Melanoma in situ,HEG1,Protein HEG homolog 1,19255,75,1.67 [0.70-3.96],0.2466491720365252
Chapter II Neoplasms,Melanoma in situ,HEPACAM2,HEPACAM family member 2,19626,77,1.33 [0.78-2.28],0.292757028783953
Chapter II Neoplasms,Melanoma in situ,HEPH,Hephaestin,19665,77,1.21 [0.50-2.91],0.6701013880265567
Chapter II Neoplasms,Melanoma in situ,HEXIM1,Protein HEXIM1,22550,90,1.14 [0.91-1.42],0.2633481875517054
Chapter II Neoplasms,Melanoma in situ,HGF,Hepatocyte growth factor,22837,90,0.76 [0.43-1.35],0.3472525157407158
Chapter II Neoplasms,Melanoma in situ,HGFAC,Hepatocyte growth factor activator,19476,76,0.92 [0.45-1.90],0.8306828486072171
Chapter II Neoplasms,Melanoma in situ,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,22078,88,1.10 [0.87-1.40],0.4312635459264845
Chapter II Neoplasms,Melanoma in situ,HHEX,Hematopoietically-expressed homeobox protein HHEX,19626,77,1.22 [0.92-1.62],0.1658293779036365
Chapter II Neoplasms,Melanoma in situ,HIF1A,Hypoxia-inducible factor 1-alpha,19117,75,0.92 [0.63-1.33],0.6537795220411027
Chapter II Neoplasms,Melanoma in situ,HIP1,Huntingtin-interacting protein 1,19066,75,0.99 [0.51-1.91],0.9669469211310516
Chapter II Neoplasms,Melanoma in situ,HIP1R,Huntingtin-interacting protein 1-related protein,19591,77,1.10 [0.68-1.78],0.6909699040724241
Chapter II Neoplasms,Melanoma in situ,HJV,Hemojuvelin,19635,77,0.96 [0.59-1.56],0.8589491340377775
Chapter II Neoplasms,Melanoma in situ,HK2,Hexokinase-2,22187,88,1.16 [0.60-2.22],0.6630614891629297
Chapter II Neoplasms,Melanoma in situ,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",19635,77,0.97 [0.50-1.89],0.9266997983855758
Chapter II Neoplasms,Melanoma in situ,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",22484,90,1.37 [0.83-2.25],0.2151418651895713
Chapter II Neoplasms,Melanoma in situ,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",22550,90,1.92 [1.05-3.49],0.0340659154170592
Chapter II Neoplasms,Melanoma in situ,HMBS,Porphobilinogen deaminase,22789,90,0.75 [0.50-1.11],0.1503214761824069
Chapter II Neoplasms,Melanoma in situ,HMCN2,Hemicentin-2,19219,75,1.07 [0.72-1.59],0.7235096095557548
Chapter II Neoplasms,Melanoma in situ,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",19167,75,0.98 [0.62-1.53],0.913159964216807
Chapter II Neoplasms,Melanoma in situ,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",19066,75,1.10 [0.68-1.79],0.7039402007359428
Chapter II Neoplasms,Melanoma in situ,HMMR,Hyaluronan mediated motility receptor,18945,75,1.05 [0.68-1.62],0.8294122004484936
Chapter II Neoplasms,Melanoma in situ,HMOX1,Heme oxygenase 1,22340,88,0.95 [0.63-1.43],0.7988217352055329
Chapter II Neoplasms,Melanoma in situ,HMOX2,Heme oxygenase 2,22029,90,0.87 [0.56-1.35],0.5417228042185351
Chapter II Neoplasms,Melanoma in situ,HNF1A,Hepatocyte nuclear factor 1-alpha,19119,72,0.87 [0.59-1.26],0.4549216465408053
Chapter II Neoplasms,Melanoma in situ,HNMT,Histamine N-methyltransferase,22322,88,0.89 [0.59-1.33],0.5607673127106938
Chapter II Neoplasms,Melanoma in situ,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,22122,87,1.00 [0.79-1.29],0.9685334403408924
Chapter II Neoplasms,Melanoma in situ,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,19635,77,1.24 [0.83-1.84],0.292313333646037
Chapter II Neoplasms,Melanoma in situ,HPCAL1,Hippocalcin-like protein 1,22837,90,1.07 [0.83-1.39],0.5873907193782522
Chapter II Neoplasms,Melanoma in situ,HPGDS,Hematopoietic prostaglandin D synthase,22078,88,0.96 [0.57-1.60],0.8731655655072755
Chapter II Neoplasms,Melanoma in situ,HPSE,Heparanase,19384,76,1.09 [0.86-1.39],0.4864645521834221
Chapter II Neoplasms,Melanoma in situ,HRAS,GTPase Hras,19251,76,0.86 [0.65-1.14],0.2920544796451209
Chapter II Neoplasms,Melanoma in situ,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,19167,75,1.00 [0.54-1.86],0.9989480828239058
Chapter II Neoplasms,Melanoma in situ,HRG,Histidine-rich glycoprotein,19577,77,0.63 [0.32-1.25],0.1874256899343761
Chapter II Neoplasms,Melanoma in situ,HS1BP3,HCLS1-binding protein 3,19167,75,1.12 [0.88-1.44],0.3600550352852896
Chapter II Neoplasms,Melanoma in situ,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,22484,88,0.79 [0.48-1.30],0.3587213885164173
Chapter II Neoplasms,Melanoma in situ,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,22789,90,1.00 [0.58-1.73],0.9933484001329742
Chapter II Neoplasms,Melanoma in situ,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,19117,75,1.12 [0.54-2.34],0.7553339358959754
Chapter II Neoplasms,Melanoma in situ,HSBP1,Heat shock factor-binding protein 1,19167,75,1.14 [0.91-1.44],0.2604263585003875
Chapter II Neoplasms,Melanoma in situ,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,22550,90,0.73 [0.46-1.17],0.1964118753774381
Chapter II Neoplasms,Melanoma in situ,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,19626,77,1.16 [0.82-1.63],0.4030440959991718
Chapter II Neoplasms,Melanoma in situ,HSD17B3,Testosterone 17-beta-dehydrogenase 3,19066,75,0.96 [0.60-1.53],0.8612785343566556
Chapter II Neoplasms,Melanoma in situ,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,19167,75,1.07 [0.67-1.71],0.7695540546854244
Chapter II Neoplasms,Melanoma in situ,HSP90B1,Endoplasmin,21927,90,1.04 [0.80-1.34],0.7930775210817297
Chapter II Neoplasms,Melanoma in situ,HSPA1A,Heat shock 70 kDa protein 1A,22658,89,1.08 [0.83-1.39],0.5678626967846572
Chapter II Neoplasms,Melanoma in situ,HSPA2,Heat shock-related 70 kDa protein 2,19560,77,0.62 [0.30-1.28],0.1950615294588253
Chapter II Neoplasms,Melanoma in situ,HSPB1,Heat shock protein beta-1,22223,88,1.45 [1.06-1.98],0.0204068620480064
Chapter II Neoplasms,Melanoma in situ,HSPB6,Heat shock protein beta-6,22789,90,1.56 [0.97-2.53],0.0690300777198996
Chapter II Neoplasms,Melanoma in situ,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,22393,89,1.69 [0.82-3.51],0.1559187194812321
Chapter II Neoplasms,Melanoma in situ,HTR1A,5-hydroxytryptamine receptor 1A,19060,77,0.97 [0.73-1.27],0.8139418891378237
Chapter II Neoplasms,Melanoma in situ,HTR1B,5-hydroxytryptamine receptor 1B,19060,77,0.88 [0.51-1.51],0.6338761825074022
Chapter II Neoplasms,Melanoma in situ,HTRA2,"Serine protease HTRA2, mitochondrial",22658,90,1.10 [0.81-1.48],0.5386849719181228
Chapter II Neoplasms,Melanoma in situ,HYAL1,Hyaluronidase-1,22423,89,0.99 [0.43-2.26],0.9721743923509336
Chapter II Neoplasms,Melanoma in situ,HYOU1,Hypoxia up-regulated protein 1,22859,89,0.66 [0.28-1.57],0.3465989912178681
Chapter II Neoplasms,Melanoma in situ,ICA1,Islet cell autoantigen 1,22161,88,1.05 [0.83-1.34],0.6704081295845008
Chapter II Neoplasms,Melanoma in situ,ICAM1,Intercellular adhesion molecule 1,22472,89,1.61 [0.84-3.09],0.1523698436136165
Chapter II Neoplasms,Melanoma in situ,ICAM2,Intercellular adhesion molecule 2,22859,89,1.43 [0.78-2.63],0.2467573044254087
Chapter II Neoplasms,Melanoma in situ,ICAM3,Intercellular adhesion molecule 3,22859,89,0.97 [0.46-2.07],0.943001002232362
Chapter II Neoplasms,Melanoma in situ,ICAM4,Intercellular adhesion molecule 4,22550,90,0.80 [0.57-1.13],0.2081134757768941
Chapter II Neoplasms,Melanoma in situ,ICAM5,Intercellular adhesion molecule 5,22589,89,0.49 [0.32-0.73],0.0005928709158333
Chapter II Neoplasms,Melanoma in situ,ICOSLG,ICOS ligand,22484,88,0.75 [0.28-2.04],0.5758361099693923
Chapter II Neoplasms,Melanoma in situ,ID4,DNA-binding protein inhibitor ID-4,19287,76,1.04 [0.65-1.66],0.8775394877259418
Chapter II Neoplasms,Melanoma in situ,IDI2,Isopentenyl-diphosphate delta-isomerase 2,22029,90,1.29 [0.91-1.82],0.1481188832357322
Chapter II Neoplasms,Melanoma in situ,IDO1,"Indoleamine 2,3-dioxygenase 1",19167,75,0.89 [0.62-1.28],0.533082828311833
Chapter II Neoplasms,Melanoma in situ,IDS,Iduronate 2-sulfatase,22837,90,0.32 [0.04-2.22],0.2461015793029434
Chapter II Neoplasms,Melanoma in situ,IDUA,Alpha-L-iduronidase,22789,90,0.90 [0.60-1.34],0.6002339774897263
Chapter II Neoplasms,Melanoma in situ,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,19084,75,1.32 [0.76-2.30],0.3267841034966848
Chapter II Neoplasms,Melanoma in situ,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,19287,76,0.71 [0.45-1.13],0.150597614711741
Chapter II Neoplasms,Melanoma in situ,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,19287,76,1.15 [0.66-2.01],0.6263784337718066
Chapter II Neoplasms,Melanoma in situ,IFNAR1,Interferon alpha/beta receptor 1,19566,77,1.31 [0.61-2.81],0.4901856416382643
Chapter II Neoplasms,Melanoma in situ,IFNG,Interferon gamma,22161,88,1.10 [0.93-1.30],0.25167936641853
Chapter II Neoplasms,Melanoma in situ,IFNGR1,Interferon gamma receptor 1,22692,90,0.70 [0.28-1.81],0.4660301829591767
Chapter II Neoplasms,Melanoma in situ,IFNGR2,Interferon gamma receptor 2,22440,89,1.17 [0.82-1.67],0.3769384589769157
Chapter II Neoplasms,Melanoma in situ,IFNL1,Interferon lambda-1,22029,90,1.10 [0.72-1.67],0.6621289595293426
Chapter II Neoplasms,Melanoma in situ,IFNL2,Interferon lambda-2,19060,77,0.91 [0.62-1.32],0.6042503549370084
Chapter II Neoplasms,Melanoma in situ,IFNLR1,Interferon lambda receptor 1,22550,90,0.74 [0.43-1.29],0.2939355316037628
Chapter II Neoplasms,Melanoma in situ,IFNW1,Interferon omega-1,19066,75,1.35 [0.86-2.12],0.1862365860561378
Chapter II Neoplasms,Melanoma in situ,IFT20,Intraflagellar transport protein 20 homolog,19119,72,1.36 [0.86-2.16],0.1891068373450036
Chapter II Neoplasms,Melanoma in situ,IGBP1,Immunoglobulin-binding protein 1,19635,77,0.99 [0.70-1.42],0.9755860093511354
Chapter II Neoplasms,Melanoma in situ,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,19060,77,1.10 [0.72-1.66],0.6643128319947138
Chapter II Neoplasms,Melanoma in situ,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,19661,77,0.75 [0.31-1.77],0.504411171905508
Chapter II Neoplasms,Melanoma in situ,IGF1R,Insulin-like growth factor 1 receptor,22484,88,0.89 [0.36-2.18],0.7997585571992495
Chapter II Neoplasms,Melanoma in situ,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,19066,75,0.65 [0.36-1.18],0.1551991250697358
Chapter II Neoplasms,Melanoma in situ,IGF2R,Cation-independent mannose-6-phosphate receptor,22597,90,0.91 [0.40-2.06],0.8165793614975658
Chapter II Neoplasms,Melanoma in situ,IGFBP1,Insulin-like growth factor-binding protein 1,22820,89,1.08 [0.92-1.27],0.3591943954769235
Chapter II Neoplasms,Melanoma in situ,IGFBP2,Insulin-like growth factor-binding protein 2,22820,88,0.82 [0.61-1.11],0.2011940342761771
Chapter II Neoplasms,Melanoma in situ,IGFBP3,Insulin-like growth factor-binding protein 3,22650,89,0.79 [0.40-1.56],0.5000755094919309
Chapter II Neoplasms,Melanoma in situ,IGFBP4,Insulin-like growth factor-binding protein 4,22300,88,0.92 [0.57-1.49],0.7372362007300071
Chapter II Neoplasms,Melanoma in situ,IGFBP6,Insulin-like growth factor-binding protein 6,22468,89,1.09 [0.56-2.13],0.8004280564954718
Chapter II Neoplasms,Melanoma in situ,IGFBP7,Insulin-like growth factor-binding protein 7,22859,89,1.32 [0.71-2.46],0.3754622444971741
Chapter II Neoplasms,Melanoma in situ,IGFBPL1,Insulin-like growth factor-binding protein-like 1,22589,89,1.07 [0.61-1.87],0.8230059105086139
Chapter II Neoplasms,Melanoma in situ,IGFL4,Insulin growth factor-like family member 4,19117,75,1.30 [1.08-1.56],0.0061193034177756
Chapter II Neoplasms,Melanoma in situ,IGHMBP2,DNA-binding protein SMUBP-2,19066,75,0.79 [0.51-1.22],0.2873182989719404
Chapter II Neoplasms,Melanoma in situ,IGLC2,Immunoglobulin lambda constant 2,19655,77,0.92 [0.36-2.32],0.8587804871391411
Chapter II Neoplasms,Melanoma in situ,IGLON5,IgLON family member 5,18973,75,1.03 [0.83-1.29],0.7866435089211068
Chapter II Neoplasms,Melanoma in situ,IGSF21,Immunoglobulin superfamily member 21,19167,75,0.82 [0.44-1.53],0.5374351235130685
Chapter II Neoplasms,Melanoma in situ,IGSF3,Immunoglobulin superfamily member 3,22484,88,1.11 [0.63-1.97],0.7210638517154333
Chapter II Neoplasms,Melanoma in situ,IGSF8,Immunoglobulin superfamily member 8,22589,89,1.39 [0.74-2.59],0.3019754902291509
Chapter II Neoplasms,Melanoma in situ,IGSF9,Protein turtle homolog A,19665,77,0.93 [0.70-1.23],0.6207688628466409
Chapter II Neoplasms,Melanoma in situ,IKBKG,NF-kappa-B essential modulator,22550,90,1.11 [0.91-1.36],0.3000195756011413
Chapter II Neoplasms,Melanoma in situ,IKZF2,Zinc finger protein Helios,22078,88,1.00 [0.81-1.22],0.9737890109590128
Chapter II Neoplasms,Melanoma in situ,IL10,Interleukin-10,22161,88,1.03 [0.82-1.28],0.806920042807155
Chapter II Neoplasms,Melanoma in situ,IL10RA,Interleukin-10 receptor subunit alpha,22161,88,0.77 [0.51-1.15],0.2000583946999796
Chapter II Neoplasms,Melanoma in situ,IL10RB,Interleukin-10 receptor subunit beta,22692,90,0.63 [0.32-1.26],0.1928616990115444
Chapter II Neoplasms,Melanoma in situ,IL11,Interleukin-11,22161,88,0.63 [0.42-0.93],0.0193782336698768
Chapter II Neoplasms,Melanoma in situ,IL12A_IL12B,Interleukin-12,22484,88,0.90 [0.70-1.15],0.3804068799739918
Chapter II Neoplasms,Melanoma in situ,IL12B,Interleukin-12 subunit beta,22837,90,0.90 [0.64-1.28],0.5664573874107027
Chapter II Neoplasms,Melanoma in situ,IL12RB1,Interleukin-12 receptor subunit beta-1,22161,88,1.22 [0.74-2.00],0.4301569243075887
Chapter II Neoplasms,Melanoma in situ,IL12RB2,Interleukin-12 receptor subunit beta-2,19117,75,1.03 [0.61-1.75],0.9033264595999831
Chapter II Neoplasms,Melanoma in situ,IL13,Interleukin-13,22161,88,0.93 [0.61-1.42],0.746504952493796
Chapter II Neoplasms,Melanoma in situ,IL13RA1,Interleukin-13 receptor subunit alpha-1,22304,90,0.66 [0.26-1.67],0.3856361104798158
Chapter II Neoplasms,Melanoma in situ,IL13RA2,Interleukin-13 receptor subunit alpha-2,19060,77,1.49 [0.70-3.15],0.302481783127943
Chapter II Neoplasms,Melanoma in situ,IL15,Interleukin-15,22550,90,1.05 [0.59-1.88],0.8566460156335653
Chapter II Neoplasms,Melanoma in situ,IL15RA,Interleukin-15 receptor subunit alpha,22161,88,0.88 [0.51-1.51],0.6345409726085183
Chapter II Neoplasms,Melanoma in situ,IL16,Pro-interleukin-16,22837,90,1.13 [0.74-1.72],0.5716195725301197
Chapter II Neoplasms,Melanoma in situ,IL17A,Interleukin-17A,22137,88,0.82 [0.51-1.33],0.4155352749583452
Chapter II Neoplasms,Melanoma in situ,IL17C,Interleukin-17C,22161,88,0.83 [0.62-1.12],0.223049916835673
Chapter II Neoplasms,Melanoma in situ,IL17D,Interleukin-17D,22161,88,0.76 [0.39-1.45],0.400381963497072
Chapter II Neoplasms,Melanoma in situ,IL17F,Interleukin-17F,22161,88,0.73 [0.53-0.99],0.045068997223741
Chapter II Neoplasms,Melanoma in situ,IL17RA,Interleukin-17 receptor A,22597,90,0.91 [0.60-1.39],0.6607501628666261
Chapter II Neoplasms,Melanoma in situ,IL17RB,Interleukin-17 receptor B,22257,90,0.73 [0.51-1.04],0.0821860964127407
Chapter II Neoplasms,Melanoma in situ,IL18,Interleukin-18,22508,89,1.06 [0.72-1.58],0.7585332387941218
Chapter II Neoplasms,Melanoma in situ,IL18BP,Interleukin-18-binding protein,22650,89,1.43 [0.78-2.61],0.2458339225457942
Chapter II Neoplasms,Melanoma in situ,IL18R1,Interleukin-18 receptor 1,22837,90,1.03 [0.58-1.82],0.92749342404078
Chapter II Neoplasms,Melanoma in situ,IL18RAP,Interleukin-18 receptor accessory protein,22294,88,0.98 [0.88-1.10],0.7685801697046593
Chapter II Neoplasms,Melanoma in situ,IL19,Interleukin-19,22025,86,1.22 [0.93-1.60],0.1444344847451506
Chapter II Neoplasms,Melanoma in situ,IL1A,Interleukin-1 alpha,22161,88,0.67 [0.43-1.04],0.0764897270721145
Chapter II Neoplasms,Melanoma in situ,IL1B,Interleukin-1 beta,22059,86,0.94 [0.66-1.33],0.7161815040002578
Chapter II Neoplasms,Melanoma in situ,IL1R1,Interleukin-1 receptor type 1,22563,90,0.50 [0.21-1.17],0.1077572906554007
Chapter II Neoplasms,Melanoma in situ,IL1R2,Interleukin-1 receptor type 2,22554,90,0.94 [0.35-2.48],0.8956054240354916
Chapter II Neoplasms,Melanoma in situ,IL1RAP,Interleukin-1 receptor accessory protein,22597,90,0.93 [0.60-1.42],0.7309130159733721
Chapter II Neoplasms,Melanoma in situ,IL1RL1,Interleukin-1 receptor-like 1,22791,89,1.21 [0.80-1.84],0.3651442739742994
Chapter II Neoplasms,Melanoma in situ,IL1RL2,Interleukin-1 receptor-like 2,22161,88,1.00 [0.62-1.62],0.9917565519474502
Chapter II Neoplasms,Melanoma in situ,IL1RN,Interleukin-1 receptor antagonist protein,22549,89,1.24 [0.91-1.67],0.1693950802519079
Chapter II Neoplasms,Melanoma in situ,IL2,Interleukin-2,22161,88,0.95 [0.52-1.75],0.8706924473367742
Chapter II Neoplasms,Melanoma in situ,IL20,Interleukin-20,22161,88,0.65 [0.41-1.05],0.0761400595130809
Chapter II Neoplasms,Melanoma in situ,IL20RA,Interleukin-20 receptor subunit alpha,22161,88,1.13 [0.79-1.62],0.5094200996316925
Chapter II Neoplasms,Melanoma in situ,IL20RB,Interleukin-20 receptor subunit beta,19117,75,0.87 [0.51-1.51],0.6287793127343471
Chapter II Neoplasms,Melanoma in situ,IL21R,Interleukin-21 receptor,19117,75,0.84 [0.53-1.34],0.4705701140441737
Chapter II Neoplasms,Melanoma in situ,IL22,Interleukin-22,19560,77,0.92 [0.65-1.29],0.6282151626030779
Chapter II Neoplasms,Melanoma in situ,IL22RA1,Interleukin-22 receptor subunit alpha-1,22161,88,0.90 [0.56-1.43],0.6486357961907551
Chapter II Neoplasms,Melanoma in situ,IL24,Interleukin-24,22161,88,1.29 [0.96-1.75],0.0962059847090621
Chapter II Neoplasms,Melanoma in situ,IL25,Interleukin-25,18903,75,0.58 [0.31-1.08],0.085900256055693
Chapter II Neoplasms,Melanoma in situ,IL2RA,Interleukin-2 receptor subunit alpha,22418,85,0.63 [0.38-1.05],0.0782764166666171
Chapter II Neoplasms,Melanoma in situ,IL2RB,Interleukin-2 receptor subunit beta,22161,88,1.00 [0.61-1.64],0.997552253422428
Chapter II Neoplasms,Melanoma in situ,IL2RG,Cytokine receptor common subunit gamma,19560,77,0.65 [0.32-1.30],0.2201046026218067
Chapter II Neoplasms,Melanoma in situ,IL3,Interleukin-3,18973,75,0.67 [0.52-0.86],0.0016101830109217
Chapter II Neoplasms,Melanoma in situ,IL31,Interleukin-31,19117,75,1.06 [0.73-1.53],0.7686007674238482
Chapter II Neoplasms,Melanoma in situ,IL31RA,Interleukin-31 receptor subunit alpha,19042,74,0.68 [0.38-1.19],0.1789094195021174
Chapter II Neoplasms,Melanoma in situ,IL32,Interleukin-32,22550,90,0.98 [0.62-1.54],0.9245111809707556
Chapter II Neoplasms,Melanoma in situ,IL33,Interleukin-33,22161,88,0.91 [0.56-1.47],0.6913377652225712
Chapter II Neoplasms,Melanoma in situ,IL34,Interleukin-34,21999,90,0.70 [0.43-1.15],0.1609896898511429
Chapter II Neoplasms,Melanoma in situ,IL36A,Interleukin-36 alpha,19117,75,0.87 [0.56-1.34],0.5187103416926249
Chapter II Neoplasms,Melanoma in situ,IL36G,Interleukin-36 gamma,19035,75,1.13 [0.84-1.52],0.425157983164006
Chapter II Neoplasms,Melanoma in situ,IL3RA,Interleukin-3 receptor subunit alpha,22161,88,1.08 [0.60-1.94],0.786477191921775
Chapter II Neoplasms,Melanoma in situ,IL4,Interleukin-4,22161,88,0.94 [0.78-1.14],0.5479326171100739
Chapter II Neoplasms,Melanoma in situ,IL4R,Interleukin-4 receptor subunit alpha,22550,90,0.95 [0.56-1.64],0.8624369084734864
Chapter II Neoplasms,Melanoma in situ,IL5,Interleukin-5,22161,88,1.01 [0.89-1.15],0.8440033451808153
Chapter II Neoplasms,Melanoma in situ,IL5RA,Interleukin-5 receptor subunit alpha,22550,90,0.86 [0.61-1.23],0.4086908496354428
Chapter II Neoplasms,Melanoma in situ,IL6,Interleukin-6,22484,88,1.06 [0.83-1.35],0.6266952553088727
Chapter II Neoplasms,Melanoma in situ,IL6R,Interleukin-6 receptor subunit alpha,22428,89,1.38 [0.79-2.41],0.2508724859912126
Chapter II Neoplasms,Melanoma in situ,IL6ST,Interleukin-6 receptor subunit beta,22589,89,1.10 [0.37-3.23],0.8666544809982011
Chapter II Neoplasms,Melanoma in situ,IL7,Interleukin-7,22550,90,0.83 [0.62-1.12],0.2216946526443868
Chapter II Neoplasms,Melanoma in situ,IL7R,Interleukin-7 receptor subunit alpha,22597,90,0.83 [0.58-1.17],0.2890312746113426
Chapter II Neoplasms,Melanoma in situ,IL9,Interleukin-9,19287,76,1.03 [0.70-1.50],0.8865711719467008
Chapter II Neoplasms,Melanoma in situ,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,22004,90,1.06 [0.77-1.47],0.7085053678924136
Chapter II Neoplasms,Melanoma in situ,IMMT,MICOS complex subunit MIC60,19560,77,1.58 [1.10-2.25],0.012437084478608
Chapter II Neoplasms,Melanoma in situ,IMPA1,Inositol monophosphatase 1,22440,89,1.18 [0.87-1.60],0.2763922040301289
Chapter II Neoplasms,Melanoma in situ,IMPACT,Protein IMPACT,19626,77,0.99 [0.68-1.45],0.9626257324204092
Chapter II Neoplasms,Melanoma in situ,IMPG1,Interphotoreceptor matrix proteoglycan 1,19060,77,0.73 [0.33-1.63],0.4397749427881364
Chapter II Neoplasms,Melanoma in situ,ING1,Inhibitor of growth protein 1,21981,90,1.17 [0.80-1.71],0.4078938218706722
Chapter II Neoplasms,Melanoma in situ,INHBB,Inhibin beta B chain,19255,75,0.73 [0.46-1.14],0.1664477455458156
Chapter II Neoplasms,Melanoma in situ,INHBC,Inhibin beta C chain,22597,90,0.98 [0.64-1.52],0.9422870390546008
Chapter II Neoplasms,Melanoma in situ,INPP1,Inositol polyphosphate 1-phosphatase,22484,88,1.12 [0.80-1.59],0.5057671231637602
Chapter II Neoplasms,Melanoma in situ,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",19167,75,1.10 [0.74-1.61],0.6426690052147408
Chapter II Neoplasms,Melanoma in situ,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",19635,77,0.87 [0.51-1.49],0.6139636698639515
Chapter II Neoplasms,Melanoma in situ,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",22484,88,1.08 [0.89-1.31],0.4230354078982111
Chapter II Neoplasms,Melanoma in situ,INSL3,Insulin-like 3,19626,77,1.05 [0.72-1.53],0.7944642846856267
Chapter II Neoplasms,Melanoma in situ,INSL4,Early placenta insulin-like peptide,19560,77,1.22 [0.87-1.69],0.2497757651782218
Chapter II Neoplasms,Melanoma in situ,INSL5,Insulin-like peptide INSL5,19566,77,0.83 [0.64-1.07],0.1425901670386004
Chapter II Neoplasms,Melanoma in situ,INSR,Insulin receptor,19117,75,1.37 [0.37-5.14],0.6406330796260531
Chapter II Neoplasms,Melanoma in situ,IPCEF1,Interactor protein for cytohesin exchange factors 1,22405,88,1.02 [0.82-1.26],0.8849442567114948
Chapter II Neoplasms,Melanoma in situ,IQGAP2,Ras GTPase-activating-like protein IQGAP2,22484,88,1.12 [0.80-1.58],0.5025652231458994
Chapter II Neoplasms,Melanoma in situ,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",22187,88,1.02 [0.82-1.26],0.8492410165974137
Chapter II Neoplasms,Melanoma in situ,IRAK1,Interleukin-1 receptor-associated kinase 1,22161,88,1.10 [0.84-1.45],0.4920064863965028
Chapter II Neoplasms,Melanoma in situ,IRAK4,Interleukin-1 receptor-associated kinase 4,22550,90,1.08 [0.90-1.29],0.403308560568813
Chapter II Neoplasms,Melanoma in situ,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,21719,87,1.05 [0.63-1.77],0.8418139308729434
Chapter II Neoplasms,Melanoma in situ,ISM1,Isthmin-1,22550,90,0.83 [0.51-1.35],0.4553917578280476
Chapter II Neoplasms,Melanoma in situ,ISM2,Isthmin-2,19661,77,0.91 [0.54-1.54],0.7268724683319552
Chapter II Neoplasms,Melanoma in situ,IST1,IST1 homolog,19426,77,1.10 [0.88-1.37],0.4108611938627386
Chapter II Neoplasms,Melanoma in situ,ITGA11,Integrin alpha-11,22550,90,1.09 [0.63-1.89],0.7451255390093026
Chapter II Neoplasms,Melanoma in situ,ITGA2,Integrin alpha-2,19255,75,1.48 [0.76-2.89],0.2506524779251473
Chapter II Neoplasms,Melanoma in situ,ITGA5,Integrin alpha-5,22597,90,0.74 [0.34-1.59],0.4356107066027151
Chapter II Neoplasms,Melanoma in situ,ITGA6,Integrin alpha-6,22550,90,1.01 [0.71-1.44],0.9339862155253872
Chapter II Neoplasms,Melanoma in situ,ITGAL,Integrin alpha-L,19117,75,1.33 [0.78-2.25],0.295322361531181
Chapter II Neoplasms,Melanoma in situ,ITGAM,Integrin alpha-M,22597,90,0.77 [0.42-1.39],0.3800338857689466
Chapter II Neoplasms,Melanoma in situ,ITGAV,Integrin alpha-V,22789,90,1.09 [0.34-3.52],0.8821408134714357
Chapter II Neoplasms,Melanoma in situ,ITGAX,Integrin alpha-X,19287,76,1.07 [0.72-1.58],0.7434826001286179
Chapter II Neoplasms,Melanoma in situ,ITGB1,Integrin beta-1,22542,89,1.79 [0.80-4.02],0.1587813819945842
Chapter II Neoplasms,Melanoma in situ,ITGB1BP1,Integrin beta-1-binding protein 1,22078,88,0.99 [0.63-1.56],0.9595769924259492
Chapter II Neoplasms,Melanoma in situ,ITGB1BP2,Integrin beta-1-binding protein 2,22187,88,1.05 [0.88-1.25],0.5853677337808462
Chapter II Neoplasms,Melanoma in situ,ITGB2,Integrin beta-2,22441,88,0.80 [0.41-1.56],0.509363639258325
Chapter II Neoplasms,Melanoma in situ,ITGB5,Integrin beta-5,22658,90,1.02 [0.62-1.70],0.929656059611576
Chapter II Neoplasms,Melanoma in situ,ITGB6,Integrin beta-6,22161,88,1.02 [0.54-1.94],0.9509510447739276
Chapter II Neoplasms,Melanoma in situ,ITGB7,Integrin beta-7,22789,90,1.06 [0.71-1.59],0.77324558085241
Chapter II Neoplasms,Melanoma in situ,ITGBL1,Integrin beta-like protein 1,19661,77,0.86 [0.44-1.65],0.6431558108897346
Chapter II Neoplasms,Melanoma in situ,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,19694,77,1.74 [0.62-4.90],0.2918703476204661
Chapter II Neoplasms,Melanoma in situ,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,22650,89,0.84 [0.51-1.38],0.5004977128280195
Chapter II Neoplasms,Melanoma in situ,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,19694,77,0.92 [0.40-2.10],0.8392076733231941
Chapter II Neoplasms,Melanoma in situ,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,19560,77,1.09 [0.69-1.73],0.7147117007730992
Chapter II Neoplasms,Melanoma in situ,ITM2A,Integral membrane protein 2A,22550,90,1.19 [0.87-1.63],0.267099434859593
Chapter II Neoplasms,Melanoma in situ,ITPA,Inosine triphosphate pyrophosphatase,19066,75,1.23 [0.89-1.70],0.2141177331727488
Chapter II Neoplasms,Melanoma in situ,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",19167,75,1.30 [1.02-1.65],0.0327719256437901
Chapter II Neoplasms,Melanoma in situ,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",19060,77,0.91 [0.55-1.52],0.7185998973266916
Chapter II Neoplasms,Melanoma in situ,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",22029,90,0.95 [0.65-1.39],0.7971157655311887
Chapter II Neoplasms,Melanoma in situ,IZUMO1,Izumo sperm-egg fusion protein 1,18973,75,0.77 [0.44-1.34],0.3513815584171617
Chapter II Neoplasms,Melanoma in situ,JAM2,Junctional adhesion molecule B,22788,90,1.12 [0.53-2.34],0.7676299791865546
Chapter II Neoplasms,Melanoma in situ,JAM3,Junctional adhesion molecule C,19255,75,0.99 [0.63-1.56],0.9690688479358348
Chapter II Neoplasms,Melanoma in situ,JCHAIN,Immunoglobulin J chain,22161,88,0.84 [0.61-1.14],0.2593746645050743
Chapter II Neoplasms,Melanoma in situ,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,18973,75,1.15 [0.81-1.64],0.4316900751219583
Chapter II Neoplasms,Melanoma in situ,JPT2,Jupiter microtubule associated homolog 2,19566,77,1.22 [0.95-1.57],0.1219753948273558
Chapter II Neoplasms,Melanoma in situ,JUN,Transcription factor AP-1,22161,88,1.03 [0.72-1.47],0.8846844543100982
Chapter II Neoplasms,Melanoma in situ,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,22484,88,1.02 [0.67-1.56],0.9136170860414888
Chapter II Neoplasms,Melanoma in situ,KAZN,Kazrin,19566,77,1.13 [0.92-1.40],0.2465363511380267
Chapter II Neoplasms,Melanoma in situ,KCNC4,Potassium voltage-gated channel subfamily C member 4,19060,77,1.76 [1.47-2.11],5.27062992944347e-10
Chapter II Neoplasms,Melanoma in situ,KCNH2,Potassium voltage-gated channel subfamily H member 2,19119,72,1.05 [0.80-1.38],0.7356257362736087
Chapter II Neoplasms,Melanoma in situ,KCNIP4,Kv channel-interacting protein 4,22029,90,0.66 [0.41-1.06],0.0837668227603995
Chapter II Neoplasms,Melanoma in situ,KCTD5,BTB/POZ domain-containing protein KCTD5,19264,77,1.00 [0.60-1.65],0.9897658813669176
Chapter II Neoplasms,Melanoma in situ,KDM3A,Lysine-specific demethylase 3A,19117,75,0.90 [0.69-1.19],0.4719976888255038
Chapter II Neoplasms,Melanoma in situ,KDR,Vascular endothelial growth factor receptor 2,22658,90,1.25 [0.59-2.64],0.5669339212239244
Chapter II Neoplasms,Melanoma in situ,KEL,Kell blood group glycoprotein,22029,90,1.26 [0.75-2.13],0.383402358045777
Chapter II Neoplasms,Melanoma in situ,KHDC3L,KH domain-containing protein 3,18973,75,0.86 [0.59-1.26],0.4319602020968686
Chapter II Neoplasms,Melanoma in situ,KHK,Ketohexokinase,19167,75,1.09 [0.77-1.55],0.6317219326666048
Chapter II Neoplasms,Melanoma in situ,KIAA0319,Dyslexia-associated protein KIAA0319,19626,77,0.89 [0.43-1.86],0.7573879043132226
Chapter II Neoplasms,Melanoma in situ,KIAA1549,UPF0606 protein KIAA1549,19287,76,0.98 [0.72-1.33],0.8913225715512991
Chapter II Neoplasms,Melanoma in situ,KIAA1549L,UPF0606 protein KIAA1549L,19287,76,0.67 [0.30-1.51],0.3314744481346695
Chapter II Neoplasms,Melanoma in situ,KIAA2013,Uncharacterized protein KIAA2013,19560,77,0.80 [0.50-1.27],0.3420426700985179
Chapter II Neoplasms,Melanoma in situ,KIF1C,Kinesin-like protein KIF1C,19066,75,0.58 [0.26-1.27],0.1701253626142181
Chapter II Neoplasms,Melanoma in situ,KIF20B,Kinesin-like protein KIF20B,19060,77,0.88 [0.65-1.19],0.4068196147525524
Chapter II Neoplasms,Melanoma in situ,KIF22,Kinesin-like protein KIF22,19066,75,1.06 [0.88-1.27],0.5467672526107921
Chapter II Neoplasms,Melanoma in situ,KIFBP,KIF-binding protein,22484,88,1.10 [0.87-1.38],0.4270711428932872
Chapter II Neoplasms,Melanoma in situ,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,19560,77,1.10 [0.86-1.41],0.4612250725826361
Chapter II Neoplasms,Melanoma in situ,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,22078,88,0.97 [0.76-1.24],0.7880945299854972
Chapter II Neoplasms,Melanoma in situ,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,19566,77,1.03 [0.91-1.16],0.6693408976289069
Chapter II Neoplasms,Melanoma in situ,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,22078,88,0.96 [0.82-1.13],0.6374256566832524
Chapter II Neoplasms,Melanoma in situ,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,18973,75,1.18 [0.97-1.43],0.0974081998504605
Chapter II Neoplasms,Melanoma in situ,KIRREL1,Kin of IRRE-like protein 1,19060,77,0.87 [0.56-1.33],0.5088396946988022
Chapter II Neoplasms,Melanoma in situ,KIRREL2,Kin of IRRE-like protein 2,22029,90,0.71 [0.43-1.16],0.1733633202365116
Chapter II Neoplasms,Melanoma in situ,KIT,Mast/stem cell growth factor receptor Kit,22613,89,1.31 [0.69-2.46],0.4115760371525173
Chapter II Neoplasms,Melanoma in situ,KITLG,Kit ligand,22589,89,0.99 [0.59-1.68],0.9830829150728806
Chapter II Neoplasms,Melanoma in situ,KLB,Beta-klotho,22029,90,0.82 [0.63-1.06],0.1357229230647687
Chapter II Neoplasms,Melanoma in situ,KLF4,Krueppel-like factor 4,19060,77,1.22 [0.73-2.05],0.4518702026000454
Chapter II Neoplasms,Melanoma in situ,KLHL41,Kelch-like protein 41,19635,77,1.20 [0.79-1.82],0.3977250462440648
Chapter II Neoplasms,Melanoma in situ,KLK1,Kallikrein-1,22349,88,1.01 [0.87-1.17],0.8612596253885133
Chapter II Neoplasms,Melanoma in situ,KLK10,Kallikrein-10,22586,90,0.77 [0.48-1.25],0.2988068897926572
Chapter II Neoplasms,Melanoma in situ,KLK11,Kallikrein-11,22435,90,0.74 [0.39-1.44],0.3796548207175469
Chapter II Neoplasms,Melanoma in situ,KLK12,Kallikrein-12,22078,88,0.98 [0.86-1.12],0.7782387410798753
Chapter II Neoplasms,Melanoma in situ,KLK13,Kallikrein-13,22087,88,1.16 [0.76-1.79],0.4876152727310454
Chapter II Neoplasms,Melanoma in situ,KLK14,Kallikrein-14,22789,90,0.79 [0.52-1.18],0.2495888602247622
Chapter II Neoplasms,Melanoma in situ,KLK15,Kallikrein-15,19535,77,0.78 [0.51-1.18],0.2345967019680415
Chapter II Neoplasms,Melanoma in situ,KLK3,Prostate-specific antigen,19661,77,0.97 [0.67-1.42],0.8934894197482983
Chapter II Neoplasms,Melanoma in situ,KLK4,Kallikrein-4,22789,90,1.22 [0.91-1.64],0.1774792580518883
Chapter II Neoplasms,Melanoma in situ,KLK6,Kallikrein-6,22631,90,1.11 [0.60-2.07],0.7392105363740985
Chapter II Neoplasms,Melanoma in situ,KLK7,Kallikrein-7,18735,75,0.69 [0.37-1.26],0.2223271219780021
Chapter II Neoplasms,Melanoma in situ,KLK8,Kallikrein-8,21830,87,1.07 [0.62-1.83],0.8161505406814134
Chapter II Neoplasms,Melanoma in situ,KLKB1,Plasma kallikrein,19296,77,1.09 [0.45-2.64],0.8433053044032408
Chapter II Neoplasms,Melanoma in situ,KLRB1,Killer cell lectin-like receptor subfamily B member 1,22837,90,0.79 [0.47-1.33],0.3768447772667372
Chapter II Neoplasms,Melanoma in situ,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,19060,77,1.09 [0.77-1.54],0.6185735423283734
Chapter II Neoplasms,Melanoma in situ,KLRD1,Natural killer cells antigen CD94,22837,90,1.09 [0.72-1.64],0.6919990156003435
Chapter II Neoplasms,Melanoma in situ,KLRF1,Killer cell lectin-like receptor subfamily F member 1,19117,75,1.05 [0.63-1.76],0.8393730591758696
Chapter II Neoplasms,Melanoma in situ,KLRK1,NKG2-D type II integral membrane protein,19626,77,1.05 [0.65-1.68],0.8431972252585984
Chapter II Neoplasms,Melanoma in situ,KRT14,"Keratin, type I cytoskeletal 14",21303,83,0.92 [0.45-1.87],0.8167737403443711
Chapter II Neoplasms,Melanoma in situ,KRT17,"Keratin, type I cytoskeletal 17",19066,75,0.98 [0.54-1.79],0.9551804484231696
Chapter II Neoplasms,Melanoma in situ,KRT18,"Keratin, type I cytoskeletal 18",22484,88,0.94 [0.73-1.21],0.6065575851331408
Chapter II Neoplasms,Melanoma in situ,KRT19,"Keratin, type I cytoskeletal 19",22517,90,1.05 [0.79-1.38],0.7451012288661694
Chapter II Neoplasms,Melanoma in situ,KRT5,"Keratin, type II cytoskeletal 5",22029,90,1.00 [0.68-1.48],0.9978001240372196
Chapter II Neoplasms,Melanoma in situ,KRT6C,"Keratin, type II cytoskeletal 6C",19066,75,0.98 [0.55-1.74],0.9496091162325444
Chapter II Neoplasms,Melanoma in situ,KRT8,"Keratin, type II cytoskeletal 8",19060,77,1.04 [0.75-1.46],0.8092506921401439
Chapter II Neoplasms,Melanoma in situ,KYAT1,Kynurenine--oxoglutarate transaminase 1,22550,89,1.18 [0.85-1.62],0.3220249875505551
Chapter II Neoplasms,Melanoma in situ,KYNU,Kynureninase,22837,90,1.26 [0.84-1.89],0.262270348388822
Chapter II Neoplasms,Melanoma in situ,L1CAM,Neural cell adhesion molecule L1,22658,90,1.00 [0.51-1.93],0.9924389985078615
Chapter II Neoplasms,Melanoma in situ,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,19665,77,1.10 [0.87-1.40],0.4295789773445956
Chapter II Neoplasms,Melanoma in situ,LACRT,Extracellular glycoprotein lacritin,19523,76,1.26 [0.89-1.79],0.1977325301399364
Chapter II Neoplasms,Melanoma in situ,LACTB2,Endoribonuclease LACTB2,22589,89,1.16 [0.88-1.54],0.2849463021754036
Chapter II Neoplasms,Melanoma in situ,LAG3,Lymphocyte activation gene 3 protein,22484,88,0.93 [0.58-1.51],0.7836871410060006
Chapter II Neoplasms,Melanoma in situ,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,22583,90,1.36 [0.81-2.30],0.2503385177483107
Chapter II Neoplasms,Melanoma in situ,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,22440,89,0.97 [0.82-1.16],0.7637718970725071
Chapter II Neoplasms,Melanoma in situ,LAMA1,Laminin subunit alpha-1,19066,75,0.82 [0.51-1.33],0.4310808968389232
Chapter II Neoplasms,Melanoma in situ,LAMA4,Laminin subunit alpha-4,22692,90,0.67 [0.37-1.21],0.1828710375150947
Chapter II Neoplasms,Melanoma in situ,LAMB1,Laminin subunit beta-1,19167,75,1.32 [0.62-2.83],0.4771571223899696
Chapter II Neoplasms,Melanoma in situ,LAMP1,Lysosome-associated membrane glycoprotein 1,19112,76,1.30 [0.79-2.13],0.2988601042686982
Chapter II Neoplasms,Melanoma in situ,LAMP2,Lysosome-associated membrane glycoprotein 2,21902,86,1.33 [0.46-3.83],0.6006201021253015
Chapter II Neoplasms,Melanoma in situ,LAMP3,Lysosome-associated membrane glycoprotein 3,22797,90,1.17 [0.81-1.70],0.3906295916686603
Chapter II Neoplasms,Melanoma in situ,LAMTOR5,Ragulator complex protein LAMTOR5,19560,77,1.17 [0.73-1.89],0.5090716282510623
Chapter II Neoplasms,Melanoma in situ,LAP3,Cytosol aminopeptidase,22161,88,1.16 [0.80-1.69],0.4273616350665911
Chapter II Neoplasms,Melanoma in situ,LARP1,La-related protein 1,19560,77,0.86 [0.60-1.25],0.4354202995793168
Chapter II Neoplasms,Melanoma in situ,LAT,Linker for activation of T-cells family member 1,22837,90,1.01 [0.79-1.28],0.9618612587088424
Chapter II Neoplasms,Melanoma in situ,LAT2,Linker for activation of T-cells family member 2,22484,88,1.00 [0.86-1.17],0.9873690433438236
Chapter II Neoplasms,Melanoma in situ,LATS1,Serine/threonine-protein kinase LATS1,19117,75,1.29 [0.99-1.67],0.05612215615041
Chapter II Neoplasms,Melanoma in situ,LAYN,Layilin,22392,89,1.00 [0.56-1.78],0.9940293231590744
Chapter II Neoplasms,Melanoma in situ,LBP,Lipopolysaccharide-binding protein,22650,89,1.02 [0.74-1.40],0.9237410906865772
Chapter II Neoplasms,Melanoma in situ,LBR,Delta(14)-sterol reductase LBR,22788,90,1.11 [0.86-1.42],0.4350990633121465
Chapter II Neoplasms,Melanoma in situ,LCAT,Phosphatidylcholine-sterol acyltransferase,19669,77,2.01 [0.72-5.63],0.1825318357217223
Chapter II Neoplasms,Melanoma in situ,LCN15,Lipocalin-15,19635,77,0.87 [0.59-1.29],0.501005878415888
Chapter II Neoplasms,Melanoma in situ,LCN2,Neutrophil gelatinase-associated lipocalin,21883,85,1.11 [0.66-1.85],0.6907135279316905
Chapter II Neoplasms,Melanoma in situ,LCP1,Plastin-2,19661,77,1.11 [0.71-1.75],0.635998690888414
Chapter II Neoplasms,Melanoma in situ,LDLR,Low-density lipoprotein receptor,22648,85,1.09 [0.76-1.57],0.643636751563369
Chapter II Neoplasms,Melanoma in situ,LDLRAP1,Low density lipoprotein receptor adapter protein 1,19635,77,1.08 [0.86-1.35],0.5315704269672918
Chapter II Neoplasms,Melanoma in situ,LECT2,Leukocyte cell-derived chemotaxin-2,19665,77,1.13 [0.82-1.57],0.4574697728196675
Chapter II Neoplasms,Melanoma in situ,LEFTY2,Left-right determination factor 2,22750,90,0.86 [0.59-1.25],0.4344250604253743
Chapter II Neoplasms,Melanoma in situ,LEG1,Protein LEG1 homolog,18593,69,1.42 [1.03-1.96],0.0303767995821007
Chapter II Neoplasms,Melanoma in situ,LELP1,Late cornified envelope-like proline-rich protein 1,19060,77,0.99 [0.73-1.34],0.9416553814113025
Chapter II Neoplasms,Melanoma in situ,LEO1,RNA polymerase-associated protein LEO1,19635,77,0.84 [0.40-1.80],0.6625480794733232
Chapter II Neoplasms,Melanoma in situ,LEP,Leptin,22589,89,1.03 [0.76-1.39],0.8481877170862102
Chapter II Neoplasms,Melanoma in situ,LEPR,Leptin receptor,22589,89,0.97 [0.52-1.81],0.9320625991083292
Chapter II Neoplasms,Melanoma in situ,LETM1,Mitochondrial proton/calcium exchanger protein,19635,77,1.04 [0.68-1.58],0.8590193395849952
Chapter II Neoplasms,Melanoma in situ,LGALS1,Galectin-1,22589,89,1.05 [0.60-1.85],0.8577614531580805
Chapter II Neoplasms,Melanoma in situ,LGALS3,Galectin-3,22642,87,0.77 [0.41-1.45],0.4154687701496156
Chapter II Neoplasms,Melanoma in situ,LGALS3BP,Galectin-3-binding protein,19694,77,0.84 [0.39-1.81],0.6618481059079322
Chapter II Neoplasms,Melanoma in situ,LGALS4,Galectin-4,22583,90,1.38 [0.98-1.94],0.0620668749084855
Chapter II Neoplasms,Melanoma in situ,LGALS7_LGALS7B,Galectin-7,22552,90,1.08 [0.68-1.71],0.741348326511106
Chapter II Neoplasms,Melanoma in situ,LGALS8,Galectin-8,22788,90,1.18 [0.87-1.59],0.2967272222025503
Chapter II Neoplasms,Melanoma in situ,LGALS9,Galectin-9,22585,90,1.14 [0.63-2.05],0.6671768941839546
Chapter II Neoplasms,Melanoma in situ,LGMN,Legumain,22692,90,0.69 [0.40-1.17],0.1679128923364174
Chapter II Neoplasms,Melanoma in situ,LHB,Lutropin subunit beta,22078,88,1.01 [0.81-1.26],0.9341443784211744
Chapter II Neoplasms,Melanoma in situ,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,22617,89,0.81 [0.58-1.12],0.206520415144722
Chapter II Neoplasms,Melanoma in situ,LIF,Leukemia inhibitory factor,22029,90,0.84 [0.56-1.26],0.4029145364057622
Chapter II Neoplasms,Melanoma in situ,LIFR,Leukemia inhibitory factor receptor,22550,90,1.43 [0.67-3.02],0.3526350983393395
Chapter II Neoplasms,Melanoma in situ,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,22597,90,1.68 [0.96-2.94],0.0717386058077095
Chapter II Neoplasms,Melanoma in situ,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,19661,77,1.00 [0.85-1.16],0.949325740199947
Chapter II Neoplasms,Melanoma in situ,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,19066,75,0.82 [0.51-1.33],0.4194336648278551
Chapter II Neoplasms,Melanoma in situ,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,22555,89,1.30 [0.72-2.37],0.3849258150681602
Chapter II Neoplasms,Melanoma in situ,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,19665,77,1.06 [0.79-1.43],0.7004095508620257
Chapter II Neoplasms,Melanoma in situ,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,22859,89,1.05 [0.53-2.09],0.8833460685463062
Chapter II Neoplasms,Melanoma in situ,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,22752,88,1.05 [0.61-1.81],0.8661852376717198
Chapter II Neoplasms,Melanoma in situ,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,22161,88,0.99 [0.64-1.55],0.9713870979686104
Chapter II Neoplasms,Melanoma in situ,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,22859,89,0.89 [0.69-1.15],0.3697149074338566
Chapter II Neoplasms,Melanoma in situ,LIPF,Gastric triacylglycerol lipase,19167,75,1.07 [0.74-1.55],0.7057461257773752
Chapter II Neoplasms,Melanoma in situ,LMNB1,Lamin-B1,19523,77,0.92 [0.63-1.32],0.635654487990631
Chapter II Neoplasms,Melanoma in situ,LMNB2,Lamin-B2,19626,77,1.37 [0.64-2.94],0.418712166012913
Chapter II Neoplasms,Melanoma in situ,LMOD1,Leiomodin-1,19635,77,0.90 [0.48-1.72],0.7600059657547397
Chapter II Neoplasms,Melanoma in situ,LMOD2,Leiomodin-2,19060,77,0.85 [0.59-1.25],0.4161132042581852
Chapter II Neoplasms,Melanoma in situ,LONP1,"Lon protease homolog, mitochondrial",19167,75,1.05 [0.81-1.36],0.7290435512235953
Chapter II Neoplasms,Melanoma in situ,LPA,Apolipoprotein(a),19202,75,0.98 [0.86-1.11],0.7342736332645423
Chapter II Neoplasms,Melanoma in situ,LPCAT2,Lysophosphatidylcholine acyltransferase 2,22484,88,1.04 [0.68-1.60],0.8580457653156711
Chapter II Neoplasms,Melanoma in situ,LPL,Lipoprotein lipase,22589,89,0.82 [0.56-1.22],0.3295315279011092
Chapter II Neoplasms,Melanoma in situ,LPO,Lactoperoxidase,21890,87,1.57 [1.16-2.14],0.003551317516018
Chapter II Neoplasms,Melanoma in situ,LPP,Lipoma-preferred partner,19066,75,1.03 [0.73-1.44],0.8759816453858008
Chapter II Neoplasms,Melanoma in situ,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,19066,75,0.99 [0.71-1.38],0.9443425541031324
Chapter II Neoplasms,Melanoma in situ,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,19119,72,1.03 [0.66-1.62],0.8857819797665062
Chapter II Neoplasms,Melanoma in situ,LRG1,Leucine-rich alpha-2-glycoprotein,19694,77,1.23 [0.54-2.81],0.617866874641807
Chapter II Neoplasms,Melanoma in situ,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,22717,90,1.32 [0.76-2.28],0.324974516276416
Chapter II Neoplasms,Melanoma in situ,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,19042,75,0.43 [0.17-1.10],0.0778252979538706
Chapter II Neoplasms,Melanoma in situ,LRP1,Prolow-density lipoprotein receptor-related protein 1,22484,88,0.81 [0.39-1.68],0.5698419578298068
Chapter II Neoplasms,Melanoma in situ,LRP11,Low-density lipoprotein receptor-related protein 11,22589,89,0.83 [0.48-1.43],0.5002651897896571
Chapter II Neoplasms,Melanoma in situ,LRP2,Low-density lipoprotein receptor-related protein 2,19119,72,0.74 [0.38-1.45],0.3764008744789138
Chapter II Neoplasms,Melanoma in situ,LRP2BP,LRP2-binding protein,19119,72,0.88 [0.65-1.19],0.404459470793626
Chapter II Neoplasms,Melanoma in situ,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,22788,90,0.79 [0.54-1.16],0.2280935197758491
Chapter II Neoplasms,Melanoma in situ,LRRC25,Leucine-rich repeat-containing protein 25,22484,88,1.07 [0.65-1.74],0.7995581178865108
Chapter II Neoplasms,Melanoma in situ,LRRC37A2,Leucine-rich repeat-containing protein 37A2,19566,77,1.23 [0.73-2.06],0.4377168264372651
Chapter II Neoplasms,Melanoma in situ,LRRC38,Leucine-rich repeat-containing protein 38,19119,72,0.89 [0.55-1.44],0.6328774309838532
Chapter II Neoplasms,Melanoma in situ,LRRC59,Leucine-rich repeat-containing protein 59,19665,77,1.32 [0.86-2.02],0.201650775564747
Chapter II Neoplasms,Melanoma in situ,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,19560,77,1.10 [0.70-1.72],0.674870867774312
Chapter II Neoplasms,Melanoma in situ,LRRN1,Leucine-rich repeat neuronal protein 1,22161,88,0.74 [0.45-1.21],0.2247540656348682
Chapter II Neoplasms,Melanoma in situ,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,19119,72,1.30 [0.81-2.08],0.2772492242942099
Chapter II Neoplasms,Melanoma in situ,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,19635,77,1.71 [0.91-3.23],0.0980392097082647
Chapter II Neoplasms,Melanoma in situ,LSM1,U6 snRNA-associated Sm-like protein LSm1,22078,88,0.97 [0.69-1.37],0.8797908747370055
Chapter II Neoplasms,Melanoma in situ,LSM8,U6 snRNA-associated Sm-like protein LSm8,19287,76,0.95 [0.73-1.22],0.6697517491041267
Chapter II Neoplasms,Melanoma in situ,LSP1,Lymphocyte-specific protein 1,22550,90,1.06 [0.67-1.68],0.7904004629052968
Chapter II Neoplasms,Melanoma in situ,LTA,Lymphotoxin-alpha,22550,90,0.73 [0.46-1.17],0.1918814514334657
Chapter II Neoplasms,Melanoma in situ,LTA4H,Leukotriene A-4 hydrolase,22789,90,1.01 [0.73-1.39],0.954710813741862
Chapter II Neoplasms,Melanoma in situ,LTB,Lymphotoxin-beta,19560,77,0.57 [0.27-1.18],0.1305975016855111
Chapter II Neoplasms,Melanoma in situ,LTBP2,Latent-transforming growth factor beta-binding protein 2,22859,89,1.03 [0.57-1.88],0.9183815884366238
Chapter II Neoplasms,Melanoma in situ,LTBP3,Latent-transforming growth factor beta-binding protein 3,22078,88,1.09 [0.77-1.53],0.6404021895410872
Chapter II Neoplasms,Melanoma in situ,LTBR,Tumor necrosis factor receptor superfamily member 3,22481,89,0.80 [0.39-1.63],0.5352722624152859
Chapter II Neoplasms,Melanoma in situ,LTO1,Protein LTO1 homolog,22161,88,1.15 [0.75-1.75],0.5289877423955136
Chapter II Neoplasms,Melanoma in situ,LUZP2,Leucine zipper protein 2,19560,77,1.15 [0.75-1.78],0.5193161427714044
Chapter II Neoplasms,Melanoma in situ,LXN,Latexin,22337,89,0.89 [0.67-1.20],0.4542032519145029
Chapter II Neoplasms,Melanoma in situ,LY6D,Lymphocyte antigen 6D,22482,89,0.93 [0.55-1.56],0.7731804123885969
Chapter II Neoplasms,Melanoma in situ,LY75,Lymphocyte antigen 75,22550,90,1.60 [0.97-2.64],0.0678582956566123
Chapter II Neoplasms,Melanoma in situ,LY9,T-lymphocyte surface antigen Ly-9,22370,88,1.20 [0.62-2.35],0.5891324734971766
Chapter II Neoplasms,Melanoma in situ,LY96,Lymphocyte antigen 96,22440,89,0.94 [0.54-1.62],0.8190760848958762
Chapter II Neoplasms,Melanoma in situ,LYAR,Cell growth-regulating nucleolar protein,22078,88,1.09 [0.79-1.50],0.6052293170133971
Chapter II Neoplasms,Melanoma in situ,LYN,Tyrosine-protein kinase Lyn,22484,88,1.03 [0.82-1.28],0.8118272066267305
Chapter II Neoplasms,Melanoma in situ,LYPD1,Ly6/PLAUR domain-containing protein 1,22029,90,0.97 [0.72-1.31],0.8408391150966952
Chapter II Neoplasms,Melanoma in situ,LYPD3,Ly6/PLAUR domain-containing protein 3,22471,90,0.66 [0.37-1.17],0.1523537624137958
Chapter II Neoplasms,Melanoma in situ,LYPD8,Ly6/PLAUR domain-containing protein 8,22078,88,0.69 [0.46-1.04],0.0763539564098419
Chapter II Neoplasms,Melanoma in situ,LYPLA2,Acyl-protein thioesterase 2,19060,77,0.87 [0.68-1.11],0.2538550909575225
Chapter II Neoplasms,Melanoma in situ,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,19119,72,1.20 [1.00-1.44],0.0447781823669905
Chapter II Neoplasms,Melanoma in situ,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,19694,77,0.61 [0.20-1.84],0.3786057182915431
Chapter II Neoplasms,Melanoma in situ,LYZL2,Lysozyme-like protein 2,18973,75,1.06 [0.57-1.95],0.8606289922518628
Chapter II Neoplasms,Melanoma in situ,LZTFL1,Leucine zipper transcription factor-like protein 1,19255,75,1.20 [0.88-1.64],0.2379491497358365
Chapter II Neoplasms,Melanoma in situ,M6PR,Cation-dependent mannose-6-phosphate receptor,19167,75,0.86 [0.48-1.55],0.6182861476292127
Chapter II Neoplasms,Melanoma in situ,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,22356,89,1.06 [0.73-1.53],0.7639271715294296
Chapter II Neoplasms,Melanoma in situ,MAEA,E3 ubiquitin-protein transferase MAEA,22078,88,0.79 [0.47-1.32],0.3682769653530741
Chapter II Neoplasms,Melanoma in situ,MAG,Myelin-associated glycoprotein,19119,72,0.93 [0.57-1.50],0.7523671409405848
Chapter II Neoplasms,Melanoma in situ,MAGEA3,Melanoma-associated antigen 3,19287,76,1.05 [0.81-1.36],0.7343235406319161
Chapter II Neoplasms,Melanoma in situ,MAGED1,Melanoma-associated antigen D1,22078,88,1.19 [0.82-1.72],0.3526957536954999
Chapter II Neoplasms,Melanoma in situ,MAMDC2,MAM domain-containing protein 2,19665,77,1.14 [0.60-2.14],0.694422507545759
Chapter II Neoplasms,Melanoma in situ,MAMDC4,Apical endosomal glycoprotein,19560,77,0.99 [0.66-1.49],0.9679152791797604
Chapter II Neoplasms,Melanoma in situ,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",19167,75,0.94 [0.39-2.26],0.8840592076097851
Chapter II Neoplasms,Melanoma in situ,MAN2B2,Epididymis-specific alpha-mannosidase,19665,77,0.86 [0.60-1.24],0.4158909703845874
Chapter II Neoplasms,Melanoma in situ,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",18973,75,0.84 [0.53-1.32],0.4522212231715387
Chapter II Neoplasms,Melanoma in situ,MANF,Mesencephalic astrocyte-derived neurotrophic factor,22692,90,1.06 [0.90-1.24],0.482095056567831
Chapter II Neoplasms,Melanoma in situ,MANSC1,MANSC domain-containing protein 1,22658,90,0.89 [0.45-1.79],0.7513102410896528
Chapter II Neoplasms,Melanoma in situ,MANSC4,MANSC domain-containing protein 4,19066,75,0.85 [0.60-1.20],0.3470205207146442
Chapter II Neoplasms,Melanoma in situ,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,19060,77,1.15 [0.58-2.28],0.6839208283223459
Chapter II Neoplasms,Melanoma in situ,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,19066,75,1.06 [0.78-1.44],0.7026152279249344
Chapter II Neoplasms,Melanoma in situ,MAP2,Microtubule-associated protein 2,19626,77,1.68 [1.14-2.48],0.0092145430913352
Chapter II Neoplasms,Melanoma in situ,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,19566,77,1.20 [0.86-1.67],0.2894222193056944
Chapter II Neoplasms,Melanoma in situ,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,22550,90,1.03 [0.86-1.24],0.7253586628624535
Chapter II Neoplasms,Melanoma in situ,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,22078,88,1.03 [0.85-1.25],0.7879638082716149
Chapter II Neoplasms,Melanoma in situ,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,22392,89,1.05 [0.89-1.24],0.5877357657487987
Chapter II Neoplasms,Melanoma in situ,MAPK13,Mitogen-activated protein kinase 13,18973,75,1.28 [0.85-1.93],0.2417713528057726
Chapter II Neoplasms,Melanoma in situ,MAPK9,Mitogen-activated protein kinase 9,22550,90,1.51 [0.99-2.32],0.055811042455468
Chapter II Neoplasms,Melanoma in situ,MAPKAPK2,MAP kinase-activated protein kinase 2,19287,76,1.26 [0.94-1.69],0.1186756557324784
Chapter II Neoplasms,Melanoma in situ,MAPRE3,Microtubule-associated protein RP/EB family member 3,18973,75,0.96 [0.82-1.13],0.6428997674263421
Chapter II Neoplasms,Melanoma in situ,MAPT,Microtubule-associated protein tau,22029,90,0.75 [0.56-0.99],0.0449878576092276
Chapter II Neoplasms,Melanoma in situ,MARCO,Macrophage receptor MARCO,22589,89,1.04 [0.51-2.12],0.9243538078116412
Chapter II Neoplasms,Melanoma in situ,MARS1,"Methionine--tRNA ligase, cytoplasmic",19212,75,1.17 [0.91-1.52],0.227562633573658
Chapter II Neoplasms,Melanoma in situ,MASP1,Mannan-binding lectin serine protease 1,22392,89,0.78 [0.35-1.75],0.549757330561879
Chapter II Neoplasms,Melanoma in situ,MATN2,Matrilin-2,22625,90,0.74 [0.39-1.40],0.3610242508752959
Chapter II Neoplasms,Melanoma in situ,MATN3,Matrilin-3,22405,88,1.18 [0.65-2.15],0.5916922781742833
Chapter II Neoplasms,Melanoma in situ,MAVS,Mitochondrial antiviral-signaling protein,22078,88,1.07 [0.87-1.32],0.5028185460314194
Chapter II Neoplasms,Melanoma in situ,MAX,Protein max,22029,90,1.09 [0.91-1.30],0.3511963844549419
Chapter II Neoplasms,Melanoma in situ,MB,Myoglobin,22859,89,1.20 [0.84-1.72],0.3123824539733627
Chapter II Neoplasms,Melanoma in situ,MBL2,Mannose-binding protein C,19406,76,0.98 [0.80-1.20],0.8456437218738216
Chapter II Neoplasms,Melanoma in situ,MCAM,Cell surface glycoprotein MUC18,22650,89,1.14 [0.66-1.98],0.6429241186929389
Chapter II Neoplasms,Melanoma in situ,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",19635,77,1.15 [0.72-1.84],0.5564935432325251
Chapter II Neoplasms,Melanoma in situ,MCEMP1,Mast cell-expressed membrane protein 1,19117,75,0.86 [0.67-1.10],0.2301278080111404
Chapter II Neoplasms,Melanoma in situ,MCFD2,Multiple coagulation factor deficiency protein 2,22492,87,1.31 [0.85-2.03],0.2203516812418686
Chapter II Neoplasms,Melanoma in situ,MCTS1,Malignant T-cell-amplified sequence 1,19566,77,0.94 [0.40-2.21],0.882121147328524
Chapter II Neoplasms,Melanoma in situ,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,22440,89,1.13 [0.86-1.48],0.3939392972690264
Chapter II Neoplasms,Melanoma in situ,MDH1,"Malate dehydrogenase, cytoplasmic",19548,77,1.07 [0.63-1.81],0.8111136186812893
Chapter II Neoplasms,Melanoma in situ,MDK,Midkine,22599,90,0.79 [0.53-1.16],0.2269052053558684
Chapter II Neoplasms,Melanoma in situ,MDM1,Nuclear protein MDM1,19119,72,0.96 [0.46-2.01],0.9070444909023978
Chapter II Neoplasms,Melanoma in situ,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",19167,75,1.10 [0.87-1.41],0.4259019984239757
Chapter II Neoplasms,Melanoma in situ,MED18,Mediator of RNA polymerase II transcription subunit 18,22078,88,1.11 [0.87-1.43],0.401466180406158
Chapter II Neoplasms,Melanoma in situ,MED21,Mediator of RNA polymerase II transcription subunit 21,19066,75,0.40 [0.20-0.79],0.0082449397640479
Chapter II Neoplasms,Melanoma in situ,MEGF10,Multiple epidermal growth factor-like domains protein 10,22583,90,1.16 [0.71-1.91],0.5465798184566192
Chapter II Neoplasms,Melanoma in situ,MEGF11,Multiple epidermal growth factor-like domains protein 11,19066,75,0.92 [0.47-1.80],0.8116289891745286
Chapter II Neoplasms,Melanoma in situ,MEGF9,Multiple epidermal growth factor-like domains protein 9,22791,89,0.78 [0.31-1.98],0.5989279938606549
Chapter II Neoplasms,Melanoma in situ,MELTF,Melanotransferrin,19665,77,1.89 [0.91-3.92],0.0885788576641026
Chapter II Neoplasms,Melanoma in situ,MENT,Protein MENT,19255,75,0.96 [0.34-2.66],0.9348894289140814
Chapter II Neoplasms,Melanoma in situ,MEP1A,Meprin A subunit alpha,19566,77,1.12 [0.82-1.54],0.4613456923547834
Chapter II Neoplasms,Melanoma in situ,MEP1B,Meprin A subunit beta,22589,89,1.04 [0.88-1.22],0.6620956368548312
Chapter II Neoplasms,Melanoma in situ,MEPE,Matrix extracellular phosphoglycoprotein,22583,90,0.94 [0.46-1.92],0.87087541332342
Chapter II Neoplasms,Melanoma in situ,MERTK,Tyrosine-protein kinase Mer,22837,90,0.83 [0.40-1.71],0.607537402118667
Chapter II Neoplasms,Melanoma in situ,MESD,LRP chaperone MESD,22597,90,1.05 [0.90-1.22],0.5374891660255586
Chapter II Neoplasms,Melanoma in situ,MET,Hepatocyte growth factor receptor,22644,86,0.77 [0.30-1.99],0.5955871695631992
Chapter II Neoplasms,Melanoma in situ,METAP1,Methionine aminopeptidase 1,22029,90,1.19 [0.66-2.15],0.5720255292221125
Chapter II Neoplasms,Melanoma in situ,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",22550,90,1.02 [0.81-1.28],0.8720799420555576
Chapter II Neoplasms,Melanoma in situ,METAP2,Methionine aminopeptidase 2,22750,90,1.04 [0.75-1.42],0.8299293614511204
Chapter II Neoplasms,Melanoma in situ,MFAP3,Microfibril-associated glycoprotein 3,22187,88,1.05 [0.73-1.51],0.7812061479652996
Chapter II Neoplasms,Melanoma in situ,MFAP3L,Microfibrillar-associated protein 3-like,19119,72,0.97 [0.68-1.37],0.8418306581179154
Chapter II Neoplasms,Melanoma in situ,MFAP4,Microfibril-associated glycoprotein 4,19255,75,1.02 [0.50-2.08],0.957824865154836
Chapter II Neoplasms,Melanoma in situ,MFAP5,Microfibrillar-associated protein 5,22859,89,1.05 [0.66-1.67],0.8406720434435289
Chapter II Neoplasms,Melanoma in situ,MFGE8,Lactadherin,22597,90,0.85 [0.54-1.34],0.489039708358838
Chapter II Neoplasms,Melanoma in situ,MGLL,Monoglyceride lipase,22653,90,1.07 [0.86-1.33],0.539008331557871
Chapter II Neoplasms,Melanoma in situ,MGMT,Methylated-DNA--protein-cysteine methyltransferase,22550,90,1.01 [0.87-1.17],0.9178761125129126
Chapter II Neoplasms,Melanoma in situ,MIA,Melanoma-derived growth regulatory protein,22658,90,0.97 [0.58-1.62],0.9104807468285347
Chapter II Neoplasms,Melanoma in situ,MICALL2,MICAL-like protein 2,19119,72,1.13 [0.83-1.54],0.4308590991311289
Chapter II Neoplasms,Melanoma in situ,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,22550,90,1.04 [0.91-1.20],0.5286216954355718
Chapter II Neoplasms,Melanoma in situ,MIF,Macrophage migration inhibitory factor,22566,89,0.98 [0.75-1.28],0.8878633092393711
Chapter II Neoplasms,Melanoma in situ,MILR1,Allergin-1,22161,88,0.64 [0.44-0.96],0.0287187357647784
Chapter II Neoplasms,Melanoma in situ,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,19560,77,1.12 [0.91-1.38],0.2692930572444548
Chapter II Neoplasms,Melanoma in situ,MINK1,Misshapen-like kinase 1,19626,77,1.23 [0.97-1.57],0.0887885920153329
Chapter II Neoplasms,Melanoma in situ,MITD1,MIT domain-containing protein 1,22440,89,1.03 [0.85-1.25],0.7599969045523891
Chapter II Neoplasms,Melanoma in situ,MKI67,Proliferation marker protein Ki-67,19117,75,1.04 [0.61-1.77],0.8974283794905763
Chapter II Neoplasms,Melanoma in situ,MLLT1,Protein ENL,18973,75,1.11 [0.83-1.49],0.4736002677212672
Chapter II Neoplasms,Melanoma in situ,MLN,Promotilin,22550,90,0.98 [0.80-1.21],0.8780419955892166
Chapter II Neoplasms,Melanoma in situ,MME,Neprilysin,22484,88,0.92 [0.72-1.16],0.4800847239052092
Chapter II Neoplasms,Melanoma in situ,MMP1,Interstitial collagenase,21720,85,0.94 [0.77-1.16],0.5895072892179379
Chapter II Neoplasms,Melanoma in situ,MMP10,Stromelysin-2,22552,90,0.83 [0.60-1.16],0.2726958619038793
Chapter II Neoplasms,Melanoma in situ,MMP12,Macrophage metalloelastase,22609,90,0.83 [0.57-1.20],0.3149802690032413
Chapter II Neoplasms,Melanoma in situ,MMP13,Collagenase 3,22029,90,0.61 [0.34-1.08],0.0884771291914397
Chapter II Neoplasms,Melanoma in situ,MMP15,Matrix metalloproteinase-15,19665,77,1.03 [0.68-1.57],0.8889535864952959
Chapter II Neoplasms,Melanoma in situ,MMP3,Stromelysin-1,22597,90,1.07 [0.72-1.58],0.7349307936702287
Chapter II Neoplasms,Melanoma in situ,MMP7,Matrilysin,22146,88,1.16 [0.77-1.72],0.4776485458923305
Chapter II Neoplasms,Melanoma in situ,MMP8,Neutrophil collagenase,22748,90,1.00 [0.78-1.29],0.9987748556328858
Chapter II Neoplasms,Melanoma in situ,MMP9,Matrix metalloproteinase-9,22556,90,0.92 [0.68-1.25],0.6014821179002856
Chapter II Neoplasms,Melanoma in situ,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",19066,75,1.14 [0.74-1.77],0.544664140985652
Chapter II Neoplasms,Melanoma in situ,MN1,Transcriptional activator MN1,19119,72,0.97 [0.66-1.43],0.8745725049124903
Chapter II Neoplasms,Melanoma in situ,MNAT1,CDK-activating kinase assembly factor MAT1,19287,76,0.93 [0.56-1.56],0.7874730862627732
Chapter II Neoplasms,Melanoma in situ,MNDA,Myeloid cell nuclear differentiation antigen,22554,89,1.03 [0.86-1.23],0.7786081640860623
Chapter II Neoplasms,Melanoma in situ,MOCS2,Molybdopterin synthase catalytic subunit,19255,75,1.03 [0.74-1.44],0.864734943171053
Chapter II Neoplasms,Melanoma in situ,MOG,Myelin-oligodendrocyte glycoprotein,22789,90,1.24 [0.69-2.22],0.4691155752207445
Chapter II Neoplasms,Melanoma in situ,MORC3,MORC family CW-type zinc finger protein 3,19626,77,0.88 [0.39-1.99],0.7551595474624667
Chapter II Neoplasms,Melanoma in situ,MORF4L1,Mortality factor 4-like protein 1,19287,76,1.14 [0.71-1.84],0.5932785820027275
Chapter II Neoplasms,Melanoma in situ,MORF4L2,Mortality factor 4-like protein 2,18973,75,0.71 [0.36-1.39],0.3152688053221242
Chapter II Neoplasms,Melanoma in situ,MORN4,MORN repeat-containing protein 4,18973,75,0.96 [0.71-1.29],0.7865271667414742
Chapter II Neoplasms,Melanoma in situ,MPHOSPH8,M-phase phosphoprotein 8,22187,88,0.92 [0.71-1.20],0.5503567884018707
Chapter II Neoplasms,Melanoma in situ,MPI,Mannose-6-phosphate isomerase,22484,88,1.00 [0.80-1.25],0.9845774345417808
Chapter II Neoplasms,Melanoma in situ,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,22653,90,1.03 [0.81-1.31],0.8217637788849198
Chapter II Neoplasms,Melanoma in situ,MPO,Myeloperoxidase,22597,90,1.12 [0.76-1.64],0.5640551076249337
Chapter II Neoplasms,Melanoma in situ,MPRIP,Myosin phosphatase Rho-interacting protein,19517,77,0.88 [0.53-1.46],0.6218831185840545
Chapter II Neoplasms,Melanoma in situ,MRC1,Macrophage mannose receptor 1,19669,77,0.96 [0.45-2.07],0.9187365093548754
Chapter II Neoplasms,Melanoma in situ,MRI1,Methylthioribose-1-phosphate isomerase,19119,72,0.94 [0.68-1.31],0.7164386571199356
Chapter II Neoplasms,Melanoma in situ,MRPL24,"39S ribosomal protein L24, mitochondrial",19066,75,0.93 [0.50-1.70],0.803961661133908
Chapter II Neoplasms,Melanoma in situ,MRPL28,"39S ribosomal protein L28, mitochondrial",19635,77,0.96 [0.52-1.77],0.9027519461183328
Chapter II Neoplasms,Melanoma in situ,MRPL46,"39S ribosomal protein L46, mitochondrial",22029,90,0.76 [0.37-1.57],0.4620992062488691
Chapter II Neoplasms,Melanoma in situ,MRPL52,"39S ribosomal protein L52, mitochondrial",18945,75,0.50 [0.20-1.22],0.1266309156393398
Chapter II Neoplasms,Melanoma in situ,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",19635,77,1.03 [0.77-1.38],0.8275321880979025
Chapter II Neoplasms,Melanoma in situ,MRPS16,"28S ribosomal protein S16, mitochondrial",19117,75,1.46 [0.81-2.64],0.212182026036717
Chapter II Neoplasms,Melanoma in situ,MSLN,Mesothelin,22453,88,1.05 [0.74-1.49],0.7882249309545128
Chapter II Neoplasms,Melanoma in situ,MSLNL,Mesothelin-like protein,19119,72,1.05 [0.59-1.88],0.8667381007997936
Chapter II Neoplasms,Melanoma in situ,MSMB,Beta-microseminoprotein,22501,87,0.97 [0.74-1.27],0.8010372999881301
Chapter II Neoplasms,Melanoma in situ,MSR1,Macrophage scavenger receptor types I and II,22788,90,1.04 [0.68-1.59],0.8492708518156118
Chapter II Neoplasms,Melanoma in situ,MSRA,Mitochondrial peptide methionine sulfoxide reductase,22658,90,1.15 [0.89-1.48],0.2863308421759768
Chapter II Neoplasms,Melanoma in situ,MST1,Hepatocyte growth factor-like protein,19357,77,1.00 [0.71-1.41],0.9907750421622442
Chapter II Neoplasms,Melanoma in situ,MSTN,Growth/differentiation factor 8,22187,88,0.95 [0.65-1.39],0.8008325794317386
Chapter II Neoplasms,Melanoma in situ,MTDH,Protein LYRIC,19117,75,1.15 [0.91-1.47],0.2474819769964534
Chapter II Neoplasms,Melanoma in situ,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",19626,77,0.75 [0.30-1.90],0.5477144959578775
Chapter II Neoplasms,Melanoma in situ,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,19287,76,1.07 [0.88-1.31],0.4751940841278095
Chapter II Neoplasms,Melanoma in situ,MTIF3,"Translation initiation factor IF-3, mitochondrial",19566,77,1.17 [0.92-1.50],0.2050718805645975
Chapter II Neoplasms,Melanoma in situ,MTPN,Myotrophin,22187,88,1.09 [0.63-1.86],0.7652273548722499
Chapter II Neoplasms,Melanoma in situ,MTR,Methionine synthase,19066,75,0.74 [0.48-1.13],0.1635695811699448
Chapter II Neoplasms,Melanoma in situ,MTSS1,Protein MTSS 1,19566,77,1.11 [0.91-1.35],0.3027574093614164
Chapter II Neoplasms,Melanoma in situ,MTSS2,Protein MTSS 2,19560,77,1.10 [0.88-1.37],0.4065817947659117
Chapter II Neoplasms,Melanoma in situ,MTUS1,Microtubule-associated tumor suppressor 1,19287,76,1.29 [0.92-1.82],0.1350302004666405
Chapter II Neoplasms,Melanoma in situ,MUC13,Mucin-13,22029,90,1.24 [0.84-1.81],0.2785482487897746
Chapter II Neoplasms,Melanoma in situ,MUC16,Mucin-16,22484,88,1.01 [0.92-1.12],0.8285633819918432
Chapter II Neoplasms,Melanoma in situ,MUC2,Mucin-2,19661,77,0.87 [0.69-1.11],0.2662026327803439
Chapter II Neoplasms,Melanoma in situ,MUCL3,Mucin-like protein 3,18973,75,0.94 [0.56-1.58],0.8162675059198864
Chapter II Neoplasms,Melanoma in situ,MVK,Mevalonate kinase,22161,88,1.09 [0.86-1.39],0.4874990911844856
Chapter II Neoplasms,Melanoma in situ,MXRA8,Matrix remodeling-associated protein 8,19255,75,0.77 [0.37-1.59],0.4792782396058865
Chapter II Neoplasms,Melanoma in situ,MYBPC1,"Myosin-binding protein C, slow-type",19665,77,1.17 [0.84-1.61],0.3528997701020829
Chapter II Neoplasms,Melanoma in situ,MYBPC2,"Myosin-binding protein C, fast-type",19167,75,0.96 [0.72-1.27],0.7696140701771824
Chapter II Neoplasms,Melanoma in situ,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,19635,77,0.92 [0.66-1.29],0.6409343101406766
Chapter II Neoplasms,Melanoma in situ,MYDGF,Myeloid-derived growth factor,19665,77,1.16 [0.93-1.44],0.1831048614744239
Chapter II Neoplasms,Melanoma in situ,MYH4,Myosin-4,19066,75,1.10 [0.70-1.73],0.6717164135040121
Chapter II Neoplasms,Melanoma in situ,MYH7B,Myosin-7B,18973,75,0.91 [0.54-1.54],0.7333492349655908
Chapter II Neoplasms,Melanoma in situ,MYH9,Myosin-9,19661,77,1.08 [0.89-1.31],0.4325356907166293
Chapter II Neoplasms,Melanoma in situ,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",19066,75,0.92 [0.51-1.66],0.7881450709524153
Chapter II Neoplasms,Melanoma in situ,MYL3,Myosin light chain 3,19167,75,1.02 [0.74-1.41],0.9073634908844735
Chapter II Neoplasms,Melanoma in situ,MYL4,Myosin light chain 4,19167,75,0.82 [0.51-1.29],0.3861889686715433
Chapter II Neoplasms,Melanoma in situ,MYL6B,Myosin light chain 6B,19119,72,0.96 [0.75-1.24],0.7640120728470786
Chapter II Neoplasms,Melanoma in situ,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",19119,72,1.14 [0.71-1.85],0.5823560190923873
Chapter II Neoplasms,Melanoma in situ,MYO6,Unconventional myosin-VI,19635,77,0.83 [0.43-1.59],0.5731274766794117
Chapter II Neoplasms,Melanoma in situ,MYO9B,Unconventional myosin-IXb,22161,88,1.01 [0.76-1.35],0.920658967108172
Chapter II Neoplasms,Melanoma in situ,MYOC,Myocilin,22597,90,0.96 [0.64-1.45],0.8495463714280623
Chapter II Neoplasms,Melanoma in situ,MYOM1,Myomesin-1,19060,77,1.14 [0.76-1.71],0.5250966523385526
Chapter II Neoplasms,Melanoma in situ,MYOM2,Myomesin-2,19066,75,0.87 [0.52-1.47],0.6109488669968248
Chapter II Neoplasms,Melanoma in situ,MYOM3,Myomesin-3,19255,75,0.98 [0.77-1.26],0.9021500161339112
Chapter II Neoplasms,Melanoma in situ,MZB1,Marginal zone B- and B1-cell-specific protein,22664,90,0.81 [0.55-1.18],0.2763905928956432
Chapter II Neoplasms,Melanoma in situ,MZT1,Mitotic-spindle organizing protein 1,22078,88,1.01 [0.70-1.45],0.9705569748309948
Chapter II Neoplasms,Melanoma in situ,NAA10,N-alpha-acetyltransferase 10,19066,75,0.99 [0.64-1.53],0.9522349758357334
Chapter II Neoplasms,Melanoma in situ,NAA80,N-alpha-acetyltransferase 80,19119,72,1.11 [0.91-1.34],0.2989861794614439
Chapter II Neoplasms,Melanoma in situ,NAAA,N-acylethanolamine-hydrolyzing acid amidase,22335,89,1.07 [0.77-1.47],0.6892752844443428
Chapter II Neoplasms,Melanoma in situ,NACC1,Nucleus accumbens-associated protein 1,19560,77,0.92 [0.61-1.39],0.6872998962456678
Chapter II Neoplasms,Melanoma in situ,NADK,NAD kinase,22589,89,0.99 [0.71-1.39],0.9656653179644936
Chapter II Neoplasms,Melanoma in situ,NAGA,Alpha-N-acetylgalactosaminidase,19078,75,0.91 [0.61-1.37],0.6662182071827907
Chapter II Neoplasms,Melanoma in situ,NAGK,N-acetyl-D-glucosamine kinase,19130,75,1.09 [0.74-1.61],0.6727938206901398
Chapter II Neoplasms,Melanoma in situ,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,19255,75,1.23 [0.42-3.60],0.7010788606627714
Chapter II Neoplasms,Melanoma in situ,NAMPT,Nicotinamide phosphoribosyltransferase,22078,88,1.03 [0.74-1.44],0.8419899334471551
Chapter II Neoplasms,Melanoma in situ,NAP1L4,Nucleosome assembly protein 1-like 4,19538,77,0.97 [0.58-1.63],0.9131788699496852
Chapter II Neoplasms,Melanoma in situ,NAPRT,Nicotinate phosphoribosyltransferase,19626,77,0.85 [0.43-1.67],0.6311117295040535
Chapter II Neoplasms,Melanoma in situ,NARS1,"Asparagine--tRNA ligase, cytoplasmic",19635,77,1.49 [0.93-2.40],0.0954602867745861
Chapter II Neoplasms,Melanoma in situ,NBL1,Neuroblastoma suppressor of tumorigenicity 1,22658,90,1.29 [0.63-2.64],0.4821163961664518
Chapter II Neoplasms,Melanoma in situ,NBN,Nibrin,22161,88,0.98 [0.68-1.41],0.9038142521083102
Chapter II Neoplasms,Melanoma in situ,NCAM1,Neural cell adhesion molecule 1,22650,89,1.29 [0.66-2.54],0.4564382040579541
Chapter II Neoplasms,Melanoma in situ,NCAM2,Neural cell adhesion molecule 2,22597,90,0.89 [0.44-1.78],0.7395145519364124
Chapter II Neoplasms,Melanoma in situ,NCAN,Neurocan core protein,22788,90,0.95 [0.58-1.57],0.8430953590346383
Chapter II Neoplasms,Melanoma in situ,NCF2,Neutrophil cytosol factor 2,22522,90,0.99 [0.80-1.23],0.9449111489956902
Chapter II Neoplasms,Melanoma in situ,NCK2,Cytoplasmic protein NCK2,22692,90,1.05 [0.88-1.26],0.5634339062963455
Chapter II Neoplasms,Melanoma in situ,NCLN,Nicalin,22161,88,1.03 [0.74-1.45],0.8493967283303484
Chapter II Neoplasms,Melanoma in situ,NCR1,Natural cytotoxicity triggering receptor 1,22517,90,0.80 [0.48-1.35],0.4105033415766818
Chapter II Neoplasms,Melanoma in situ,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,19566,77,0.97 [0.49-1.93],0.93998450531775
Chapter II Neoplasms,Melanoma in situ,NCS1,Neuronal calcium sensor 1,22789,90,1.22 [0.63-2.36],0.5565806409671255
Chapter II Neoplasms,Melanoma in situ,NDRG1,Protein NDRG1,22029,90,0.99 [0.75-1.29],0.91866901225373
Chapter II Neoplasms,Melanoma in situ,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,19560,77,1.01 [0.72-1.41],0.956228149274041
Chapter II Neoplasms,Melanoma in situ,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,19083,75,0.88 [0.46-1.66],0.6872303047267536
Chapter II Neoplasms,Melanoma in situ,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,19566,77,1.08 [0.84-1.37],0.552646011456353
Chapter II Neoplasms,Melanoma in situ,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",22078,88,1.01 [0.79-1.28],0.9580538975533492
Chapter II Neoplasms,Melanoma in situ,NEB,Nebulin,19066,75,1.37 [0.88-2.15],0.1678679895893562
Chapter II Neoplasms,Melanoma in situ,NECAP2,Adaptin ear-binding coat-associated protein 2,19066,75,1.01 [0.73-1.39],0.9675976390101688
Chapter II Neoplasms,Melanoma in situ,NECTIN1,Nectin-1,19117,75,0.92 [0.45-1.87],0.8157050146277105
Chapter II Neoplasms,Melanoma in situ,NECTIN2,Nectin-2,22555,89,1.38 [0.71-2.67],0.3420264273925224
Chapter II Neoplasms,Melanoma in situ,NECTIN4,Nectin-4,22658,90,0.77 [0.40-1.50],0.4478395475128039
Chapter II Neoplasms,Melanoma in situ,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,19117,75,1.00 [0.64-1.56],0.9899576095365538
Chapter II Neoplasms,Melanoma in situ,NEDD9,Enhancer of filamentation 1,19117,75,1.09 [0.58-2.06],0.7861922606035774
Chapter II Neoplasms,Melanoma in situ,NEFL,Neurofilament light polypeptide,21950,89,0.91 [0.57-1.46],0.6971582944525312
Chapter II Neoplasms,Melanoma in situ,NEK7,Serine/threonine-protein kinase Nek7,19287,76,0.91 [0.67-1.24],0.5595387749271837
Chapter II Neoplasms,Melanoma in situ,NELL1,Protein kinase C-binding protein NELL1,22658,90,0.89 [0.57-1.38],0.6030115122512578
Chapter II Neoplasms,Melanoma in situ,NELL2,Protein kinase C-binding protein NELL2,22692,90,0.82 [0.42-1.62],0.569466773140574
Chapter II Neoplasms,Melanoma in situ,NENF,Neudesin,19560,77,1.03 [0.86-1.24],0.7326215426840005
Chapter II Neoplasms,Melanoma in situ,NEO1,Neogenin,19635,77,0.64 [0.23-1.82],0.4066417135908463
Chapter II Neoplasms,Melanoma in situ,NEXN,Nexilin,19669,77,1.23 [0.90-1.67],0.1877970715891611
Chapter II Neoplasms,Melanoma in situ,NFASC,Neurofascin,22837,90,0.80 [0.39-1.61],0.5266764007168654
Chapter II Neoplasms,Melanoma in situ,NFAT5,Nuclear factor of activated T-cells 5,19117,75,1.11 [0.87-1.42],0.3949039771001833
Chapter II Neoplasms,Melanoma in situ,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",22550,90,1.05 [0.87-1.28],0.6097478668044443
Chapter II Neoplasms,Melanoma in situ,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",22161,88,1.22 [0.90-1.65],0.1948042094770923
Chapter II Neoplasms,Melanoma in situ,NFE2,Transcription factor NF-E2 45 kDa subunit,19167,75,1.11 [0.83-1.49],0.4902476471892194
Chapter II Neoplasms,Melanoma in situ,NFIC,Nuclear factor 1 C-type,19635,77,1.18 [0.79-1.75],0.4279178030580284
Chapter II Neoplasms,Melanoma in situ,NFKB1,Nuclear factor NF-kappa-B p105 subunit,19066,75,1.16 [0.86-1.57],0.3294088940232277
Chapter II Neoplasms,Melanoma in situ,NFKB2,Nuclear factor NF-kappa-B p100 subunit,19287,76,0.66 [0.37-1.18],0.1643307337197032
Chapter II Neoplasms,Melanoma in situ,NFKBIE,NF-kappa-B inhibitor epsilon,22078,88,1.03 [0.70-1.51],0.8785424837996105
Chapter II Neoplasms,Melanoma in situ,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",19566,77,1.11 [0.90-1.38],0.3333506745862055
Chapter II Neoplasms,Melanoma in situ,NFX1,Transcriptional repressor NF-X1,19066,75,1.03 [0.74-1.43],0.8815044828016194
Chapter II Neoplasms,Melanoma in situ,NFYA,Nuclear transcription factor Y subunit alpha,19066,75,0.96 [0.53-1.71],0.877643440029494
Chapter II Neoplasms,Melanoma in situ,NGF,Beta-nerve growth factor,22440,89,0.38 [0.08-1.77],0.2171528111119081
Chapter II Neoplasms,Melanoma in situ,NGFR,Tumor necrosis factor receptor superfamily member 16,19665,77,1.20 [0.63-2.30],0.5797385485832693
Chapter II Neoplasms,Melanoma in situ,NGRN,Neugrin,19626,77,1.17 [0.47-2.93],0.7390222614221836
Chapter II Neoplasms,Melanoma in situ,NHLRC3,NHL repeat-containing protein 3,18776,75,2.07 [0.99-4.33],0.0540128761600022
Chapter II Neoplasms,Melanoma in situ,NID1,Nidogen-1,22573,89,0.81 [0.51-1.31],0.3975465874856058
Chapter II Neoplasms,Melanoma in situ,NID2,Nidogen-2,22597,90,0.97 [0.75-1.23],0.7776201437433002
Chapter II Neoplasms,Melanoma in situ,NINJ1,Ninjurin-1,22078,88,1.13 [0.85-1.51],0.3945904938258429
Chapter II Neoplasms,Melanoma in situ,NIT1,Deaminated glutathione amidase,19167,75,1.04 [0.67-1.63],0.8568296450533722
Chapter II Neoplasms,Melanoma in situ,NIT2,Omega-amidase NIT2,19596,77,1.21 [0.90-1.62],0.2069685541304068
Chapter II Neoplasms,Melanoma in situ,NLGN1,Neuroligin-1,19119,72,0.77 [0.51-1.17],0.2270072048920208
Chapter II Neoplasms,Melanoma in situ,NLGN2,Neuroligin-2,19060,77,0.81 [0.49-1.35],0.4228448414063427
Chapter II Neoplasms,Melanoma in situ,NME1,Nucleoside diphosphate kinase A,19117,75,0.70 [0.24-2.03],0.5114185025306632
Chapter II Neoplasms,Melanoma in situ,NME3,Nucleoside diphosphate kinase 3,22625,90,0.67 [0.29-1.57],0.3610769659624647
Chapter II Neoplasms,Melanoma in situ,NMI,N-myc-interactor,19489,77,1.09 [0.81-1.47],0.5811101566541735
Chapter II Neoplasms,Melanoma in situ,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,22440,89,0.99 [0.77-1.28],0.9593487075100772
Chapter II Neoplasms,Melanoma in situ,NMRK2,Nicotinamide riboside kinase 2,18973,75,1.05 [0.63-1.73],0.860298421406789
Chapter II Neoplasms,Melanoma in situ,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,19635,77,1.20 [0.92-1.58],0.1801194308734993
Chapter II Neoplasms,Melanoma in situ,NOMO1,Nodal modulator 1,22597,90,0.95 [0.43-2.10],0.8964346981858788
Chapter II Neoplasms,Melanoma in situ,NOP56,Nucleolar protein 56,19066,75,0.95 [0.76-1.17],0.6078270229302927
Chapter II Neoplasms,Melanoma in situ,NOS1,"Nitric oxide synthase, brain",22029,90,1.67 [1.17-2.37],0.0044781590899088
Chapter II Neoplasms,Melanoma in situ,NOS2,"Nitric oxide synthase, inducible",19066,75,1.11 [0.64-1.92],0.7123999998571839
Chapter II Neoplasms,Melanoma in situ,NOS3,"Nitric oxide synthase, endothelial",22029,90,0.77 [0.52-1.15],0.2031979967941962
Chapter II Neoplasms,Melanoma in situ,NOTCH1,Neurogenic locus notch homolog protein 1,22859,89,0.56 [0.16-1.94],0.3635111090457097
Chapter II Neoplasms,Melanoma in situ,NOTCH2,Neurogenic locus notch homolog protein 2,19661,77,0.69 [0.22-2.14],0.517184099402944
Chapter II Neoplasms,Melanoma in situ,NOTCH3,Neurogenic locus notch homolog protein 3,22859,89,1.02 [0.59-1.77],0.948633463712618
Chapter II Neoplasms,Melanoma in situ,NPC2,NPC intracellular cholesterol transporter 2,19326,76,0.97 [0.47-1.99],0.934333478114471
Chapter II Neoplasms,Melanoma in situ,NPDC1,Neural proliferation differentiation and control protein 1,22589,89,1.40 [0.77-2.54],0.274794750065526
Chapter II Neoplasms,Melanoma in situ,NPHS1,Nephrin,19117,75,0.76 [0.38-1.51],0.4304936890131792
Chapter II Neoplasms,Melanoma in situ,NPHS2,Podocin,19117,75,1.01 [0.82-1.25],0.9083262520084248
Chapter II Neoplasms,Melanoma in situ,NPL,N-acetylneuraminate lyase,19665,77,0.83 [0.50-1.38],0.476958493938542
Chapter II Neoplasms,Melanoma in situ,NPPB,Natriuretic peptides B,22187,88,1.05 [0.91-1.22],0.5068026925350484
Chapter II Neoplasms,Melanoma in situ,NPPC,C-type natriuretic peptide,22550,90,0.98 [0.62-1.54],0.9167032844201314
Chapter II Neoplasms,Melanoma in situ,NPR1,Atrial natriuretic peptide receptor 1,19066,75,0.92 [0.52-1.64],0.7871082904907019
Chapter II Neoplasms,Melanoma in situ,NPTN,Neuroplastin,22078,88,1.11 [0.92-1.35],0.2790352880482832
Chapter II Neoplasms,Melanoma in situ,NPTX1,Neuronal pentraxin-1,22597,90,0.65 [0.39-1.07],0.0887041167263179
Chapter II Neoplasms,Melanoma in situ,NPTX2,Neuronal pentraxin-2,19661,77,0.79 [0.39-1.57],0.4991968120775691
Chapter II Neoplasms,Melanoma in situ,NPTXR,Neuronal pentraxin receptor,22589,89,1.10 [0.64-1.89],0.7430948563643937
Chapter II Neoplasms,Melanoma in situ,NPY,Pro-neuropeptide Y,22789,90,0.78 [0.59-1.03],0.0782976348271314
Chapter II Neoplasms,Melanoma in situ,NRCAM,Neuronal cell adhesion molecule,22589,89,0.91 [0.46-1.79],0.7741018961254393
Chapter II Neoplasms,Melanoma in situ,NRGN,Neurogranin,19669,77,1.20 [0.95-1.53],0.1257809793931901
Chapter II Neoplasms,Melanoma in situ,NRN1,Neuritin,19635,77,1.41 [0.96-2.07],0.0833533128802229
Chapter II Neoplasms,Melanoma in situ,NRP1,Neuropilin-1,22693,89,1.45 [0.75-2.81],0.2686166586377344
Chapter II Neoplasms,Melanoma in situ,NRP2,Neuropilin-2,22597,90,0.64 [0.33-1.25],0.192506332461208
Chapter II Neoplasms,Melanoma in situ,NRTN,Neurturin,22161,88,1.14 [0.81-1.61],0.4441648352427397
Chapter II Neoplasms,Melanoma in situ,NRXN3,Neurexin-3,19119,72,0.78 [0.38-1.60],0.5002823170218774
Chapter II Neoplasms,Melanoma in situ,NSFL1C,NSFL1 cofactor p47,22788,90,0.99 [0.75-1.31],0.9471041305191958
Chapter II Neoplasms,Melanoma in situ,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",19665,77,1.12 [0.84-1.51],0.4393043969256669
Chapter II Neoplasms,Melanoma in situ,NT5C1A,Cytosolic 5'-nucleotidase 1A,19626,77,1.37 [0.79-2.37],0.2571553205791706
Chapter II Neoplasms,Melanoma in situ,NT5C3A,Cytosolic 5'-nucleotidase 3A,22520,90,1.07 [0.87-1.32],0.5278465725689577
Chapter II Neoplasms,Melanoma in situ,NT5E,5'-nucleotidase,22658,90,0.93 [0.67-1.29],0.6627116691040753
Chapter II Neoplasms,Melanoma in situ,NTF3,Neurotrophin-3,22550,90,0.77 [0.45-1.32],0.3461292900713233
Chapter II Neoplasms,Melanoma in situ,NTF4,Neurotrophin-4,22078,88,0.88 [0.51-1.49],0.6246604510962688
Chapter II Neoplasms,Melanoma in situ,NTRK2,BDNF/NT-3 growth factors receptor,22589,89,1.19 [0.57-2.47],0.6392208398605003
Chapter II Neoplasms,Melanoma in situ,NTRK3,NT-3 growth factor receptor,22788,90,0.75 [0.32-1.78],0.5143289587772202
Chapter II Neoplasms,Melanoma in situ,NTproBNP,N-terminal prohormone of brain natriuretic peptide,22589,89,1.18 [0.99-1.42],0.0717893792144981
Chapter II Neoplasms,Melanoma in situ,NUB1,NEDD8 ultimate buster 1,22550,90,1.05 [0.84-1.31],0.6643984227564783
Chapter II Neoplasms,Melanoma in situ,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,19560,77,1.03 [0.84-1.28],0.7625626969314073
Chapter II Neoplasms,Melanoma in situ,NUCB2,Nucleobindin-2,22748,90,1.36 [0.83-2.22],0.2234478040028717
Chapter II Neoplasms,Melanoma in situ,NUDC,Nuclear migration protein nudC,22837,90,1.16 [0.86-1.56],0.325322449614069
Chapter II Neoplasms,Melanoma in situ,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,19167,75,0.56 [0.20-1.61],0.2843039575800979
Chapter II Neoplasms,Melanoma in situ,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,19066,75,0.65 [0.37-1.11],0.1157232841951252
Chapter II Neoplasms,Melanoma in situ,NUDT16,U8 snoRNA-decapping enzyme,19530,77,1.08 [0.84-1.38],0.5628130135857728
Chapter II Neoplasms,Melanoma in situ,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],22484,88,1.18 [0.86-1.60],0.3015793630695595
Chapter II Neoplasms,Melanoma in situ,NUDT5,ADP-sugar pyrophosphatase,22597,90,1.00 [0.70-1.44],0.9885435163378238
Chapter II Neoplasms,Melanoma in situ,NUMB,Protein numb homolog,19117,75,1.18 [0.90-1.55],0.233273892450491
Chapter II Neoplasms,Melanoma in situ,NUP50,Nuclear pore complex protein Nup50,19066,75,0.55 [0.24-1.30],0.1725266792255011
Chapter II Neoplasms,Melanoma in situ,NXPE4,NXPE family member 4,19066,75,0.73 [0.35-1.53],0.4061459693780637
Chapter II Neoplasms,Melanoma in situ,NXPH1,Neurexophilin-1,22029,90,1.39 [0.91-2.14],0.1276496804314984
Chapter II Neoplasms,Melanoma in situ,NXPH3,Neurexophilin-3,19117,75,0.77 [0.37-1.61],0.4926605336418788
Chapter II Neoplasms,Melanoma in situ,OBP2B,Odorant-binding protein 2b,22369,88,1.15 [0.85-1.55],0.3680812930780465
Chapter II Neoplasms,Melanoma in situ,OCLN,Occludin,19635,77,1.18 [0.71-1.94],0.5262345694113904
Chapter II Neoplasms,Melanoma in situ,ODAM,Odontogenic ameloblast-associated protein,21999,90,0.68 [0.46-1.00],0.0494723004961143
Chapter II Neoplasms,Melanoma in situ,OFD1,Oral-facial-digital syndrome 1 protein,19287,76,0.76 [0.50-1.15],0.193657022155041
Chapter II Neoplasms,Melanoma in situ,OGA,Protein O-GlcNAcase,19566,77,1.19 [0.88-1.61],0.2674588409859093
Chapter II Neoplasms,Melanoma in situ,OGFR,Opioid growth factor receptor,22484,88,1.04 [0.58-1.85],0.9001327471699108
Chapter II Neoplasms,Melanoma in situ,OGN,Mimecan,22597,90,0.96 [0.60-1.54],0.8777885214816853
Chapter II Neoplasms,Melanoma in situ,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,19287,76,0.92 [0.64-1.33],0.6552818439892178
Chapter II Neoplasms,Melanoma in situ,OLFM4,Olfactomedin-4,18530,74,1.04 [0.86-1.25],0.6765532411292857
Chapter II Neoplasms,Melanoma in situ,OLR1,Oxidized low-density lipoprotein receptor 1,22370,87,0.82 [0.58-1.16],0.2602226509723214
Chapter II Neoplasms,Melanoma in situ,OMD,Osteomodulin,22692,90,0.69 [0.47-1.03],0.0681138883052487
Chapter II Neoplasms,Melanoma in situ,OMG,Oligodendrocyte-myelin glycoprotein,22484,88,1.03 [0.76-1.39],0.8382277591770632
Chapter II Neoplasms,Melanoma in situ,OMP,Olfactory marker protein,19060,77,0.97 [0.62-1.50],0.8739031916701975
Chapter II Neoplasms,Melanoma in situ,OPHN1,Oligophrenin-1,19626,77,1.10 [0.89-1.35],0.3786653428382468
Chapter II Neoplasms,Melanoma in situ,OPLAH,5-oxoprolinase,19167,75,1.10 [0.80-1.52],0.5546656234708792
Chapter II Neoplasms,Melanoma in situ,OPTC,Opticin,22484,88,1.16 [0.80-1.67],0.4409882539857425
Chapter II Neoplasms,Melanoma in situ,ORM1,Alpha-1-acid glycoprotein 1,19626,77,1.06 [0.35-3.19],0.9194937566320716
Chapter II Neoplasms,Melanoma in situ,OSBPL2,Oxysterol-binding protein-related protein 2,19626,77,1.37 [0.92-2.03],0.1212904778088769
Chapter II Neoplasms,Melanoma in situ,OSCAR,Osteoclast-associated immunoglobulin-like receptor,22625,90,0.97 [0.55-1.71],0.919953448613578
Chapter II Neoplasms,Melanoma in situ,OSM,Oncostatin-M,22447,90,0.87 [0.67-1.13],0.3055599413153772
Chapter II Neoplasms,Melanoma in situ,OSMR,Oncostatin-M-specific receptor subunit beta,22693,89,1.06 [0.43-2.63],0.8924484272573566
Chapter II Neoplasms,Melanoma in situ,OSTN,Osteocrin,19119,72,0.83 [0.45-1.54],0.5612549428764257
Chapter II Neoplasms,Melanoma in situ,OTOA,Otoancorin,19060,77,1.31 [0.99-1.74],0.0627159263725002
Chapter II Neoplasms,Melanoma in situ,OTUD6B,Deubiquitinase OTUD6B,19566,77,1.24 [0.86-1.78],0.2451964287134677
Chapter II Neoplasms,Melanoma in situ,OTUD7B,OTU domain-containing protein 7B,19635,77,1.24 [0.88-1.74],0.2238927454111776
Chapter II Neoplasms,Melanoma in situ,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",19167,75,1.18 [0.85-1.64],0.3129108724549405
Chapter II Neoplasms,Melanoma in situ,OXT,Oxytocin-neurophysin 1,22788,90,1.04 [0.90-1.20],0.5809399427706459
Chapter II Neoplasms,Melanoma in situ,P4HB,Protein disulfide-isomerase,22474,89,1.08 [0.66-1.77],0.749540973654566
Chapter II Neoplasms,Melanoma in situ,PACS2,Phosphofurin acidic cluster sorting protein 2,19066,75,0.99 [0.69-1.43],0.970817203162571
Chapter II Neoplasms,Melanoma in situ,PADI2,Protein-arginine deiminase type-2,22161,88,1.07 [0.79-1.46],0.6559461384713308
Chapter II Neoplasms,Melanoma in situ,PADI4,Protein-arginine deiminase type-4,21999,90,1.01 [0.79-1.30],0.9110782590050446
Chapter II Neoplasms,Melanoma in situ,PAEP,Glycodelin,22440,89,0.97 [0.82-1.15],0.7557202323370839
Chapter II Neoplasms,Melanoma in situ,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,19635,77,0.98 [0.81-1.18],0.8356366006411817
Chapter II Neoplasms,Melanoma in situ,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",19287,76,1.07 [0.69-1.67],0.754213505454
Chapter II Neoplasms,Melanoma in situ,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,22187,88,1.09 [0.78-1.53],0.5957677596403634
Chapter II Neoplasms,Melanoma in situ,PAGR1,PAXIP1-associated glutamate-rich protein 1,19167,75,0.76 [0.44-1.31],0.3225856303550184
Chapter II Neoplasms,Melanoma in situ,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,18935,75,0.97 [0.63-1.49],0.8908179630580859
Chapter II Neoplasms,Melanoma in situ,PAK4,Serine/threonine-protein kinase PAK 4,22029,90,1.09 [0.81-1.46],0.5646781735380639
Chapter II Neoplasms,Melanoma in situ,PALLD,Palladin,19117,75,0.91 [0.51-1.63],0.7619304821414324
Chapter II Neoplasms,Melanoma in situ,PALM,Paralemmin-1,19463,77,0.79 [0.37-1.69],0.5461534339820056
Chapter II Neoplasms,Melanoma in situ,PALM2,Paralemmin-2,19626,77,1.09 [0.60-1.99],0.7729746390631353
Chapter II Neoplasms,Melanoma in situ,PALM3,Paralemmin-3,19066,75,0.94 [0.68-1.29],0.6862673303630995
Chapter II Neoplasms,Melanoma in situ,PAM,Peptidyl-glycine alpha-amidating monooxygenase,22730,88,0.99 [0.50-1.95],0.9795346034616657
Chapter II Neoplasms,Melanoma in situ,PAMR1,Inactive serine protease PAMR1,22597,90,1.11 [0.56-2.19],0.7660667995936862
Chapter II Neoplasms,Melanoma in situ,PAPPA,Pappalysin-1,22161,88,0.79 [0.53-1.20],0.2756635489146573
Chapter II Neoplasms,Melanoma in situ,PARD3,Partitioning defective 3 homolog,19287,76,1.04 [0.78-1.39],0.7888114864316254
Chapter II Neoplasms,Melanoma in situ,PARK7,Parkinson disease protein 7,22597,90,0.97 [0.68-1.37],0.8557909096745191
Chapter II Neoplasms,Melanoma in situ,PARP1,Poly [ADP-ribose] polymerase 1,22550,90,0.83 [0.56-1.23],0.3547801577818772
Chapter II Neoplasms,Melanoma in situ,PAXX,Protein PAXX,19255,75,0.95 [0.58-1.55],0.8326489732661301
Chapter II Neoplasms,Melanoma in situ,PBK,Lymphokine-activated killer T-cell-originated protein kinase,18973,75,0.77 [0.37-1.61],0.4948610066436043
Chapter II Neoplasms,Melanoma in situ,PBLD,Phenazine biosynthesis-like domain-containing protein,22029,90,1.32 [0.92-1.89],0.1319996158192828
Chapter II Neoplasms,Melanoma in situ,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,19566,77,1.15 [0.57-2.31],0.6903421051917231
Chapter II Neoplasms,Melanoma in situ,PCARE,Photoreceptor cilium actin regulator,19060,77,0.94 [0.72-1.23],0.659331854662468
Chapter II Neoplasms,Melanoma in situ,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,19216,75,1.04 [0.64-1.69],0.8737402725440397
Chapter II Neoplasms,Melanoma in situ,PCBP2,Poly(rC)-binding protein 2,19635,77,1.08 [0.80-1.46],0.6264596397089188
Chapter II Neoplasms,Melanoma in situ,PCDH1,Protocadherin-1,22766,89,0.66 [0.25-1.69],0.3815420390107853
Chapter II Neoplasms,Melanoma in situ,PCDH12,Protocadherin-12,19635,77,0.76 [0.32-1.76],0.5182093462239361
Chapter II Neoplasms,Melanoma in situ,PCDH17,Protocadherin-17,22589,89,0.62 [0.35-1.09],0.099028098511514
Chapter II Neoplasms,Melanoma in situ,PCDH7,Protocadherin-7,19566,77,1.21 [0.69-2.14],0.504214093887527
Chapter II Neoplasms,Melanoma in situ,PCDH9,Protocadherin-9,19566,77,1.52 [0.79-2.92],0.2127911538080503
Chapter II Neoplasms,Melanoma in situ,PCDHB15,Protocadherin beta-15,19560,77,0.97 [0.56-1.69],0.9113111858342636
Chapter II Neoplasms,Melanoma in situ,PCNA,Proliferating cell nuclear antigen,18973,75,0.95 [0.65-1.38],0.7910740228563344
Chapter II Neoplasms,Melanoma in situ,PCSK7,Proprotein convertase subtilisin/kexin type 7,19560,77,0.83 [0.49-1.39],0.477906221191028
Chapter II Neoplasms,Melanoma in situ,PCSK9,Proprotein convertase subtilisin/kexin type 9,22859,89,0.82 [0.50-1.32],0.4096388374356043
Chapter II Neoplasms,Melanoma in situ,PCYT2,Ethanolamine-phosphate cytidylyltransferase,19566,77,1.24 [0.93-1.64],0.1444120415105302
Chapter II Neoplasms,Melanoma in situ,PDAP1,28 kDa heat- and acid-stable phosphoprotein,19665,77,1.18 [0.94-1.48],0.1441665685405431
Chapter II Neoplasms,Melanoma in situ,PDCD1,Programmed cell death protein 1,22757,90,0.93 [0.60-1.45],0.7428901521083702
Chapter II Neoplasms,Melanoma in situ,PDCD1LG2,Programmed cell death 1 ligand 2,22484,88,1.04 [0.56-1.92],0.895050858229586
Chapter II Neoplasms,Melanoma in situ,PDCD5,Programmed cell death protein 5,22788,90,1.00 [0.73-1.38],0.9829471817329554
Chapter II Neoplasms,Melanoma in situ,PDCD6,Programmed cell death protein 6,22589,89,1.00 [0.76-1.32],0.9807929907263436
Chapter II Neoplasms,Melanoma in situ,PDCL2,Phosducin-like protein 2,18973,75,1.06 [0.72-1.55],0.7812802447003245
Chapter II Neoplasms,Melanoma in situ,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",18973,75,0.64 [0.36-1.12],0.1148981077790042
Chapter II Neoplasms,Melanoma in situ,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",19066,75,1.00 [0.69-1.43],0.9873773620407492
Chapter II Neoplasms,Melanoma in situ,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",19255,75,1.13 [0.91-1.40],0.282109730377921
Chapter II Neoplasms,Melanoma in situ,PDGFA,Platelet-derived growth factor subunit A,22859,89,0.90 [0.70-1.17],0.4365038026802172
Chapter II Neoplasms,Melanoma in situ,PDGFB,Platelet-derived growth factor subunit B,22692,90,0.85 [0.69-1.05],0.1383385632283035
Chapter II Neoplasms,Melanoma in situ,PDGFC,Platelet-derived growth factor C,22078,88,0.72 [0.37-1.41],0.343389017870694
Chapter II Neoplasms,Melanoma in situ,PDGFRA,Platelet-derived growth factor receptor alpha,22589,89,0.74 [0.38-1.44],0.3719453914055549
Chapter II Neoplasms,Melanoma in situ,PDGFRB,Platelet-derived growth factor receptor beta,22859,89,0.75 [0.44-1.26],0.276694830392694
Chapter II Neoplasms,Melanoma in situ,PDIA2,Protein disulfide-isomerase A2,18973,75,0.48 [0.25-0.93],0.0301883044401798
Chapter II Neoplasms,Melanoma in situ,PDIA3,Protein disulfide-isomerase A3,19255,75,1.02 [0.42-2.46],0.9631136667522848
Chapter II Neoplasms,Melanoma in situ,PDIA4,Protein disulfide-isomerase A4,19661,77,1.18 [0.82-1.68],0.3708697432866611
Chapter II Neoplasms,Melanoma in situ,PDIA5,Protein disulfide-isomerase A5,18973,75,0.80 [0.53-1.21],0.2902464172576114
Chapter II Neoplasms,Melanoma in situ,PDLIM5,PDZ and LIM domain protein 5,19635,77,1.15 [0.95-1.39],0.1630593674814376
Chapter II Neoplasms,Melanoma in situ,PDLIM7,PDZ and LIM domain protein 7,22692,90,1.07 [0.92-1.24],0.3953074605588225
Chapter II Neoplasms,Melanoma in situ,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",22078,88,0.76 [0.49-1.17],0.2163048744343028
Chapter II Neoplasms,Melanoma in situ,PDRG1,p53 and DNA damage-regulated protein 1,19119,72,0.81 [0.50-1.32],0.4041166978317168
Chapter II Neoplasms,Melanoma in situ,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,18973,75,1.01 [0.70-1.46],0.9467732646293788
Chapter II Neoplasms,Melanoma in situ,PDZD2,PDZ domain-containing protein 2,19066,75,0.96 [0.66-1.41],0.8448506221754541
Chapter II Neoplasms,Melanoma in situ,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,19117,75,1.07 [0.65-1.76],0.7960384177766789
Chapter II Neoplasms,Melanoma in situ,PEAR1,Platelet endothelial aggregation receptor 1,22859,89,1.22 [0.52-2.81],0.6490129618284505
Chapter II Neoplasms,Melanoma in situ,PEBP1,Phosphatidylethanolamine-binding protein 1,22597,90,0.95 [0.69-1.30],0.7366854805157584
Chapter II Neoplasms,Melanoma in situ,PECAM1,Platelet endothelial cell adhesion molecule,22597,90,1.38 [0.75-2.54],0.2972556640610864
Chapter II Neoplasms,Melanoma in situ,PECR,Peroxisomal trans-2-enoyl-CoA reductase,19167,75,0.85 [0.39-1.87],0.6874194888276538
Chapter II Neoplasms,Melanoma in situ,PENK,Proenkephalin-A,19255,75,1.35 [0.71-2.59],0.3578285711353547
Chapter II Neoplasms,Melanoma in situ,PEPD,Xaa-Pro dipeptidase,19669,77,0.97 [0.42-2.23],0.940172068504429
Chapter II Neoplasms,Melanoma in situ,PER3,Period circadian protein homolog 3,19117,75,1.10 [0.91-1.32],0.3207224849176114
Chapter II Neoplasms,Melanoma in situ,PF4,Platelet factor 4,19553,77,1.01 [0.81-1.26],0.953297069717114
Chapter II Neoplasms,Melanoma in situ,PFDN2,Prefoldin subunit 2,22029,90,1.10 [0.80-1.52],0.5562026391715704
Chapter II Neoplasms,Melanoma in situ,PFDN4,Prefoldin subunit 4,18973,75,0.66 [0.40-1.08],0.0973985591720456
Chapter II Neoplasms,Melanoma in situ,PFDN6,Prefoldin subunit 6,19119,72,1.15 [0.86-1.53],0.3491237452033905
Chapter II Neoplasms,Melanoma in situ,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",22444,88,1.08 [0.85-1.38],0.5281619638544017
Chapter II Neoplasms,Melanoma in situ,PGA4,Pepsin A-4,19669,77,1.00 [0.74-1.36],0.9989734763361808
Chapter II Neoplasms,Melanoma in situ,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",19665,77,1.18 [0.79-1.74],0.4191829362836433
Chapter II Neoplasms,Melanoma in situ,PGF,Placenta growth factor,22837,90,0.98 [0.45-2.14],0.9542826684661404
Chapter II Neoplasms,Melanoma in situ,PGLYRP1,Peptidoglycan recognition protein 1,22752,88,0.99 [0.63-1.55],0.9532543772823736
Chapter II Neoplasms,Melanoma in situ,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,19435,76,0.59 [0.30-1.16],0.1265189022691663
Chapter II Neoplasms,Melanoma in situ,PGLYRP4,Peptidoglycan recognition protein 4,19066,75,0.95 [0.65-1.37],0.7698804958542396
Chapter II Neoplasms,Melanoma in situ,PGM2,Phosphoglucomutase-2,19119,72,0.95 [0.63-1.43],0.8116706437851927
Chapter II Neoplasms,Melanoma in situ,PGR,Progesterone receptor,19117,75,1.04 [0.85-1.27],0.7307454157245942
Chapter II Neoplasms,Melanoma in situ,PHACTR2,Phosphatase and actin regulator 2,19635,77,1.07 [0.88-1.29],0.5085246391002964
Chapter II Neoplasms,Melanoma in situ,PHLDB1,Pleckstrin homology-like domain family B member 1,19566,77,1.29 [0.86-1.94],0.2129437807572467
Chapter II Neoplasms,Melanoma in situ,PHLDB2,Pleckstrin homology-like domain family B member 2,18973,75,0.96 [0.75-1.22],0.7183800757721115
Chapter II Neoplasms,Melanoma in situ,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,22440,89,1.31 [0.68-2.50],0.418175158636396
Chapter II Neoplasms,Melanoma in situ,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,19255,75,1.45 [0.84-2.50],0.1868955916709751
Chapter II Neoplasms,Melanoma in situ,PI16,Peptidase inhibitor 16,19669,77,0.64 [0.27-1.53],0.3158312026113861
Chapter II Neoplasms,Melanoma in situ,PI3,Elafin,22290,84,1.13 [0.80-1.61],0.4895765103420969
Chapter II Neoplasms,Melanoma in situ,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",19635,77,1.14 [0.87-1.50],0.3542950767416756
Chapter II Neoplasms,Melanoma in situ,PIGR,Polymeric immunoglobulin receptor,22309,88,1.52 [0.88-2.61],0.1297612959634115
Chapter II Neoplasms,Melanoma in situ,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,22550,90,1.04 [0.77-1.40],0.8144282339682373
Chapter II Neoplasms,Melanoma in situ,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,22597,90,0.87 [0.41-1.84],0.7250292079943976
Chapter II Neoplasms,Melanoma in situ,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,19117,75,1.02 [0.69-1.51],0.9162078246671872
Chapter II Neoplasms,Melanoma in situ,PILRA,Paired immunoglobulin-like type 2 receptor alpha,22597,90,0.87 [0.56-1.35],0.5318545911636299
Chapter II Neoplasms,Melanoma in situ,PILRB,Paired immunoglobulin-like type 2 receptor beta,22589,89,0.97 [0.70-1.35],0.8614457522398968
Chapter II Neoplasms,Melanoma in situ,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,19255,75,0.88 [0.64-1.21],0.4312206412527739
Chapter II Neoplasms,Melanoma in situ,PITHD1,PITH domain-containing protein 1,18935,75,1.15 [0.92-1.43],0.2134974095671123
Chapter II Neoplasms,Melanoma in situ,PKD1,Polycystin-1,19665,77,1.06 [0.46-2.47],0.8899972919126881
Chapter II Neoplasms,Melanoma in situ,PKD2,Polycystin-2,19066,75,1.00 [0.68-1.47],0.9994493788455552
Chapter II Neoplasms,Melanoma in situ,PKLR,Pyruvate kinase PKLR,22619,89,0.83 [0.62-1.11],0.2140452628687497
Chapter II Neoplasms,Melanoma in situ,PKN3,Serine/threonine-protein kinase N3,19287,76,1.10 [0.84-1.45],0.4787964311980561
Chapter II Neoplasms,Melanoma in situ,PLA2G10,Group 10 secretory phospholipase A2,22440,89,0.87 [0.64-1.18],0.3688144393755937
Chapter II Neoplasms,Melanoma in situ,PLA2G15,Phospholipase A2 group XV,22658,90,0.56 [0.26-1.18],0.1262686884477295
Chapter II Neoplasms,Melanoma in situ,PLA2G1B,Phospholipase A2,22820,88,1.11 [0.71-1.75],0.6373738359090246
Chapter II Neoplasms,Melanoma in situ,PLA2G2A,"Phospholipase A2, membrane associated",22514,88,0.95 [0.68-1.33],0.7672601032928874
Chapter II Neoplasms,Melanoma in situ,PLA2G4A,Cytosolic phospholipase A2,22692,90,1.10 [0.88-1.36],0.4020943408080085
Chapter II Neoplasms,Melanoma in situ,PLA2G7,Platelet-activating factor acetylhydrolase,22597,90,0.91 [0.50-1.64],0.7467779026035364
Chapter II Neoplasms,Melanoma in situ,PLAT,Tissue-type plasminogen activator,22791,89,0.88 [0.60-1.28],0.5107361916497398
Chapter II Neoplasms,Melanoma in situ,PLAU,Urokinase-type plasminogen activator,22597,90,0.84 [0.44-1.60],0.5875904438965753
Chapter II Neoplasms,Melanoma in situ,PLAUR,Urokinase plasminogen activator surface receptor,22441,90,0.67 [0.32-1.40],0.2842624207451518
Chapter II Neoplasms,Melanoma in situ,PLB1,"Phospholipase B1, membrane-associated",19626,77,1.11 [0.77-1.60],0.5876668202646012
Chapter II Neoplasms,Melanoma in situ,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",19117,75,0.76 [0.43-1.35],0.3544943195424322
Chapter II Neoplasms,Melanoma in situ,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",19626,77,1.18 [0.94-1.49],0.1461195963550916
Chapter II Neoplasms,Melanoma in situ,PLEKHO1,Pleckstrin homology domain-containing family O member 1,19626,77,1.20 [0.88-1.63],0.2560540021754064
Chapter II Neoplasms,Melanoma in situ,PLG,Plasminogen,19176,74,0.49 [0.18-1.28],0.1446864385174684
Chapter II Neoplasms,Melanoma in situ,PLIN1,Perilipin-1,22029,90,0.99 [0.58-1.70],0.9700522204768078
Chapter II Neoplasms,Melanoma in situ,PLIN3,Perilipin-3,22589,89,1.12 [0.73-1.72],0.6068446366736086
Chapter II Neoplasms,Melanoma in situ,PLPBP,Pyridoxal phosphate homeostasis protein,22589,89,1.03 [0.78-1.35],0.8438462204933308
Chapter II Neoplasms,Melanoma in situ,PLSCR3,Phospholipid scramblase 3,19596,77,1.00 [0.69-1.45],0.9991146492298664
Chapter II Neoplasms,Melanoma in situ,PLTP,Phospholipid transfer protein,22772,88,0.82 [0.48-1.43],0.4884708595742226
Chapter II Neoplasms,Melanoma in situ,PLXDC1,Plexin domain-containing protein 1,22078,88,0.77 [0.41-1.46],0.4272577180187207
Chapter II Neoplasms,Melanoma in situ,PLXDC2,Plexin domain-containing protein 2,19626,77,1.22 [0.57-2.61],0.6137735295154485
Chapter II Neoplasms,Melanoma in situ,PLXNA4,Plexin-A4,22550,90,1.05 [0.84-1.31],0.6796134265686196
Chapter II Neoplasms,Melanoma in situ,PLXNB2,Plexin-B2,22758,89,0.73 [0.32-1.65],0.4471715420096056
Chapter II Neoplasms,Melanoma in situ,PLXNB3,Plexin-B3,22523,88,1.32 [0.89-1.96],0.1718987524442316
Chapter II Neoplasms,Melanoma in situ,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,22484,89,1.08 [0.97-1.21],0.156704469457543
Chapter II Neoplasms,Melanoma in situ,PMCH,Pro-MCH,19066,75,1.16 [0.96-1.41],0.132386220209331
Chapter II Neoplasms,Melanoma in situ,PMM2,Phosphomannomutase 2,19066,75,0.95 [0.65-1.38],0.7754384331176545
Chapter II Neoplasms,Melanoma in situ,PMS1,PMS1 protein homolog 1,19119,72,0.86 [0.53-1.38],0.520689651582553
Chapter II Neoplasms,Melanoma in situ,PMVK,Phosphomevalonate kinase,21990,90,1.05 [0.88-1.26],0.564242500049851
Chapter II Neoplasms,Melanoma in situ,PNLIP,Pancreatic triacylglycerol lipase,19669,77,1.14 [0.80-1.62],0.4824390456658441
Chapter II Neoplasms,Melanoma in situ,PNLIPRP1,Inactive pancreatic lipase-related protein 1,19626,77,1.32 [1.00-1.75],0.0504783329003678
Chapter II Neoplasms,Melanoma in situ,PNLIPRP2,Pancreatic lipase-related protein 2,22583,90,1.02 [0.95-1.09],0.5800810246354114
Chapter II Neoplasms,Melanoma in situ,PNMA1,Paraneoplastic antigen Ma1,19167,75,1.43 [0.99-2.06],0.0555415605165633
Chapter II Neoplasms,Melanoma in situ,PNMA2,Paraneoplastic antigen Ma2,19060,77,0.64 [0.37-1.11],0.1136152429025722
Chapter II Neoplasms,Melanoma in situ,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",22161,88,0.89 [0.75-1.07],0.209348978822426
Chapter II Neoplasms,Melanoma in situ,PODXL,Podocalyxin,22484,88,0.71 [0.21-2.44],0.58496478370363
Chapter II Neoplasms,Melanoma in situ,PODXL2,Podocalyxin-like protein 2,22658,90,0.87 [0.44-1.73],0.6906467381081309
Chapter II Neoplasms,Melanoma in situ,POF1B,Protein POF1B,19117,75,1.03 [0.64-1.67],0.8966604882656949
Chapter II Neoplasms,Melanoma in situ,POLR2A,DNA-directed RNA polymerase II subunit RPB1,19117,75,0.76 [0.34-1.68],0.4920358436812118
Chapter II Neoplasms,Melanoma in situ,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",22484,88,1.03 [0.60-1.77],0.9106620636488276
Chapter II Neoplasms,Melanoma in situ,POMC,Pro-opiomelanocortin,19167,75,0.87 [0.63-1.22],0.4228705651535264
Chapter II Neoplasms,Melanoma in situ,PON1,Serum paraoxonase/arylesterase 1,19669,77,1.18 [0.49-2.80],0.7143313039682977
Chapter II Neoplasms,Melanoma in situ,PON2,Serum paraoxonase/arylesterase 2,22187,88,0.70 [0.40-1.23],0.2148412326557849
Chapter II Neoplasms,Melanoma in situ,PON3,Serum paraoxonase/lactonase 3,22692,90,0.59 [0.33-1.05],0.0706469286257906
Chapter II Neoplasms,Melanoma in situ,POSTN,Periostin,19661,77,0.82 [0.45-1.49],0.5131262589712524
Chapter II Neoplasms,Melanoma in situ,PPBP,Platelet basic protein,19549,77,1.06 [0.82-1.37],0.6521961931428093
Chapter II Neoplasms,Melanoma in situ,PPCDC,Phosphopantothenoylcysteine decarboxylase,22788,90,1.17 [0.80-1.73],0.4180081333512833
Chapter II Neoplasms,Melanoma in situ,PPIB,Peptidyl-prolyl cis-trans isomerase B,22597,87,1.12 [0.91-1.37],0.2820634438076721
Chapter II Neoplasms,Melanoma in situ,PPIE,Peptidyl-prolyl cis-trans isomerase E,19287,76,1.20 [0.92-1.57],0.1859690309996455
Chapter II Neoplasms,Melanoma in situ,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",19661,77,1.15 [0.83-1.59],0.3954084714525496
Chapter II Neoplasms,Melanoma in situ,PPL,Periplakin,19117,75,0.91 [0.45-1.82],0.7910276422068448
Chapter II Neoplasms,Melanoma in situ,PPM1A,Protein phosphatase 1A,22078,88,1.51 [0.94-2.44],0.0881176668212048
Chapter II Neoplasms,Melanoma in situ,PPM1B,Protein phosphatase 1B,19117,75,1.14 [0.84-1.53],0.3971351287640742
Chapter II Neoplasms,Melanoma in situ,PPM1F,Protein phosphatase 1F,19665,77,1.28 [0.85-1.94],0.2435073807114665
Chapter II Neoplasms,Melanoma in situ,PPME1,Protein phosphatase methylesterase 1,22484,88,0.94 [0.69-1.27],0.6706677717414196
Chapter II Neoplasms,Melanoma in situ,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,19560,77,1.12 [0.86-1.46],0.3854925063394593
Chapter II Neoplasms,Melanoma in situ,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,22658,90,1.10 [0.91-1.33],0.3422886920484439
Chapter II Neoplasms,Melanoma in situ,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,19287,76,0.91 [0.65-1.26],0.5605576923069888
Chapter II Neoplasms,Melanoma in situ,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,19635,77,1.18 [0.93-1.51],0.1704408508118736
Chapter II Neoplasms,Melanoma in situ,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,19635,77,1.26 [0.75-2.12],0.374259221599506
Chapter II Neoplasms,Melanoma in situ,PPP1R2,Protein phosphatase inhibitor 2,22589,89,1.13 [0.89-1.43],0.3055569164814994
Chapter II Neoplasms,Melanoma in situ,PPP1R9B,Neurabin-2,22837,90,1.16 [0.95-1.41],0.1402096075769067
Chapter II Neoplasms,Melanoma in situ,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,19566,77,1.05 [0.87-1.26],0.6116582614868527
Chapter II Neoplasms,Melanoma in situ,PPP3R1,Calcineurin subunit B type 1,22440,89,1.01 [0.64-1.60],0.950309324159178
Chapter II Neoplasms,Melanoma in situ,PPT1,Palmitoyl-protein thioesterase 1,19119,72,0.86 [0.61-1.21],0.3793536649722333
Chapter II Neoplasms,Melanoma in situ,PPY,Pancreatic prohormone,22576,90,1.02 [0.85-1.23],0.8070825845247515
Chapter II Neoplasms,Melanoma in situ,PQBP1,Polyglutamine-binding protein 1,22078,88,0.92 [0.64-1.31],0.634385388951307
Chapter II Neoplasms,Melanoma in situ,PRAME,Melanoma antigen preferentially expressed in tumors,18973,75,0.57 [0.23-1.39],0.2137961011045558
Chapter II Neoplasms,Melanoma in situ,PRAP1,Proline-rich acidic protein 1,19661,77,1.13 [0.66-1.91],0.660929572954118
Chapter II Neoplasms,Melanoma in situ,PRC1,Protein regulator of cytokinesis 1,19560,77,0.92 [0.55-1.56],0.7648809138595194
Chapter II Neoplasms,Melanoma in situ,PRCP,Lysosomal Pro-X carboxypeptidase,22726,88,0.61 [0.33-1.15],0.1245416706250644
Chapter II Neoplasms,Melanoma in situ,PRDX1,Peroxiredoxin-1,21975,88,1.11 [0.90-1.37],0.325059056551181
Chapter II Neoplasms,Melanoma in situ,PRDX2,Peroxiredoxin-2,19330,77,0.77 [0.54-1.11],0.1609466868887673
Chapter II Neoplasms,Melanoma in situ,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",22161,88,0.91 [0.70-1.19],0.4994030869000359
Chapter II Neoplasms,Melanoma in situ,PRDX5,"Peroxiredoxin-5, mitochondrial",22837,90,1.11 [0.84-1.46],0.4682792391631086
Chapter II Neoplasms,Melanoma in situ,PRDX6,Peroxiredoxin-6,22789,90,1.16 [0.86-1.57],0.3429241778087041
Chapter II Neoplasms,Melanoma in situ,PREB,Prolactin regulatory element-binding protein,22161,88,1.04 [0.56-1.93],0.8908756774895598
Chapter II Neoplasms,Melanoma in situ,PRELP,Prolargin,22583,90,0.95 [0.43-2.10],0.8896977160461703
Chapter II Neoplasms,Melanoma in situ,PRG2,Bone marrow proteoglycan,19661,77,1.18 [0.78-1.78],0.4355487680917702
Chapter II Neoplasms,Melanoma in situ,PRG3,Proteoglycan 3,19661,77,0.92 [0.59-1.44],0.7196285877645263
Chapter II Neoplasms,Melanoma in situ,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,22161,88,1.19 [0.86-1.66],0.2980801974539444
Chapter II Neoplasms,Melanoma in situ,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,19119,72,1.20 [0.64-2.24],0.574382735474661
Chapter II Neoplasms,Melanoma in situ,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,22589,89,1.05 [0.84-1.32],0.6455755987748084
Chapter II Neoplasms,Melanoma in situ,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,19590,77,1.18 [0.91-1.53],0.2120684232376289
Chapter II Neoplasms,Melanoma in situ,PRKCQ,Protein kinase C theta type,22161,88,0.63 [0.38-1.06],0.0806897270534886
Chapter II Neoplasms,Melanoma in situ,PRKD2,Serine/threonine-protein kinase D2,19066,75,0.96 [0.60-1.55],0.8740803196381881
Chapter II Neoplasms,Melanoma in situ,PRKG1,cGMP-dependent protein kinase 1,19255,75,1.09 [0.92-1.31],0.3216878213658536
Chapter II Neoplasms,Melanoma in situ,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,22078,88,1.08 [0.81-1.43],0.6030975485338058
Chapter II Neoplasms,Melanoma in situ,PRL,Prolactin,22788,90,1.29 [1.02-1.62],0.0335418903180509
Chapter II Neoplasms,Melanoma in situ,PRND,Prion-like protein doppel,19626,77,0.80 [0.52-1.22],0.293769924608432
Chapter II Neoplasms,Melanoma in situ,PROC,Vitamin K-dependent protein C,22613,89,1.30 [0.60-2.82],0.4996959974458121
Chapter II Neoplasms,Melanoma in situ,PROCR,Endothelial protein C receptor,19066,75,0.79 [0.39-1.58],0.5032308864152921
Chapter II Neoplasms,Melanoma in situ,PROK1,Prokineticin-1,22550,90,1.19 [0.91-1.57],0.205659320180518
Chapter II Neoplasms,Melanoma in situ,PROS1,Vitamin K-dependent protein S,19694,77,0.93 [0.38-2.27],0.8681011682002069
Chapter II Neoplasms,Melanoma in situ,PRR4,Proline-rich protein 4,19116,74,1.21 [0.89-1.65],0.225046842620697
Chapter II Neoplasms,Melanoma in situ,PRR5,Proline-rich protein 5,19117,75,1.30 [0.88-1.92],0.1893225635323595
Chapter II Neoplasms,Melanoma in situ,PRRT3,Proline-rich transmembrane protein 3,19167,75,0.96 [0.52-1.74],0.8815889707204488
Chapter II Neoplasms,Melanoma in situ,PRSS2,Trypsin-2,22650,89,1.22 [0.85-1.75],0.2697731016201273
Chapter II Neoplasms,Melanoma in situ,PRSS22,Brain-specific serine protease 4,19117,75,0.94 [0.50-1.79],0.8566457395628363
Chapter II Neoplasms,Melanoma in situ,PRSS27,Serine protease 27,22522,89,1.18 [0.74-1.87],0.48156025429363
Chapter II Neoplasms,Melanoma in situ,PRSS53,Serine protease 53,19626,77,0.83 [0.45-1.53],0.5478520496279684
Chapter II Neoplasms,Melanoma in situ,PRSS8,Prostasin,22508,89,1.06 [0.66-1.69],0.8107713640540165
Chapter II Neoplasms,Melanoma in situ,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,22029,90,1.06 [0.89-1.25],0.5110304783991546
Chapter II Neoplasms,Melanoma in situ,PRTG,Protogenin,22789,90,1.03 [0.49-2.18],0.9317896138608652
Chapter II Neoplasms,Melanoma in situ,PRTN3,Myeloblastin,22002,85,0.91 [0.60-1.39],0.6743311370364125
Chapter II Neoplasms,Melanoma in situ,PRUNE2,Protein prune homolog 2,19287,76,1.09 [0.54-2.19],0.807839441121387
Chapter II Neoplasms,Melanoma in situ,PSAP,Prosaposin,19471,76,1.16 [0.56-2.41],0.6906656094693882
Chapter II Neoplasms,Melanoma in situ,PSAPL1,Proactivator polypeptide-like 1,19566,77,1.07 [0.69-1.66],0.7582712833293723
Chapter II Neoplasms,Melanoma in situ,PSCA,Prostate stem cell antigen,19566,77,0.99 [0.91-1.08],0.8629955772993029
Chapter II Neoplasms,Melanoma in situ,PSG1,Pregnancy-specific beta-1-glycoprotein 1,22440,89,1.04 [0.89-1.23],0.6078064310186722
Chapter II Neoplasms,Melanoma in situ,PSIP1,PC4 and SFRS1-interacting protein,22550,90,1.13 [0.87-1.47],0.3545323232022439
Chapter II Neoplasms,Melanoma in situ,PSMA1,Proteasome subunit alpha type-1,22078,88,0.82 [0.53-1.27],0.3683869438324156
Chapter II Neoplasms,Melanoma in situ,PSMC3,26S proteasome regulatory subunit 6A,18973,75,0.54 [0.25-1.15],0.1082195929055396
Chapter II Neoplasms,Melanoma in situ,PSMD1,26S proteasome non-ATPase regulatory subunit 1,19635,77,0.92 [0.59-1.44],0.7166411648869335
Chapter II Neoplasms,Melanoma in situ,PSMD5,26S proteasome non-ATPase regulatory subunit 5,19119,72,1.26 [0.93-1.69],0.1305297515794299
Chapter II Neoplasms,Melanoma in situ,PSMD9,26S proteasome non-ATPase regulatory subunit 9,22484,88,0.77 [0.54-1.10],0.1480028740465042
Chapter II Neoplasms,Melanoma in situ,PSME1,Proteasome activator complex subunit 1,22410,89,0.79 [0.48-1.29],0.3437325504784559
Chapter II Neoplasms,Melanoma in situ,PSME2,Proteasome activator complex subunit 2,22328,89,0.99 [0.60-1.63],0.9653138377199296
Chapter II Neoplasms,Melanoma in situ,PSMG3,Proteasome assembly chaperone 3,22550,90,0.79 [0.55-1.14],0.2076944226785117
Chapter II Neoplasms,Melanoma in situ,PSMG4,Proteasome assembly chaperone 4,19117,75,0.91 [0.62-1.35],0.656196933004505
Chapter II Neoplasms,Melanoma in situ,PSPN,Persephin,22550,90,1.06 [0.88-1.28],0.5512478675520465
Chapter II Neoplasms,Melanoma in situ,PSRC1,Proline/serine-rich coiled-coil protein 1,22078,88,0.87 [0.62-1.23],0.4409776569807243
Chapter II Neoplasms,Melanoma in situ,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,18568,73,1.17 [0.93-1.46],0.1761312663764724
Chapter II Neoplasms,Melanoma in situ,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",22029,90,0.59 [0.32-1.10],0.0968178395946741
Chapter II Neoplasms,Melanoma in situ,PTGDS,Prostaglandin-H2 D-isomerase,22391,89,1.18 [0.61-2.26],0.6207546743010723
Chapter II Neoplasms,Melanoma in situ,PTGES2,Prostaglandin E synthase 2,18967,73,1.41 [0.95-2.08],0.0855986151432563
Chapter II Neoplasms,Melanoma in situ,PTGR1,Prostaglandin reductase 1,19665,77,1.10 [0.84-1.44],0.4949650818630877
Chapter II Neoplasms,Melanoma in situ,PTH,Parathyroid hormone,19119,72,1.20 [0.91-1.59],0.1959511056368581
Chapter II Neoplasms,Melanoma in situ,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,22550,90,1.17 [0.77-1.77],0.4702245677802417
Chapter II Neoplasms,Melanoma in situ,PTK7,Inactive tyrosine-protein kinase 7,22029,90,0.90 [0.55-1.49],0.6823122654330709
Chapter II Neoplasms,Melanoma in situ,PTN,Pleiotrophin,22187,88,1.28 [0.88-1.86],0.1932187340060275
Chapter II Neoplasms,Melanoma in situ,PTP4A3,Protein tyrosine phosphatase type IVA 3,19117,75,0.93 [0.60-1.42],0.7254563162512999
Chapter II Neoplasms,Melanoma in situ,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,22440,89,1.10 [0.87-1.39],0.4411642026024326
Chapter II Neoplasms,Melanoma in situ,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,22653,90,1.04 [0.85-1.29],0.684881937905482
Chapter II Neoplasms,Melanoma in situ,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,19079,75,0.93 [0.50-1.73],0.814538944970233
Chapter II Neoplasms,Melanoma in situ,PTPRB,Receptor-type tyrosine-protein phosphatase beta,19665,77,0.69 [0.32-1.51],0.3531994797915138
Chapter II Neoplasms,Melanoma in situ,PTPRC,Receptor-type tyrosine-protein phosphatase C,19661,77,0.73 [0.27-1.96],0.5321505259907282
Chapter II Neoplasms,Melanoma in situ,PTPRF,Receptor-type tyrosine-protein phosphatase F,22859,89,0.57 [0.30-1.09],0.0898919853700312
Chapter II Neoplasms,Melanoma in situ,PTPRH,Receptor-type tyrosine-protein phosphatase H,19566,77,1.15 [0.73-1.80],0.550543126349015
Chapter II Neoplasms,Melanoma in situ,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,19566,77,0.63 [0.21-1.89],0.4118236547251876
Chapter II Neoplasms,Melanoma in situ,PTPRM,Receptor-type tyrosine-protein phosphatase mu,22513,90,1.69 [0.79-3.62],0.1796453164631731
Chapter II Neoplasms,Melanoma in situ,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,22361,88,1.41 [0.78-2.55],0.2605723560517579
Chapter II Neoplasms,Melanoma in situ,PTPRR,Receptor-type tyrosine-protein phosphatase R,19626,77,1.37 [0.75-2.49],0.3093325181483176
Chapter II Neoplasms,Melanoma in situ,PTPRS,Receptor-type tyrosine-protein phosphatase S,22859,89,0.82 [0.38-1.79],0.6236352155685303
Chapter II Neoplasms,Melanoma in situ,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,19665,77,0.86 [0.44-1.67],0.65477781738838
Chapter II Neoplasms,Melanoma in situ,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,19255,75,1.11 [0.77-1.61],0.5597379285809729
Chapter II Neoplasms,Melanoma in situ,PTS,6-pyruvoyl tetrahydrobiopterin synthase,21938,89,1.10 [0.79-1.55],0.5721855403210596
Chapter II Neoplasms,Melanoma in situ,PTTG1,Securin,19287,76,0.97 [0.57-1.67],0.9254204646636408
Chapter II Neoplasms,Melanoma in situ,PTX3,Pentraxin-related protein PTX3,22550,90,0.74 [0.53-1.04],0.0834758400569437
Chapter II Neoplasms,Melanoma in situ,PVALB,Parvalbumin alpha,22677,90,1.11 [0.94-1.32],0.2275604844992403
Chapter II Neoplasms,Melanoma in situ,PVR,Poliovirus receptor,22788,90,0.94 [0.56-1.58],0.805116089146451
Chapter II Neoplasms,Melanoma in situ,PXDNL,Peroxidasin-like protein,19560,77,0.99 [0.67-1.47],0.9684426667229684
Chapter II Neoplasms,Melanoma in situ,PXN,Paxillin,22029,90,1.02 [0.72-1.45],0.9064128803528334
Chapter II Neoplasms,Melanoma in situ,PYDC1,Pyrin domain-containing protein 1,19167,75,1.42 [0.95-2.12],0.0861204982169754
Chapter II Neoplasms,Melanoma in situ,PYY,Peptide YY,19066,75,0.66 [0.51-0.86],0.0018875504610157
Chapter II Neoplasms,Melanoma in situ,PZP,Pregnancy zone protein,19694,77,1.01 [0.72-1.43],0.9564431197084116
Chapter II Neoplasms,Melanoma in situ,QDPR,Dihydropteridine reductase,22490,88,1.09 [0.71-1.67],0.7061534426713809
Chapter II Neoplasms,Melanoma in situ,QPCT,Glutaminyl-peptide cyclotransferase,22629,88,0.93 [0.45-1.91],0.8395117514960578
Chapter II Neoplasms,Melanoma in situ,QSOX1,Sulfhydryl oxidase 1,19288,75,0.62 [0.28-1.36],0.2318686391768836
Chapter II Neoplasms,Melanoma in situ,RAB10,Ras-related protein Rab-10,19665,77,1.08 [0.72-1.61],0.719599268100239
Chapter II Neoplasms,Melanoma in situ,RAB11FIP3,Rab11 family-interacting protein 3,19665,77,1.14 [0.93-1.40],0.2215679359139595
Chapter II Neoplasms,Melanoma in situ,RAB27B,Ras-related protein Rab-27B,19665,77,1.15 [0.87-1.52],0.3171470976988761
Chapter II Neoplasms,Melanoma in situ,RAB2B,Ras-related protein Rab-2B,19560,77,1.20 [0.85-1.71],0.2959116102171684
Chapter II Neoplasms,Melanoma in situ,RAB33A,Ras-related protein Rab-33A,19066,75,1.13 [0.82-1.57],0.4568508984797871
Chapter II Neoplasms,Melanoma in situ,RAB37,Ras-related protein Rab-37,22161,88,0.85 [0.65-1.10],0.2038309425996173
Chapter II Neoplasms,Melanoma in situ,RAB39B,Ras-related protein Rab-39B,19066,75,1.26 [1.07-1.49],0.0049235985386561
Chapter II Neoplasms,Melanoma in situ,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,19060,77,1.30 [0.98-1.73],0.0731209689471775
Chapter II Neoplasms,Melanoma in situ,RAB44,Ras-related protein Rab-44,19560,77,1.13 [0.75-1.71],0.5585362616598519
Chapter II Neoplasms,Melanoma in situ,RAB6A,Ras-related protein Rab-6A,22550,90,0.84 [0.56-1.26],0.4065458758054712
Chapter II Neoplasms,Melanoma in situ,RAB6B,Ras-related protein Rab-6B,22029,90,1.03 [0.71-1.49],0.870266434806946
Chapter II Neoplasms,Melanoma in situ,RABEP1,Rab GTPase-binding effector protein 1,19255,75,1.07 [0.81-1.43],0.6155111905600283
Chapter II Neoplasms,Melanoma in situ,RABEPK,Rab9 effector protein with kelch motifs,22078,88,0.97 [0.70-1.34],0.8439160907012266
Chapter II Neoplasms,Melanoma in situ,RABGAP1L,Rab GTPase-activating protein 1-like,22161,88,0.92 [0.67-1.27],0.6146107434214454
Chapter II Neoplasms,Melanoma in situ,RAC3,Ras-related C3 botulinum toxin substrate 3,19119,72,1.19 [0.92-1.53],0.1853808101372524
Chapter II Neoplasms,Melanoma in situ,RAD23B,UV excision repair protein RAD23 homolog B,22078,88,0.95 [0.63-1.43],0.8082990115691153
Chapter II Neoplasms,Melanoma in situ,RAD51,DNA repair protein RAD51 homolog 1,19287,76,1.23 [0.93-1.64],0.1521195949360517
Chapter II Neoplasms,Melanoma in situ,RALB,Ras-related protein Ral-B,19117,75,1.86 [1.08-3.19],0.0243539226501985
Chapter II Neoplasms,Melanoma in situ,RALY,RNA-binding protein Raly,19560,77,1.28 [0.91-1.81],0.1571193564122091
Chapter II Neoplasms,Melanoma in situ,RANBP1,Ran-specific GTPase-activating protein,19167,75,0.94 [0.62-1.41],0.7529362010138569
Chapter II Neoplasms,Melanoma in situ,RANBP2,E3 SUMO-protein ligase RanBP2,19060,77,1.85 [1.09-3.14],0.0234386802713424
Chapter II Neoplasms,Melanoma in situ,RANGAP1,Ran GTPase-activating protein 1,22078,88,1.04 [0.71-1.51],0.8513069381369347
Chapter II Neoplasms,Melanoma in situ,RAP1A,Ras-related protein Rap-1A,19117,75,0.86 [0.59-1.24],0.4187467163432666
Chapter II Neoplasms,Melanoma in situ,RAPGEF2,Rap guanine nucleotide exchange factor 2,19287,76,1.29 [0.87-1.90],0.206156132847559
Chapter II Neoplasms,Melanoma in situ,RARRES1,Retinoic acid receptor responder protein 1,22078,88,1.33 [0.87-2.02],0.1827912036978661
Chapter II Neoplasms,Melanoma in situ,RARRES2,Retinoic acid receptor responder protein 2,22693,89,1.02 [0.68-1.54],0.9097136917016984
Chapter II Neoplasms,Melanoma in situ,RASA1,Ras GTPase-activating protein 1,22029,90,0.88 [0.50-1.56],0.6586775235583853
Chapter II Neoplasms,Melanoma in situ,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,18973,75,1.14 [0.70-1.86],0.6033041743135744
Chapter II Neoplasms,Melanoma in situ,RASSF2,Ras association domain-containing protein 2,22078,88,0.99 [0.71-1.38],0.9483488543884284
Chapter II Neoplasms,Melanoma in situ,RBFOX3,RNA binding protein fox-1 homolog 3,19635,77,0.95 [0.51-1.75],0.859285525851418
Chapter II Neoplasms,Melanoma in situ,RBKS,Ribokinase,22051,88,1.00 [0.69-1.46],0.9815345900494168
Chapter II Neoplasms,Melanoma in situ,RBM17,Splicing factor 45,19635,77,1.22 [0.92-1.60],0.1628734034542851
Chapter II Neoplasms,Melanoma in situ,RBM19,Probable RNA-binding protein 19,19066,75,0.78 [0.46-1.33],0.3634338465720773
Chapter II Neoplasms,Melanoma in situ,RBM25,RNA-binding protein 25,18973,75,1.10 [0.69-1.74],0.6991122667512065
Chapter II Neoplasms,Melanoma in situ,RBP1,Retinol-binding protein 1,19119,72,0.93 [0.66-1.32],0.6793435227108134
Chapter II Neoplasms,Melanoma in situ,RBP2,Retinol-binding protein 2,22484,88,1.11 [0.87-1.43],0.3923926472453242
Chapter II Neoplasms,Melanoma in situ,RBP5,Retinol-binding protein 5,22484,88,1.24 [0.90-1.71],0.1943476809497588
Chapter II Neoplasms,Melanoma in situ,RBP7,Retinoid-binding protein 7,19566,77,0.99 [0.69-1.42],0.961527564575372
Chapter II Neoplasms,Melanoma in situ,RBPMS,RNA-binding protein with multiple splicing,19117,75,1.04 [0.76-1.42],0.8013392092947424
Chapter II Neoplasms,Melanoma in situ,RBPMS2,RNA-binding protein with multiple splicing 2,19167,75,1.14 [0.92-1.41],0.2267852671890866
Chapter II Neoplasms,Melanoma in situ,RCC1,Regulator of chromosome condensation,19560,77,1.02 [0.68-1.52],0.9396264418786928
Chapter II Neoplasms,Melanoma in situ,RCOR1,REST corepressor 1,22187,88,0.74 [0.43-1.28],0.2805248584787451
Chapter II Neoplasms,Melanoma in situ,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,19167,75,0.51 [0.17-1.55],0.2318868945812886
Chapter II Neoplasms,Melanoma in situ,REEP4,Receptor expression-enhancing protein 4,19635,77,1.13 [0.80-1.58],0.4931111859439698
Chapter II Neoplasms,Melanoma in situ,REG1A,Lithostathine-1-alpha,22430,89,1.11 [0.77-1.62],0.5713456091348289
Chapter II Neoplasms,Melanoma in situ,REG1B,Lithostathine-1-beta,22859,89,1.01 [0.73-1.41],0.935710657419396
Chapter II Neoplasms,Melanoma in situ,REG3A,Regenerating islet-derived protein 3-alpha,22859,89,1.14 [0.84-1.53],0.3988279197119954
Chapter II Neoplasms,Melanoma in situ,REG3G,Regenerating islet-derived protein 3-gamma,19560,77,0.74 [0.41-1.31],0.2983218122712939
Chapter II Neoplasms,Melanoma in situ,REG4,Regenerating islet-derived protein 4,22625,90,0.77 [0.51-1.16],0.2090015464801607
Chapter II Neoplasms,Melanoma in situ,RELB,Transcription factor RelB,19117,75,1.29 [0.92-1.82],0.1387373846297907
Chapter II Neoplasms,Melanoma in situ,RELT,Tumor necrosis factor receptor superfamily member 19L,22597,90,1.09 [0.54-2.19],0.8163967656592237
Chapter II Neoplasms,Melanoma in situ,REN,Renin,22589,89,0.98 [0.75-1.27],0.8560363161119486
Chapter II Neoplasms,Melanoma in situ,REPS1,RalBP1-associated Eps domain-containing protein 1,19117,75,1.37 [0.83-2.26],0.2212172269198316
Chapter II Neoplasms,Melanoma in situ,REST,RE1-silencing transcription factor,18973,75,1.05 [0.57-1.96],0.8703520805933853
Chapter II Neoplasms,Melanoma in situ,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,22484,88,0.73 [0.46-1.16],0.177157865966158
Chapter II Neoplasms,Melanoma in situ,RETN,Resistin,22521,86,1.27 [0.80-2.01],0.304524087548945
Chapter II Neoplasms,Melanoma in situ,REXO2,"Oligoribonuclease, mitochondrial",19066,75,0.84 [0.51-1.40],0.5122045495850689
Chapter II Neoplasms,Melanoma in situ,RFC4,Replication factor C subunit 4,19560,77,1.56 [0.60-4.05],0.3636022159436662
Chapter II Neoplasms,Melanoma in situ,RGCC,Regulator of cell cycle RGCC,19635,77,1.16 [0.87-1.54],0.3128959192731126
Chapter II Neoplasms,Melanoma in situ,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,19287,76,0.87 [0.59-1.27],0.4675102593570399
Chapter II Neoplasms,Melanoma in situ,RGMA,Repulsive guidance molecule A,22788,90,0.94 [0.51-1.74],0.8490342207010173
Chapter II Neoplasms,Melanoma in situ,RGMB,RGM domain family member B,22788,90,0.96 [0.46-2.00],0.91390047315302
Chapter II Neoplasms,Melanoma in situ,RGS10,Regulator of G-protein signaling 10,19635,77,1.18 [0.84-1.67],0.342619114439337
Chapter II Neoplasms,Melanoma in situ,RGS8,Regulator of G-protein signaling 8,22161,88,1.26 [1.01-1.57],0.0381232362436972
Chapter II Neoplasms,Melanoma in situ,RHOC,Rho-related GTP-binding protein RhoC,22284,89,1.05 [0.89-1.24],0.5640696996881536
Chapter II Neoplasms,Melanoma in situ,RICTOR,Rapamycin-insensitive companion of mTOR,19117,75,1.03 [0.67-1.60],0.888646527265782
Chapter II Neoplasms,Melanoma in situ,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,19255,75,0.97 [0.62-1.54],0.9102844956123494
Chapter II Neoplasms,Melanoma in situ,RILP,Rab-interacting lysosomal protein,22717,90,0.91 [0.67-1.23],0.5295349141455019
Chapter II Neoplasms,Melanoma in situ,RILPL2,RILP-like protein 2,19665,77,1.17 [0.93-1.48],0.1673289381122706
Chapter II Neoplasms,Melanoma in situ,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,19066,75,0.69 [0.45-1.06],0.0910287499204679
Chapter II Neoplasms,Melanoma in situ,RLN1,Prorelaxin H1,19635,77,1.03 [0.76-1.41],0.8381459427544898
Chapter II Neoplasms,Melanoma in situ,RLN2,Prorelaxin H2,19219,75,1.07 [0.89-1.30],0.4710168804790582
Chapter II Neoplasms,Melanoma in situ,RNASE1,Ribonuclease pancreatic,19669,77,1.72 [0.86-3.46],0.1262780681398688
Chapter II Neoplasms,Melanoma in situ,RNASE10,Inactive ribonuclease-like protein 10,19167,75,1.15 [0.75-1.77],0.5247178220564774
Chapter II Neoplasms,Melanoma in situ,RNASE3,Eosinophil cationic protein,22487,89,1.08 [0.92-1.26],0.3530574779600864
Chapter II Neoplasms,Melanoma in situ,RNASE4,Ribonuclease 4,19001,74,0.97 [0.42-2.21],0.9354897304061462
Chapter II Neoplasms,Melanoma in situ,RNASE6,Ribonuclease K6,19514,77,0.81 [0.37-1.78],0.602535970004858
Chapter II Neoplasms,Melanoma in situ,RNASEH2A,Ribonuclease H2 subunit A,19635,77,1.12 [0.75-1.67],0.5901936418121267
Chapter II Neoplasms,Melanoma in situ,RNASET2,Ribonuclease T2,22758,88,0.82 [0.39-1.70],0.5866333270805787
Chapter II Neoplasms,Melanoma in situ,RNF149,E3 ubiquitin-protein ligase RNF149,19167,75,1.14 [0.55-2.35],0.7202147210561048
Chapter II Neoplasms,Melanoma in situ,RNF168,E3 ubiquitin-protein ligase RNF168,19117,75,1.04 [0.61-1.75],0.8928915698637658
Chapter II Neoplasms,Melanoma in situ,RNF31,E3 ubiquitin-protein ligase RNF31,19117,75,1.33 [0.83-2.12],0.2373261013005507
Chapter II Neoplasms,Melanoma in situ,RNF4,E3 ubiquitin-protein ligase RNF4,19287,76,1.05 [0.77-1.44],0.7537934833353186
Chapter II Neoplasms,Melanoma in situ,RNF41,E3 ubiquitin-protein ligase NRDP1,22078,88,0.99 [0.75-1.32],0.9653953621989536
Chapter II Neoplasms,Melanoma in situ,RNF43,E3 ubiquitin-protein ligase RNF43,19287,76,0.94 [0.62-1.41],0.7598561729677361
Chapter II Neoplasms,Melanoma in situ,RNF5,E3 ubiquitin-protein ligase RNF5,19167,75,1.21 [0.88-1.65],0.2434591922667013
Chapter II Neoplasms,Melanoma in situ,ROBO1,Roundabout homolog 1,22625,90,0.86 [0.39-1.90],0.7089538928173778
Chapter II Neoplasms,Melanoma in situ,ROBO2,Roundabout homolog 2,22788,90,0.83 [0.37-1.86],0.6479039629682277
Chapter II Neoplasms,Melanoma in situ,ROBO4,Roundabout homolog 4,19167,75,1.03 [0.29-3.64],0.9654307163085128
Chapter II Neoplasms,Melanoma in situ,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,22589,89,1.11 [0.61-2.03],0.7283161079502964
Chapter II Neoplasms,Melanoma in situ,RP2,Protein XRP2,22484,88,0.94 [0.59-1.49],0.7942451024916087
Chapter II Neoplasms,Melanoma in situ,RPA2,Replication protein A 32 kDa subunit,19117,75,0.79 [0.37-1.69],0.5407128214587998
Chapter II Neoplasms,Melanoma in situ,RPE,Ribulose-phosphate 3-epimerase,19287,76,1.09 [0.81-1.46],0.5675590890898554
Chapter II Neoplasms,Melanoma in situ,RPGR,X-linked retinitis pigmentosa GTPase regulator,19119,72,1.10 [0.66-1.84],0.7126163704293029
Chapter II Neoplasms,Melanoma in situ,RPL14,60S ribosomal protein L14,19167,75,0.94 [0.54-1.65],0.8314091178390607
Chapter II Neoplasms,Melanoma in situ,RPS10,40S ribosomal protein S10,19066,75,0.66 [0.35-1.25],0.2037173008947546
Chapter II Neoplasms,Melanoma in situ,RRAS,Ras-related protein R-Ras,19119,72,1.08 [0.91-1.28],0.3845155248230054
Chapter II Neoplasms,Melanoma in situ,RRM2,Ribonucleoside-diphosphate reductase subunit M2,22078,88,0.74 [0.48-1.16],0.195912441572688
Chapter II Neoplasms,Melanoma in situ,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,22078,88,1.02 [0.77-1.35],0.8984140592561765
Chapter II Neoplasms,Melanoma in situ,RRP15,RRP15-like protein,19060,77,1.10 [0.87-1.38],0.4289742908971252
Chapter II Neoplasms,Melanoma in situ,RSPO1,R-spondin-1,22440,89,0.88 [0.51-1.54],0.657715206874446
Chapter II Neoplasms,Melanoma in situ,RSPO3,R-spondin-3,22789,90,0.95 [0.48-1.87],0.886563812651848
Chapter II Neoplasms,Melanoma in situ,RTBDN,Retbindin,22484,88,1.22 [0.63-2.37],0.5600218554756176
Chapter II Neoplasms,Melanoma in situ,RTKN2,Rhotekin-2,19066,75,0.77 [0.47-1.29],0.3269855644111691
Chapter II Neoplasms,Melanoma in situ,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",19635,77,1.11 [0.87-1.41],0.390305754145866
Chapter II Neoplasms,Melanoma in situ,RTN4R,Reticulon-4 receptor,22789,90,1.01 [0.59-1.74],0.9599617728978044
Chapter II Neoplasms,Melanoma in situ,RUVBL1,RuvB-like 1,22078,88,0.97 [0.81-1.16],0.7353437720081941
Chapter II Neoplasms,Melanoma in situ,RWDD1,RWD domain-containing protein 1,22788,90,1.08 [0.81-1.45],0.5830289378493341
Chapter II Neoplasms,Melanoma in situ,RYR1,Ryanodine receptor 1,19066,75,0.76 [0.36-1.58],0.4573465098116497
Chapter II Neoplasms,Melanoma in situ,S100A11,Protein S100-A11,22409,89,1.02 [0.69-1.51],0.9105172484481088
Chapter II Neoplasms,Melanoma in situ,S100A12,Protein S100-A12,22282,87,1.13 [0.89-1.44],0.3154840848420573
Chapter II Neoplasms,Melanoma in situ,S100A13,Protein S100-A13,19117,75,0.81 [0.42-1.57],0.5296959534444269
Chapter II Neoplasms,Melanoma in situ,S100A14,Protein S100-A14,19635,77,1.15 [0.78-1.70],0.4725182885419613
Chapter II Neoplasms,Melanoma in situ,S100A16,Protein S100-A16,21999,90,1.20 [0.91-1.58],0.1862866888465472
Chapter II Neoplasms,Melanoma in situ,S100A3,Protein S100-A3,19560,77,1.26 [0.89-1.77],0.1920479772267048
Chapter II Neoplasms,Melanoma in situ,S100A4,Protein S100-A4,22658,90,0.92 [0.67-1.27],0.6059741326941006
Chapter II Neoplasms,Melanoma in situ,S100G,Protein S100-G,19635,77,1.10 [0.68-1.78],0.690899746507109
Chapter II Neoplasms,Melanoma in situ,S100P,Protein S100-P,22187,88,1.18 [0.87-1.62],0.2889202625416015
Chapter II Neoplasms,Melanoma in situ,SAA4,Serum amyloid A-4 protein,19694,77,0.50 [0.13-1.91],0.3124875560127148
Chapter II Neoplasms,Melanoma in situ,SAFB2,Scaffold attachment factor B2,19635,77,0.87 [0.40-1.93],0.7396246451384738
Chapter II Neoplasms,Melanoma in situ,SAG,S-arrestin,19060,77,0.90 [0.58-1.39],0.6269974679124886
Chapter II Neoplasms,Melanoma in situ,SAMD9L,Sterile alpha motif domain-containing protein 9-like,22550,90,1.07 [0.83-1.38],0.5872458483805684
Chapter II Neoplasms,Melanoma in situ,SAP18,Histone deacetylase complex subunit SAP18,19287,76,0.82 [0.58-1.16],0.2615974200410195
Chapter II Neoplasms,Melanoma in situ,SARG,Specifically androgen-regulated gene protein,19590,77,1.17 [0.95-1.43],0.1331728323037986
Chapter II Neoplasms,Melanoma in situ,SART1,U4/U6.U5 tri-snRNP-associated protein 1,19066,75,0.94 [0.50-1.76],0.8449732313175706
Chapter II Neoplasms,Melanoma in situ,SAT1,Diamine acetyltransferase 1,19066,75,0.90 [0.56-1.43],0.648262994131682
Chapter II Neoplasms,Melanoma in situ,SAT2,Thialysine N-epsilon-acetyltransferase,19287,76,1.22 [0.93-1.59],0.1443262633860902
Chapter II Neoplasms,Melanoma in situ,SATB1,DNA-binding protein SATB1,19635,77,0.84 [0.39-1.82],0.6614230987312895
Chapter II Neoplasms,Melanoma in situ,SBSN,Suprabasin,19623,77,0.60 [0.31-1.16],0.1305419555780173
Chapter II Neoplasms,Melanoma in situ,SCAMP3,Secretory carrier-associated membrane protein 3,22484,88,1.05 [0.84-1.31],0.6502839872998363
Chapter II Neoplasms,Melanoma in situ,SCARA5,Scavenger receptor class A member 5,22788,90,0.52 [0.27-0.99],0.0474138120861768
Chapter II Neoplasms,Melanoma in situ,SCARB1,Scavenger receptor class B member 1,22029,90,1.09 [0.81-1.46],0.5713646004005379
Chapter II Neoplasms,Melanoma in situ,SCARB2,Lysosome membrane protein 2,22018,89,1.24 [0.66-2.34],0.500410215238983
Chapter II Neoplasms,Melanoma in situ,SCARF1,Scavenger receptor class F member 1,22859,89,1.03 [0.66-1.60],0.9061720960256356
Chapter II Neoplasms,Melanoma in situ,SCARF2,Scavenger receptor class F member 2,22788,90,0.83 [0.44-1.59],0.580904781369898
Chapter II Neoplasms,Melanoma in situ,SCG2,Secretogranin-2,22676,90,0.84 [0.46-1.52],0.5559939199610502
Chapter II Neoplasms,Melanoma in situ,SCG3,Secretogranin-3,22625,90,0.85 [0.49-1.49],0.5731840026734424
Chapter II Neoplasms,Melanoma in situ,SCGB1A1,Uteroglobin,22619,90,0.92 [0.66-1.29],0.6319058734985756
Chapter II Neoplasms,Melanoma in situ,SCGB2A2,Mammaglobin-A,19066,75,0.92 [0.44-1.91],0.820515233483129
Chapter II Neoplasms,Melanoma in situ,SCGB3A1,Secretoglobin family 3A member 1,19255,75,2.21 [0.91-5.35],0.0780043263074437
Chapter II Neoplasms,Melanoma in situ,SCGB3A2,Secretoglobin family 3A member 2,22653,90,0.93 [0.73-1.17],0.5132250056788282
Chapter II Neoplasms,Melanoma in situ,SCGN,Secretagogin,22161,88,0.81 [0.52-1.26],0.3427043855727703
Chapter II Neoplasms,Melanoma in situ,SCIN,Adseverin,19060,77,0.98 [0.72-1.33],0.8885837024417345
Chapter II Neoplasms,Melanoma in situ,SCLY,Selenocysteine lyase,22717,90,1.09 [0.74-1.61],0.6666006366355247
Chapter II Neoplasms,Melanoma in situ,SCN2A,Sodium channel protein type 2 subunit alpha,19060,77,0.77 [0.46-1.32],0.3451273119822784
Chapter II Neoplasms,Melanoma in situ,SCN2B,Sodium channel subunit beta-2,19119,72,1.05 [0.49-2.26],0.8987840975187705
Chapter II Neoplasms,Melanoma in situ,SCN3A,Sodium channel protein type 3 subunit alpha,19119,72,1.32 [0.82-2.11],0.2516360575895519
Chapter II Neoplasms,Melanoma in situ,SCN3B,Sodium channel subunit beta-3,19060,77,1.14 [0.75-1.72],0.536826829965398
Chapter II Neoplasms,Melanoma in situ,SCN4B,Sodium channel subunit beta-4,19167,75,1.04 [0.61-1.78],0.8760711449473048
Chapter II Neoplasms,Melanoma in situ,SCP2,Non-specific lipid-transfer protein,22078,88,0.86 [0.65-1.14],0.2940598354127017
Chapter II Neoplasms,Melanoma in situ,SCPEP1,Retinoid-inducible serine carboxypeptidase,19092,75,1.18 [0.75-1.84],0.4724991227505608
Chapter II Neoplasms,Melanoma in situ,SCRG1,Scrapie-responsive protein 1,19665,77,1.35 [0.61-2.99],0.4525922194070501
Chapter II Neoplasms,Melanoma in situ,SCRIB,Protein scribble homolog,19167,75,1.07 [0.86-1.33],0.5563489935968755
Chapter II Neoplasms,Melanoma in situ,SCRN1,Secernin-1,22550,90,1.27 [0.93-1.72],0.1311768577771268
Chapter II Neoplasms,Melanoma in situ,SCT,Secretin,19119,72,1.22 [0.76-1.96],0.4028280459018634
Chapter II Neoplasms,Melanoma in situ,SDC1,Syndecan-1,22589,89,1.22 [0.76-1.96],0.4128128228813595
Chapter II Neoplasms,Melanoma in situ,SDC4,Syndecan-4,22589,89,0.71 [0.47-1.07],0.1038495544926073
Chapter II Neoplasms,Melanoma in situ,SDCCAG8,Serologically defined colon cancer antigen 8,19560,77,1.12 [0.93-1.36],0.2371986150299853
Chapter II Neoplasms,Melanoma in situ,SDHB,Succinate dehydrogenase,19566,77,0.89 [0.64-1.24],0.4972754103678427
Chapter II Neoplasms,Melanoma in situ,SDK2,Protein sidekick-2,19255,75,1.04 [0.58-1.86],0.9002512760179521
Chapter II Neoplasms,Melanoma in situ,SEC31A,Protein transport protein Sec31A,19167,75,1.18 [0.87-1.58],0.2879179525924348
Chapter II Neoplasms,Melanoma in situ,SEL1L,Protein sel-1 homolog 1,19167,75,1.44 [0.89-2.34],0.1354645372268243
Chapter II Neoplasms,Melanoma in situ,SELE,E-selectin,22859,89,1.37 [0.93-2.01],0.1085747948505689
Chapter II Neoplasms,Melanoma in situ,SELENOP,Selenoprotein P,19694,77,0.72 [0.27-1.94],0.5152539496336274
Chapter II Neoplasms,Melanoma in situ,SELL,L-selectin,19694,77,0.99 [0.38-2.58],0.977179987998959
Chapter II Neoplasms,Melanoma in situ,SELP,P-selectin,22650,89,1.12 [0.81-1.55],0.481508651317675
Chapter II Neoplasms,Melanoma in situ,SELPLG,P-selectin glycoprotein ligand 1,22550,90,0.92 [0.45-1.89],0.820403361786146
Chapter II Neoplasms,Melanoma in situ,SEMA3F,Semaphorin-3F,22589,89,2.08 [1.02-4.26],0.0440383917526309
Chapter II Neoplasms,Melanoma in situ,SEMA3G,Semaphorin-3G,19255,75,1.27 [0.77-2.09],0.3480061222158235
Chapter II Neoplasms,Melanoma in situ,SEMA4C,Semaphorin-4C,22484,88,0.93 [0.46-1.88],0.8341400958765031
Chapter II Neoplasms,Melanoma in situ,SEMA4D,Semaphorin-4D,22788,90,1.24 [0.66-2.32],0.4997598127288799
Chapter II Neoplasms,Melanoma in situ,SEMA6C,Semaphorin-6C,19117,75,0.74 [0.30-1.83],0.5165742318588469
Chapter II Neoplasms,Melanoma in situ,SEMA7A,Semaphorin-7A,22791,89,0.93 [0.45-1.92],0.8413004121709268
Chapter II Neoplasms,Melanoma in situ,SEPTIN3,Neuronal-specific septin-3,19635,77,0.73 [0.53-1.01],0.0566520453312305
Chapter II Neoplasms,Melanoma in situ,SEPTIN7,Septin-7,19287,76,1.01 [0.66-1.52],0.9775483218417236
Chapter II Neoplasms,Melanoma in situ,SEPTIN8,Septin-8,19585,77,0.67 [0.32-1.40],0.2884696646756032
Chapter II Neoplasms,Melanoma in situ,SEPTIN9,Septin-9,22484,88,0.91 [0.46-1.79],0.7806124318117664
Chapter II Neoplasms,Melanoma in situ,SERPINA1,Alpha-1-antitrypsin,19307,77,1.43 [0.09-22.95],0.8019556951065248
Chapter II Neoplasms,Melanoma in situ,SERPINA11,Serpin A11,22859,89,1.08 [0.67-1.72],0.7595317744059553
Chapter II Neoplasms,Melanoma in situ,SERPINA12,Serpin A12,21944,85,1.00 [0.83-1.21],0.9661321054327552
Chapter II Neoplasms,Melanoma in situ,SERPINA3,Alpha-1-antichymotrypsin,19614,77,1.23 [0.29-5.27],0.7819032178099229
Chapter II Neoplasms,Melanoma in situ,SERPINA4,Kallistatin,19318,76,0.76 [0.30-1.90],0.5500411263404714
Chapter II Neoplasms,Melanoma in situ,SERPINA5,Plasma serine protease inhibitor,19390,77,0.42 [0.19-0.91],0.0284165299589372
Chapter II Neoplasms,Melanoma in situ,SERPINA6,Corticosteroid-binding globulin,19694,77,1.11 [0.31-4.01],0.8777846253205598
Chapter II Neoplasms,Melanoma in situ,SERPINA7,Thyroxine-binding globulin,19694,77,1.27 [0.39-4.08],0.689201579954302
Chapter II Neoplasms,Melanoma in situ,SERPINA9,Serpin A9,22353,88,0.86 [0.65-1.13],0.2879989537988855
Chapter II Neoplasms,Melanoma in situ,SERPINB1,Leukocyte elastase inhibitor,22525,89,1.07 [0.87-1.31],0.5076674993162666
Chapter II Neoplasms,Melanoma in situ,SERPINB5,Serpin B5,22187,88,0.85 [0.59-1.23],0.401461559962771
Chapter II Neoplasms,Melanoma in situ,SERPINB6,Serpin B6,22717,89,1.11 [0.81-1.52],0.4981588086206705
Chapter II Neoplasms,Melanoma in situ,SERPINB8,Serpin B8,22837,90,1.12 [0.84-1.49],0.4546493670150294
Chapter II Neoplasms,Melanoma in situ,SERPINB9,Serpin B9,22440,89,1.03 [0.59-1.78],0.9223870628920744
Chapter II Neoplasms,Melanoma in situ,SERPINC1,Antithrombin-III,19650,77,1.18 [0.27-5.20],0.8274633447876774
Chapter II Neoplasms,Melanoma in situ,SERPIND1,Heparin cofactor 2,19650,77,0.81 [0.36-1.83],0.6146033792479609
Chapter II Neoplasms,Melanoma in situ,SERPINE1,Plasminogen activator inhibitor 1,22859,89,0.93 [0.71-1.22],0.5866790981906476
Chapter II Neoplasms,Melanoma in situ,SERPINE2,Glia-derived nexin,19665,77,0.99 [0.70-1.38],0.9332502713982704
Chapter II Neoplasms,Melanoma in situ,SERPINF1,Pigment epithelium-derived factor,19392,77,0.71 [0.30-1.67],0.4318069252198986
Chapter II Neoplasms,Melanoma in situ,SERPINF2,Alpha-2-antiplasmin,19316,77,1.64 [0.33-8.13],0.5439425801855775
Chapter II Neoplasms,Melanoma in situ,SERPING1,Plasma protease C1 inhibitor,19650,77,0.61 [0.19-1.98],0.4086197946807937
Chapter II Neoplasms,Melanoma in situ,SERPINH1,Serpin H1,19287,76,1.05 [0.89-1.25],0.5518888621566509
Chapter II Neoplasms,Melanoma in situ,SERPINI1,Neuroserpin,19212,75,0.86 [0.42-1.78],0.687023513213479
Chapter II Neoplasms,Melanoma in situ,SERPINI2,Serpin I2,19566,77,1.19 [0.81-1.73],0.3792853642143168
Chapter II Neoplasms,Melanoma in situ,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,22029,90,1.03 [0.77-1.37],0.8598816526609785
Chapter II Neoplasms,Melanoma in situ,SETMAR,Histone-lysine N-methyltransferase SETMAR,22378,88,1.22 [0.65-2.30],0.5272254120020281
Chapter II Neoplasms,Melanoma in situ,SEZ6,Seizure protein 6 homolog,19119,72,0.95 [0.44-2.02],0.8838327408218905
Chapter II Neoplasms,Melanoma in situ,SEZ6L,Seizure 6-like protein,22658,90,0.62 [0.31-1.25],0.179825867607312
Chapter II Neoplasms,Melanoma in situ,SEZ6L2,Seizure 6-like protein 2,22484,88,1.15 [0.51-2.57],0.7386042886704138
Chapter II Neoplasms,Melanoma in situ,SF3B4,Splicing factor 3B subunit 4,22484,88,1.04 [0.81-1.33],0.7815128160397886
Chapter II Neoplasms,Melanoma in situ,SFRP1,Secreted frizzled-related protein 1,22374,87,1.54 [1.04-2.29],0.0329751110043012
Chapter II Neoplasms,Melanoma in situ,SFRP4,Secreted frizzled-related protein 4,19255,75,1.11 [0.64-1.92],0.7103603609043314
Chapter II Neoplasms,Melanoma in situ,SFTPA1,Pulmonary surfactant-associated protein A1,22078,88,0.98 [0.70-1.37],0.8979422704463222
Chapter II Neoplasms,Melanoma in situ,SFTPA2,Pulmonary surfactant-associated protein A2,22078,88,0.97 [0.66-1.43],0.8925468831965002
Chapter II Neoplasms,Melanoma in situ,SFTPD,Pulmonary surfactant-associated protein D,22589,89,1.01 [0.76-1.35],0.9317856118115706
Chapter II Neoplasms,Melanoma in situ,SGSH,N-sulphoglucosamine sulphohydrolase,19314,77,0.72 [0.47-1.09],0.1219445968075406
Chapter II Neoplasms,Melanoma in situ,SH2B3,SH2B adapter protein 3,22078,88,1.08 [0.89-1.31],0.4371879207800705
Chapter II Neoplasms,Melanoma in situ,SH2D1A,SH2 domain-containing protein 1A,22550,90,1.03 [0.74-1.42],0.8687690852143555
Chapter II Neoplasms,Melanoma in situ,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,19060,77,0.72 [0.46-1.14],0.1671820361802117
Chapter II Neoplasms,Melanoma in situ,SH3BP1,SH3 domain-binding protein 1,19566,77,1.17 [0.79-1.74],0.4350614437678158
Chapter II Neoplasms,Melanoma in situ,SH3GL3,Endophilin-A3,19182,76,1.26 [0.98-1.62],0.0713032723931298
Chapter II Neoplasms,Melanoma in situ,SH3GLB2,Endophilin-B2,19626,77,0.80 [0.58-1.11],0.1798861779017455
Chapter II Neoplasms,Melanoma in situ,SHBG,Sex hormone-binding globulin,19669,77,1.02 [0.67-1.54],0.9320412759090986
Chapter II Neoplasms,Melanoma in situ,SHC1,SHC-transforming protein 1,18973,75,0.87 [0.71-1.07],0.1995809717659006
Chapter II Neoplasms,Melanoma in situ,SHD,SH2 domain-containing adapter protein D,19027,75,0.78 [0.55-1.09],0.143478702923462
Chapter II Neoplasms,Melanoma in situ,SHH,Sonic hedgehog protein,19117,75,0.78 [0.45-1.36],0.3824154951645915
Chapter II Neoplasms,Melanoma in situ,SHISA5,Protein shisa-5,19661,77,1.12 [0.48-2.62],0.7972419105206368
Chapter II Neoplasms,Melanoma in situ,SHMT1,"Serine hydroxymethyltransferase, cytosolic",22653,90,1.02 [0.82-1.26],0.8583825761263186
Chapter II Neoplasms,Melanoma in situ,SHPK,Sedoheptulokinase,19287,76,1.24 [0.78-1.96],0.3593231937327685
Chapter II Neoplasms,Melanoma in situ,SIAE,Sialate O-acetylesterase,22622,90,1.10 [0.74-1.64],0.626942559242464
Chapter II Neoplasms,Melanoma in situ,SIGLEC1,Sialoadhesin,22692,90,0.72 [0.48-1.09],0.1160816460381898
Chapter II Neoplasms,Melanoma in situ,SIGLEC10,Sialic acid-binding Ig-like lectin 10,22550,90,1.34 [0.76-2.39],0.3122160526070398
Chapter II Neoplasms,Melanoma in situ,SIGLEC15,Sialic acid-binding Ig-like lectin 15,22029,90,0.86 [0.65-1.13],0.2810985781572697
Chapter II Neoplasms,Melanoma in situ,SIGLEC5,Sialic acid-binding Ig-like lectin 5,22597,90,0.94 [0.81-1.09],0.4159328006227574
Chapter II Neoplasms,Melanoma in situ,SIGLEC6,Sialic acid-binding Ig-like lectin 6,22789,90,0.90 [0.51-1.58],0.7043645096119646
Chapter II Neoplasms,Melanoma in situ,SIGLEC7,Sialic acid-binding Ig-like lectin 7,22589,89,1.36 [0.69-2.68],0.3751428028675767
Chapter II Neoplasms,Melanoma in situ,SIGLEC8,Sialic acid-binding Ig-like lectin 8,19167,75,1.19 [0.72-1.96],0.499864505064756
Chapter II Neoplasms,Melanoma in situ,SIGLEC9,Sialic acid-binding Ig-like lectin 9,22756,90,1.09 [0.57-2.09],0.7933963857776876
Chapter II Neoplasms,Melanoma in situ,SIL1,Nucleotide exchange factor SIL1,19167,75,0.55 [0.21-1.43],0.2185574554715283
Chapter II Neoplasms,Melanoma in situ,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,22640,88,0.88 [0.64-1.21],0.4275728680881311
Chapter II Neoplasms,Melanoma in situ,SIRPB1,Signal-regulatory protein beta-1,22549,89,0.89 [0.59-1.36],0.6015527931639073
Chapter II Neoplasms,Melanoma in situ,SIRT1,NAD-dependent protein deacetylase sirtuin-1,19117,75,1.05 [0.83-1.33],0.6887816255001362
Chapter II Neoplasms,Melanoma in situ,SIRT2,NAD-dependent protein deacetylase sirtuin-2,22484,88,1.05 [0.85-1.30],0.6464286777015993
Chapter II Neoplasms,Melanoma in situ,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",22029,90,1.29 [0.99-1.68],0.057165565179733
Chapter II Neoplasms,Melanoma in situ,SIT1,Signaling threshold-regulating transmembrane adapter 1,22161,88,1.06 [0.76-1.49],0.7224420694016832
Chapter II Neoplasms,Melanoma in situ,SKAP1,Src kinase-associated phosphoprotein 1,22392,89,1.12 [0.88-1.43],0.3672062435901412
Chapter II Neoplasms,Melanoma in situ,SKAP2,Src kinase-associated phosphoprotein 2,22692,90,1.08 [0.90-1.29],0.421185726744899
Chapter II Neoplasms,Melanoma in situ,SKIV2L,Helicase SKI2W,19066,75,0.65 [0.34-1.24],0.1913543897831076
Chapter II Neoplasms,Melanoma in situ,SLA2,Src-like-adapter 2,19635,77,1.10 [0.89-1.36],0.3841908542891571
Chapter II Neoplasms,Melanoma in situ,SLAMF1,Signaling lymphocytic activation molecule,22161,88,1.05 [0.76-1.46],0.7694940055139683
Chapter II Neoplasms,Melanoma in situ,SLAMF6,SLAM family member 6,22078,88,0.82 [0.49-1.38],0.4578195846340388
Chapter II Neoplasms,Melanoma in situ,SLAMF7,SLAM family member 7,22550,90,0.94 [0.68-1.30],0.7058326046811387
Chapter II Neoplasms,Melanoma in situ,SLAMF8,SLAM family member 8,22078,88,1.28 [0.90-1.84],0.1747280704889267
Chapter II Neoplasms,Melanoma in situ,SLC12A2,Solute carrier family 12 member 2,19066,75,0.52 [0.21-1.29],0.1566999104848054
Chapter II Neoplasms,Melanoma in situ,SLC13A1,Solute carrier family 13 member 1,19560,77,0.93 [0.63-1.38],0.7251487115593912
Chapter II Neoplasms,Melanoma in situ,SLC16A1,Monocarboxylate transporter 1,22029,90,0.83 [0.58-1.18],0.2987343056907205
Chapter II Neoplasms,Melanoma in situ,SLC1A4,Neutral amino acid transporter A,19119,72,0.74 [0.44-1.24],0.2509543718650447
Chapter II Neoplasms,Melanoma in situ,SLC27A4,Long-chain fatty acid transport protein 4,22029,90,1.05 [0.79-1.40],0.7261018528113108
Chapter II Neoplasms,Melanoma in situ,SLC28A1,Sodium/nucleoside cotransporter 1,18973,75,0.76 [0.49-1.18],0.2239437272124481
Chapter II Neoplasms,Melanoma in situ,SLC34A3,Sodium-dependent phosphate transport protein 2C,18973,75,1.35 [0.98-1.86],0.0653455166031255
Chapter II Neoplasms,Melanoma in situ,SLC39A14,Zinc transporter ZIP14,22029,90,0.64 [0.35-1.17],0.1446341658034548
Chapter II Neoplasms,Melanoma in situ,SLC39A5,Zinc transporter ZIP5,22550,90,0.87 [0.61-1.26],0.4699036954197724
Chapter II Neoplasms,Melanoma in situ,SLC44A4,Choline transporter-like protein 4,19119,72,0.80 [0.54-1.19],0.2796661312206693
Chapter II Neoplasms,Melanoma in situ,SLC4A1,Band 3 anion transport protein,19661,77,0.92 [0.57-1.47],0.7254428001346394
Chapter II Neoplasms,Melanoma in situ,SLC51B,Organic solute transporter subunit beta,19066,75,1.18 [0.91-1.51],0.2073861809609805
Chapter II Neoplasms,Melanoma in situ,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,19255,75,1.24 [0.95-1.61],0.1127265257483234
Chapter II Neoplasms,Melanoma in situ,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,19566,77,0.60 [0.33-1.09],0.09294587924085
Chapter II Neoplasms,Melanoma in situ,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",18973,75,1.07 [0.74-1.54],0.7372114462628707
Chapter II Neoplasms,Melanoma in situ,SLIT2,Slit homolog 2 protein,22029,90,1.01 [0.70-1.46],0.9487643501215384
Chapter II Neoplasms,Melanoma in situ,SLITRK1,SLIT and NTRK-like protein 1,19117,75,1.71 [0.86-3.39],0.1287628410526818
Chapter II Neoplasms,Melanoma in situ,SLITRK2,SLIT and NTRK-like protein 2,22789,90,1.01 [0.61-1.65],0.9795586855197208
Chapter II Neoplasms,Melanoma in situ,SLITRK6,SLIT and NTRK-like protein 6,22187,88,0.86 [0.49-1.51],0.6051380206342611
Chapter II Neoplasms,Melanoma in situ,SLK,STE20-like serine/threonine-protein kinase,19287,76,0.95 [0.71-1.27],0.7052494099922272
Chapter II Neoplasms,Melanoma in situ,SLMAP,Sarcolemmal membrane-associated protein,19566,77,1.14 [0.88-1.48],0.3133625812731337
Chapter II Neoplasms,Melanoma in situ,SLURP1,Secreted Ly-6/uPAR-related protein 1,19508,77,0.71 [0.37-1.38],0.3106568534659795
Chapter II Neoplasms,Melanoma in situ,SMAD1,Mothers against decapentaplegic homolog 1,22078,88,1.07 [0.84-1.35],0.5926344989034795
Chapter II Neoplasms,Melanoma in situ,SMAD2,Mothers against decapentaplegic homolog 2,19560,77,1.15 [0.84-1.56],0.3850308728261263
Chapter II Neoplasms,Melanoma in situ,SMAD3,Mothers against decapentaplegic homolog 3,19560,77,1.32 [0.87-1.99],0.1890225142562302
Chapter II Neoplasms,Melanoma in situ,SMAD5,Mothers against decapentaplegic homolog 5,22484,88,1.83 [0.70-4.74],0.2147783868215874
Chapter II Neoplasms,Melanoma in situ,SMARCA2,Probable global transcription activator SNF2L2,22029,90,0.92 [0.70-1.21],0.5537937525526647
Chapter II Neoplasms,Melanoma in situ,SMC3,Structural maintenance of chromosomes protein 3,18973,75,0.80 [0.50-1.26],0.3266153128852811
Chapter II Neoplasms,Melanoma in situ,SMNDC1,Survival of motor neuron-related-splicing factor 30,19566,77,1.08 [0.78-1.50],0.6330607737987075
Chapter II Neoplasms,Melanoma in situ,SMOC1,SPARC-related modular calcium-binding protein 1,22789,90,0.87 [0.49-1.53],0.6222448398758316
Chapter II Neoplasms,Melanoma in situ,SMOC2,SPARC-related modular calcium-binding protein 2,22692,90,0.99 [0.60-1.65],0.978377641475678
Chapter II Neoplasms,Melanoma in situ,SMPD1,Sphingomyelin phosphodiesterase,22675,90,0.92 [0.61-1.37],0.6755538529858092
Chapter II Neoplasms,Melanoma in situ,SMPD3,Sphingomyelin phosphodiesterase 3,19117,75,1.08 [0.77-1.52],0.6636242730967548
Chapter II Neoplasms,Melanoma in situ,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,22658,89,0.89 [0.67-1.18],0.4175464422538768
Chapter II Neoplasms,Melanoma in situ,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,19560,77,1.04 [0.80-1.35],0.7543740416036137
Chapter II Neoplasms,Melanoma in situ,SMS,Spermine synthase,19060,77,1.09 [0.79-1.50],0.5891185803094807
Chapter II Neoplasms,Melanoma in situ,SMTN,Smoothelin,19594,77,1.19 [0.96-1.48],0.1057803375420307
Chapter II Neoplasms,Melanoma in situ,SNAP23,Synaptosomal-associated protein 23,22589,89,1.10 [0.88-1.36],0.4171691863935702
Chapter II Neoplasms,Melanoma in situ,SNAP25,Synaptosomal-associated protein 25,19060,77,1.37 [0.86-2.16],0.1822622006735688
Chapter II Neoplasms,Melanoma in situ,SNAP29,Synaptosomal-associated protein 29,22658,90,1.06 [0.86-1.30],0.5779818920678971
Chapter II Neoplasms,Melanoma in situ,SNAPIN,SNARE-associated protein Snapin,19635,77,1.19 [0.82-1.73],0.3548251702381976
Chapter II Neoplasms,Melanoma in situ,SNCA,Alpha-synuclein,19255,75,1.04 [0.85-1.26],0.7305737861950392
Chapter II Neoplasms,Melanoma in situ,SNCG,Gamma-synuclein,22440,89,1.07 [0.81-1.42],0.6375645569619532
Chapter II Neoplasms,Melanoma in situ,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",19167,75,0.58 [0.28-1.20],0.1407342584331253
Chapter II Neoplasms,Melanoma in situ,SNRPB2,U2 small nuclear ribonucleoprotein B'',19626,77,1.20 [0.83-1.73],0.3352371401646564
Chapter II Neoplasms,Melanoma in situ,SNU13,NHP2-like protein 1,19066,75,0.63 [0.39-1.02],0.0620591060951762
Chapter II Neoplasms,Melanoma in situ,SNX15,Sorting nexin-15,19255,75,1.06 [0.70-1.58],0.7937677022307608
Chapter II Neoplasms,Melanoma in situ,SNX18,Sorting nexin-18,19566,77,0.91 [0.54-1.53],0.7234668473251942
Chapter II Neoplasms,Melanoma in situ,SNX2,Sorting nexin-2,19560,77,1.02 [0.78-1.34],0.8611795711671411
Chapter II Neoplasms,Melanoma in situ,SNX5,Sorting nexin-5,19167,75,1.09 [0.53-2.26],0.817122162280847
Chapter II Neoplasms,Melanoma in situ,SNX9,Sorting nexin-9,22589,89,1.07 [0.82-1.41],0.6125212027611443
Chapter II Neoplasms,Melanoma in situ,SOD1,Superoxide dismutase [Cu-Zn],22106,86,1.05 [0.71-1.54],0.8177040943500649
Chapter II Neoplasms,Melanoma in situ,SOD2,"Superoxide dismutase [Mn], mitochondrial",22597,90,1.00 [0.61-1.66],0.9867191659419842
Chapter II Neoplasms,Melanoma in situ,SOD3,Extracellular superoxide dismutase,19669,77,0.78 [0.48-1.26],0.3093914500791614
Chapter II Neoplasms,Melanoma in situ,SORBS1,Sorbin and SH3 domain-containing protein 1,19635,77,1.24 [0.80-1.92],0.3445049111822421
Chapter II Neoplasms,Melanoma in situ,SORCS2,VPS10 domain-containing receptor SorCS2,22078,88,1.02 [0.59-1.78],0.9321206616300012
Chapter II Neoplasms,Melanoma in situ,SORD,Sorbitol dehydrogenase,22680,90,0.95 [0.72-1.25],0.7185708192132447
Chapter II Neoplasms,Melanoma in situ,SORT1,Sortilin,22555,89,1.08 [0.64-1.82],0.7660218289404099
Chapter II Neoplasms,Melanoma in situ,SOST,Sclerostin,22555,89,0.95 [0.58-1.55],0.8404697993089046
Chapter II Neoplasms,Melanoma in situ,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,19119,72,1.15 [0.79-1.69],0.4682442899154837
Chapter II Neoplasms,Melanoma in situ,SOX2,Transcription factor SOX-2,19608,77,1.64 [0.71-3.79],0.2439352755615292
Chapter II Neoplasms,Melanoma in situ,SOX9,Transcription factor SOX-9,19119,72,1.12 [0.48-2.59],0.7951460819223922
Chapter II Neoplasms,Melanoma in situ,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,19635,77,1.25 [0.64-2.45],0.5195011657524242
Chapter II Neoplasms,Melanoma in situ,SPAG1,Sperm-associated antigen 1,19635,77,1.00 [0.68-1.45],0.9852467442829356
Chapter II Neoplasms,Melanoma in situ,SPARC,SPARC,22658,90,0.86 [0.67-1.11],0.2519970789140194
Chapter II Neoplasms,Melanoma in situ,SPARCL1,SPARC-like protein 1,22577,89,1.99 [1.18-3.35],0.0097194409369921
Chapter II Neoplasms,Melanoma in situ,SPART,Spartin,19255,75,1.14 [0.86-1.51],0.3691453506075226
Chapter II Neoplasms,Melanoma in situ,SPESP1,Sperm equatorial segment protein 1,19665,77,0.92 [0.42-2.00],0.8322647663511087
Chapter II Neoplasms,Melanoma in situ,SPINK1,Serine protease inhibitor Kazal-type 1,22597,90,0.93 [0.59-1.47],0.754671560974955
Chapter II Neoplasms,Melanoma in situ,SPINK2,Serine protease inhibitor Kazal-type 2,19255,75,0.90 [0.49-1.66],0.7419541375555946
Chapter II Neoplasms,Melanoma in situ,SPINK4,Serine protease inhibitor Kazal-type 4,22550,90,1.20 [0.91-1.58],0.1882576687473152
Chapter II Neoplasms,Melanoma in situ,SPINK5,Serine protease inhibitor Kazal-type 5,22597,90,0.71 [0.39-1.29],0.2568426358714816
Chapter II Neoplasms,Melanoma in situ,SPINK6,Serine protease inhibitor Kazal-type 6,22789,90,0.87 [0.62-1.24],0.4499752499716033
Chapter II Neoplasms,Melanoma in situ,SPINK8,Serine protease inhibitor Kazal-type 8,19066,75,0.53 [0.25-1.12],0.0945847907891239
Chapter II Neoplasms,Melanoma in situ,SPINT1,Kunitz-type protease inhibitor 1,22532,89,1.04 [0.47-2.29],0.9234798228599288
Chapter II Neoplasms,Melanoma in situ,SPINT2,Kunitz-type protease inhibitor 2,22692,90,0.88 [0.57-1.37],0.5802934785433435
Chapter II Neoplasms,Melanoma in situ,SPINT3,Kunitz-type protease inhibitor 3,19566,77,1.03 [0.87-1.22],0.7395413202796801
Chapter II Neoplasms,Melanoma in situ,SPOCK1,Testican-1,22440,89,1.28 [0.60-2.70],0.5232332911576987
Chapter II Neoplasms,Melanoma in situ,SPON1,Spondin-1,22625,90,0.72 [0.39-1.30],0.2717787850735355
Chapter II Neoplasms,Melanoma in situ,SPON2,Spondin-2,22489,89,0.80 [0.46-1.41],0.4493642158981776
Chapter II Neoplasms,Melanoma in situ,SPP1,Osteopontin,22820,88,1.00 [0.67-1.49],0.987128080352414
Chapter II Neoplasms,Melanoma in situ,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",19117,75,1.17 [0.73-1.89],0.5109878318992102
Chapter II Neoplasms,Melanoma in situ,SPRING1,SREBP regulating gene protein,18973,75,1.05 [0.74-1.49],0.7766418539341761
Chapter II Neoplasms,Melanoma in situ,SPRR1B,Cornifin-B,19287,76,0.96 [0.72-1.26],0.7510365377801028
Chapter II Neoplasms,Melanoma in situ,SPRR3,Small proline-rich protein 3,19626,77,0.85 [0.63-1.16],0.307914845118142
Chapter II Neoplasms,Melanoma in situ,SPRY2,Protein sprouty homolog 2,22161,88,1.03 [0.84-1.27],0.7531173077878535
Chapter II Neoplasms,Melanoma in situ,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",19060,77,0.82 [0.40-1.67],0.5860586818387364
Chapter II Neoplasms,Melanoma in situ,SPTLC1,Serine palmitoyltransferase 1,19626,77,0.96 [0.52-1.77],0.9022163208017496
Chapter II Neoplasms,Melanoma in situ,SRC,Proto-oncogene tyrosine-protein kinase Src,22618,90,1.07 [0.91-1.25],0.404374455109594
Chapter II Neoplasms,Melanoma in situ,SRP14,Signal recognition particle 14 kDa protein,22484,88,1.20 [0.89-1.60],0.2279001176369001
Chapter II Neoplasms,Melanoma in situ,SRPK2,SRSF protein kinase 2,22550,90,1.10 [0.88-1.36],0.4119778871426149
Chapter II Neoplasms,Melanoma in situ,SRPX,Sushi repeat-containing protein SRPX,19665,77,1.16 [0.59-2.26],0.662795482675151
Chapter II Neoplasms,Melanoma in situ,SSB,Lupus La protein,22029,90,1.04 [0.77-1.41],0.7899851582812285
Chapter II Neoplasms,Melanoma in situ,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",19117,75,1.02 [0.55-1.89],0.9565706525064548
Chapter II Neoplasms,Melanoma in situ,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,22555,89,0.97 [0.80-1.16],0.7178469128420838
Chapter II Neoplasms,Melanoma in situ,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,22650,89,1.22 [0.78-1.92],0.3869715279975735
Chapter II Neoplasms,Melanoma in situ,SSH3,Protein phosphatase Slingshot homolog 3,18973,75,1.14 [0.55-2.39],0.7266014306302491
Chapter II Neoplasms,Melanoma in situ,SSNA1,Sjoegren syndrome nuclear autoantigen 1,19566,77,1.05 [0.69-1.59],0.8199426775593655
Chapter II Neoplasms,Melanoma in situ,ST13,Hsc70-interacting protein,19255,75,0.91 [0.62-1.34],0.6339686434410883
Chapter II Neoplasms,Melanoma in situ,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",22484,88,0.85 [0.52-1.39],0.5155160534119647
Chapter II Neoplasms,Melanoma in situ,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",22859,89,0.82 [0.42-1.59],0.5608522723638779
Chapter II Neoplasms,Melanoma in situ,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",19117,75,1.03 [0.65-1.61],0.9065701896646198
Chapter II Neoplasms,Melanoma in situ,STAB2,Stabilin-2,19661,77,1.13 [0.53-2.44],0.7507170931574447
Chapter II Neoplasms,Melanoma in situ,STAM,Signal transducing adapter molecule 1,19560,77,0.88 [0.48-1.59],0.6628387138629617
Chapter II Neoplasms,Melanoma in situ,STAMBP,STAM-binding protein,22392,89,1.03 [0.77-1.37],0.8562233765381997
Chapter II Neoplasms,Melanoma in situ,STAT2,Signal transducer and activator of transcription 2,19117,75,1.16 [0.87-1.54],0.3266538399870013
Chapter II Neoplasms,Melanoma in situ,STAT5B,Signal transducer and activator of transcription 5B,22484,88,1.02 [0.89-1.17],0.7516171993782139
Chapter II Neoplasms,Melanoma in situ,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,18973,75,0.96 [0.68-1.34],0.8035725540994255
Chapter II Neoplasms,Melanoma in situ,STC1,Stanniocalcin-1,22788,90,0.86 [0.53-1.40],0.5511119737734809
Chapter II Neoplasms,Melanoma in situ,STC2,Stanniocalcin-2,22564,90,2.57 [1.20-5.50],0.0151034591722485
Chapter II Neoplasms,Melanoma in situ,STEAP4,Metalloreductase STEAP4,19060,77,1.22 [0.97-1.53],0.0945611302205982
Chapter II Neoplasms,Melanoma in situ,STIP1,Stress-induced-phosphoprotein 1,22566,89,1.03 [0.78-1.37],0.8374326195402254
Chapter II Neoplasms,Melanoma in situ,STK11,Serine/threonine-protein kinase STK11,22187,88,0.96 [0.74-1.24],0.7343081349369451
Chapter II Neoplasms,Melanoma in situ,STK24,Serine/threonine-protein kinase 24,22029,90,1.05 [0.77-1.42],0.7707750009415024
Chapter II Neoplasms,Melanoma in situ,STK4,Serine/threonine-protein kinase 4,22589,89,1.08 [0.87-1.35],0.4781804894540312
Chapter II Neoplasms,Melanoma in situ,STOML2,"Stomatin-like protein 2, mitochondrial",18973,75,1.15 [0.93-1.41],0.2067036981943885
Chapter II Neoplasms,Melanoma in situ,STX16,Syntaxin-16,22078,88,1.16 [0.86-1.57],0.3343331406719557
Chapter II Neoplasms,Melanoma in situ,STX1B,Syntaxin-1B,19119,72,1.12 [0.69-1.80],0.6511912972293665
Chapter II Neoplasms,Melanoma in situ,STX3,Syntaxin-3,19626,77,1.24 [0.78-1.95],0.3619772516242671
Chapter II Neoplasms,Melanoma in situ,STX4,Syntaxin-4,22484,88,1.04 [0.77-1.42],0.7888396786781637
Chapter II Neoplasms,Melanoma in situ,STX5,Syntaxin-5,19117,75,0.75 [0.40-1.41],0.3739272393706988
Chapter II Neoplasms,Melanoma in situ,STX6,Syntaxin-6,22078,88,1.27 [1.01-1.60],0.0396407307235361
Chapter II Neoplasms,Melanoma in situ,STX7,Syntaxin-7,19117,75,0.96 [0.62-1.50],0.8652828240084803
Chapter II Neoplasms,Melanoma in situ,STX8,Syntaxin-8,22550,90,1.15 [0.80-1.66],0.4550894183190634
Chapter II Neoplasms,Melanoma in situ,STXBP1,Syntaxin-binding protein 1,19635,77,1.11 [0.84-1.48],0.4590266023296891
Chapter II Neoplasms,Melanoma in situ,STXBP3,Syntaxin-binding protein 3,22078,88,1.12 [0.74-1.69],0.595947092659092
Chapter II Neoplasms,Melanoma in situ,SUGP1,SURP and G-patch domain-containing protein 1,19566,77,0.93 [0.53-1.62],0.7969384214152433
Chapter II Neoplasms,Melanoma in situ,SUGT1,Protein SGT1 homolog,22078,88,1.08 [0.86-1.37],0.5028017308069064
Chapter II Neoplasms,Melanoma in situ,SULT1A1,Sulfotransferase 1A1,22788,90,1.04 [0.90-1.21],0.5607055509398093
Chapter II Neoplasms,Melanoma in situ,SULT2A1,Bile salt sulfotransferase,22550,90,1.02 [0.72-1.44],0.9295440431545104
Chapter II Neoplasms,Melanoma in situ,SUMF1,Formylglycine-generating enzyme,19117,75,1.12 [0.86-1.45],0.40838219270107
Chapter II Neoplasms,Melanoma in situ,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,22788,90,1.02 [0.71-1.46],0.9091501077411208
Chapter II Neoplasms,Melanoma in situ,SUOX,"Sulfite oxidase, mitochondrial",19635,77,0.85 [0.59-1.24],0.3991089988048834
Chapter II Neoplasms,Melanoma in situ,SUSD1,Sushi domain-containing protein 1,22187,88,1.15 [0.78-1.70],0.490672365870303
Chapter II Neoplasms,Melanoma in situ,SUSD2,Sushi domain-containing protein 2,22597,90,0.99 [0.51-1.92],0.9863363824522412
Chapter II Neoplasms,Melanoma in situ,SUSD4,Sushi domain-containing protein 4,19560,77,1.11 [0.69-1.79],0.656023247308607
Chapter II Neoplasms,Melanoma in situ,SUSD5,Sushi domain-containing protein 5,19139,75,1.11 [0.57-2.15],0.7663901538869912
Chapter II Neoplasms,Melanoma in situ,SV2A,Synaptic vesicle glycoprotein 2A,19119,72,1.07 [0.75-1.52],0.7161566687882119
Chapter II Neoplasms,Melanoma in situ,SWAP70,Switch-associated protein 70,19566,77,0.81 [0.42-1.55],0.5218924196653005
Chapter II Neoplasms,Melanoma in situ,SYAP1,Synapse-associated protein 1,19255,75,1.34 [0.92-1.95],0.1221172457269341
Chapter II Neoplasms,Melanoma in situ,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,19060,77,0.91 [0.61-1.36],0.6568855832211652
Chapter II Neoplasms,Melanoma in situ,SYT1,Synaptotagmin-1,19626,77,1.17 [0.72-1.91],0.5213086205750821
Chapter II Neoplasms,Melanoma in situ,SYTL4,Synaptotagmin-like protein 4,19665,77,1.09 [0.82-1.46],0.5494055372806597
Chapter II Neoplasms,Melanoma in situ,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,19287,76,1.14 [0.93-1.40],0.2171956907952804
Chapter II Neoplasms,Melanoma in situ,TACC3,Transforming acidic coiled-coil-containing protein 3,22484,88,1.07 [0.91-1.26],0.4257771352785132
Chapter II Neoplasms,Melanoma in situ,TACSTD2,Tumor-associated calcium signal transducer 2,20058,76,1.16 [0.57-2.34],0.6859209748697487
Chapter II Neoplasms,Melanoma in situ,TADA3,Transcriptional adapter 3,19560,77,1.30 [0.76-2.25],0.3400715818106989
Chapter II Neoplasms,Melanoma in situ,TAFA5,Chemokine-like protein TAFA-5,22484,88,0.84 [0.48-1.46],0.5334888588047924
Chapter II Neoplasms,Melanoma in situ,TAGLN3,Transgelin-3,18973,75,0.96 [0.67-1.39],0.8379796649247526
Chapter II Neoplasms,Melanoma in situ,TALDO1,Transaldolase,19578,77,1.26 [0.79-2.00],0.3337190714384702
Chapter II Neoplasms,Melanoma in situ,TANK,TRAF family member-associated NF-kappa-B activator,22161,88,1.17 [0.90-1.53],0.2435405236745252
Chapter II Neoplasms,Melanoma in situ,TAP1,Antigen peptide transporter 1,19287,76,0.84 [0.55-1.29],0.4260307701566934
Chapter II Neoplasms,Melanoma in situ,TARBP2,RISC-loading complex subunit TARBP2,22029,90,1.12 [0.89-1.42],0.3343534132450174
Chapter II Neoplasms,Melanoma in situ,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",19119,72,1.17 [0.92-1.49],0.2033421129831017
Chapter II Neoplasms,Melanoma in situ,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",19560,77,0.89 [0.49-1.61],0.6996774477771042
Chapter II Neoplasms,Melanoma in situ,TAX1BP1,Tax1-binding protein 1,19626,77,1.21 [0.87-1.67],0.2532087678113882
Chapter II Neoplasms,Melanoma in situ,TBC1D17,TBC1 domain family member 17,22029,90,0.85 [0.55-1.31],0.4724527262582615
Chapter II Neoplasms,Melanoma in situ,TBC1D23,TBC1 domain family member 23,22484,88,1.10 [0.89-1.35],0.3921364388659007
Chapter II Neoplasms,Melanoma in situ,TBC1D5,TBC1 domain family member 5,22550,90,1.07 [0.85-1.34],0.5830182573742329
Chapter II Neoplasms,Melanoma in situ,TBCA,Tubulin-specific chaperone A,19255,75,1.07 [0.83-1.38],0.6040159412243484
Chapter II Neoplasms,Melanoma in situ,TBCB,Tubulin-folding cofactor B,22440,89,1.04 [0.86-1.26],0.6525633488657068
Chapter II Neoplasms,Melanoma in situ,TBCC,Tubulin-specific chaperone C,22440,89,1.08 [0.86-1.36],0.5005226790667945
Chapter II Neoplasms,Melanoma in situ,TBL1X,F-box-like/WD repeat-containing protein TBL1X,22078,88,1.06 [0.85-1.33],0.5922034706045615
Chapter II Neoplasms,Melanoma in situ,TBR1,T-box brain protein 1,19119,72,0.79 [0.45-1.38],0.4063096705831673
Chapter II Neoplasms,Melanoma in situ,TCL1A,T-cell leukemia/lymphoma protein 1A,22400,88,0.85 [0.70-1.05],0.1316091929602356
Chapter II Neoplasms,Melanoma in situ,TCL1B,T-cell leukemia/lymphoma protein 1B,22187,88,1.16 [0.97-1.39],0.114623726353252
Chapter II Neoplasms,Melanoma in situ,TCN1,Transcobalamin-1,19257,74,1.63 [0.91-2.95],0.1028620146753029
Chapter II Neoplasms,Melanoma in situ,TCN2,Transcobalamin-2,22820,88,1.04 [0.56-1.93],0.910467706707802
Chapter II Neoplasms,Melanoma in situ,TCOF1,Treacle protein,19665,77,0.79 [0.37-1.68],0.5340841003476061
Chapter II Neoplasms,Melanoma in situ,TCP11,T-complex protein 11 homolog,19287,76,1.06 [0.74-1.51],0.7529545542558302
Chapter II Neoplasms,Melanoma in situ,TCTN3,Tectonic-3,19665,77,1.18 [0.55-2.51],0.6736286300613819
Chapter II Neoplasms,Melanoma in situ,TDGF1,Teratocarcinoma-derived growth factor 1,22029,90,0.93 [0.82-1.07],0.3056586034806098
Chapter II Neoplasms,Melanoma in situ,TDO2,"Tryptophan 2,3-dioxygenase",19119,72,0.63 [0.31-1.29],0.2085194710208943
Chapter II Neoplasms,Melanoma in situ,TDP1,Tyrosyl-DNA phosphodiesterase 1,19560,77,0.94 [0.68-1.30],0.7198435112595671
Chapter II Neoplasms,Melanoma in situ,TDRKH,Tudor and KH domain-containing protein,22029,90,1.09 [0.88-1.36],0.436735913291183
Chapter II Neoplasms,Melanoma in situ,TEF,Thyrotroph embryonic factor,19066,75,1.25 [0.80-1.94],0.3307815670040132
Chapter II Neoplasms,Melanoma in situ,TEK,Angiopoietin-1 receptor,22658,90,0.86 [0.36-2.06],0.7305602093569608
Chapter II Neoplasms,Melanoma in situ,TERF1,Telomeric repeat-binding factor 1,19117,75,1.26 [0.64-2.49],0.5110372480225374
Chapter II Neoplasms,Melanoma in situ,TET2,Methylcytosine dioxygenase TET2,19251,76,0.91 [0.71-1.17],0.4608786476543505
Chapter II Neoplasms,Melanoma in situ,TEX101,Testis-expressed protein 101,19119,72,0.86 [0.48-1.55],0.6179491215266558
Chapter II Neoplasms,Melanoma in situ,TEX33,Testis-expressed protein 33,19287,76,0.69 [0.35-1.36],0.2885270131672773
Chapter II Neoplasms,Melanoma in situ,TF,Serotransferrin,19694,77,1.55 [0.56-4.23],0.3967808752449983
Chapter II Neoplasms,Melanoma in situ,TFAP2A,Transcription factor AP-2-alpha,19060,77,0.98 [0.68-1.41],0.905893066551985
Chapter II Neoplasms,Melanoma in situ,TFF1,Trefoil factor 1,22487,90,1.08 [0.85-1.37],0.5108373435359548
Chapter II Neoplasms,Melanoma in situ,TFF2,Trefoil factor 2,22653,90,1.18 [0.85-1.64],0.3235899058706584
Chapter II Neoplasms,Melanoma in situ,TFF3,Trefoil factor 3,22546,88,1.09 [0.76-1.57],0.6343956228781782
Chapter II Neoplasms,Melanoma in situ,TFPI,Tissue factor pathway inhibitor,22505,89,0.89 [0.47-1.66],0.7075485756795328
Chapter II Neoplasms,Melanoma in situ,TFPI2,Tissue factor pathway inhibitor 2,22586,90,0.72 [0.41-1.27],0.2538295529661093
Chapter II Neoplasms,Melanoma in situ,TFRC,Transferrin receptor protein 1,22662,89,1.38 [0.87-2.21],0.1744596605714158
Chapter II Neoplasms,Melanoma in situ,TG,Thyroglobulin,19560,77,0.92 [0.76-1.12],0.4153169551404126
Chapter II Neoplasms,Melanoma in situ,TGFA,Protransforming growth factor alpha,22550,90,1.08 [0.73-1.59],0.7165632040908892
Chapter II Neoplasms,Melanoma in situ,TGFB1,Transforming growth factor beta-1 proprotein,22797,90,0.84 [0.51-1.39],0.5066362485463622
Chapter II Neoplasms,Melanoma in situ,TGFB2,Transforming growth factor beta-2 proprotein,19560,77,0.92 [0.60-1.39],0.6798404442505219
Chapter II Neoplasms,Melanoma in situ,TGFBI,Transforming growth factor-beta-induced protein ig-h3,22428,89,1.27 [0.63-2.53],0.5045202412864418
Chapter II Neoplasms,Melanoma in situ,TGFBR1,TGF-beta receptor type-1,19117,75,0.67 [0.23-1.96],0.4610551367661383
Chapter II Neoplasms,Melanoma in situ,TGFBR2,TGF-beta receptor type-2,22658,90,0.99 [0.54-1.83],0.9717740403410122
Chapter II Neoplasms,Melanoma in situ,TGFBR3,Transforming growth factor beta receptor type 3,22859,89,0.79 [0.46-1.37],0.4078825444598573
Chapter II Neoplasms,Melanoma in situ,TGM2,Protein-glutamine gamma-glutamyltransferase 2,22559,89,0.96 [0.75-1.22],0.7312403800606713
Chapter II Neoplasms,Melanoma in situ,TGOLN2,Trans-Golgi network integral membrane protein 2,19669,77,1.02 [0.44-2.37],0.9620510794067696
Chapter II Neoplasms,Melanoma in situ,THAP12,52 kDa repressor of the inhibitor of the protein kinase,18935,75,0.90 [0.69-1.19],0.4673457988640801
Chapter II Neoplasms,Melanoma in situ,THBD,Thrombomodulin,22589,89,1.05 [0.53-2.08],0.8956396994014133
Chapter II Neoplasms,Melanoma in situ,THBS2,Thrombospondin-2,22597,90,1.10 [0.65-1.86],0.7268882924105239
Chapter II Neoplasms,Melanoma in situ,THBS4,Thrombospondin-4,22573,89,1.14 [0.75-1.74],0.5431389066305721
Chapter II Neoplasms,Melanoma in situ,THOP1,Thimet oligopeptidase,22486,89,0.85 [0.45-1.60],0.6144431406326523
Chapter II Neoplasms,Melanoma in situ,THPO,Thrombopoietin,22187,88,0.76 [0.46-1.26],0.2928607215204122
Chapter II Neoplasms,Melanoma in situ,THRAP3,Thyroid hormone receptor-associated protein 3,19066,75,1.05 [0.88-1.25],0.5949733616398196
Chapter II Neoplasms,Melanoma in situ,THSD1,Thrombospondin type-1 domain-containing protein 1,18973,74,1.52 [0.87-2.65],0.143272333598689
Chapter II Neoplasms,Melanoma in situ,THTPA,Thiamine-triphosphatase,19533,77,1.13 [0.88-1.44],0.343070386531228
Chapter II Neoplasms,Melanoma in situ,THY1,Thy-1 membrane glycoprotein,22788,90,0.81 [0.41-1.60],0.5385860618661888
Chapter II Neoplasms,Melanoma in situ,TIA1,Nucleolysin TIA-1 isoform p40,21944,85,1.03 [0.88-1.21],0.7363930327565742
Chapter II Neoplasms,Melanoma in situ,TIE1,Tyrosine-protein kinase receptor Tie-1,22859,89,0.76 [0.52-1.13],0.1757817269068289
Chapter II Neoplasms,Melanoma in situ,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",21981,90,0.89 [0.60-1.34],0.5892776947193885
Chapter II Neoplasms,Melanoma in situ,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,19287,76,1.34 [0.78-2.33],0.2922094245463063
Chapter II Neoplasms,Melanoma in situ,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,22650,89,1.26 [0.82-1.93],0.2861727132323222
Chapter II Neoplasms,Melanoma in situ,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,19665,77,1.30 [0.77-2.18],0.3242815760519222
Chapter II Neoplasms,Melanoma in situ,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,19626,77,1.29 [1.01-1.66],0.0410497089985893
Chapter II Neoplasms,Melanoma in situ,TIMP1,Metalloproteinase inhibitor 1,22314,86,1.14 [0.58-2.25],0.7071699644672926
Chapter II Neoplasms,Melanoma in situ,TIMP2,Metalloproteinase inhibitor 2,19665,77,0.45 [0.16-1.31],0.1424386522194319
Chapter II Neoplasms,Melanoma in situ,TIMP3,Metalloproteinase inhibitor 3,22692,90,0.90 [0.78-1.04],0.1490673234915894
Chapter II Neoplasms,Melanoma in situ,TIMP4,Metalloproteinase inhibitor 4,22597,90,0.95 [0.60-1.51],0.8224845901768096
Chapter II Neoplasms,Melanoma in situ,TINAGL1,Tubulointerstitial nephritis antigen-like,22514,89,1.53 [0.66-3.55],0.3237318604297787
Chapter II Neoplasms,Melanoma in situ,TJAP1,Tight junction-associated protein 1,22658,90,1.12 [0.89-1.40],0.3381992935199386
Chapter II Neoplasms,Melanoma in situ,TJP3,Tight junction protein ZO-3,19060,77,1.07 [0.66-1.73],0.7810059736540443
Chapter II Neoplasms,Melanoma in situ,TK1,"Thymidine kinase, cytosolic",19287,76,0.69 [0.39-1.23],0.2129774571978845
Chapter II Neoplasms,Melanoma in situ,TLR1,Toll-like receptor 1,19117,75,1.18 [0.52-2.69],0.6981438626706827
Chapter II Neoplasms,Melanoma in situ,TLR2,Toll-like receptor 2,19287,76,0.44 [0.17-1.15],0.0927226701378457
Chapter II Neoplasms,Melanoma in situ,TLR3,Toll-like receptor 3,22837,90,0.95 [0.71-1.28],0.7541513197508718
Chapter II Neoplasms,Melanoma in situ,TLR4,Toll-like receptor 4,19117,75,0.41 [0.18-0.92],0.0316801468465887
Chapter II Neoplasms,Melanoma in situ,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,19119,72,0.86 [0.55-1.34],0.5159194002640158
Chapter II Neoplasms,Melanoma in situ,TMED1,Transmembrane emp24 domain-containing protein 1,19287,76,0.82 [0.53-1.27],0.3702171950664162
Chapter II Neoplasms,Melanoma in situ,TMED10,Transmembrane emp24 domain-containing protein 10,19066,75,1.11 [0.77-1.59],0.5856815917745566
Chapter II Neoplasms,Melanoma in situ,TMED4,Transmembrane emp24 domain-containing protein 4,19066,75,0.80 [0.50-1.27],0.3398931098683206
Chapter II Neoplasms,Melanoma in situ,TMED8,Protein TMED8,19566,77,1.18 [0.95-1.47],0.1283858666868222
Chapter II Neoplasms,Melanoma in situ,TMEM106A,Transmembrane protein 106A,19560,77,1.22 [0.92-1.62],0.1761986970542245
Chapter II Neoplasms,Melanoma in situ,TMEM132A,Transmembrane protein 132A,19167,75,0.94 [0.66-1.34],0.7432904613613158
Chapter II Neoplasms,Melanoma in situ,TMEM25,Transmembrane protein 25,19635,77,1.08 [0.67-1.71],0.7609972116525949
Chapter II Neoplasms,Melanoma in situ,TMOD4,Tropomodulin-4,18973,75,0.99 [0.58-1.70],0.9752363589136528
Chapter II Neoplasms,Melanoma in situ,TMPRSS11B,Transmembrane protease serine 11B,19060,77,1.11 [0.86-1.42],0.42707826985554
Chapter II Neoplasms,Melanoma in situ,TMPRSS11D,Transmembrane protease serine 11D,19585,77,0.86 [0.48-1.51],0.5956829402893109
Chapter II Neoplasms,Melanoma in situ,TMPRSS15,Enteropeptidase,22484,88,0.99 [0.81-1.22],0.940977496070018
Chapter II Neoplasms,Melanoma in situ,TMPRSS5,Transmembrane protease serine 5,22331,87,0.99 [0.60-1.63],0.9565054560410926
Chapter II Neoplasms,Melanoma in situ,TMSB10,Thymosin beta-10,22597,90,1.08 [0.84-1.38],0.5677375977178839
Chapter II Neoplasms,Melanoma in situ,TNC,Tenascin,22650,89,1.07 [0.73-1.59],0.7204544954136369
Chapter II Neoplasms,Melanoma in situ,TNF,Tumor necrosis factor,22146,88,1.10 [0.70-1.71],0.6900999645719355
Chapter II Neoplasms,Melanoma in situ,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,19566,77,1.00 [0.63-1.58],0.9838500880105192
Chapter II Neoplasms,Melanoma in situ,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,22161,88,1.20 [0.73-1.96],0.4726020424608659
Chapter II Neoplasms,Melanoma in situ,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,19255,75,1.12 [0.79-1.59],0.5111956714209295
Chapter II Neoplasms,Melanoma in situ,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,22440,89,1.21 [0.68-2.13],0.517918077215437
Chapter II Neoplasms,Melanoma in situ,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,22440,89,0.97 [0.58-1.62],0.91220087991554
Chapter II Neoplasms,Melanoma in situ,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,22622,88,1.22 [0.83-1.79],0.3202057284188844
Chapter II Neoplasms,Melanoma in situ,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,22837,90,0.97 [0.59-1.61],0.915822083937016
Chapter II Neoplasms,Melanoma in situ,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,22583,90,0.77 [0.39-1.50],0.4398352991651922
Chapter II Neoplasms,Melanoma in situ,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,22658,90,1.63 [0.96-2.76],0.0687330644932493
Chapter II Neoplasms,Melanoma in situ,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,22625,90,0.90 [0.48-1.67],0.7355512381190777
Chapter II Neoplasms,Melanoma in situ,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,22161,88,0.92 [0.57-1.49],0.737566496310879
Chapter II Neoplasms,Melanoma in situ,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,22625,90,0.87 [0.45-1.67],0.6699478037778339
Chapter II Neoplasms,Melanoma in situ,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,19255,75,0.95 [0.54-1.66],0.8561130219129969
Chapter II Neoplasms,Melanoma in situ,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,22789,90,1.21 [0.66-2.24],0.5359721582455949
Chapter II Neoplasms,Melanoma in situ,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,22597,90,0.94 [0.48-1.87],0.8698001421715444
Chapter II Neoplasms,Melanoma in situ,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,22597,90,1.04 [0.62-1.76],0.8807076612059397
Chapter II Neoplasms,Melanoma in situ,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,22788,90,0.94 [0.47-1.89],0.8659761258459714
Chapter II Neoplasms,Melanoma in situ,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,22797,90,0.84 [0.50-1.41],0.5074597724965215
Chapter II Neoplasms,Melanoma in situ,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,22440,89,0.87 [0.60-1.24],0.4351400837854802
Chapter II Neoplasms,Melanoma in situ,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,22788,90,0.76 [0.49-1.18],0.2232321871589879
Chapter II Neoplasms,Melanoma in situ,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,22440,89,0.98 [0.60-1.61],0.9430421992432214
Chapter II Neoplasms,Melanoma in situ,TNFSF10,Tumor necrosis factor ligand superfamily member 10,22837,90,0.64 [0.31-1.32],0.2292429715859102
Chapter II Neoplasms,Melanoma in situ,TNFSF11,Tumor necrosis factor ligand superfamily member 11,22550,90,0.75 [0.55-1.02],0.0633922528582545
Chapter II Neoplasms,Melanoma in situ,TNFSF12,Tumor necrosis factor ligand superfamily member 12,22837,90,0.58 [0.30-1.12],0.1073683962244977
Chapter II Neoplasms,Melanoma in situ,TNFSF13,Tumor necrosis factor ligand superfamily member 13,22692,90,0.90 [0.44-1.84],0.7632587270866735
Chapter II Neoplasms,Melanoma in situ,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,22820,89,1.02 [0.50-2.07],0.95536128690717
Chapter II Neoplasms,Melanoma in situ,TNFSF14,Tumor necrosis factor ligand superfamily member 14,22440,89,0.79 [0.56-1.10],0.157992816853319
Chapter II Neoplasms,Melanoma in situ,TNFSF8,Tumor necrosis factor ligand superfamily member 8,19661,77,0.94 [0.51-1.74],0.8469819115036504
Chapter II Neoplasms,Melanoma in situ,TNIP1,TNFAIP3-interacting protein 1,19626,77,1.11 [0.87-1.41],0.4003964820465483
Chapter II Neoplasms,Melanoma in situ,TNN,Tenascin-N,19661,77,1.09 [0.67-1.79],0.7217213008989617
Chapter II Neoplasms,Melanoma in situ,TNNI3,"Troponin I, cardiac muscle",22187,88,1.01 [0.80-1.26],0.9497182360346428
Chapter II Neoplasms,Melanoma in situ,TNPO1,Transportin-1,19287,76,0.85 [0.45-1.63],0.6314810775710322
Chapter II Neoplasms,Melanoma in situ,TNR,Tenascin-R,22440,89,0.86 [0.55-1.35],0.5215057439189033
Chapter II Neoplasms,Melanoma in situ,TNXB,Tenascin-X,22597,90,0.74 [0.35-1.55],0.4281805956290589
Chapter II Neoplasms,Melanoma in situ,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,19665,77,1.09 [0.83-1.44],0.5201804187663855
Chapter II Neoplasms,Melanoma in situ,TOP1,DNA topoisomerase 1,19566,77,0.97 [0.79-1.19],0.766667912008475
Chapter II Neoplasms,Melanoma in situ,TOP1MT,"DNA topoisomerase I, mitochondrial",18973,75,1.00 [0.64-1.56],0.9844577965988492
Chapter II Neoplasms,Melanoma in situ,TOP2B,DNA topoisomerase 2-beta,19117,75,1.16 [0.88-1.52],0.2976521009702864
Chapter II Neoplasms,Melanoma in situ,TOR1AIP1,Torsin-1A-interacting protein 1,19167,75,1.04 [0.70-1.56],0.8294740950951234
Chapter II Neoplasms,Melanoma in situ,TP53,Cellular tumor antigen p53,22078,88,1.16 [0.75-1.80],0.4990344509122122
Chapter II Neoplasms,Melanoma in situ,TP53BP1,TP53-binding protein 1,19117,75,1.02 [0.80-1.31],0.8698951657129093
Chapter II Neoplasms,Melanoma in situ,TP53I3,Quinone oxidoreductase PIG3,18832,74,1.18 [0.77-1.79],0.4443904986209031
Chapter II Neoplasms,Melanoma in situ,TP53INP1,Tumor protein p53-inducible nuclear protein 1,22187,88,0.95 [0.52-1.72],0.8563355275008075
Chapter II Neoplasms,Melanoma in situ,TP73,Tumor protein p73,19119,72,1.00 [0.52-1.93],0.9991200789078648
Chapter II Neoplasms,Melanoma in situ,TPBGL,Trophoblast glycoprotein-like,19119,72,0.72 [0.39-1.33],0.2920329286442351
Chapter II Neoplasms,Melanoma in situ,TPD52L2,Tumor protein D54,19255,75,1.18 [0.95-1.46],0.1379724965100762
Chapter II Neoplasms,Melanoma in situ,TPK1,Thiamin pyrophosphokinase 1,19665,77,0.82 [0.36-1.85],0.6296041883819326
Chapter II Neoplasms,Melanoma in situ,TPM3,Tropomyosin alpha-3 chain,19066,75,0.84 [0.48-1.48],0.5527918434873086
Chapter II Neoplasms,Melanoma in situ,TPMT,Thiopurine S-methyltransferase,22078,88,1.03 [0.80-1.33],0.7985109573406557
Chapter II Neoplasms,Melanoma in situ,TPP1,Tripeptidyl-peptidase 1,22440,90,0.82 [0.52-1.29],0.3881288023739302
Chapter II Neoplasms,Melanoma in situ,TPPP2,Tubulin polymerization-promoting protein family member 2,19287,76,0.94 [0.70-1.25],0.6579432165650534
Chapter II Neoplasms,Melanoma in situ,TPPP3,Tubulin polymerization-promoting protein family member 3,22029,90,1.09 [0.70-1.68],0.7050852937549426
Chapter II Neoplasms,Melanoma in situ,TPR,Nucleoprotein TPR,19066,75,1.08 [0.73-1.62],0.6923829650137792
Chapter II Neoplasms,Melanoma in situ,TPRKB,EKC/KEOPS complex subunit TPRKB,18973,75,0.54 [0.33-0.87],0.0109081169089821
Chapter II Neoplasms,Melanoma in situ,TPSAB1,Tryptase alpha/beta-1,22800,90,0.96 [0.68-1.37],0.8228590356462623
Chapter II Neoplasms,Melanoma in situ,TPSD1,Tryptase delta,19635,77,1.09 [0.63-1.88],0.7580493529841823
Chapter II Neoplasms,Melanoma in situ,TPSG1,Tryptase gamma,19117,75,0.88 [0.38-2.05],0.7637515596318171
Chapter II Neoplasms,Melanoma in situ,TPT1,Translationally-controlled tumor protein,22161,88,1.00 [0.75-1.33],0.976154436521877
Chapter II Neoplasms,Melanoma in situ,TRAF2,TNF receptor-associated factor 2,22550,90,1.13 [0.88-1.47],0.3419503748388688
Chapter II Neoplasms,Melanoma in situ,TRAF3,"TNF receptor-associated factor 3, Isoform 2",19117,75,1.09 [0.61-1.95],0.7613750318853695
Chapter II Neoplasms,Melanoma in situ,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,19066,75,0.67 [0.37-1.21],0.1819232264666989
Chapter II Neoplasms,Melanoma in situ,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,19287,76,1.20 [0.97-1.48],0.093616929331839
Chapter II Neoplasms,Melanoma in situ,TREH,Trehalase,19661,77,1.01 [0.76-1.36],0.9297035033409696
Chapter II Neoplasms,Melanoma in situ,TREM2,Triggering receptor expressed on myeloid cells 2,22583,90,0.95 [0.65-1.38],0.7855381252096789
Chapter II Neoplasms,Melanoma in situ,TREML1,Trem-like transcript 1 protein,19669,77,1.03 [0.68-1.55],0.8972118926513465
Chapter II Neoplasms,Melanoma in situ,TREML2,Trem-like transcript 2 protein,22597,90,0.68 [0.38-1.21],0.1914158083698933
Chapter II Neoplasms,Melanoma in situ,TRIAP1,TP53-regulated inhibitor of apoptosis 1,22789,90,1.18 [0.88-1.58],0.268130794757644
Chapter II Neoplasms,Melanoma in situ,TRIM21,E3 ubiquitin-protein ligase TRIM21,22550,90,1.09 [0.86-1.39],0.4899599800424163
Chapter II Neoplasms,Melanoma in situ,TRIM24,Transcription intermediary factor 1-alpha,19244,76,1.13 [0.82-1.55],0.4678912984072849
Chapter II Neoplasms,Melanoma in situ,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,19566,77,1.09 [0.89-1.33],0.3964327816601239
Chapter II Neoplasms,Melanoma in situ,TRIM26,Tripartite motif-containing protein 26,18973,75,0.96 [0.65-1.42],0.8412204366913654
Chapter II Neoplasms,Melanoma in situ,TRIM40,E3 ubiquitin ligase TRIM40,19119,72,1.22 [0.91-1.64],0.1776700398347037
Chapter II Neoplasms,Melanoma in situ,TRIM5,Tripartite motif-containing protein 5,22550,90,1.12 [0.90-1.39],0.3243884949590505
Chapter II Neoplasms,Melanoma in situ,TRIM58,E3 ubiquitin-protein ligase TRIM58,19560,77,1.01 [0.79-1.30],0.9341357442199726
Chapter II Neoplasms,Melanoma in situ,TRPV3,Transient receptor potential cation channel subfamily V member 3,19066,75,0.72 [0.42-1.22],0.224053135807263
Chapter II Neoplasms,Melanoma in situ,TSC1,Hamartin,19117,75,0.88 [0.63-1.24],0.4618539620590293
Chapter II Neoplasms,Melanoma in situ,TSC22D1,TSC22 domain family protein 1,19635,77,1.19 [0.89-1.61],0.2368809542604842
Chapter II Neoplasms,Melanoma in situ,TSHB,Thyrotropin subunit beta,22589,89,1.06 [0.85-1.32],0.6144220559092808
Chapter II Neoplasms,Melanoma in situ,TSLP,Thymic stromal lymphopoietin,22187,88,0.69 [0.47-1.03],0.0675840692825048
Chapter II Neoplasms,Melanoma in situ,TSNAX,Translin-associated protein X,19066,75,0.66 [0.37-1.18],0.1599634804881694
Chapter II Neoplasms,Melanoma in situ,TSPAN1,Tetraspanin-1,22187,88,0.80 [0.39-1.64],0.5354693018220367
Chapter II Neoplasms,Melanoma in situ,TSPAN15,Tetraspanin-15,19066,75,0.98 [0.63-1.52],0.9200272592466054
Chapter II Neoplasms,Melanoma in situ,TSPAN7,Tetraspanin-7,19060,77,0.95 [0.75-1.22],0.7073839907561621
Chapter II Neoplasms,Melanoma in situ,TSPAN8,Tetraspanin-8,19566,77,1.10 [0.90-1.36],0.3488044889771369
Chapter II Neoplasms,Melanoma in situ,TSPYL1,Testis-specific Y-encoded-like protein 1,19117,75,1.09 [0.64-1.87],0.7469579533085826
Chapter II Neoplasms,Melanoma in situ,TST,Thiosulfate sulfurtransferase,21990,89,0.99 [0.77-1.27],0.9162515965277668
Chapter II Neoplasms,Melanoma in situ,TTF2,Transcription termination factor 2,19119,72,0.93 [0.58-1.48],0.7488402421650141
Chapter II Neoplasms,Melanoma in situ,TTN,Titin,19066,75,0.96 [0.68-1.35],0.8026915032370536
Chapter II Neoplasms,Melanoma in situ,TTR,Transthyretin,19468,76,1.00 [0.41-2.41],0.9948150914829572
Chapter II Neoplasms,Melanoma in situ,TUBB3,Tubulin beta-3 chain,19060,77,1.07 [0.49-2.35],0.8633891647642055
Chapter II Neoplasms,Melanoma in situ,TWF2,Twinfilin-2,19661,77,1.13 [0.87-1.46],0.3656664590451332
Chapter II Neoplasms,Melanoma in situ,TXK,Tyrosine-protein kinase TXK,19287,76,0.95 [0.71-1.28],0.7284391950933448
Chapter II Neoplasms,Melanoma in situ,TXLNA,Alpha-taxilin,22440,89,1.05 [0.85-1.30],0.6363199212347133
Chapter II Neoplasms,Melanoma in situ,TXN,Thioredoxin,19328,77,0.75 [0.44-1.28],0.2891306415428899
Chapter II Neoplasms,Melanoma in situ,TXNDC15,Thioredoxin domain-containing protein 15,22658,90,0.86 [0.43-1.72],0.6723437561657974
Chapter II Neoplasms,Melanoma in situ,TXNDC5,Thioredoxin domain-containing protein 5,22788,90,1.11 [0.84-1.46],0.4756150343657995
Chapter II Neoplasms,Melanoma in situ,TXNDC9,Thioredoxin domain-containing protein 9,19626,77,1.35 [0.93-1.96],0.1141405180189981
Chapter II Neoplasms,Melanoma in situ,TXNL1,Thioredoxin-like protein 1,19024,76,1.02 [0.82-1.27],0.8341844580283898
Chapter II Neoplasms,Melanoma in situ,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",22597,90,1.18 [0.79-1.75],0.4140534921081541
Chapter II Neoplasms,Melanoma in situ,TYMP,Thymidine phosphorylase,22443,89,1.20 [0.90-1.58],0.207385877272937
Chapter II Neoplasms,Melanoma in situ,TYRO3,Tyrosine-protein kinase receptor TYRO3,22589,89,1.37 [0.71-2.65],0.3531140243646326
Chapter II Neoplasms,Melanoma in situ,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",19117,75,1.26 [0.88-1.82],0.2119159280362574
Chapter II Neoplasms,Melanoma in situ,UBAC1,Ubiquitin-associated domain-containing protein 1,22484,88,0.73 [0.43-1.24],0.2473099357485124
Chapter II Neoplasms,Melanoma in situ,UBE2B,Ubiquitin-conjugating enzyme E2 B,19560,77,0.88 [0.41-1.86],0.7332057458644159
Chapter II Neoplasms,Melanoma in situ,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,19665,77,1.36 [0.97-1.91],0.0786389065367315
Chapter II Neoplasms,Melanoma in situ,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,19117,75,1.12 [0.79-1.58],0.5266886167056494
Chapter II Neoplasms,Melanoma in situ,UBQLN3,Ubiquilin-3,19066,75,1.05 [0.65-1.68],0.850226500758658
Chapter II Neoplasms,Melanoma in situ,UBXN1,UBX domain-containing protein 1,19255,75,0.99 [0.71-1.37],0.9393325961875312
Chapter II Neoplasms,Melanoma in situ,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,19566,77,1.17 [1.00-1.37],0.0572697796924719
Chapter II Neoplasms,Melanoma in situ,UGDH,UDP-glucose 6-dehydrogenase,19066,75,0.91 [0.71-1.18],0.483340775736237
Chapter II Neoplasms,Melanoma in situ,UHRF2,E3 ubiquitin-protein ligase UHRF2,19066,75,0.34 [0.16-0.75],0.0072001852693841
Chapter II Neoplasms,Melanoma in situ,ULBP2,UL16-binding protein 2,22440,89,0.86 [0.50-1.47],0.573704936607948
Chapter II Neoplasms,Melanoma in situ,UMOD,Uromodulin,22795,89,0.94 [0.67-1.33],0.7373864555169847
Chapter II Neoplasms,Melanoma in situ,UNC5D,Netrin receptor UNC5D,19117,75,0.69 [0.28-1.67],0.409294914143984
Chapter II Neoplasms,Melanoma in situ,UNC79,Protein unc-79 homolog,18973,75,1.04 [0.71-1.51],0.8505865241320709
Chapter II Neoplasms,Melanoma in situ,UNG,Uracil-DNA glycosylase,19560,77,1.02 [0.54-1.92],0.9605947333817088
Chapter II Neoplasms,Melanoma in situ,UPB1,Beta-ureidopropionase,19665,77,1.02 [0.80-1.30],0.8797771061904541
Chapter II Neoplasms,Melanoma in situ,UPK3A,Uroplakin-3a,19060,77,1.00 [0.65-1.55],0.988125055310598
Chapter II Neoplasms,Melanoma in situ,UPK3BL1,Uroplakin-3b-like protein 1,19259,76,0.65 [0.37-1.15],0.1379091315548289
Chapter II Neoplasms,Melanoma in situ,UROD,Uroporphyrinogen decarboxylase,19255,75,1.07 [0.78-1.46],0.6867950022678052
Chapter II Neoplasms,Melanoma in situ,UROS,Uroporphyrinogen-III synthase,19119,72,0.94 [0.67-1.31],0.6946120741444273
Chapter II Neoplasms,Melanoma in situ,USO1,General vesicular transport factor p115,22484,88,1.06 [0.86-1.30],0.5829300675454716
Chapter II Neoplasms,Melanoma in situ,USP25,Ubiquitin carboxyl-terminal hydrolase 25,19560,77,1.16 [0.86-1.56],0.334967800866201
Chapter II Neoplasms,Melanoma in situ,USP28,Ubiquitin carboxyl-terminal hydrolase 28,19626,77,0.76 [0.39-1.48],0.4169360193802709
Chapter II Neoplasms,Melanoma in situ,USP47,Ubiquitin carboxyl-terminal hydrolase 47,19066,75,1.26 [1.02-1.55],0.0316708839356178
Chapter II Neoplasms,Melanoma in situ,USP8,Ubiquitin carboxyl-terminal hydrolase 8,22187,88,1.02 [0.84-1.25],0.8298808507869426
Chapter II Neoplasms,Melanoma in situ,UXS1,UDP-glucuronic acid decarboxylase 1,22078,88,0.91 [0.63-1.31],0.6091796564939249
Chapter II Neoplasms,Melanoma in situ,VAMP5,Vesicle-associated membrane protein 5,22187,88,1.10 [0.81-1.50],0.5376123732708414
Chapter II Neoplasms,Melanoma in situ,VAMP8,Vesicle-associated membrane protein 8,19117,75,1.14 [0.89-1.46],0.3137069293211556
Chapter II Neoplasms,Melanoma in situ,VASH1,Tubulinyl-Tyr carboxypeptidase 1,22550,90,1.13 [0.91-1.42],0.2723388426124877
Chapter II Neoplasms,Melanoma in situ,VASN,Vasorin,22203,89,1.20 [0.59-2.43],0.6096757353768866
Chapter II Neoplasms,Melanoma in situ,VASP,Vasodilator-stimulated phosphoprotein,19669,77,1.20 [0.89-1.61],0.2300561335145712
Chapter II Neoplasms,Melanoma in situ,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,22484,88,1.23 [0.48-3.14],0.6724662341914069
Chapter II Neoplasms,Melanoma in situ,VAV3,Guanine nucleotide exchange factor VAV3,19060,77,1.13 [0.91-1.41],0.2804445202464218
Chapter II Neoplasms,Melanoma in situ,VCAM1,Vascular cell adhesion protein 1,22613,89,1.27 [0.63-2.58],0.4997209339958214
Chapter II Neoplasms,Melanoma in situ,VCAN,Versican core protein,22788,90,1.02 [0.55-1.90],0.9398241529057032
Chapter II Neoplasms,Melanoma in situ,VCPKMT,Protein-lysine methyltransferase METTL21D,18973,75,0.98 [0.75-1.27],0.8739118026858008
Chapter II Neoplasms,Melanoma in situ,VEGFA,Vascular endothelial growth factor A,22768,90,0.91 [0.66-1.26],0.5875044571005132
Chapter II Neoplasms,Melanoma in situ,VEGFB,Vascular endothelial growth factor B,19117,75,1.06 [0.48-2.34],0.8798622268196569
Chapter II Neoplasms,Melanoma in situ,VEGFC,Vascular endothelial growth factor C,22658,90,0.75 [0.54-1.04],0.0808217936529348
Chapter II Neoplasms,Melanoma in situ,VEGFD,Vascular endothelial growth factor D,22797,90,0.94 [0.53-1.64],0.8179093357094678
Chapter II Neoplasms,Melanoma in situ,VGF,Neurosecretory protein VGF,19635,77,1.25 [0.61-2.57],0.5440526230930183
Chapter II Neoplasms,Melanoma in situ,VIM,Vimentin,22187,88,0.97 [0.83-1.13],0.6726337015991397
Chapter II Neoplasms,Melanoma in situ,VIPR1,Vasoactive intestinal polypeptide receptor 1,19167,75,1.37 [0.65-2.91],0.4122177520266492
Chapter II Neoplasms,Melanoma in situ,VIT,Vitrin,19665,77,0.81 [0.45-1.47],0.4903506180896071
Chapter II Neoplasms,Melanoma in situ,VMO1,Vitelline membrane outer layer protein 1 homolog,22484,88,1.30 [0.96-1.76],0.0901327635477927
Chapter II Neoplasms,Melanoma in situ,VNN1,Pantetheinase,19669,77,0.94 [0.70-1.26],0.6635447413676187
Chapter II Neoplasms,Melanoma in situ,VNN2,Vascular non-inflammatory molecule 2,22484,88,0.92 [0.61-1.39],0.6791620608571514
Chapter II Neoplasms,Melanoma in situ,VPS28,Vacuolar protein sorting-associated protein 28 homolog,19287,76,1.29 [0.96-1.74],0.095612979016949
Chapter II Neoplasms,Melanoma in situ,VPS37A,Vacuolar protein sorting-associated protein 37A,22484,88,1.08 [0.85-1.36],0.5317345410929657
Chapter II Neoplasms,Melanoma in situ,VPS4B,Vacuolar protein sorting-associated protein 4B,19560,77,1.07 [0.85-1.35],0.5445822157469928
Chapter II Neoplasms,Melanoma in situ,VPS53,Vacuolar protein sorting-associated protein 53 homolog,22484,88,1.07 [0.84-1.37],0.5728722036910863
Chapter II Neoplasms,Melanoma in situ,VSIG10,V-set and immunoglobulin domain-containing protein 10,19560,77,0.94 [0.49-1.79],0.8488185136147295
Chapter II Neoplasms,Melanoma in situ,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,19066,75,1.12 [0.59-2.15],0.729344309360782
Chapter II Neoplasms,Melanoma in situ,VSIG2,V-set and immunoglobulin domain-containing protein 2,19560,77,1.15 [0.81-1.65],0.4291739281431463
Chapter II Neoplasms,Melanoma in situ,VSIG4,V-set and immunoglobulin domain-containing protein 4,22564,90,0.84 [0.51-1.39],0.5003864243423494
Chapter II Neoplasms,Melanoma in situ,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,22554,89,1.13 [0.84-1.52],0.4063377246045867
Chapter II Neoplasms,Melanoma in situ,VSNL1,Visinin-like protein 1,19626,77,1.02 [0.57-1.83],0.9468825159947144
Chapter II Neoplasms,Melanoma in situ,VSTM1,V-set and transmembrane domain-containing protein 1,22029,90,0.90 [0.61-1.33],0.5850463786751553
Chapter II Neoplasms,Melanoma in situ,VSTM2B,V-set and transmembrane domain-containing protein 2B,19287,76,0.95 [0.56-1.60],0.8350076321408559
Chapter II Neoplasms,Melanoma in situ,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,22187,88,1.08 [0.79-1.48],0.6245846971210056
Chapter II Neoplasms,Melanoma in situ,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,22788,90,1.05 [0.81-1.35],0.7105193070397434
Chapter II Neoplasms,Melanoma in situ,VTCN1,V-set domain-containing T-cell activation inhibitor 1,22078,88,1.02 [0.55-1.89],0.9497549986006908
Chapter II Neoplasms,Melanoma in situ,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,19255,75,1.23 [0.86-1.77],0.2539186881182149
Chapter II Neoplasms,Melanoma in situ,VWA1,von Willebrand factor A domain-containing protein 1,22750,90,0.81 [0.52-1.27],0.3658701727398604
Chapter II Neoplasms,Melanoma in situ,VWA5A,von Willebrand factor A domain-containing protein 5A,18973,75,0.99 [0.74-1.31],0.9192111006230524
Chapter II Neoplasms,Melanoma in situ,VWC2,Brorin,22357,88,0.81 [0.49-1.33],0.4082265327830059
Chapter II Neoplasms,Melanoma in situ,VWC2L,von Willebrand factor C domain-containing protein 2-like,19635,77,1.11 [0.73-1.69],0.6329696778437175
Chapter II Neoplasms,Melanoma in situ,VWF,von Willebrand factor,22859,89,0.87 [0.67-1.12],0.2862760570618084
Chapter II Neoplasms,Melanoma in situ,WARS,"Tryptophan--tRNA ligase, cytoplasmic",22597,90,1.25 [0.76-2.04],0.3815860537695331
Chapter II Neoplasms,Melanoma in situ,WAS,Wiskott-Aldrich syndrome protein,22161,88,0.79 [0.58-1.07],0.1231733946162653
Chapter II Neoplasms,Melanoma in situ,WASF1,Wiskott-Aldrich syndrome protein family member 1,22187,88,1.04 [0.85-1.28],0.706493973147851
Chapter II Neoplasms,Melanoma in situ,WASF3,Wiskott-Aldrich syndrome protein family member 3,22029,90,1.01 [0.80-1.26],0.957654056477168
Chapter II Neoplasms,Melanoma in situ,WASHC3,WASH complex subunit 3,19626,77,1.09 [0.82-1.44],0.5436742995330512
Chapter II Neoplasms,Melanoma in situ,WASL,Neural Wiskott-Aldrich syndrome protein,19117,75,0.73 [0.48-1.12],0.1545282705267076
Chapter II Neoplasms,Melanoma in situ,WDR46,WD repeat-containing protein 46,19560,77,0.65 [0.33-1.28],0.2084838134119407
Chapter II Neoplasms,Melanoma in situ,WFDC1,WAP four-disulfide core domain protein 1,19175,77,0.86 [0.55-1.36],0.5301672937808823
Chapter II Neoplasms,Melanoma in situ,WFDC12,WAP four-disulfide core domain protein 12,22761,90,1.09 [0.82-1.45],0.5591870005178452
Chapter II Neoplasms,Melanoma in situ,WFDC2,WAP four-disulfide core domain protein 2,21421,81,1.35 [0.80-2.29],0.2568925040321781
Chapter II Neoplasms,Melanoma in situ,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",22378,88,0.95 [0.59-1.52],0.835650475762676
Chapter II Neoplasms,Melanoma in situ,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",22625,90,0.67 [0.39-1.16],0.1544705665727883
Chapter II Neoplasms,Melanoma in situ,WIF1,Wnt inhibitory factor 1,22789,90,0.86 [0.50-1.48],0.5902656889350856
Chapter II Neoplasms,Melanoma in situ,WNT9A,Protein Wnt-9a,22161,88,1.15 [0.60-2.24],0.6711346179350697
Chapter II Neoplasms,Melanoma in situ,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,22440,89,1.06 [0.76-1.50],0.7210996287470471
Chapter II Neoplasms,Melanoma in situ,XCL1,Lymphotactin,22789,90,1.16 [0.87-1.55],0.3039447607417791
Chapter II Neoplasms,Melanoma in situ,XG,Glycoprotein Xg,22744,87,0.88 [0.46-1.69],0.6970769312601128
Chapter II Neoplasms,Melanoma in situ,XIAP,E3 ubiquitin-protein ligase XIAP,19117,75,1.20 [0.82-1.75],0.3514973339237353
Chapter II Neoplasms,Melanoma in situ,XPNPEP2,Xaa-Pro aminopeptidase 2,22658,90,1.06 [0.86-1.32],0.5893398213628063
Chapter II Neoplasms,Melanoma in situ,XRCC4,DNA repair protein XRCC4,22029,90,1.00 [0.60-1.67],0.9994436525129744
Chapter II Neoplasms,Melanoma in situ,YAP1,Transcriptional coactivator YAP1,19626,77,1.23 [0.54-2.76],0.6235196788386057
Chapter II Neoplasms,Melanoma in situ,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",19566,77,1.11 [0.96-1.30],0.1643885095124762
Chapter II Neoplasms,Melanoma in situ,YES1,Tyrosine-protein kinase Yes,22484,88,1.05 [0.89-1.24],0.5371297865456393
Chapter II Neoplasms,Melanoma in situ,YJU2,Splicing factor YJU2,19560,77,0.98 [0.50-1.91],0.9490263612019872
Chapter II Neoplasms,Melanoma in situ,YOD1,Ubiquitin thioesterase OTU1,19066,75,0.81 [0.57-1.15],0.2281766735898766
Chapter II Neoplasms,Melanoma in situ,YTHDF3,YTH domain-containing family protein 3,22161,88,1.11 [0.88-1.38],0.377333407963624
Chapter II Neoplasms,Melanoma in situ,YWHAQ,14-3-3 protein theta,19255,75,1.09 [0.81-1.48],0.556971423976558
Chapter II Neoplasms,Melanoma in situ,YY1,Transcriptional repressor protein YY1,19117,75,0.91 [0.41-2.03],0.8164928231771772
Chapter II Neoplasms,Melanoma in situ,ZBP1,Z-DNA-binding protein 1,19117,75,1.01 [0.59-1.74],0.9587291392751984
Chapter II Neoplasms,Melanoma in situ,ZBTB16,Zinc finger and BTB domain-containing protein 16,22078,88,1.27 [0.98-1.64],0.0655728918530977
Chapter II Neoplasms,Melanoma in situ,ZBTB17,Zinc finger and BTB domain-containing protein 17,22187,88,0.82 [0.49-1.35],0.4316740882552503
Chapter II Neoplasms,Melanoma in situ,ZCCHC8,Zinc finger CCHC domain-containing protein 8,19066,75,0.81 [0.53-1.23],0.3188780746794178
Chapter II Neoplasms,Melanoma in situ,ZFYVE19,Abscission/NoCut checkpoint regulator,19566,77,1.06 [0.83-1.35],0.6230737983371507
Chapter II Neoplasms,Melanoma in situ,ZHX2,Zinc fingers and homeoboxes protein 2,19626,77,1.14 [0.65-2.03],0.6430834544987554
Chapter II Neoplasms,Melanoma in situ,ZNF174,Zinc finger protein 174,19117,75,0.96 [0.53-1.72],0.8862944320765651
Chapter II Neoplasms,Melanoma in situ,ZNF75D,Zinc finger protein 75D,19287,76,0.96 [0.67-1.38],0.8214816737712872
Chapter II Neoplasms,Melanoma in situ,ZNF830,Zinc finger protein 830,19560,77,0.81 [0.59-1.11],0.1925445273621338
Chapter II Neoplasms,Melanoma in situ,ZNRD2,Protein ZNRD2,19566,77,0.98 [0.71-1.36],0.9173267869487206
Chapter II Neoplasms,Melanoma in situ,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,19560,77,1.16 [0.79-1.71],0.4394968457379066
Chapter II Neoplasms,Melanoma in situ,ZP3,Zona pellucida sperm-binding protein 3,19167,75,1.04 [0.95-1.13],0.367413642026608
Chapter II Neoplasms,Melanoma in situ,ZP4,Zona pellucida sperm-binding protein 4,18973,75,0.72 [0.32-1.61],0.4287849442361097
Chapter II Neoplasms,Melanoma in situ,ZPR1,Zinc finger protein ZPR1,19060,77,1.03 [0.83-1.28],0.7958466576354043
